<SEC-DOCUMENT>0001156039-26-000052.txt : 20260617
<SEC-HEADER>0001156039-26-000052.hdr.sgml : 20260617
<ACCEPTANCE-DATETIME>20260617135710
ACCESSION NUMBER:		0001156039-26-000052
CONFORMED SUBMISSION TYPE:	11-K
PUBLIC DOCUMENT COUNT:		25
CONFORMED PERIOD OF REPORT:	20251231
FILED AS OF DATE:		20260617
DATE AS OF CHANGE:		20260617

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Elevance Health, Inc.
		CENTRAL INDEX KEY:			0001156039
		STANDARD INDUSTRIAL CLASSIFICATION:	HOSPITAL & MEDICAL SERVICE PLANS [6324]
		ORGANIZATION NAME:           	02 Finance
		EIN:				352145715
		STATE OF INCORPORATION:			IN
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		11-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-16751
		FILM NUMBER:		261097560

	BUSINESS ADDRESS:	
		STREET 1:		220 VIRGINIA AVENUE
		CITY:			INDIANAPOLIS
		STATE:			IN
		ZIP:			46204
		BUSINESS PHONE:		8003311476

	MAIL ADDRESS:	
		STREET 1:		220 VIRGINIA AVENUE
		CITY:			INDIANAPOLIS
		STATE:			IN
		ZIP:			46204

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Anthem, Inc.
		DATE OF NAME CHANGE:	20141202

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	WELLPOINT, INC
		DATE OF NAME CHANGE:	20100105

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	WELLPOINT INC
		DATE OF NAME CHANGE:	20041130
</SEC-HEADER>
<DOCUMENT>
<TYPE>11-K
<SEQUENCE>1
<FILENAME>elv-20251231.htm
<DESCRIPTION>11-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019d97e9-6345-7c3e-aadc-cd30fd2ce9cd,g:dc9c1a7d-ae85-4e42-ad7d-8ea7d89a0d3f,d:bb49980fdfe94db09f63ca8013e8ab29-->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2026" xmlns:us-gaap-ebp="http://fasb.org/us-gaap-ebp/2026" xmlns:srt="http://fasb.org/srt/2026" xmlns:us-gaap="http://fasb.org/us-gaap/2026" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:elv="http://www.elevancehealth.com/20251231" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>elv-20251231</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-2" name="dei:AmendmentFlag" id="f-11">false</ix:nonNumeric><ix:nonNumeric contextRef="c-2" name="dei:EntityCentralIndexKey" id="f-12">0001156039</ix:nonNumeric><ix:nonNumeric contextRef="c-2" name="dei:EntityRegistrantName" id="f-13">Elevance Health, Inc.</ix:nonNumeric><ix:nonNumeric contextRef="c-2" name="dei:DocumentType" id="f-14">11-K</ix:nonNumeric><ix:nonNumeric contextRef="c-69" name="us-gaap-ebp:EmployeeBenefitPlanInvestmentIssuerNameExtensibleEnumeration" id="f-168">http://www.elevancehealth.com/20251231#JPMorganMember</ix:nonNumeric><ix:nonNumeric contextRef="c-69" name="us-gaap-ebp:EmployeeBenefitPlanInvestmentTypeExtensibleEnumeration" id="f-169">http://fasb.org/us-gaap/2026#MiscellaneousInvestmentsMember</ix:nonNumeric><ix:nonNumeric contextRef="c-68" name="us-gaap-ebp:EmployeeBenefitPlanAssetHeldForInvestmentPlanInterestInMasterTrustParticipationStatusExtensibleEnumeration" id="f-170">http://fasb.org/us-gaap-ebp/2026#EmployeeBenefitPlanParticipantDirectedMember</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="elv-20251231.xsd"/></ix:references><ix:resources><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="elv:EBPEmployerMatchTrancheAxis">elv:EBPEmployerMatchTrancheOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="elv:EBPEmployerMatchTrancheAxis">elv:EBPEmployerMatchTrancheTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-10"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-11"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DefinedBenefitPlanCommonCollectiveTrustMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap-ebp:EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustAxis">us-gaap-ebp:EmployeeBenefitPlanNonconsolidatedMasterTrustMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-12"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DefinedBenefitPlanCommonCollectiveTrustMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap-ebp:EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustAxis">us-gaap-ebp:EmployeeBenefitPlanNonconsolidatedPlanInterestInMasterTrustMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-13"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DefinedBenefitPlanCommonCollectiveTrustMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap-ebp:EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustAxis">us-gaap-ebp:EmployeeBenefitPlanNonconsolidatedMasterTrustMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-14"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DefinedBenefitPlanCommonCollectiveTrustMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap-ebp:EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustAxis">us-gaap-ebp:EmployeeBenefitPlanNonconsolidatedPlanInterestInMasterTrustMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-15"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap-ebp:EmployeeBenefitPlanEmployerCommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap-ebp:EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustAxis">us-gaap-ebp:EmployeeBenefitPlanNonconsolidatedMasterTrustMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-16"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap-ebp:EmployeeBenefitPlanEmployerCommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap-ebp:EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustAxis">us-gaap-ebp:EmployeeBenefitPlanNonconsolidatedPlanInterestInMasterTrustMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-17"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap-ebp:EmployeeBenefitPlanEmployerCommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap-ebp:EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustAxis">us-gaap-ebp:EmployeeBenefitPlanNonconsolidatedMasterTrustMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-18"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap-ebp:EmployeeBenefitPlanEmployerCommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap-ebp:EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustAxis">us-gaap-ebp:EmployeeBenefitPlanNonconsolidatedPlanInterestInMasterTrustMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-19"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MutualFundMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap-ebp:EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustAxis">us-gaap-ebp:EmployeeBenefitPlanNonconsolidatedMasterTrustMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-20"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MutualFundMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap-ebp:EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustAxis">us-gaap-ebp:EmployeeBenefitPlanNonconsolidatedPlanInterestInMasterTrustMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-21"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MutualFundMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap-ebp:EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustAxis">us-gaap-ebp:EmployeeBenefitPlanNonconsolidatedMasterTrustMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-22"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MutualFundMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap-ebp:EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustAxis">us-gaap-ebp:EmployeeBenefitPlanNonconsolidatedPlanInterestInMasterTrustMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-23"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap-ebp:EmployeeBenefitPlanSelfDirectedBrokerageAccountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap-ebp:EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustAxis">us-gaap-ebp:EmployeeBenefitPlanNonconsolidatedMasterTrustMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-24"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap-ebp:EmployeeBenefitPlanSelfDirectedBrokerageAccountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap-ebp:EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustAxis">us-gaap-ebp:EmployeeBenefitPlanNonconsolidatedPlanInterestInMasterTrustMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-25"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap-ebp:EmployeeBenefitPlanSelfDirectedBrokerageAccountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap-ebp:EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustAxis">us-gaap-ebp:EmployeeBenefitPlanNonconsolidatedMasterTrustMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-26"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap-ebp:EmployeeBenefitPlanSelfDirectedBrokerageAccountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap-ebp:EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustAxis">us-gaap-ebp:EmployeeBenefitPlanNonconsolidatedPlanInterestInMasterTrustMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-27"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap-ebp:EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustAxis">us-gaap-ebp:EmployeeBenefitPlanNonconsolidatedMasterTrustMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-28"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap-ebp:EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustAxis">us-gaap-ebp:EmployeeBenefitPlanNonconsolidatedPlanInterestInMasterTrustMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-29"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap-ebp:EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustAxis">us-gaap-ebp:EmployeeBenefitPlanNonconsolidatedMasterTrustMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap-ebp:EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustAxis">us-gaap-ebp:EmployeeBenefitPlanNonconsolidatedPlanInterestInMasterTrustMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap-ebp:EmployeeBenefitPlanEmployerCommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-32"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap-ebp:EmployeeBenefitPlanEmployerCommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-33"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap-ebp:EmployeeBenefitPlanEmployerCommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-34"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap-ebp:EmployeeBenefitPlanEmployerCommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-35"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MutualFundMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-36"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MutualFundMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-37"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MutualFundMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-38"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MutualFundMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-39"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap-ebp:EmployeeBenefitPlanSelfDirectedBrokerageAccountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-40"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap-ebp:EmployeeBenefitPlanSelfDirectedBrokerageAccountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-41"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap-ebp:EmployeeBenefitPlanSelfDirectedBrokerageAccountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-42"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap-ebp:EmployeeBenefitPlanSelfDirectedBrokerageAccountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-43"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-44"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-45"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-46"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-47"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-48"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap-ebp:EmployeeBenefitPlanEmployerCommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-49"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap-ebp:EmployeeBenefitPlanEmployerCommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-50"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap-ebp:EmployeeBenefitPlanEmployerCommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-51"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap-ebp:EmployeeBenefitPlanEmployerCommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-52"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MutualFundMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-53"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MutualFundMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-54"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MutualFundMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-55"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MutualFundMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-56"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap-ebp:EmployeeBenefitPlanSelfDirectedBrokerageAccountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-57"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap-ebp:EmployeeBenefitPlanSelfDirectedBrokerageAccountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-58"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap-ebp:EmployeeBenefitPlanSelfDirectedBrokerageAccountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-59"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap-ebp:EmployeeBenefitPlanSelfDirectedBrokerageAccountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-60"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-61"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-62"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-63"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-64"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-65"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap-ebp:EmployeeBenefitPlanRelatedPartyAndPartyInInterestAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-66"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap-ebp:EmployeeBenefitPlanRelatedPartyAndPartyInInterestAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-67"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap-ebp:EmployeeBenefitPlanRelatedPartyAndPartyInInterestAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-68"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:limitedToken.domain>JP Morgan</us-gaap:limitedToken.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-69"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001156039</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember><xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis"><us-gaap:limitedToken.domain>JP Morgan</us-gaap:limitedToken.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="ibb49980fdfe94db09f63ca8013e8ab29_1"></div><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.871%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-bottom:7pt;margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">11-K</ix:nonNumeric></span></div><div style="margin-bottom:7pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.711%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(Mark One)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:2.585%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.215%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentAnnualReport" format="ixt-sec:boolballotbox" id="f-2">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%">ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-bottom:9pt;margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">For the fiscal year ended <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-3">December&#160;31, 2025</ix:nonNumeric> </span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">OR</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:2.585%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.215%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-bottom:9pt;margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from ________to_________</span></div><div style="margin-bottom:9pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Commission file number: <ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-4">001-16751</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.871%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.275%"><tr><td style="width:1.0%"/><td style="width:2.689%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.111%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Full title of the plan and the address of the plan, if different from that of the issuer named below:</span></td></tr></table></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="us-gaap-ebp:EbpPlanName" id="f-5">ELEVANCE HEALTH 401(k) PLAN</ix:nonNumeric></span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.275%"><tr><td style="width:1.0%"/><td style="width:2.689%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.111%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">B.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Name of issuer of the securities held pursuant to the plan and the address of its principal executive office:</span></td></tr></table></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-6">Elevance Health, Inc.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-7">220 Virginia Avenue</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-8">Indianapolis</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" id="f-9">IN</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-10">46204</ix:nonNumeric></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div></div><div id="ibb49980fdfe94db09f63ca8013e8ab29_4"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">REQUIRED INFORMATION</span></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Elevance Health 401(k)&#160;Plan (the &#8220;Plan&#8221;) is subject to the Employee Retirement Income Security Act of 1974, as amended (&#8220;ERISA&#8221;). In lieu of the requirements of Items 1-3 of Form 11-K, the financial statements of the Plan and the supplemental schedule presented herein have been prepared in accordance with the financial reporting requirements of ERISA.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><div id="ibb49980fdfe94db09f63ca8013e8ab29_7"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ELEVANCE HEALTH 401(k) PLAN</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Financial Statements and Supplemental Schedule</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">December&#160;31, 2025 and 2024 and for the</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Year Ended December&#160;31, 2025 </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">With Report of Independent Registered Public Accounting Firm</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div></div><div id="ibb49980fdfe94db09f63ca8013e8ab29_10"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ELEVANCE HEALTH 401(k) PLAN</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Financial Statements and Supplemental Schedule</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">December&#160;31, 2025 and 2024 and for the</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Year Ended December&#160;31, 2025 </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Contents</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:93.611%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.189%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ibb49980fdfe94db09f63ca8013e8ab29_13">Report of Independent</a> Registered Public Accounting Firm</span></div></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Audited Financial Statements:</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ibb49980fdfe94db09f63ca8013e8ab29_16">Statements of Net Assets Available for Benefits</a></span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ibb49980fdfe94db09f63ca8013e8ab29_19">Statement of Changes in Net Assets Available for Benefits</a></span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ibb49980fdfe94db09f63ca8013e8ab29_22">Notes to Financial Statements</a></span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Supplemental Schedule:</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ibb49980fdfe94db09f63ca8013e8ab29_49">Schedule H, Line 4i &#8211; Schedule of Assets (Held at End of Year)</a></span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="ibb49980fdfe94db09f63ca8013e8ab29_13"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Report of Independent Registered Public Accounting Firm</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">To the Plan Participants and the Plan Administrator of Elevance Health 401(k) Plan</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Opinion on the Financial Statements</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We have audited the accompanying statements of net assets available for benefits of Elevance Health 401(k) Plan (the Plan) as of December 31, 2025 and 2024, and the related statement of changes in net assets available for benefits for the year ended December&#160;31, 2025, and the related notes (collectively referred to as the &#8220;financial statements&#8221;). In our opinion, the financial statements present fairly, in all material respects, the net assets available for benefits of the Plan at December 31, 2025 and 2024, and the changes in its net assets available for benefits for the year ended December&#160;31, 2025, in conformity with U.S. generally accepted accounting principles.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Basis for Opinion</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">These financial statements are the responsibility of the Plan&#8217;s management. Our responsibility is to express an opinion on the Plan&#8217;s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Plan in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Plan is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Plan&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Supplemental Schedule Required by ERISA</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying supplemental schedule of assets (held at end of year) as of December&#160;31, 2025 (referred to as the &#8220;supplemental schedule&#8221;), has been subjected to audit procedures performed in conjunction with the audit of the Plan&#8217;s financial statements. The information in the supplemental schedule is the responsibility of the Plan&#8217;s management. Our audit procedures included determining whether the information reconciles to the financial statements or the underlying accounting and other records, as applicable, and performing procedures to test the completeness and accuracy of the information presented in the supplemental schedule. In forming our opinion on the information, we evaluated whether such information, including its form and content, is presented in conformity with the Department of Labor&#8217;s Rules and Regulations for Reporting and Disclosure under the Employee Retirement Income Security Act of 1974. In our opinion, the information is fairly stated, in all material respects, in relation to the financial statements as a whole.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Ernst &amp; Young LLP</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We have served as the Plan&#8217;s auditor since at least 2002, but we are unable to determine the specific year.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Indianapolis, Indiana</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">June&#160;17, 2026 </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="ibb49980fdfe94db09f63ca8013e8ab29_16"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Elevance Health 401(k) Plan</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Statements of Net Assets Available for Benefits</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.596%"><tr><td style="width:1.0%"/><td style="width:64.417%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.991%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.098%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.994%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Plan's interest in EH Master Trust</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanInvestmentPlanInterestInMasterTrustFairValue" format="ixt:num-dot-decimal" id="f-15">13,065,058,854</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanInvestmentPlanInterestInMasterTrustFairValue" format="ixt:num-dot-decimal" id="f-16">11,861,354,869</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Receivables:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Notes receivable from participants</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanNoteReceivableFromParticipant" format="ixt:num-dot-decimal" id="f-17">238,395,440</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanNoteReceivableFromParticipant" format="ixt:num-dot-decimal" id="f-18">234,538,393</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Contributions receivable from employer</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanEmployerContributionReceivable" format="ixt:num-dot-decimal" id="f-19">9,458,553</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanEmployerContributionReceivable" format="ixt:num-dot-decimal" id="f-20">14,692,281</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total receivables</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanReceivable" format="ixt:num-dot-decimal" id="f-21">247,853,993</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanReceivable" format="ixt:num-dot-decimal" id="f-22">249,230,674</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net assets available for benefits</span></td><td style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanNetAssetAvailableForBenefit" format="ixt:num-dot-decimal" id="f-23">13,312,912,847</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanNetAssetAvailableForBenefit" format="ixt:num-dot-decimal" id="f-24">12,110,585,543</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See Notes to Financial Statements.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="ibb49980fdfe94db09f63ca8013e8ab29_19"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Elevance Health 401(k) Plan</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Statement of Changes in Net Assets Available for Benefits</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Year Ended December&#160;31, 2025 </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.874%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.926%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Additions to net assets attributable to</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Contributions:</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Participants</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForParticipantContributionExcludingRollover" format="ixt:num-dot-decimal" id="f-25">555,710,479</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Employer</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForEmployerContributionCash" format="ixt:num-dot-decimal" id="f-26">292,872,276</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Rollovers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForParticipantContributionRollover" format="ixt:num-dot-decimal" id="f-27">88,135,249</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total contributions</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForContribution" format="ixt:num-dot-decimal" id="f-28">936,718,004</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Plan's interest in EH Master Trust net investment income</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForChangeInPlanInterestInMasterTrust" format="ixt:num-dot-decimal" id="f-29">1,817,823,441</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Interest income on notes receivable from participants</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForInterestIncomeOnNoteReceivableFromParticipant" format="ixt:num-dot-decimal" id="f-30">19,589,802</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total additions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncrease" format="ixt:num-dot-decimal" id="f-31">2,774,131,247</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Deductions from net assets attributable to</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid to participants</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecreaseForPaymentToParticipant" format="ixt:num-dot-decimal" id="f-32">1,565,382,437</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Administrative expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecreaseForAdministrativeExpense" format="ixt:num-dot-decimal" id="f-33">6,421,506</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total deductions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecrease" format="ixt:num-dot-decimal" id="f-34">1,571,803,943</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Increase in net assets available for benefits</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecrease" format="ixt:num-dot-decimal" id="f-35">1,202,327,304</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Net assets available for benefits</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanNetAssetAvailableForBenefit" format="ixt:num-dot-decimal" id="f-36">12,110,585,543</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">End of year</span></td><td style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanNetAssetAvailableForBenefit" format="ixt:num-dot-decimal" id="f-37">13,312,912,847</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See Notes to Financial Statements.</span></div><div style="margin-bottom:9pt;text-align:center"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="ibb49980fdfe94db09f63ca8013e8ab29_22"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Elevance Health 401(k) Plan</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Financial Statements</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">December&#160;31, 2025 </span></div><div id="ibb49980fdfe94db09f63ca8013e8ab29_25"></div><ix:nonNumeric contextRef="c-1" name="us-gaap-ebp:EmployeeBenefitPlanDescriptionOfPlanTextBlock" id="f-38" continuedAt="f-38-1" escape="true"><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">1. Description of the Plan</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following description of the Elevance Health 401(k) Plan (the &#8220;Plan&#8221;) provides only general information. More detailed information concerning the Plan may be found by consulting the summary plan description.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">General </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Plan is a qualified defined contribution plan which provides savings opportunities for eligible employees of Elevance Health, Inc. (&#8220;Elevance Health&#8221;) and certain of its subsidiaries (the &#8220;Participating Employers&#8221;) and is subject to the provisions of the Employee Retirement Income Security Act of 1974, as amended  ("ERISA"). Employees of the Participating Employers are generally eligible to participate in the Plan <ix:nonNumeric contextRef="c-1" name="elv:EBPEligibilityServicePeriod" format="ixt-sec:durday" id="f-39">30</ix:nonNumeric> days after their date of hire. The net assets of the Plan, excluding notes receivable from participants, are held in the Elevance Health Defined Contribution Master Trust (the "EH Master Trust"). Fidelity Management Trust Company serves as the trustee for the EH Master Trust and Fidelity Workplace Services LLC serves as the recordkeeper (collectively, "Fidelity"). The Plan Sponsor is ATH Holding Company, LLC, a wholly owned subsidiary of Elevance Health. The Retirement Committee of ATH Holding Company, LLC is the Plan Administrator.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Participant Accounts</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">An individual account is maintained by the Plan for each eligible employee who participates in the Plan.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Each participant&#8217;s account is credited with the participant&#8217;s contributions, rollover contributions, allocations of the Plan Sponsor&#8217;s contributions, and an allocation of investment earnings or losses, reduced by participant withdrawals and certain administrative expenses. The benefit to which a participant is entitled is the benefit that can be provided from the participant&#8217;s account.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Contributions</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Participants may make voluntary contributions of <ix:nonFraction unitRef="number" contextRef="c-5" decimals="2" name="elv:EBPParticipantContributionEligibleCompensationPercentage" scale="-2" id="f-40">1</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="c-6" decimals="2" name="elv:EBPParticipantContributionEligibleCompensationPercentage" scale="-2" id="f-41">80</ix:nonFraction>% of eligible compensation, as defined in the Plan document, subject to limitations imposed by applicable Internal Revenue Service (&#8220;IRS&#8221;) regulations. Participants may make pretax contributions to a traditional 401(k) account, after-tax contributions to a Roth 401(k) account or a combination of the two through automatic payroll deduction. Participants are automatically enrolled in the Plan at an initial pretax deferral rate of <ix:nonFraction unitRef="number" contextRef="c-1" decimals="2" name="us-gaap-ebp:EmployeeBenefitPlanParticipantContributionAutomaticDeferralRate" scale="-2" id="f-42">6</ix:nonFraction>%, with an annual automatic increase of the rate of <ix:nonFraction unitRef="number" contextRef="c-1" decimals="2" name="elv:EBPParticipantContributionIncrementalIncreaseOfAutomaticAnnualEscalation" scale="-2" id="f-43">1</ix:nonFraction>%, up to <ix:nonFraction unitRef="number" contextRef="c-1" decimals="2" name="elv:EBPParticipantContributionCapOfAutomaticAnnualEscalation" scale="-2" id="f-44">15</ix:nonFraction>% of the participant's eligible compensation, unless the participant directs otherwise.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Plan Sponsor provides a matching contribution of <ix:nonFraction unitRef="number" contextRef="c-7" decimals="2" name="us-gaap-ebp:EmployeeBenefitPlanEmployerContributionMatchingPercentage" scale="-2" id="f-45">100</ix:nonFraction>% on the first <ix:nonFraction unitRef="number" contextRef="c-7" decimals="2" name="us-gaap-ebp:EmployeeBenefitPlanEmployerContributionParticipantCompensationMatchedPercentage" scale="-2" id="f-46">4</ix:nonFraction>% of the participant's eligible compensation, plus <ix:nonFraction unitRef="number" contextRef="c-8" decimals="2" name="us-gaap-ebp:EmployeeBenefitPlanEmployerContributionMatchingPercentage" scale="-2" id="f-47">50</ix:nonFraction>% of the next <ix:nonFraction unitRef="number" contextRef="c-8" decimals="2" name="us-gaap-ebp:EmployeeBenefitPlanEmployerContributionParticipantCompensationMatchedPercentage" scale="-2" id="f-48">2</ix:nonFraction>% of the participant's eligible compensation contributed, for a total potential Plan Sponsor matching contribution of <ix:nonFraction unitRef="number" contextRef="c-1" decimals="2" name="us-gaap-ebp:EmployeeBenefitPlanEmployerContributionParticipantCompensationMatchedPercentage" scale="-2" id="f-49">5</ix:nonFraction>%. Additionally, the Plan provides for a true-up matching contribution to ensure that eligible participants who elected to contribute the maximum contribution allowed by the Plan receive the maximum matching contribution of eligible compensation determined as of the end of the plan year. The Plan permits additional Plan Sponsor discretionary contributions to be made, but no such discretionary contributions were made during the 2025 plan year. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Participants who attain age <ix:nonFraction unitRef="number" contextRef="c-1" decimals="0" name="elv:EBPParticipantCatchUpContributionMinimumAge" format="ixt:num-dot-decimal" id="f-50">50</ix:nonFraction> by the end of the plan year may contribute additional "catch up" contributions to their account beyond the regular annual IRS limit, in accordance with applicable law and the Plan's terms. Catch-up contributions are eligible for matching contributions.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Rollover Contributions</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Plan may accept rollover contributions. Rollover contributions represent distributions received from other qualified retirement plans, as defined in Section 401(a)(31)(E) of the Internal Revenue Code (the "Code"), including </span></div></ix:nonNumeric><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Elevance Health 401(k) Plan</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Financial Statements (continued)</span></div></div><ix:continuation id="f-38-1" continuedAt="f-38-2"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">any such distributions contributed via a "conduit" individual retirement account. Distributions from other plans are subject to certain conditions to be eligible for rollover into the Plan.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Vesting</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Participants have a <ix:nonFraction unitRef="number" contextRef="c-1" decimals="2" name="elv:EBPEmployerContributionVestingPercentage" scale="-2" id="f-51">100</ix:nonFraction>% vested interest in the Plan Sponsor match after completing a <ix:nonNumeric contextRef="c-1" name="elv:EBPEmployerContributionVestingPeriod" format="ixt-sec:durwordsen" id="f-52">two-year</ix:nonNumeric> period of service. Nonvested account balances of terminated employees are forfeited (subject to reinstatement upon reemployment as required by applicable law and the Plan's terms).</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Investments</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Participants direct their elective contributions and employer matching contributions into various investment options offered by the Plan, including target date funds, several mutual and collective investment trust funds, all of which are subject to change from time to time by the Plan Administrator, and the Elevance Health Stock Fund, which is provided for in the Plan document and overseen by an independent fiduciary. The Plan also provides access to a self-directed brokerage option. If a participant has not elected an investment option, their contributions will automatically be invested in the Plan&#8217;s qualified default investment alternative, which is the target date fund aligned with the year the participant turns 65.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Elevance Health Stock Fund is a unitized fund, which means participants do not actually own shares of Elevance Health common stock but rather own an interest in the unitized fund. A portion of the fund may be invested in short-term reserves to accommodate daily transactions. Investment in the Elevance Health Stock Fund is limited to no more than <ix:nonFraction unitRef="number" contextRef="c-1" decimals="2" name="elv:EBPParticipantContributionMaximumContributionToEmployeeStockPlan" scale="-2" id="f-53">20</ix:nonFraction>% of a participant's total account balance. Each participant is entitled to exercise voting rights attributable to the shares allocated to his or her account. Any cash dividends paid to the participant&#8217;s account will be reinvested in the Elevance Health Stock Fund unless the participant elects to receive the dividend in cash paid directly to the participant. Participants may change their election to receive dividends in cash or to reinvest dividends at least quarterly. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Benefit Payments and Withdrawals</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">A participant may make a withdrawal of voluntary after-tax contributions made to a traditional 401(k) account prior to January 1, 2012, or take a qualified distribution of Roth 401(k) contributions, as defined by the IRS, at any time. Additionally, after attaining age 59&#189;, a participant may withdraw participant and Plan Sponsor matching contributions for any reason. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Subject to the provisions and conditions specified in the Plan document, an active participant in the Plan may make certain hardship withdrawals of amounts held in the participant&#8217;s account attributable to the participant&#8217;s contributions, vested Plan Sponsor matching contributions, rollovers, pre-2006 employer match, and income allocated to the contributions account.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Upon termination of employment, the participant is entitled to receive the fully vested current value of his or her account. If the current value of the vested account is $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="elv:EBPAutomaticDistributionToParticipantThreshold" format="ixt:num-dot-decimal" scale="0" id="f-54">1,000</ix:nonFraction> or less, the account is paid in a lump-sum payment. If the vested account value is $<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="0" name="elv:EBPDistributionOfAccountBalanceRolledIntoIRAThreshold" format="ixt:num-dot-decimal" id="f-55">1,000</ix:nonFraction> or more, but less than $<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="0" name="elv:EBPDistributionOfAccountBalanceRolledIntoIRAThreshold" format="ixt:num-dot-decimal" id="f-56">5,000</ix:nonFraction>, the account will be rolled over into an individual retirement account unless the participant elects otherwise. If the vested account value is $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="elv:EBPDistributionOfAccountBalanceStaysInPlanThreshold" format="ixt:num-dot-decimal" scale="0" id="f-57">5,000</ix:nonFraction> or more, the account will remain in the Plan unless the participant elects otherwise. The participant may elect to have the entire portion, if any, of the account held in the Elevance Health Stock Fund paid in whole shares of Elevance Health common stock, with fractional shares and any uninvested funds paid in cash. Distribution of participant accounts must commence by the later of retirement or the latest date permitted under Section 401(a)(9) of the Code, as amended by federal legislation known as the SECURE Act and SECURE 2.0 (including regulatory guidance issued thereunder). Upon death, payments are made to the participant&#8217;s beneficiary in the form of a lump-sum payment or in installments.</span></div></ix:continuation><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Elevance Health 401(k) Plan</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Financial Statements (continued)</span></div></div><ix:continuation id="f-38-2"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Notes Receivable from Participants</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Participants may request a loan not in excess of the lesser of: (1) <ix:nonFraction unitRef="number" contextRef="c-3" decimals="2" name="us-gaap-ebp:EmployeeBenefitPlanNoteReceivableFromParticipantAccountMaximumBorrowingToTotalAccountPercentage" scale="-2" id="f-58">50</ix:nonFraction>% of the vested account balance, or (2) $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanNoteReceivableFromParticipantAccountMaximumBorrowingAmount" format="ixt:num-dot-decimal" scale="0" id="f-59">50,000</ix:nonFraction>, less the highest outstanding loan balance during the preceding year. A participant may not have more than two loans outstanding at any one time and must wait 30 days from when a loan is paid off before requesting a new loan. Repayment of loans shall not exceed <ix:nonNumeric contextRef="c-1" name="elv:EBPNoteReceivableFromParticipantGeneralLoanTerm" format="ixt-sec:durwordsen" id="f-60">five years</ix:nonNumeric> except for loans used to acquire the participant&#8217;s principal residence. Each loan bears interest in accordance with the Plan's loan policy and applicable regulations. Repayments are made by payroll deduction or remitted directly to Fidelity. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Forfeitures and Certain Plan Expenses</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Forfeited nonvested account balances totaled $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanForfeitedNonvestedAccount" format="ixt:num-dot-decimal" scale="0" id="f-61">3,875,557</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanForfeitedNonvestedAccount" format="ixt:num-dot-decimal" scale="0" id="f-62">506,167</ix:nonFraction> as of December 31, 2025 and 2024, respectively. Forfeitures may be used to offset employer contributions or to pay certain administrative expenses, as determined by the Plan Sponsor. During the year ended December&#160;31, 2025, forfeitures of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanForfeitedNonvestedAccountDecreaseForEmployerContribution" format="ixt:num-dot-decimal" scale="0" id="f-63">6,093,646</ix:nonFraction> were used to offset employer contributions and forfeitures of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanForfeitedNonvestedAccountDecreaseForAdministrativeExpense" format="ixt:num-dot-decimal" scale="0" id="f-64">73,579</ix:nonFraction> were used to pay Plan administrative expenses.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In addition, Fidelity maintains, on behalf of the Plan, a</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">plan revenue credit account in connection with net float earnings received from certain investment managers and amounts (if any) owed by Fidelity with respect to performance guarantees under the recordkeeping agreement.</span><span style="color:#ff0000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During the plan year ended December&#160;31, 2025,</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">the plan</span><span style="color:#e97132;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">revenue credit account was used to pay Plan administrative expenses totaling $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="elv:EBPPlanRevenueCreditAccountDecreaseFromAdministrativeExpense" format="ixt:num-dot-decimal" scale="0" id="f-65">360,106</ix:nonFraction>.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Plan Termination</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Although it has not expressed any intent to do so, the Plan Sponsor has the right to terminate the Plan subject to the terms of the Plan and the provisions of ERISA. In the event the Plan is terminated, each participant&#8217;s account shall be non-forfeitable with respect to both the participant&#8217;s and the Plan Sponsor&#8217;s contributions. The Plan Sponsor has the right to amend the Plan or to suspend matching contributions to the Plan at any time, either permanently or temporarily, for any length of time.</span></div></ix:continuation><div id="ibb49980fdfe94db09f63ca8013e8ab29_28"></div><ix:nonNumeric contextRef="c-1" name="us-gaap-ebp:EmployeeBenefitPlanSummaryOfAccountingPolicyTextBlock" id="f-66" continuedAt="f-66-1" escape="true"><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">2. Significant Accounting Policies</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap-ebp:EmployeeBenefitPlanBasisOfAccountingPolicyTextBlock" id="f-67" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying financial statements of the Plan have been prepared on the accrual basis of accounting and are in conformity with U.S. generally accepted accounting principles (&#8220;GAAP&#8221;).</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap-ebp:EmployeeBenefitPlanUseOfEstimatePolicyTextBlock" id="f-68" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in accordance with GAAP requires the use of estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results may differ from those estimates.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap-ebp:EmployeeBenefitPlanInvestmentPolicyTextBlock" id="f-69" continuedAt="f-69-1" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Investment Valuation and Income Recognition</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The EH Master Trust's investments are stated at fair value. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. See Note&#160;4, "Fair Value Measurements", for further discussion.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Plan's interest in the net investment income of the EH Master Trust consists of the Plan's allocation of realized gains and losses on investments that were sold during the period, unrealized appreciation and depreciation of the underlying investments held at year end, and net investment income/loss based upon the total of each Plan participant's share of the EH Master Trust.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Purchases and sales of securities are recorded on a trade-date basis and interest income is recorded on the accrual basis. Dividends are recorded on the ex-dividend date. </span></div></ix:nonNumeric></ix:nonNumeric><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Elevance Health 401(k) Plan</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Financial Statements (continued)</span></div></div><ix:continuation id="f-66-1"><ix:continuation id="f-69-1"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Investment securities are exposed to various risks, such as interest rate, market, and credit risks. Due to the level of risk associated with certain investment securities, it is reasonably possible that changes in the values of investment securities will occur in the near term and that such changes could materially affect the amounts reported in the statements of net assets available for benefits, participant accounts and the statement of changes in net assets available for benefits.</span></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap-ebp:EmployeeBenefitPlanNoteReceivableFromParticipantPolicyTextBlock" id="f-70" continuedAt="f-70-1" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Notes Receivable from Participants</span></div></ix:nonNumeric><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-70-1">Notes receivable from participants represent participant loans that are recorded at their unpaid principal balance plus any accrued but unpaid interest. Interest income on notes receivable from participants is recorded when it is earned. Related fees are recorded as administrative expenses and are expensed when they are incurred. Delinquent participant loans are recorded as distributions based on the terms of the Plan document. No allowance for credit losses has been recorded as of December&#160;31, 2025 or 2024.</ix:continuation> </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap-ebp:EmployeeBenefitPlanPaymentToParticipantPolicyTextBlock" id="f-71" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Benefits Paid to Participants</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Benefit payments to participants are recorded upon distribution.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap-ebp:EmployeeBenefitPlanExpensePolicyTextBlock" id="f-72" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Administrative Expenses</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Certain administrative expenses of maintaining the Plan are paid from Plan assets. The Plan Sponsor may bear certain costs associated with administering the Plan; these costs are not included in the accompanying financial statements and constitute exempt party-in-interest transactions. Certain transaction fees, such as those related to loan processing, are paid from individual participant accounts and are included in administrative expenses. Investment related expenses are included in the Plan's interest in EH Master Trust net investment income.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="elv:EBPAccountingPolicyAdoptionPolicyTextBlock" id="f-73" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">There have been no recently adopted or issued accounting standards that had, or will have, a material impact on the financial statements.</span></div></ix:nonNumeric></ix:continuation><div id="ibb49980fdfe94db09f63ca8013e8ab29_31"></div><ix:nonNumeric contextRef="c-1" name="us-gaap-ebp:EmployeeBenefitPlanMasterTrustTextBlock" id="f-74" continuedAt="f-74-1" escape="true"><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">3. Plan's Interest in EH Master Trust</span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Elevance Health Defined Contribution Master Trust was established on January 1, 2024 pursuant to a trust agreement between the Plan Administrator and Fidelity in order to facilitate the administration of transactions in certain investment options offered in both this Plan and the Elevance Health Puerto Rico Retirement Savings Plan (together, the "Participating Plans"). Each Participating Plan has a divided interest in specific investment assets held in the EH Master Trust. </span></div></ix:nonNumeric><div style="margin-bottom:9pt;margin-top:12pt"><span><br/></span></div><div style="margin-bottom:9pt;margin-top:12pt"><span><br/></span></div><div style="margin-bottom:9pt;margin-top:12pt"><span><br/></span></div><div style="margin-bottom:9pt;margin-top:12pt"><span><br/></span></div><div style="margin-bottom:9pt;margin-top:12pt"><span><br/></span></div><div style="margin-bottom:9pt;margin-top:12pt"><span><br/></span></div><div style="margin-bottom:9pt;margin-top:12pt"><span><br/></span></div><div style="margin-bottom:9pt;margin-top:12pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Elevance Health 401(k) Plan</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Financial Statements (continued)</span></div></div><ix:nonNumeric contextRef="c-1" name="us-gaap-ebp:EmployeeBenefitPlanMasterTrustTableTextBlock" id="f-75" escape="true"><ix:continuation id="f-74-1"><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the net assets of the EH Master Trust and the Plan's interest in the net assets of the EH Master Trust as of December&#160;31, 2025 is as follows:</span></div><div style="margin-bottom:9pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"/><td style="width:2.188%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:30.747%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.596%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.664%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.436%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.664%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.436%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.664%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.436%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.669%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="6" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">EH Master Trust Balances</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Plan's Interest in EH Master Trust Balances</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">EH Master Trust Balances</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Plan's Interest in EH Master Trust Balances</span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Investments at fair value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Collective investment trusts</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanInvestmentFairValue" format="ixt:num-dot-decimal" id="f-76">12,095,039,709</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanInvestmentFairValue" format="ixt:num-dot-decimal" id="f-77">12,093,468,072</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanInvestmentFairValue" format="ixt:num-dot-decimal" id="f-78">10,874,772,817</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanInvestmentFairValue" format="ixt:num-dot-decimal" id="f-79">10,873,336,349</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Elevance Health common stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanInvestmentFairValue" format="ixt:num-dot-decimal" id="f-80">352,309,761</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanInvestmentFairValue" format="ixt:num-dot-decimal" id="f-81">352,194,754</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanInvestmentFairValue" format="ixt:num-dot-decimal" id="f-82">408,045,086</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanInvestmentFairValue" format="ixt:num-dot-decimal" id="f-83">408,004,931</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Mutual funds</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanInvestmentFairValue" format="ixt:num-dot-decimal" id="f-84">302,657,683</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanInvestmentFairValue" format="ixt:num-dot-decimal" id="f-85">302,656,679</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-21" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanInvestmentFairValue" format="ixt:num-dot-decimal" id="f-86">329,248,156</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanInvestmentFairValue" format="ixt:num-dot-decimal" id="f-87">329,247,804</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Self-directed brokerage accounts</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-23" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanInvestmentFairValue" format="ixt:num-dot-decimal" id="f-88">316,803,497</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-24" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanInvestmentFairValue" format="ixt:num-dot-decimal" id="f-89">316,803,497</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanInvestmentFairValue" format="ixt:num-dot-decimal" id="f-90">250,803,504</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-26" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanInvestmentFairValue" format="ixt:num-dot-decimal" id="f-91">250,803,504</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total investments at fair value</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanInvestmentFairValue" format="ixt:num-dot-decimal" id="f-92">13,066,810,650</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-28" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanInvestmentFairValue" format="ixt:num-dot-decimal" id="f-93">13,065,123,002</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-29" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanInvestmentFairValue" format="ixt:num-dot-decimal" id="f-94">11,862,869,563</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-30" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanInvestmentFairValue" format="ixt:num-dot-decimal" id="f-95">11,861,392,588</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other assets (liabilities)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="0" sign="-" name="us-gaap-ebp:EmployeeBenefitPlanOtherAsset" format="ixt:num-dot-decimal" id="f-96">64,169</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-28" decimals="0" sign="-" name="us-gaap-ebp:EmployeeBenefitPlanOtherAsset" format="ixt:num-dot-decimal" id="f-97">64,148</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-29" decimals="0" sign="-" name="us-gaap-ebp:EmployeeBenefitPlanOtherAsset" format="ixt:num-dot-decimal" id="f-98">37,723</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-30" decimals="0" sign="-" name="us-gaap-ebp:EmployeeBenefitPlanOtherAsset" format="ixt:num-dot-decimal" id="f-99">37,719</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Total net assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanNetAssetAvailableForBenefit" format="ixt:num-dot-decimal" id="f-100">13,066,746,481</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-28" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanNetAssetAvailableForBenefit" format="ixt:num-dot-decimal" id="f-101">13,065,058,854</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-29" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanNetAssetAvailableForBenefit" format="ixt:num-dot-decimal" id="f-102">11,862,831,840</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-30" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanNetAssetAvailableForBenefit" format="ixt:num-dot-decimal" id="f-103">11,861,354,869</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2025, the EH Master Trust net investment income was comprised of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.874%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.926%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">EH Master Trust Balances</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net appreciation in fair value of investments</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForGainLossOnInvestment" format="ixt:num-dot-decimal" id="f-104">1,774,360,282</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Interest and dividends</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForInterestAndDividendIncomeOnInvestment" format="ixt:num-dot-decimal" id="f-105">43,516,628</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total EH Master Trust net investment income</span></div></td><td colspan="2" style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForIncomeLossOnInvestment" format="ixt:num-dot-decimal" id="f-106">1,817,876,910</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:nonNumeric><div id="ibb49980fdfe94db09f63ca8013e8ab29_34"></div><ix:nonNumeric contextRef="c-1" name="us-gaap-ebp:EmployeeBenefitPlanInvestmentFairValueAndNavTextBlock" id="f-107" continuedAt="f-107-1" escape="true"><div style="margin-bottom:9pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">4. Fair Value Measurements</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The framework for measuring fair value provides a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. Level inputs, as defined by the Financial Accounting Standards Board guidance for fair value measurements and disclosures, are as follows: Level 1, inputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date; Level 2, inputs other than quoted prices included in Level 1 that are observable for the asset or liability through corroboration with market data; and Level 3, unobservable inputs that reflect management's best estimate of what market participants would use in pricing the asset or liability. Assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following methods and assumptions were used to determine the fair value of investments recorded at fair value in the statements of net assets available for benefits.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Elevance Health common stock: </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Valued at the closing price on the New York Stock Exchange on the last business day of the plan year.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mutual funds:</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Valued at quoted market prices, which represent net asset value ("NAV") of shares held by the Plan.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Self-directed brokerage accounts: </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The self-directed brokerage account allows participants the opportunity to invest in a wide array of individual securities including stocks, mutual funds, exchange-traded funds, unit investment trusts, corporate bonds, U.S. Treasury securities, and certificates of deposits, which are primarily valued using quoted prices in active markets.</span></div></ix:nonNumeric><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Elevance Health 401(k) Plan</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Financial Statements (continued)</span></div></div><ix:continuation id="f-107-1"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Collective investment trusts (CITs):</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Valued based on the NAV of the units of a collective trust. The NAV, as provided by the trustee, is used as a practical expedient to estimate fair value. The NAV is based on the fair value of the underlying investments held by the trust less its liabilities. There are no restrictions on redemptions from the CITs and no unfunded commitments.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap-ebp:EmployeeBenefitPlanInvestmentFairValueAndNavTableTextBlock" id="f-108" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth by level within the fair value hierarchy a summary of the EH Master Trust investments by general types measured at fair value on a recurring basis as of December&#160;31, 2025:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:33.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.203%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.845%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;3</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Elevance Health common stock</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue" format="ixt:num-dot-decimal" id="f-109">352,309,761</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue" format="ixt:num-dot-decimal" id="f-110">352,309,761</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue" format="ixt:fixed-zero" id="f-111">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-34" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue" format="ixt:fixed-zero" id="f-112">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Mutual funds</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-35" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue" format="ixt:num-dot-decimal" id="f-113">302,657,683</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue" format="ixt:num-dot-decimal" id="f-114">302,657,683</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue" format="ixt:fixed-zero" id="f-115">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue" format="ixt:fixed-zero" id="f-116">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Self-directed brokerage accounts</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-39" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue" format="ixt:num-dot-decimal" id="f-117">316,803,497</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-40" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue" format="ixt:num-dot-decimal" id="f-118">312,048,032</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-41" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue" format="ixt:num-dot-decimal" id="f-119">4,544,392</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-42" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue" format="ixt:num-dot-decimal" id="f-120">211,073</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Investments measured at fair value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-43" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue" format="ixt:num-dot-decimal" id="f-121">971,770,941</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-44" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue" format="ixt:num-dot-decimal" id="f-122">967,015,476</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-45" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue" format="ixt:num-dot-decimal" id="f-123">4,544,392</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-46" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue" format="ixt:num-dot-decimal" id="f-124">211,073</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Investments measured at NAV</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-47" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue" format="ixt:num-dot-decimal" id="f-125">12,095,039,709</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total investments at fair value</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue" format="ixt:num-dot-decimal" id="f-126">13,066,810,650</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth by level within the fair value hierarchy a summary of the EH Master Trust investments by general types measured at fair value on a recurring basis as of December&#160;31, 2024:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.198%"><tr><td style="width:1.0%"/><td style="width:32.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.738%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.893%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.954%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.738%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.954%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.959%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;3</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Elevance Health common stock</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-48" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue" format="ixt:num-dot-decimal" id="f-127">408,045,086</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-49" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue" format="ixt:num-dot-decimal" id="f-128">408,045,086</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-50" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue" format="ixt:fixed-zero" id="f-129">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-51" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue" format="ixt:fixed-zero" id="f-130">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Mutual funds</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-52" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue" format="ixt:num-dot-decimal" id="f-131">329,248,156</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-53" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue" format="ixt:num-dot-decimal" id="f-132">329,248,156</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-54" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue" format="ixt:fixed-zero" id="f-133">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-55" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue" format="ixt:fixed-zero" id="f-134">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Self-directed brokerage accounts</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-56" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue" format="ixt:num-dot-decimal" id="f-135">250,803,504</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-57" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue" format="ixt:num-dot-decimal" id="f-136">246,848,476</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-58" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue" format="ixt:num-dot-decimal" id="f-137">3,920,987</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-59" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue" format="ixt:num-dot-decimal" id="f-138">34,041</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Investments measured at fair value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-60" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue" format="ixt:num-dot-decimal" id="f-139">988,096,746</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-61" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue" format="ixt:num-dot-decimal" id="f-140">984,141,718</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-62" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue" format="ixt:num-dot-decimal" id="f-141">3,920,987</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-63" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue" format="ixt:num-dot-decimal" id="f-142">34,041</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Investments measured at NAV</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-64" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue" format="ixt:num-dot-decimal" id="f-143">10,874,772,817</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total investments at fair value</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue" format="ixt:num-dot-decimal" id="f-144">11,862,869,563</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our Level 3 securities as of December&#160;31, 2025 and December&#160;31, 2024 primarily consisted of certain corporate fixed maturity securities for which observable inputs were not always available. The fair values of these securities were estimated using inputs including, but not limited to, credit spreads, default rates and benchmark yields. There were no material transfers in or out of Level 3 during either the year ended December&#160;31, 2025 or the year ended  December&#160;31, 2024.</span></div></ix:continuation><div id="ibb49980fdfe94db09f63ca8013e8ab29_37"></div><ix:nonNumeric contextRef="c-1" name="us-gaap-ebp:EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsTextBlock" id="f-145" continuedAt="f-145-1" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">5. Exempt Related Party and Party-In-Interest Transactions</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Parties-in-interest are defined under Department of Labor regulations as any fiduciary of the Plan, any party rendering services to the Plan, the employer, and certain others. Certain administrative functions are performed by officers and employees of the Plan Sponsor or affiliates of the Plan Sponsor. No such officer or employee is compensated from the Plan.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2025, the Plan reimbursed the Plan Sponsor $<ix:nonFraction unitRef="usd" contextRef="c-65" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecreaseForAdministrativeExpense" format="ixt:num-dot-decimal" id="f-146">59,943</ix:nonFraction> for administrative expenses. This reimbursement is included in administrative expenses in the statement of changes in net assets available for benefits.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Transactions in shares of Elevance Health common stock qualify as exempt party-in-interest transactions under the provisions of ERISA. The Plan owned approximately <ix:nonFraction unitRef="shares" contextRef="c-66" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanInvestmentNumberOfShares" format="ixt:num-dot-decimal" scale="0" id="f-147">1,004,692</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-67" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanInvestmentNumberOfShares" format="ixt:num-dot-decimal" scale="0" id="f-148">1,105,902</ix:nonFraction> shares of Elevance Health common stock as of December&#160;31, 2025 and 2024, respectively. During the year ended December&#160;31, 2025, the Plan had net sales of Elevance Health common stock totaling $<ix:nonFraction unitRef="shares" contextRef="c-65" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanInvestmentNumberOfSharesSold" format="ixt:num-dot-decimal" scale="0" id="f-149">38,322,881</ix:nonFraction> and the total dividends on Elevance Health common stock in the Elevance Health Stock Fund were $<ix:nonFraction unitRef="usd" contextRef="c-65" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForDividendIncomeOnInvestment" format="ixt:num-dot-decimal" scale="0" id="f-150">7,148,373</ix:nonFraction>.</span></div></ix:nonNumeric><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Elevance Health 401(k) Plan</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Financial Statements (continued)</span></div></div><ix:continuation id="f-145-1"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Certain Plan investments include funds that are managed by affiliates of Fidelity, which constitute party-in-interest transactions. In addition, certain investments in the self-directed brokerage accounts are issued by Fidelity.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Notes receivable from participants also reflect exempt party-in-interest transactions.</span></div></ix:continuation><div id="ibb49980fdfe94db09f63ca8013e8ab29_40"></div><ix:nonNumeric contextRef="c-1" name="us-gaap-ebp:EmployeeBenefitPlanTaxStatusTextBlock" id="f-151" continuedAt="f-151-1" escape="true"><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">6. Income Tax Status</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Plan has received a determination letter from the IRS dated October 24, 2017, stating the Plan is qualified under Section 401(a) of the Code and, therefore, exempt from taxation. Although the Plan has been restated and amended since receiving the determination letter, the Plan Sponsor believes the Plan is designed and being operated in compliance with the applicable requirements of the Code. The Plan's EH Master Trust is intended to be considered as an organization as described in Section 401(a) of the Code and exempt under Section 501(a) of the Code. </span></div></ix:nonNumeric><div><span><br/></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"><ix:continuation id="f-151-1">GAAP requires Plan management to evaluate tax positions taken by the Plan and recognize a tax liability if the Plan has taken an uncertain tax position that more likely than not would not be sustained upon examination by the IRS. Plan management has analyzed the tax positions taken by the Plan and has concluded there are no uncertain positions taken or expected to be taken. The Plan is subject to routine audits by taxing jurisdictions; however, there are currently no audits for any tax periods in progress.</ix:continuation> </span></div><div id="ibb49980fdfe94db09f63ca8013e8ab29_43"></div><ix:nonNumeric contextRef="c-1" name="us-gaap-ebp:EmployeeBenefitPlanReconciliationToForm5500TextBlock" id="f-152" escape="true"><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">7. Reconciliation to Form 5500</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap-ebp:EmployeeBenefitPlanReconciliationToForm5500TableTextBlock" id="f-153" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Reconciliation of net assets available for benefits per the financial statements to the Form 5500 as of December&#160;31, 2025 and 2024, is as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.047%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.925%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.927%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net assets available for benefits per the financial statements</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanNetAssetAvailableForBenefit" format="ixt:num-dot-decimal" id="f-154">13,312,912,847</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanNetAssetAvailableForBenefit" format="ixt:num-dot-decimal" id="f-155">12,110,585,543</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Less: deemed distributions of participant loans</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanReconciliationToForm5500NetAssetAvailableForBenefitDeemedDistribution" format="ixt:num-dot-decimal" id="f-156">776,730</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanReconciliationToForm5500NetAssetAvailableForBenefitDeemedDistribution" format="ixt:num-dot-decimal" id="f-157">721,481</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net assets available for benefits per the Form 5500</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanForm5500CaptionNetAssetAvailableForBenefit" format="ixt:num-dot-decimal" id="f-158">13,312,136,117</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanForm5500CaptionNetAssetAvailableForBenefit" format="ixt:num-dot-decimal" id="f-159">12,109,864,062</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Reconciliation of the increase in net assets available for benefits per the financial statements to the net income (loss) per the Form 5500 for the year ended December&#160;31, 2025 is as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.874%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.926%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Increase in net assets available for benefits per the financial statements</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecrease" format="ixt:num-dot-decimal" id="f-160">1,202,327,304</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Deemed distributions of participant loans activity</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanReconciliationToForm5500PaymentToParticipantIncreaseDecreaseForDeemedDistribution" format="ixt:num-dot-decimal" id="f-161">55,249</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) per the Form 5500</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanForm5500CaptionNetIncomeLoss" format="ixt:num-dot-decimal" id="f-162">1,202,272,055</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:nonNumeric><div id="ibb49980fdfe94db09f63ca8013e8ab29_46"></div><ix:nonNumeric contextRef="c-1" name="us-gaap-ebp:EmployeeBenefitPlanSubsequentEventTextBlock" id="f-163" escape="true"><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">8. Subsequent Events</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Plan Sponsor has evaluated the impact of subsequent events through June&#160;17, 2026, the date the financial statements were issued. No subsequent events have been recognized or required additional disclosure in the financial statements.</span></div></ix:nonNumeric><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><div id="ibb49980fdfe94db09f63ca8013e8ab29_49"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><ix:nonNumeric contextRef="c-1" name="us-gaap-ebp:EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentTableTextBlock" id="f-164" escape="true"><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Elevance Health 401(k) Plan</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Schedule H, Line 4i&#8212;Schedule of Assets (Held at End of Year)</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Plan Sponsor: ATH Holding Company, LLC.     EIN #<ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-165">11-3713086</ix:nonNumeric>     Plan #<ix:nonNumeric contextRef="c-1" name="us-gaap-ebp:EmployeeBenefitPlanPlanNumber" id="f-166">003</ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:81.805%"><tr><td style="width:1.0%"/><td style="width:2.125%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.857%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.499%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.200%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.125%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.596%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.988%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.521%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.479%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.714%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">(b)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">(c)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">(d)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">(e)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Identity of issuer, borrower,<br/>lessor, or similar party</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Description of&#160;investment including maturity date, <br/>interest rate, collateral and par or maturity value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Cost**</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Current<br/>value</span></td></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-68" name="us-gaap-ebp:EmployeeBenefitPlanAssetHeldForInvestmentPartyInInterest" format="ixt:fixed-true" id="f-167">*</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-168">JP Morgan</span></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-169">Plan's interest in EH Master Trust</span></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-170">&#8212;</span>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanInvestmentPlanInterestInMasterTrustFairValue" format="ixt:num-dot-decimal" id="f-171">13,065,058,854</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Notes receivable from participants</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Interest rates range from</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-5" decimals="4" name="us-gaap-ebp:EmployeeBenefitPlanParticipantLoanInterestRate" scale="-2" id="f-172">3.25</ix:nonFraction>%</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">to</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-6" decimals="4" name="us-gaap-ebp:EmployeeBenefitPlanParticipantLoanInterestRate" scale="-2" id="f-173">10.50</ix:nonFraction>%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="us-gaap-ebp:EmployeeBenefitPlanAssetHeldForInvestmentParticipantLoanAfterDeemedDistribution" format="ixt:num-dot-decimal" id="f-174">237,618,710</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">maturing at various dates through</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-6" name="us-gaap-ebp:EmployeeBenefitPlanParticipantLoanMaturityDate" format="ixt:date-month-day-year" id="f-175">5/26/2045</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">* Party-in-interest</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">** Historical cost is not required as all investments are participant-directed</span></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><div id="ibb49980fdfe94db09f63ca8013e8ab29_52"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the Retirement Committee of ATH Holding Company, LLC has duly caused this annual report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">ELEVANCE HEALTH 401(k) PLAN</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;     </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:48.557%"><tr><td style="width:1.0%"/><td style="width:15.731%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:82.069%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Ronald W. Penczek</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Ronald W. Penczek</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Member, Retirement Committee<br/>of ATH Holding Company, LLC</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Date: June&#160;17, 2026 </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><div id="ibb49980fdfe94db09f63ca8013e8ab29_55"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">EXHIBIT INDEX</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"/><td style="width:16.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.259%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:69.046%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit&#160;Number</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Description</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">23</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Consent of Independent Registered Public Accounting Firm</span></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23
<SEQUENCE>2
<FILENAME>elv-12312025x11kex23.htm
<DESCRIPTION>EX-23
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2026 Workiva -->
<title>Document</title></head><body><div id="i6f63f9292c674bcbba273faf9a3260bd_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 23</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Consent of Independent Registered Public Accounting Firm</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We consent to the incorporation by reference in the Registration Statement (Form S-8 No.&#160;333-84906 and Form S-8 No. 333-129334) pertaining to the Elevance Health 401(k) Plan of our report dated June&#160;17, 2026, with respect to the financial statements and schedule of the Elevance Health 401(k) Plan included in this Annual Report (Form 11-K) for the year ended December&#160;31, 2025.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:31.304%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Ernst &#38; Young LLP</font></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Indianapolis, Indiana</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">June&#160;17, 2026 </font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>elv-20251231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019d97e9-6345-7c3e-aadc-cd30fd2ce9cd,g:dc9c1a7d-ae85-4e42-ad7d-8ea7d89a0d3f-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:elv="http://www.elevancehealth.com/20251231" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.elevancehealth.com/20251231">
  <xs:import namespace="http://fasb.org/srt/2026" schemaLocation="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap-ebp/2026" schemaLocation="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2026" schemaLocation="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2026" schemaLocation="https://xbrl.sec.gov/dei/2026/dei-2026.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="elv-20251231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="elv-20251231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="elv-20251231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="elv-20251231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.elevancehealth.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitPlanStatementofNetAssetAvailableforBenefitStatement" roleURI="http://www.elevancehealth.com/role/EmployeeBenefitPlanStatementofNetAssetAvailableforBenefitStatement">
        <link:definition>0000002 - Statement - Employee Benefit Plan, Statement of Net Asset Available for Benefit (Statement)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitPlanStatementofChangeinNetAssetAvailableforBenefitStatement" roleURI="http://www.elevancehealth.com/role/EmployeeBenefitPlanStatementofChangeinNetAssetAvailableforBenefitStatement">
        <link:definition>0000003 - Statement - Employee Benefit Plan, Statement of Change in Net Asset Available for Benefit (Statement)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitPlanDescriptionofPlanTables" roleURI="http://www.elevancehealth.com/role/EmployeeBenefitPlanDescriptionofPlanTables">
        <link:definition>0000004 - Disclosure - Employee Benefit Plan, Description of Plan (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitPlanMasterTrustTables" roleURI="http://www.elevancehealth.com/role/EmployeeBenefitPlanMasterTrustTables">
        <link:definition>0000005 - Disclosure - Employee Benefit Plan, Master Trust (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitPlanFairValueandNAVTables" roleURI="http://www.elevancehealth.com/role/EmployeeBenefitPlanFairValueandNAVTables">
        <link:definition>0000006 - Disclosure - Employee Benefit Plan, Fair Value and NAV (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitPlanTaxStatusTables" roleURI="http://www.elevancehealth.com/role/EmployeeBenefitPlanTaxStatusTables">
        <link:definition>0000007 - Disclosure - Employee Benefit Plan, Tax Status (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitPlanSubsequentEventTables" roleURI="http://www.elevancehealth.com/role/EmployeeBenefitPlanSubsequentEventTables">
        <link:definition>0000008 - Disclosure - Employee Benefit Plan, Subsequent Event (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitPlanSummaryofAccountingPolicyTables" roleURI="http://www.elevancehealth.com/role/EmployeeBenefitPlanSummaryofAccountingPolicyTables">
        <link:definition>0000009 - Disclosure - Employee Benefit Plan, Summary of Accounting Policy (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitPlanReconciliationofFinancialStatementtoForm5500Tables" roleURI="http://www.elevancehealth.com/role/EmployeeBenefitPlanReconciliationofFinancialStatementtoForm5500Tables">
        <link:definition>0000010 - Disclosure - Employee Benefit Plan, Reconciliation of Financial Statement to Form 5500 (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitPlanSubsequentEventTables_1" roleURI="http://www.elevancehealth.com/role/EmployeeBenefitPlanSubsequentEventTables_1">
        <link:definition>0000011 - Disclosure - Employee Benefit Plan, Subsequent Event (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitPlanMasterTrustDetails" roleURI="http://www.elevancehealth.com/role/EmployeeBenefitPlanMasterTrustDetails">
        <link:definition>0000012 - Disclosure - Employee Benefit Plan, Master Trust (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitPlanFairValueandNAVDetails" roleURI="http://www.elevancehealth.com/role/EmployeeBenefitPlanFairValueandNAVDetails">
        <link:definition>0000013 - Disclosure - Employee Benefit Plan, Fair Value and NAV (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitPlanRelatedPartyandPartyinInterestTransactionsDetails" roleURI="http://www.elevancehealth.com/role/EmployeeBenefitPlanRelatedPartyandPartyinInterestTransactionsDetails">
        <link:definition>0000014 - Disclosure - Employee Benefit Plan, Related-Party and Party-in-Interest Transactions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitPlanReconciliationofFinancialStatementtoForm5500Details" roleURI="http://www.elevancehealth.com/role/EmployeeBenefitPlanReconciliationofFinancialStatementtoForm5500Details">
        <link:definition>0000015 - Disclosure - Employee Benefit Plan, Reconciliation of Financial Statement to Form 5500 (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitPlanScheduleAssetHeldforInvestmentDetails" roleURI="http://www.elevancehealth.com/role/EmployeeBenefitPlanScheduleAssetHeldforInvestmentDetails">
        <link:definition>0000016 - Disclosure - Employee Benefit Plan, Schedule, Asset Held for Investment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitPlanScheduleAssetHeldforInvestmentDetails_1" roleURI="http://www.elevancehealth.com/role/EmployeeBenefitPlanScheduleAssetHeldforInvestmentDetails_1">
        <link:definition>0000016 - Disclosure - Employee Benefit Plan, Schedule, Asset Held for Investment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="elv_EBP003Member" abstract="true" name="EBP003Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="elv_EBPEmployerMatchTrancheAxis" abstract="true" name="EBPEmployerMatchTrancheAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="elv_EBPEmployerMatchTrancheDomain" abstract="true" name="EBPEmployerMatchTrancheDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="elv_EBPEmployerMatchTrancheOneMember" abstract="true" name="EBPEmployerMatchTrancheOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="elv_EBPEmployerMatchTrancheTwoMember" abstract="true" name="EBPEmployerMatchTrancheTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="elv_EBPEligibilityServicePeriod" abstract="false" name="EBPEligibilityServicePeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="elv_EBPParticipantContributionEligibleCompensationPercentage" abstract="false" name="EBPParticipantContributionEligibleCompensationPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="elv_EBPParticipantContributionIncrementalIncreaseOfAutomaticAnnualEscalation" abstract="false" name="EBPParticipantContributionIncrementalIncreaseOfAutomaticAnnualEscalation" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="elv_EBPParticipantContributionCapOfAutomaticAnnualEscalation" abstract="false" name="EBPParticipantContributionCapOfAutomaticAnnualEscalation" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="elv_EBPParticipantCatchUpContributionMinimumAge" abstract="false" name="EBPParticipantCatchUpContributionMinimumAge" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="elv_EBPEmployerContributionVestingPercentage" abstract="false" name="EBPEmployerContributionVestingPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="elv_EBPEmployerContributionVestingPeriod" abstract="false" name="EBPEmployerContributionVestingPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="elv_EBPParticipantContributionMaximumContributionToEmployeeStockPlan" abstract="false" name="EBPParticipantContributionMaximumContributionToEmployeeStockPlan" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="elv_EBPAutomaticDistributionToParticipantThreshold" abstract="false" name="EBPAutomaticDistributionToParticipantThreshold" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="elv_EBPDistributionOfAccountBalanceRolledIntoIRAThreshold" abstract="false" name="EBPDistributionOfAccountBalanceRolledIntoIRAThreshold" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="elv_EBPDistributionOfAccountBalanceStaysInPlanThreshold" abstract="false" name="EBPDistributionOfAccountBalanceStaysInPlanThreshold" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="elv_EBPNoteReceivableFromParticipantGeneralLoanTerm" abstract="false" name="EBPNoteReceivableFromParticipantGeneralLoanTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="elv_EBPPlanRevenueCreditAccountDecreaseFromAdministrativeExpense" abstract="false" name="EBPPlanRevenueCreditAccountDecreaseFromAdministrativeExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="elv_EBPAccountingPolicyAdoptionPolicyTextBlock" abstract="false" name="EBPAccountingPolicyAdoptionPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="elv_JPMorganMember" abstract="true" name="JPMorganMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>4
<FILENAME>elv-20251231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019d97e9-6345-7c3e-aadc-cd30fd2ce9cd,g:dc9c1a7d-ae85-4e42-ad7d-8ea7d89a0d3f-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="https://xbrl.org/2023/arcrole/summation-item" xlink:type="simple" xlink:href="https://www.xbrl.org/2023/calculation-1.1.xsd#summation-item"/>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/EmployeeBenefitPlanStatementofNetAssetAvailableforBenefitStatement" xlink:type="simple" xlink:href="elv-20251231.xsd#EmployeeBenefitPlanStatementofNetAssetAvailableforBenefitStatement"/>
  <link:calculationLink xlink:role="http://www.elevancehealth.com/role/EmployeeBenefitPlanStatementofNetAssetAvailableforBenefitStatement" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanReceivable_019e1c8e-aaac-718c-a3df-8d1e24a41b38" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanReceivable"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanNoteReceivableFromParticipant_019e1c8e-f5e7-7d41-8efa-76afb89520b2" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanNoteReceivableFromParticipant"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanReceivable_019e1c8e-aaac-718c-a3df-8d1e24a41b38" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanNoteReceivableFromParticipant_019e1c8e-f5e7-7d41-8efa-76afb89520b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanEmployerContributionReceivable_019e1c8f-3fbe-79d9-a89b-7b5e9cdd922a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanEmployerContributionReceivable"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanReceivable_019e1c8e-aaac-718c-a3df-8d1e24a41b38" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanEmployerContributionReceivable_019e1c8f-3fbe-79d9-a89b-7b5e9cdd922a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanNetAssetAvailableForBenefit_019e1c8c-764f-755d-8fb7-5873389fd04a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanNetAssetAvailableForBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanReceivable_019e1c8c-e883-74c9-8590-5a1cd2ca7933" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanReceivable"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanNetAssetAvailableForBenefit_019e1c8c-764f-755d-8fb7-5873389fd04a" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanReceivable_019e1c8c-e883-74c9-8590-5a1cd2ca7933" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentPlanInterestInMasterTrustFairValue_019e1c8d-676b-74c4-aa41-a45c89920c2e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanInvestmentPlanInterestInMasterTrustFairValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanNetAssetAvailableForBenefit_019e1c8c-764f-755d-8fb7-5873389fd04a" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentPlanInterestInMasterTrustFairValue_019e1c8d-676b-74c4-aa41-a45c89920c2e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/EmployeeBenefitPlanStatementofChangeinNetAssetAvailableforBenefitStatement" xlink:type="simple" xlink:href="elv-20251231.xsd#EmployeeBenefitPlanStatementofChangeinNetAssetAvailableforBenefitStatement"/>
  <link:calculationLink xlink:role="http://www.elevancehealth.com/role/EmployeeBenefitPlanStatementofChangeinNetAssetAvailableforBenefitStatement" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecrease_019e1ca3-47c0-7842-8ff3-03b5816b6282" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecrease"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncrease_019e1ca3-82c7-7477-9c26-ed1df157ce92" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncrease"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecrease_019e1ca3-47c0-7842-8ff3-03b5816b6282" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncrease_019e1ca3-82c7-7477-9c26-ed1df157ce92" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecrease_019e1ca3-b330-70c5-9da2-4f253cfbb8c2" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecrease"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecrease_019e1ca3-47c0-7842-8ff3-03b5816b6282" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecrease_019e1ca3-b330-70c5-9da2-4f253cfbb8c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncrease_019e1c9b-ee3a-79a9-94bf-d79d6dd95175" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncrease"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForParticipantContributionExcludingRollover_019e1c9c-56d8-77b1-b4de-5edddb801ce3" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForParticipantContributionExcludingRollover"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncrease_019e1c9b-ee3a-79a9-94bf-d79d6dd95175" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForParticipantContributionExcludingRollover_019e1c9c-56d8-77b1-b4de-5edddb801ce3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForEmployerContributionCash_019e1c9c-ec7f-7e93-bf9d-951a9bcd69a7" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForEmployerContributionCash"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncrease_019e1c9b-ee3a-79a9-94bf-d79d6dd95175" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForEmployerContributionCash_019e1c9c-ec7f-7e93-bf9d-951a9bcd69a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForParticipantContributionRollover_019e1c9c-96a7-72e6-922e-ff8d6ee61c00" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForParticipantContributionRollover"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncrease_019e1c9b-ee3a-79a9-94bf-d79d6dd95175" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForParticipantContributionRollover_019e1c9c-96a7-72e6-922e-ff8d6ee61c00" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForChangeInPlanInterestInMasterTrust_019e1c9d-b44b-7bc7-b45c-ec23b1f6b946" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForChangeInPlanInterestInMasterTrust"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncrease_019e1c9b-ee3a-79a9-94bf-d79d6dd95175" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForChangeInPlanInterestInMasterTrust_019e1c9d-b44b-7bc7-b45c-ec23b1f6b946" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForInterestIncomeOnNoteReceivableFromParticipant_019e1ca1-098b-76de-bd70-8ff6e6c27604" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForInterestIncomeOnNoteReceivableFromParticipant"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncrease_019e1c9b-ee3a-79a9-94bf-d79d6dd95175" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForInterestIncomeOnNoteReceivableFromParticipant_019e1ca1-098b-76de-bd70-8ff6e6c27604" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecrease_019e1ca1-e2f7-75d5-8a1f-9795a93f09f9" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecrease"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecreaseForPaymentToParticipant_019e1ca2-545f-7ce7-8db5-8c1e8ed90d5b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecreaseForPaymentToParticipant"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecrease_019e1ca1-e2f7-75d5-8a1f-9795a93f09f9" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecreaseForPaymentToParticipant_019e1ca2-545f-7ce7-8db5-8c1e8ed90d5b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecreaseForAdministrativeExpense_019e1ca2-a88c-7fbe-a934-162650425d29" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecreaseForAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecrease_019e1ca1-e2f7-75d5-8a1f-9795a93f09f9" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecreaseForAdministrativeExpense_019e1ca2-a88c-7fbe-a934-162650425d29" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/EmployeeBenefitPlanMasterTrustDetails" xlink:type="simple" xlink:href="elv-20251231.xsd#EmployeeBenefitPlanMasterTrustDetails"/>
  <link:calculationLink xlink:role="http://www.elevancehealth.com/role/EmployeeBenefitPlanMasterTrustDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForIncomeLossOnInvestment_019ddf57-72a1-79eb-919c-4a0f681686a2" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForIncomeLossOnInvestment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForInterestAndDividendIncomeOnInvestment_019ddf57-fae3-7ea7-a302-91719d804843" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForInterestAndDividendIncomeOnInvestment"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForIncomeLossOnInvestment_019ddf57-72a1-79eb-919c-4a0f681686a2" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForInterestAndDividendIncomeOnInvestment_019ddf57-fae3-7ea7-a302-91719d804843" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForGainLossOnInvestment_019ddf58-fa2c-78a4-b76e-e54801989d7d" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForGainLossOnInvestment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForIncomeLossOnInvestment_019ddf57-72a1-79eb-919c-4a0f681686a2" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForGainLossOnInvestment_019ddf58-fa2c-78a4-b76e-e54801989d7d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanNetAssetAvailableForBenefit_019e1d27-021f-7ab7-a0b7-6369a3fbf98a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanNetAssetAvailableForBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValue_019e1d27-3e93-7aaf-8aed-7860945a500f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanNetAssetAvailableForBenefit_019e1d27-021f-7ab7-a0b7-6369a3fbf98a" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValue_019e1d27-3e93-7aaf-8aed-7860945a500f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanOtherAsset_019e8356-e0b2-7158-abcd-d92e77259636" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanOtherAsset"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanNetAssetAvailableForBenefit_019e1d27-021f-7ab7-a0b7-6369a3fbf98a" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanOtherAsset_019e8356-e0b2-7158-abcd-d92e77259636" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/EmployeeBenefitPlanReconciliationofFinancialStatementtoForm5500Details" xlink:type="simple" xlink:href="elv-20251231.xsd#EmployeeBenefitPlanReconciliationofFinancialStatementtoForm5500Details"/>
  <link:calculationLink xlink:role="http://www.elevancehealth.com/role/EmployeeBenefitPlanReconciliationofFinancialStatementtoForm5500Details" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanForm5500CaptionNetIncomeLoss_019e1d3f-fb99-7332-8fa8-a60d59c394cc" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanForm5500CaptionNetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecrease_019e1d40-5efc-79b2-913a-189bacac6116" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecrease"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanForm5500CaptionNetIncomeLoss_019e1d3f-fb99-7332-8fa8-a60d59c394cc" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecrease_019e1d40-5efc-79b2-913a-189bacac6116" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500PaymentToParticipantIncreaseDecreaseForDeemedDistribution_019e1d40-1ed1-71b6-8dab-e20a627ff92a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500PaymentToParticipantIncreaseDecreaseForDeemedDistribution"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanForm5500CaptionNetIncomeLoss_019e1d3f-fb99-7332-8fa8-a60d59c394cc" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500PaymentToParticipantIncreaseDecreaseForDeemedDistribution_019e1d40-1ed1-71b6-8dab-e20a627ff92a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanForm5500CaptionNetAssetAvailableForBenefit_019e1d3e-f80d-700b-8df4-b51aee69240e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanForm5500CaptionNetAssetAvailableForBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanNetAssetAvailableForBenefit_019e1d3f-971b-7369-9b16-9d67b39c80d6" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanNetAssetAvailableForBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanForm5500CaptionNetAssetAvailableForBenefit_019e1d3e-f80d-700b-8df4-b51aee69240e" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanNetAssetAvailableForBenefit_019e1d3f-971b-7369-9b16-9d67b39c80d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500NetAssetAvailableForBenefitDeemedDistribution_019e1d3f-7768-79af-aca9-821de900d895" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500NetAssetAvailableForBenefitDeemedDistribution"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanForm5500CaptionNetAssetAvailableForBenefit_019e1d3e-f80d-700b-8df4-b51aee69240e" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500NetAssetAvailableForBenefitDeemedDistribution_019e1d3f-7768-79af-aca9-821de900d895" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>5
<FILENAME>elv-20251231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019d97e9-6345-7c3e-aadc-cd30fd2ce9cd,g:dc9c1a7d-ae85-4e42-ad7d-8ea7d89a0d3f-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/Cover" xlink:type="simple" xlink:href="elv-20251231.xsd#Cover"/>
  <link:definitionLink xlink:role="http://www.elevancehealth.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_019e0865-499a-7561-9a54-f9868367e655" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_019e0865-499a-7b3a-b68f-ecc2f6948192" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentInformationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_DocumentInformationLineItems_019e0865-499a-7561-9a54-f9868367e655" xlink:to="loc_dei_DocumentInformationTable_019e0865-499a-7b3a-b68f-ecc2f6948192" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_019e08b4-1860-7a41-92b5-49cf1ea69528" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_DocumentInformationTable_019e0865-499a-7b3a-b68f-ecc2f6948192" xlink:to="loc_dei_LegalEntityAxis_019e08b4-1860-7a41-92b5-49cf1ea69528" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_019e08b4-1860-7a41-92b5-49cf1ea69528_default" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_019e08b4-1860-7a41-92b5-49cf1ea69528" xlink:to="loc_dei_EntityDomain_019e08b4-1860-7a41-92b5-49cf1ea69528_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_019e08b4-1860-766c-81aa-93489985b2d6" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_019e08b4-1860-7a41-92b5-49cf1ea69528" xlink:to="loc_dei_EntityDomain_019e08b4-1860-766c-81aa-93489985b2d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_EBP003Member_019e08b4-3001-7038-9799-1b3cdc740174" xlink:href="elv-20251231.xsd#elv_EBP003Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_019e08b4-1860-766c-81aa-93489985b2d6" xlink:to="loc_elv_EBP003Member_019e08b4-3001-7038-9799-1b3cdc740174" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_019e0862-eb2f-7d3a-8694-88ace06c1934" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019e0865-499a-7561-9a54-f9868367e655" xlink:to="loc_dei_DocumentType_019e0862-eb2f-7d3a-8694-88ace06c1934" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_019e0865-499a-74e6-b6e9-0b6bc2b430b0" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentAnnualReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019e0865-499a-7561-9a54-f9868367e655" xlink:to="loc_dei_DocumentAnnualReport_019e0865-499a-74e6-b6e9-0b6bc2b430b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_019e0863-bc8b-749e-a65e-96b169bd79b6" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019e0865-499a-7561-9a54-f9868367e655" xlink:to="loc_dei_DocumentPeriodEndDate_019e0863-bc8b-749e-a65e-96b169bd79b6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_019e0874-aaae-7497-b137-591604243a1c" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019e0865-499a-7561-9a54-f9868367e655" xlink:to="loc_dei_AmendmentFlag_019e0874-aaae-7497-b137-591604243a1c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_019e0876-8b74-7344-b198-9d3538d2e704" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019e0865-499a-7561-9a54-f9868367e655" xlink:to="loc_dei_EntityCentralIndexKey_019e0876-8b74-7344-b198-9d3538d2e704" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_019e0866-e587-71e7-aaba-d69941f10885" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019e0865-499a-7561-9a54-f9868367e655" xlink:to="loc_dei_EntityFileNumber_019e0866-e587-71e7-aaba-d69941f10885" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EbpPlanName_019e0869-96ff-7454-93f5-20e148744e7a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EbpPlanName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019e0865-499a-7561-9a54-f9868367e655" xlink:to="loc_us-gaap-ebp_EbpPlanName_019e0869-96ff-7454-93f5-20e148744e7a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_019e0867-913c-723d-8340-e4bf9d0c2838" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019e0865-499a-7561-9a54-f9868367e655" xlink:to="loc_dei_EntityRegistrantName_019e0867-913c-723d-8340-e4bf9d0c2838" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_019e086a-2c98-7623-afd9-534ef74752b8" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019e0865-499a-7561-9a54-f9868367e655" xlink:to="loc_dei_EntityAddressAddressLine1_019e086a-2c98-7623-afd9-534ef74752b8" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_019e086b-a0be-71f3-a86e-021cd19820fb" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019e0865-499a-7561-9a54-f9868367e655" xlink:to="loc_dei_EntityAddressCityOrTown_019e086b-a0be-71f3-a86e-021cd19820fb" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_019e086b-d99d-702c-bc7e-401a515af2f1" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressStateOrProvince"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019e0865-499a-7561-9a54-f9868367e655" xlink:to="loc_dei_EntityAddressStateOrProvince_019e086b-d99d-702c-bc7e-401a515af2f1" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_019e086c-0ace-7832-aab6-1ba15519548d" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019e0865-499a-7561-9a54-f9868367e655" xlink:to="loc_dei_EntityAddressPostalZipCode_019e086c-0ace-7832-aab6-1ba15519548d" xlink:type="arc" order="11"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/EmployeeBenefitPlanStatementofNetAssetAvailableforBenefitStatement" xlink:type="simple" xlink:href="elv-20251231.xsd#EmployeeBenefitPlanStatementofNetAssetAvailableforBenefitStatement"/>
  <link:definitionLink xlink:role="http://www.elevancehealth.com/role/EmployeeBenefitPlanStatementofNetAssetAvailableforBenefitStatement" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanStatementOfNetAssetAvailableForBenefitLineItems_019d9d2a-4f37-7a23-9689-46e70f71a2e3" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanStatementOfNetAssetAvailableForBenefitLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanStatementOfNetAssetAvailableForBenefitTable_019d9d2a-4f37-76fe-b419-6117e3205712" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanStatementOfNetAssetAvailableForBenefitTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanStatementOfNetAssetAvailableForBenefitLineItems_019d9d2a-4f37-7a23-9689-46e70f71a2e3" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanStatementOfNetAssetAvailableForBenefitTable_019d9d2a-4f37-76fe-b419-6117e3205712" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_019d9d2b-01b5-759d-a339-6c0dad06155e" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanStatementOfNetAssetAvailableForBenefitTable_019d9d2a-4f37-76fe-b419-6117e3205712" xlink:to="loc_dei_LegalEntityAxis_019d9d2b-01b5-759d-a339-6c0dad06155e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_019d9d2b-01b5-759d-a339-6c0dad06155e_default" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_019d9d2b-01b5-759d-a339-6c0dad06155e" xlink:to="loc_dei_EntityDomain_019d9d2b-01b5-759d-a339-6c0dad06155e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_019d9d2b-01b5-74e3-940b-94b245ffe2eb" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_019d9d2b-01b5-759d-a339-6c0dad06155e" xlink:to="loc_dei_EntityDomain_019d9d2b-01b5-74e3-940b-94b245ffe2eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_EBP003Member_019d9d2b-1211-721d-9c4b-3af537147d11" xlink:href="elv-20251231.xsd#elv_EBP003Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_019d9d2b-01b5-74e3-940b-94b245ffe2eb" xlink:to="loc_elv_EBP003Member_019d9d2b-1211-721d-9c4b-3af537147d11" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentPlanInterestInMasterTrustFairValue_019d9d2f-4462-7a3a-a8bc-24429aeb9ca1" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanInvestmentPlanInterestInMasterTrustFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanStatementOfNetAssetAvailableForBenefitLineItems_019d9d2a-4f37-7a23-9689-46e70f71a2e3" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentPlanInterestInMasterTrustFairValue_019d9d2f-4462-7a3a-a8bc-24429aeb9ca1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanNoteReceivableFromParticipant_019d9d33-e7a8-7216-99e0-08b0e0141cbf" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanNoteReceivableFromParticipant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanStatementOfNetAssetAvailableForBenefitLineItems_019d9d2a-4f37-7a23-9689-46e70f71a2e3" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanNoteReceivableFromParticipant_019d9d33-e7a8-7216-99e0-08b0e0141cbf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanEmployerContributionReceivable_019d9d34-d33a-7b19-adff-9862d0b460f7" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanEmployerContributionReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanStatementOfNetAssetAvailableForBenefitLineItems_019d9d2a-4f37-7a23-9689-46e70f71a2e3" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanEmployerContributionReceivable_019d9d34-d33a-7b19-adff-9862d0b460f7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanReceivable_019d9d36-1842-72ba-9c05-1b43668c2993" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanStatementOfNetAssetAvailableForBenefitLineItems_019d9d2a-4f37-7a23-9689-46e70f71a2e3" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanReceivable_019d9d36-1842-72ba-9c05-1b43668c2993" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanNetAssetAvailableForBenefit_019d9d2a-4f37-760c-8a70-d0c2f9299456" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanNetAssetAvailableForBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanStatementOfNetAssetAvailableForBenefitLineItems_019d9d2a-4f37-7a23-9689-46e70f71a2e3" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanNetAssetAvailableForBenefit_019d9d2a-4f37-760c-8a70-d0c2f9299456" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/EmployeeBenefitPlanStatementofChangeinNetAssetAvailableforBenefitStatement" xlink:type="simple" xlink:href="elv-20251231.xsd#EmployeeBenefitPlanStatementofChangeinNetAssetAvailableforBenefitStatement"/>
  <link:definitionLink xlink:role="http://www.elevancehealth.com/role/EmployeeBenefitPlanStatementofChangeinNetAssetAvailableforBenefitStatement" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanStatementOfChangeInNetAssetAvailableForBenefitLineItems_019d9d45-a194-7c7f-98eb-2cbe5d396653" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanStatementOfChangeInNetAssetAvailableForBenefitLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanStatementOfChangeInNetAssetAvailableForBenefitTable_019d9d41-4c4a-7dac-b7ab-3e72eae70eab" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanStatementOfChangeInNetAssetAvailableForBenefitTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanStatementOfChangeInNetAssetAvailableForBenefitLineItems_019d9d45-a194-7c7f-98eb-2cbe5d396653" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanStatementOfChangeInNetAssetAvailableForBenefitTable_019d9d41-4c4a-7dac-b7ab-3e72eae70eab" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_019d9d42-6126-7f57-8401-d2136cee2a05" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanStatementOfChangeInNetAssetAvailableForBenefitTable_019d9d41-4c4a-7dac-b7ab-3e72eae70eab" xlink:to="loc_dei_LegalEntityAxis_019d9d42-6126-7f57-8401-d2136cee2a05" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_019d9d42-6126-7f57-8401-d2136cee2a05_default" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_019d9d42-6126-7f57-8401-d2136cee2a05" xlink:to="loc_dei_EntityDomain_019d9d42-6126-7f57-8401-d2136cee2a05_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_019ddf9c-432c-7a61-bd9f-5462fe14b364" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_019d9d42-6126-7f57-8401-d2136cee2a05" xlink:to="loc_dei_EntityDomain_019ddf9c-432c-7a61-bd9f-5462fe14b364" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_EBP003Member_019ddf9c-5f25-725b-92b8-6ddbe2b6465b" xlink:href="elv-20251231.xsd#elv_EBP003Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_019ddf9c-432c-7a61-bd9f-5462fe14b364" xlink:to="loc_elv_EBP003Member_019ddf9c-5f25-725b-92b8-6ddbe2b6465b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForParticipantContributionExcludingRollover_019d9d46-46c3-7356-be92-e0b1da7d56cf" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForParticipantContributionExcludingRollover"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanStatementOfChangeInNetAssetAvailableForBenefitLineItems_019d9d45-a194-7c7f-98eb-2cbe5d396653" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForParticipantContributionExcludingRollover_019d9d46-46c3-7356-be92-e0b1da7d56cf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForEmployerContributionCash_019dcf29-3cc4-70e5-9aea-688ac1cd4898" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForEmployerContributionCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanStatementOfChangeInNetAssetAvailableForBenefitLineItems_019d9d45-a194-7c7f-98eb-2cbe5d396653" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForEmployerContributionCash_019dcf29-3cc4-70e5-9aea-688ac1cd4898" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForParticipantContributionRollover_019dcf2a-2090-7be8-9bf6-0560392789f4" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForParticipantContributionRollover"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanStatementOfChangeInNetAssetAvailableForBenefitLineItems_019d9d45-a194-7c7f-98eb-2cbe5d396653" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForParticipantContributionRollover_019dcf2a-2090-7be8-9bf6-0560392789f4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForContribution_019dd4e0-91a0-7988-8a35-87d53074e118" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForContribution"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanStatementOfChangeInNetAssetAvailableForBenefitLineItems_019d9d45-a194-7c7f-98eb-2cbe5d396653" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForContribution_019dd4e0-91a0-7988-8a35-87d53074e118" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForChangeInPlanInterestInMasterTrust_019dd4e2-9598-76cc-867c-2e00b806da6c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForChangeInPlanInterestInMasterTrust"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanStatementOfChangeInNetAssetAvailableForBenefitLineItems_019d9d45-a194-7c7f-98eb-2cbe5d396653" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForChangeInPlanInterestInMasterTrust_019dd4e2-9598-76cc-867c-2e00b806da6c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForInterestIncomeOnNoteReceivableFromParticipant_019dd4e4-3729-74a1-8159-d9ba09a158e6" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForInterestIncomeOnNoteReceivableFromParticipant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanStatementOfChangeInNetAssetAvailableForBenefitLineItems_019d9d45-a194-7c7f-98eb-2cbe5d396653" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForInterestIncomeOnNoteReceivableFromParticipant_019dd4e4-3729-74a1-8159-d9ba09a158e6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncrease_019dd500-ea3f-76a6-9553-852908fab41f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanStatementOfChangeInNetAssetAvailableForBenefitLineItems_019d9d45-a194-7c7f-98eb-2cbe5d396653" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncrease_019dd500-ea3f-76a6-9553-852908fab41f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecreaseForPaymentToParticipant_019dd50b-24c4-7014-935c-67a580e105c9" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecreaseForPaymentToParticipant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanStatementOfChangeInNetAssetAvailableForBenefitLineItems_019d9d45-a194-7c7f-98eb-2cbe5d396653" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecreaseForPaymentToParticipant_019dd50b-24c4-7014-935c-67a580e105c9" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecreaseForAdministrativeExpense_019dd50c-b074-7bdc-b63b-9ea328a48142" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecreaseForAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanStatementOfChangeInNetAssetAvailableForBenefitLineItems_019d9d45-a194-7c7f-98eb-2cbe5d396653" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecreaseForAdministrativeExpense_019dd50c-b074-7bdc-b63b-9ea328a48142" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecrease_019dd50d-908c-70e3-9ed7-ee38385450ed" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanStatementOfChangeInNetAssetAvailableForBenefitLineItems_019d9d45-a194-7c7f-98eb-2cbe5d396653" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecrease_019dd50d-908c-70e3-9ed7-ee38385450ed" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecrease_019dd50f-6cc8-7944-ba40-649a2be2d578" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanStatementOfChangeInNetAssetAvailableForBenefitLineItems_019d9d45-a194-7c7f-98eb-2cbe5d396653" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecrease_019dd50f-6cc8-7944-ba40-649a2be2d578" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanNetAssetAvailableForBenefit_019dd512-e097-701d-89f2-14e420d6f659" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanNetAssetAvailableForBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanStatementOfChangeInNetAssetAvailableForBenefitLineItems_019d9d45-a194-7c7f-98eb-2cbe5d396653" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanNetAssetAvailableForBenefit_019dd512-e097-701d-89f2-14e420d6f659" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanNetAssetAvailableForBenefit_019e1cf3-68b0-7a75-8dad-81fc56c03a73" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanNetAssetAvailableForBenefit"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/EmployeeBenefitPlanDescriptionofPlanTables" xlink:type="simple" xlink:href="elv-20251231.xsd#EmployeeBenefitPlanDescriptionofPlanTables"/>
  <link:definitionLink xlink:role="http://www.elevancehealth.com/role/EmployeeBenefitPlanDescriptionofPlanTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanLineItems_019dde8f-d65f-7e20-9cbc-29bf1fa671ee" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanTable_019dde8f-d65f-7395-b54d-f0d9663a3a28" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanLineItems_019dde8f-d65f-7e20-9cbc-29bf1fa671ee" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanTable_019dde8f-d65f-7395-b54d-f0d9663a3a28" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_019ead44-8285-70ce-94ab-e5b494bb37d3" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanTable_019dde8f-d65f-7395-b54d-f0d9663a3a28" xlink:to="loc_dei_LegalEntityAxis_019ead44-8285-70ce-94ab-e5b494bb37d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_019ead44-8285-70ce-94ab-e5b494bb37d3_default" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_019ead44-8285-70ce-94ab-e5b494bb37d3" xlink:to="loc_dei_EntityDomain_019ead44-8285-70ce-94ab-e5b494bb37d3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_019ead44-8285-72ac-ace4-d6ec12b37d51" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_019ead44-8285-70ce-94ab-e5b494bb37d3" xlink:to="loc_dei_EntityDomain_019ead44-8285-72ac-ace4-d6ec12b37d51" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_EBP003Member_019ead44-8285-715b-a28d-4f4e8bfd7b2d" xlink:href="elv-20251231.xsd#elv_EBP003Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_019ead44-8285-72ac-ace4-d6ec12b37d51" xlink:to="loc_elv_EBP003Member_019ead44-8285-715b-a28d-4f4e8bfd7b2d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_019e4194-f329-71f9-a97c-b7de812b9625" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanTable_019dde8f-d65f-7395-b54d-f0d9663a3a28" xlink:to="loc_srt_RangeAxis_019e4194-f329-71f9-a97c-b7de812b9625" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019e4194-f329-71f9-a97c-b7de812b9625_default" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_019e4194-f329-71f9-a97c-b7de812b9625" xlink:to="loc_srt_RangeMember_019e4194-f329-71f9-a97c-b7de812b9625_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019e4194-f329-7212-9ccb-a590fb41ad02" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_019e4194-f329-71f9-a97c-b7de812b9625" xlink:to="loc_srt_RangeMember_019e4194-f329-7212-9ccb-a590fb41ad02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_019e4195-1300-7451-bc3f-ed046767e9df" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_019e4194-f329-7212-9ccb-a590fb41ad02" xlink:to="loc_srt_MinimumMember_019e4195-1300-7451-bc3f-ed046767e9df" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_019e4195-f170-798d-b8e9-eda811ebd643" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_019e4194-f329-7212-9ccb-a590fb41ad02" xlink:to="loc_srt_MaximumMember_019e4195-f170-798d-b8e9-eda811ebd643" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_EBPEmployerMatchTrancheAxis_019e41ab-0f31-7e1a-8ab9-0e7c6c2623bb" xlink:href="elv-20251231.xsd#elv_EBPEmployerMatchTrancheAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanTable_019dde8f-d65f-7395-b54d-f0d9663a3a28" xlink:to="loc_elv_EBPEmployerMatchTrancheAxis_019e41ab-0f31-7e1a-8ab9-0e7c6c2623bb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_EBPEmployerMatchTrancheDomain_019e41ab-0f31-7e1a-8ab9-0e7c6c2623bb_default" xlink:href="elv-20251231.xsd#elv_EBPEmployerMatchTrancheDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_elv_EBPEmployerMatchTrancheAxis_019e41ab-0f31-7e1a-8ab9-0e7c6c2623bb" xlink:to="loc_elv_EBPEmployerMatchTrancheDomain_019e41ab-0f31-7e1a-8ab9-0e7c6c2623bb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_EBPEmployerMatchTrancheDomain_019e41ab-0f31-763f-b038-1f5d2a95e056" xlink:href="elv-20251231.xsd#elv_EBPEmployerMatchTrancheDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_elv_EBPEmployerMatchTrancheAxis_019e41ab-0f31-7e1a-8ab9-0e7c6c2623bb" xlink:to="loc_elv_EBPEmployerMatchTrancheDomain_019e41ab-0f31-763f-b038-1f5d2a95e056" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_EBPEmployerMatchTrancheOneMember_019e41ab-67ea-779b-a6e3-f9da9059cd22" xlink:href="elv-20251231.xsd#elv_EBPEmployerMatchTrancheOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_elv_EBPEmployerMatchTrancheDomain_019e41ab-0f31-763f-b038-1f5d2a95e056" xlink:to="loc_elv_EBPEmployerMatchTrancheOneMember_019e41ab-67ea-779b-a6e3-f9da9059cd22" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_EBPEmployerMatchTrancheTwoMember_019e82e6-2f9e-7629-a0af-5f625bb987dd" xlink:href="elv-20251231.xsd#elv_EBPEmployerMatchTrancheTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_elv_EBPEmployerMatchTrancheDomain_019e41ab-0f31-763f-b038-1f5d2a95e056" xlink:to="loc_elv_EBPEmployerMatchTrancheTwoMember_019e82e6-2f9e-7629-a0af-5f625bb987dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanTextBlock_019e9492-56e0-7788-b8e9-51cd91c62049" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanLineItems_019dde8f-d65f-7e20-9cbc-29bf1fa671ee" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanTextBlock_019e9492-56e0-7788-b8e9-51cd91c62049" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_EBPEligibilityServicePeriod_019e419e-07ba-7543-8e41-77106cdf67bb" xlink:href="elv-20251231.xsd#elv_EBPEligibilityServicePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanLineItems_019dde8f-d65f-7e20-9cbc-29bf1fa671ee" xlink:to="loc_elv_EBPEligibilityServicePeriod_019e419e-07ba-7543-8e41-77106cdf67bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_EBPParticipantContributionEligibleCompensationPercentage_019e418b-0348-7a92-baa1-ff0d2d34118a" xlink:href="elv-20251231.xsd#elv_EBPParticipantContributionEligibleCompensationPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanLineItems_019dde8f-d65f-7e20-9cbc-29bf1fa671ee" xlink:to="loc_elv_EBPParticipantContributionEligibleCompensationPercentage_019e418b-0348-7a92-baa1-ff0d2d34118a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanParticipantContributionAutomaticDeferralRate_019e282d-5be3-72cc-a94d-21cc11ba7da9" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanParticipantContributionAutomaticDeferralRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanLineItems_019dde8f-d65f-7e20-9cbc-29bf1fa671ee" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanParticipantContributionAutomaticDeferralRate_019e282d-5be3-72cc-a94d-21cc11ba7da9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_EBPParticipantContributionIncrementalIncreaseOfAutomaticAnnualEscalation_019e41a5-a71e-70dd-93ca-70bbf0c09bc8" xlink:href="elv-20251231.xsd#elv_EBPParticipantContributionIncrementalIncreaseOfAutomaticAnnualEscalation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanLineItems_019dde8f-d65f-7e20-9cbc-29bf1fa671ee" xlink:to="loc_elv_EBPParticipantContributionIncrementalIncreaseOfAutomaticAnnualEscalation_019e41a5-a71e-70dd-93ca-70bbf0c09bc8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_EBPParticipantContributionCapOfAutomaticAnnualEscalation_019e41a7-1681-734a-99dc-e77e3f2b68c5" xlink:href="elv-20251231.xsd#elv_EBPParticipantContributionCapOfAutomaticAnnualEscalation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanLineItems_019dde8f-d65f-7e20-9cbc-29bf1fa671ee" xlink:to="loc_elv_EBPParticipantContributionCapOfAutomaticAnnualEscalation_019e41a7-1681-734a-99dc-e77e3f2b68c5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanEmployerContributionMatchingPercentage_019e41aa-1df0-7af1-979f-8b0e2fbc2e92" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanEmployerContributionMatchingPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanLineItems_019dde8f-d65f-7e20-9cbc-29bf1fa671ee" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanEmployerContributionMatchingPercentage_019e41aa-1df0-7af1-979f-8b0e2fbc2e92" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanEmployerContributionParticipantCompensationMatchedPercentage_019e41ab-ed5f-7497-aa3b-fd8c66f3f8cd" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanEmployerContributionParticipantCompensationMatchedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanLineItems_019dde8f-d65f-7e20-9cbc-29bf1fa671ee" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanEmployerContributionParticipantCompensationMatchedPercentage_019e41ab-ed5f-7497-aa3b-fd8c66f3f8cd" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_EBPParticipantCatchUpContributionMinimumAge_019e41bb-5d61-7b5b-8b55-8063f43ec1e3" xlink:href="elv-20251231.xsd#elv_EBPParticipantCatchUpContributionMinimumAge"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanLineItems_019dde8f-d65f-7e20-9cbc-29bf1fa671ee" xlink:to="loc_elv_EBPParticipantCatchUpContributionMinimumAge_019e41bb-5d61-7b5b-8b55-8063f43ec1e3" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_EBPEmployerContributionVestingPercentage_019e41c0-1005-7cb2-968a-49fc9440a9c4" xlink:href="elv-20251231.xsd#elv_EBPEmployerContributionVestingPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanLineItems_019dde8f-d65f-7e20-9cbc-29bf1fa671ee" xlink:to="loc_elv_EBPEmployerContributionVestingPercentage_019e41c0-1005-7cb2-968a-49fc9440a9c4" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_EBPEmployerContributionVestingPeriod_019e41c1-28d7-7e58-b50e-6c8f969b31fb" xlink:href="elv-20251231.xsd#elv_EBPEmployerContributionVestingPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanLineItems_019dde8f-d65f-7e20-9cbc-29bf1fa671ee" xlink:to="loc_elv_EBPEmployerContributionVestingPeriod_019e41c1-28d7-7e58-b50e-6c8f969b31fb" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_EBPParticipantContributionMaximumContributionToEmployeeStockPlan_019e840e-7ede-714d-835e-962eaa87b249" xlink:href="elv-20251231.xsd#elv_EBPParticipantContributionMaximumContributionToEmployeeStockPlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanLineItems_019dde8f-d65f-7e20-9cbc-29bf1fa671ee" xlink:to="loc_elv_EBPParticipantContributionMaximumContributionToEmployeeStockPlan_019e840e-7ede-714d-835e-962eaa87b249" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_EBPAutomaticDistributionToParticipantThreshold_019e8f49-3614-7230-9e70-7565f0ef63b5" xlink:href="elv-20251231.xsd#elv_EBPAutomaticDistributionToParticipantThreshold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanLineItems_019dde8f-d65f-7e20-9cbc-29bf1fa671ee" xlink:to="loc_elv_EBPAutomaticDistributionToParticipantThreshold_019e8f49-3614-7230-9e70-7565f0ef63b5" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_EBPDistributionOfAccountBalanceRolledIntoIRAThreshold_019e8f56-b397-7142-a1de-57e356a7856b" xlink:href="elv-20251231.xsd#elv_EBPDistributionOfAccountBalanceRolledIntoIRAThreshold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanLineItems_019dde8f-d65f-7e20-9cbc-29bf1fa671ee" xlink:to="loc_elv_EBPDistributionOfAccountBalanceRolledIntoIRAThreshold_019e8f56-b397-7142-a1de-57e356a7856b" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_EBPDistributionOfAccountBalanceStaysInPlanThreshold_019e8f5d-4a31-7491-8d60-28b1c1bdb34c" xlink:href="elv-20251231.xsd#elv_EBPDistributionOfAccountBalanceStaysInPlanThreshold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanLineItems_019dde8f-d65f-7e20-9cbc-29bf1fa671ee" xlink:to="loc_elv_EBPDistributionOfAccountBalanceStaysInPlanThreshold_019e8f5d-4a31-7491-8d60-28b1c1bdb34c" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanNoteReceivableFromParticipantAccountMaximumBorrowingToTotalAccountPercentage_019e2834-65c4-71ab-b9bd-ff32747007f6" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanNoteReceivableFromParticipantAccountMaximumBorrowingToTotalAccountPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanLineItems_019dde8f-d65f-7e20-9cbc-29bf1fa671ee" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanNoteReceivableFromParticipantAccountMaximumBorrowingToTotalAccountPercentage_019e2834-65c4-71ab-b9bd-ff32747007f6" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanNoteReceivableFromParticipantAccountMaximumBorrowingAmount_019e2838-b666-7ef4-96aa-4536054295f1" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanNoteReceivableFromParticipantAccountMaximumBorrowingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanLineItems_019dde8f-d65f-7e20-9cbc-29bf1fa671ee" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanNoteReceivableFromParticipantAccountMaximumBorrowingAmount_019e2838-b666-7ef4-96aa-4536054295f1" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_EBPNoteReceivableFromParticipantGeneralLoanTerm_019e2842-bb70-7a81-9f7e-4c5cc1ebd485" xlink:href="elv-20251231.xsd#elv_EBPNoteReceivableFromParticipantGeneralLoanTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanLineItems_019dde8f-d65f-7e20-9cbc-29bf1fa671ee" xlink:to="loc_elv_EBPNoteReceivableFromParticipantGeneralLoanTerm_019e2842-bb70-7a81-9f7e-4c5cc1ebd485" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanForfeitedNonvestedAccount_019e2833-3a42-7730-b6ce-073f195ddb18" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanForfeitedNonvestedAccount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanLineItems_019dde8f-d65f-7e20-9cbc-29bf1fa671ee" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanForfeitedNonvestedAccount_019e2833-3a42-7730-b6ce-073f195ddb18" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanForfeitedNonvestedAccountDecreaseForEmployerContribution_019e838c-7ed4-7294-b680-d2257e327882" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanForfeitedNonvestedAccountDecreaseForEmployerContribution"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanLineItems_019dde8f-d65f-7e20-9cbc-29bf1fa671ee" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanForfeitedNonvestedAccountDecreaseForEmployerContribution_019e838c-7ed4-7294-b680-d2257e327882" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanForfeitedNonvestedAccountDecreaseForAdministrativeExpense_019e838d-4bfd-702d-bfd2-cf55f485f4a9" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanForfeitedNonvestedAccountDecreaseForAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanLineItems_019dde8f-d65f-7e20-9cbc-29bf1fa671ee" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanForfeitedNonvestedAccountDecreaseForAdministrativeExpense_019e838d-4bfd-702d-bfd2-cf55f485f4a9" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_EBPPlanRevenueCreditAccountDecreaseFromAdministrativeExpense_019ead66-65f1-789e-afd9-c0688416762c" xlink:href="elv-20251231.xsd#elv_EBPPlanRevenueCreditAccountDecreaseFromAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanLineItems_019dde8f-d65f-7e20-9cbc-29bf1fa671ee" xlink:to="loc_elv_EBPPlanRevenueCreditAccountDecreaseFromAdministrativeExpense_019ead66-65f1-789e-afd9-c0688416762c" xlink:type="arc" order="21"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/EmployeeBenefitPlanMasterTrustTables" xlink:type="simple" xlink:href="elv-20251231.xsd#EmployeeBenefitPlanMasterTrustTables"/>
  <link:definitionLink xlink:role="http://www.elevancehealth.com/role/EmployeeBenefitPlanMasterTrustTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanMasterTrustLineItems_019dd9de-bab9-784d-ac4f-12bbd0c85439" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanMasterTrustLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanMasterTrustTable_019dd9de-bab9-7fef-ae90-b422974c2ade" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanMasterTrustTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanMasterTrustLineItems_019dd9de-bab9-784d-ac4f-12bbd0c85439" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanMasterTrustTable_019dd9de-bab9-7fef-ae90-b422974c2ade" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustAxis_019dd9e0-74fb-73ce-a8ce-96df102732bb" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanMasterTrustTable_019dd9de-bab9-7fef-ae90-b422974c2ade" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustAxis_019dd9e0-74fb-73ce-a8ce-96df102732bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustDomain_019dd9e0-74fb-73ce-a8ce-96df102732bb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustAxis_019dd9e0-74fb-73ce-a8ce-96df102732bb" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustDomain_019dd9e0-74fb-73ce-a8ce-96df102732bb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustDomain_019dd9e0-74fb-7364-b61e-1965c4706b4c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustAxis_019dd9e0-74fb-73ce-a8ce-96df102732bb" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustDomain_019dd9e0-74fb-7364-b61e-1965c4706b4c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedMasterTrustMember_019dd9e2-90ad-72b3-b715-43d429a49e18" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedMasterTrustMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustDomain_019dd9e0-74fb-7364-b61e-1965c4706b4c" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedMasterTrustMember_019dd9e2-90ad-72b3-b715-43d429a49e18" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedPlanInterestInMasterTrustMember_019dd9e4-37c4-7a1c-9576-58f759b5d647" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedPlanInterestInMasterTrustMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustDomain_019dd9e0-74fb-7364-b61e-1965c4706b4c" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedPlanInterestInMasterTrustMember_019dd9e4-37c4-7a1c-9576-58f759b5d647" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_019dd9eb-7f9c-7ddd-970d-084380a28bf8" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanMasterTrustTable_019dd9de-bab9-7fef-ae90-b422974c2ade" xlink:to="loc_us-gaap_InvestmentTypeAxis_019dd9eb-7f9c-7ddd-970d-084380a28bf8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_019dd9eb-7f9c-7ddd-970d-084380a28bf8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_019dd9eb-7f9c-7ddd-970d-084380a28bf8" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_019dd9eb-7f9c-7ddd-970d-084380a28bf8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_019dd9eb-7f9c-74f1-938b-bb5701c2a390" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_019dd9eb-7f9c-7ddd-970d-084380a28bf8" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_019dd9eb-7f9c-74f1-938b-bb5701c2a390" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCommonCollectiveTrustMember_019dd9eb-a479-7a9a-bfb5-b95949a46134" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DefinedBenefitPlanCommonCollectiveTrustMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_019dd9eb-7f9c-74f1-938b-bb5701c2a390" xlink:to="loc_us-gaap_DefinedBenefitPlanCommonCollectiveTrustMember_019dd9eb-a479-7a9a-bfb5-b95949a46134" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanEmployerCommonStockMember_019dd9ed-0e6a-79f9-8ba0-329633b639d7" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanEmployerCommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_019dd9eb-7f9c-74f1-938b-bb5701c2a390" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanEmployerCommonStockMember_019dd9ed-0e6a-79f9-8ba0-329633b639d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MutualFundMember_019dd9ed-f06f-7f7b-bfd0-d9cf60b8b981" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_MutualFundMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_019dd9eb-7f9c-74f1-938b-bb5701c2a390" xlink:to="loc_us-gaap_MutualFundMember_019dd9ed-f06f-7f7b-bfd0-d9cf60b8b981" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanSelfDirectedBrokerageAccountMember_019dd9ee-79e2-7856-af77-464eca85fc5c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanSelfDirectedBrokerageAccountMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_019dd9eb-7f9c-74f1-938b-bb5701c2a390" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanSelfDirectedBrokerageAccountMember_019dd9ee-79e2-7856-af77-464eca85fc5c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_019dd9e1-371d-77aa-9041-a98bf06808cf" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanMasterTrustTable_019dd9de-bab9-7fef-ae90-b422974c2ade" xlink:to="loc_dei_LegalEntityAxis_019dd9e1-371d-77aa-9041-a98bf06808cf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_019dd9e1-371d-77aa-9041-a98bf06808cf_default" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_019dd9e1-371d-77aa-9041-a98bf06808cf" xlink:to="loc_dei_EntityDomain_019dd9e1-371d-77aa-9041-a98bf06808cf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_019dd9e1-371d-76e6-a82a-700778cfb442" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_019dd9e1-371d-77aa-9041-a98bf06808cf" xlink:to="loc_dei_EntityDomain_019dd9e1-371d-76e6-a82a-700778cfb442" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_EBP003Member_019dd9e1-ce0b-725d-bd62-ed090227be8d" xlink:href="elv-20251231.xsd#elv_EBP003Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_019dd9e1-371d-76e6-a82a-700778cfb442" xlink:to="loc_elv_EBP003Member_019dd9e1-ce0b-725d-bd62-ed090227be8d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanMasterTrustTextBlock_019e2bbe-d247-7997-be57-d85beeed0fe9" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanMasterTrustTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanMasterTrustLineItems_019dd9de-bab9-784d-ac4f-12bbd0c85439" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanMasterTrustTextBlock_019e2bbe-d247-7997-be57-d85beeed0fe9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanMasterTrustTableTextBlock_019eada7-04c6-7f93-a64a-c31721f36e86" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanMasterTrustTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanMasterTrustLineItems_019dd9de-bab9-784d-ac4f-12bbd0c85439" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanMasterTrustTableTextBlock_019eada7-04c6-7f93-a64a-c31721f36e86" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValue_019dd9e5-b675-7f66-9443-cac157fb38d2" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanMasterTrustLineItems_019dd9de-bab9-784d-ac4f-12bbd0c85439" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValue_019dd9e5-b675-7f66-9443-cac157fb38d2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanOtherAsset_019e0942-8213-7fcc-8095-251e0dbd2d4c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanOtherAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanMasterTrustLineItems_019dd9de-bab9-784d-ac4f-12bbd0c85439" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanOtherAsset_019e0942-8213-7fcc-8095-251e0dbd2d4c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanNetAssetAvailableForBenefit_019dd9de-bab9-7059-8384-e81f5f313d57" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanNetAssetAvailableForBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanMasterTrustLineItems_019dd9de-bab9-784d-ac4f-12bbd0c85439" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanNetAssetAvailableForBenefit_019dd9de-bab9-7059-8384-e81f5f313d57" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForGainLossOnInvestment_019dda08-88c1-74f0-8e54-7e0c35b31f72" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForGainLossOnInvestment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanMasterTrustLineItems_019dd9de-bab9-784d-ac4f-12bbd0c85439" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForGainLossOnInvestment_019dda08-88c1-74f0-8e54-7e0c35b31f72" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForInterestAndDividendIncomeOnInvestment_019ddf44-fc44-7bd4-8ee2-cc85d206d433" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForInterestAndDividendIncomeOnInvestment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanMasterTrustLineItems_019dd9de-bab9-784d-ac4f-12bbd0c85439" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForInterestAndDividendIncomeOnInvestment_019ddf44-fc44-7bd4-8ee2-cc85d206d433" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForIncomeLossOnInvestment_019dda06-80c3-7824-92a1-067d69f2f4a7" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForIncomeLossOnInvestment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanMasterTrustLineItems_019dd9de-bab9-784d-ac4f-12bbd0c85439" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForIncomeLossOnInvestment_019dda06-80c3-7824-92a1-067d69f2f4a7" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/EmployeeBenefitPlanFairValueandNAVTables" xlink:type="simple" xlink:href="elv-20251231.xsd#EmployeeBenefitPlanFairValueandNAVTables"/>
  <link:definitionLink xlink:role="http://www.elevancehealth.com/role/EmployeeBenefitPlanFairValueandNAVTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavLineItems_019ecb4b-0b32-71fa-9342-c77f90c9c54e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavTable_019ecb4b-0b32-7e75-85ba-62e79ca53f2d" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavLineItems_019ecb4b-0b32-71fa-9342-c77f90c9c54e" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavTable_019ecb4b-0b32-7e75-85ba-62e79ca53f2d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_019ecb4b-0b32-7574-b77c-6555a8a7e143" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavTable_019ecb4b-0b32-7e75-85ba-62e79ca53f2d" xlink:to="loc_dei_LegalEntityAxis_019ecb4b-0b32-7574-b77c-6555a8a7e143" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_019ecb4b-0b32-7574-b77c-6555a8a7e143_default" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_019ecb4b-0b32-7574-b77c-6555a8a7e143" xlink:to="loc_dei_EntityDomain_019ecb4b-0b32-7574-b77c-6555a8a7e143_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_019ecb4b-0b32-72f3-b837-0cdc20f76b33" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_019ecb4b-0b32-7574-b77c-6555a8a7e143" xlink:to="loc_dei_EntityDomain_019ecb4b-0b32-72f3-b837-0cdc20f76b33" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_EBP003Member_019ecb4b-0b32-7824-a590-2337c18dda69" xlink:href="elv-20251231.xsd#elv_EBP003Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_019ecb4b-0b32-72f3-b837-0cdc20f76b33" xlink:to="loc_elv_EBP003Member_019ecb4b-0b32-7824-a590-2337c18dda69" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_019ecb2e-fd4b-752d-a70b-9d2b50fa37e5" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavTable_019ecb4b-0b32-7e75-85ba-62e79ca53f2d" xlink:to="loc_us-gaap_InvestmentTypeAxis_019ecb2e-fd4b-752d-a70b-9d2b50fa37e5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_019ecb2e-fd4b-752d-a70b-9d2b50fa37e5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_019ecb2e-fd4b-752d-a70b-9d2b50fa37e5" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_019ecb2e-fd4b-752d-a70b-9d2b50fa37e5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_019ecb2e-fd4b-7602-a7de-3c04d96131fe" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_019ecb2e-fd4b-752d-a70b-9d2b50fa37e5" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_019ecb2e-fd4b-7602-a7de-3c04d96131fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanEmployerCommonStockMember_019ecb75-eb5c-7cc8-aeb7-c1bad5e65a10" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanEmployerCommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_019ecb2e-fd4b-7602-a7de-3c04d96131fe" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanEmployerCommonStockMember_019ecb75-eb5c-7cc8-aeb7-c1bad5e65a10" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MutualFundMember_019ecb76-5e02-719e-be60-27de7d9958ff" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_MutualFundMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_019ecb2e-fd4b-7602-a7de-3c04d96131fe" xlink:to="loc_us-gaap_MutualFundMember_019ecb76-5e02-719e-be60-27de7d9958ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanSelfDirectedBrokerageAccountMember_019ecb3a-92bf-7be1-8ab4-278f2dc19d1a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanSelfDirectedBrokerageAccountMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_019ecb2e-fd4b-7602-a7de-3c04d96131fe" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanSelfDirectedBrokerageAccountMember_019ecb3a-92bf-7be1-8ab4-278f2dc19d1a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_019ecb38-555b-7080-8f98-f457b137ee26" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavTable_019ecb4b-0b32-7e75-85ba-62e79ca53f2d" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_019ecb38-555b-7080-8f98-f457b137ee26" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019ecb38-555b-7080-8f98-f457b137ee26_default" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_019ecb38-555b-7080-8f98-f457b137ee26" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019ecb38-555b-7080-8f98-f457b137ee26_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019ecb38-555b-7285-9735-96d144e3138e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_019ecb38-555b-7080-8f98-f457b137ee26" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019ecb38-555b-7285-9735-96d144e3138e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel12And3Member_019ecb38-8dee-7cf2-96a5-e12290732899" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FairValueInputsLevel12And3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019ecb38-555b-7285-9735-96d144e3138e" xlink:to="loc_us-gaap_FairValueInputsLevel12And3Member_019ecb38-8dee-7cf2-96a5-e12290732899" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_019ecb70-55d2-79e8-90a5-f540d56bfc26" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019ecb38-555b-7285-9735-96d144e3138e" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_019ecb70-55d2-79e8-90a5-f540d56bfc26" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_019ecb70-aeec-757c-864a-7979b3012cc3" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019ecb38-555b-7285-9735-96d144e3138e" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_019ecb70-aeec-757c-864a-7979b3012cc3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_019ecb70-f85e-70f4-958c-6cb1fe65b719" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019ecb38-555b-7285-9735-96d144e3138e" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_019ecb70-f85e-70f4-958c-6cb1fe65b719" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_019ecb5d-e184-7a3c-a3bf-edb3fb0bd3e8" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019ecb38-555b-7285-9735-96d144e3138e" xlink:to="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_019ecb5d-e184-7a3c-a3bf-edb3fb0bd3e8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavTextBlock_019ecb4b-0b32-79f8-8c7f-309244f2a599" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavLineItems_019ecb4b-0b32-71fa-9342-c77f90c9c54e" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavTextBlock_019ecb4b-0b32-79f8-8c7f-309244f2a599" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavTableTextBlock_019eada8-dece-7033-bcf7-f06b779d9e63" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavLineItems_019ecb4b-0b32-71fa-9342-c77f90c9c54e" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavTableTextBlock_019eada8-dece-7033-bcf7-f06b779d9e63" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue_019ecb38-20c9-73cd-8dc0-fc06f1ffb847" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavLineItems_019ecb4b-0b32-71fa-9342-c77f90c9c54e" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue_019ecb38-20c9-73cd-8dc0-fc06f1ffb847" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/EmployeeBenefitPlanTaxStatusTables" xlink:type="simple" xlink:href="elv-20251231.xsd#EmployeeBenefitPlanTaxStatusTables"/>
  <link:definitionLink xlink:role="http://www.elevancehealth.com/role/EmployeeBenefitPlanTaxStatusTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanTaxStatusLineItems_019e2be4-0402-7cbb-bea6-b1fc44a75618" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanTaxStatusLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanTaxStatusTable_019e2be4-0402-75c4-926a-6ea162bb5f40" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanTaxStatusTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanTaxStatusLineItems_019e2be4-0402-7cbb-bea6-b1fc44a75618" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanTaxStatusTable_019e2be4-0402-75c4-926a-6ea162bb5f40" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_019e2be4-0402-719b-b193-4a5cc51047c9" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanTaxStatusTable_019e2be4-0402-75c4-926a-6ea162bb5f40" xlink:to="loc_dei_LegalEntityAxis_019e2be4-0402-719b-b193-4a5cc51047c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_019e2be4-0402-719b-b193-4a5cc51047c9_default" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_019e2be4-0402-719b-b193-4a5cc51047c9" xlink:to="loc_dei_EntityDomain_019e2be4-0402-719b-b193-4a5cc51047c9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_019e2be4-0402-7364-8331-2ca494b51231" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_019e2be4-0402-719b-b193-4a5cc51047c9" xlink:to="loc_dei_EntityDomain_019e2be4-0402-7364-8331-2ca494b51231" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_EBP003Member_019e2be4-0402-7739-bf61-e912926b9a2d" xlink:href="elv-20251231.xsd#elv_EBP003Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_019e2be4-0402-7364-8331-2ca494b51231" xlink:to="loc_elv_EBP003Member_019e2be4-0402-7739-bf61-e912926b9a2d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanTaxStatusTextBlock_019e2be4-0402-7cec-b28b-bc15f6187595" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanTaxStatusTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanTaxStatusLineItems_019e2be4-0402-7cbb-bea6-b1fc44a75618" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanTaxStatusTextBlock_019e2be4-0402-7cec-b28b-bc15f6187595" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/EmployeeBenefitPlanSubsequentEventTables" xlink:type="simple" xlink:href="elv-20251231.xsd#EmployeeBenefitPlanSubsequentEventTables"/>
  <link:definitionLink xlink:role="http://www.elevancehealth.com/role/EmployeeBenefitPlanSubsequentEventTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EbpSubsequentEventLineItems_019e2bea-dc69-79bc-a3ec-f2a8cd3012c0" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EbpSubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EbpSubsequentEventTable_019e2bea-dc69-7e36-b056-096037f53277" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EbpSubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap-ebp_EbpSubsequentEventLineItems_019e2bea-dc69-79bc-a3ec-f2a8cd3012c0" xlink:to="loc_us-gaap-ebp_EbpSubsequentEventTable_019e2bea-dc69-7e36-b056-096037f53277" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_019e2bea-dc69-7e74-b9a4-25d17dbb0232" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap-ebp_EbpSubsequentEventTable_019e2bea-dc69-7e36-b056-096037f53277" xlink:to="loc_dei_LegalEntityAxis_019e2bea-dc69-7e74-b9a4-25d17dbb0232" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_019e2bea-dc69-7e74-b9a4-25d17dbb0232_default" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_019e2bea-dc69-7e74-b9a4-25d17dbb0232" xlink:to="loc_dei_EntityDomain_019e2bea-dc69-7e74-b9a4-25d17dbb0232_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_019e2bea-dc69-7a9a-b9b1-55a9e860d421" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_019e2bea-dc69-7e74-b9a4-25d17dbb0232" xlink:to="loc_dei_EntityDomain_019e2bea-dc69-7a9a-b9b1-55a9e860d421" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_EBP003Member_019e2bea-dc69-786c-9056-801000c614a8" xlink:href="elv-20251231.xsd#elv_EBP003Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_019e2bea-dc69-7a9a-b9b1-55a9e860d421" xlink:to="loc_elv_EBP003Member_019e2bea-dc69-786c-9056-801000c614a8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanSubsequentEventTextBlock_019e2bea-dc69-79d1-8e04-77c1688635dc" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanSubsequentEventTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EbpSubsequentEventLineItems_019e2bea-dc69-79bc-a3ec-f2a8cd3012c0" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanSubsequentEventTextBlock_019e2bea-dc69-79d1-8e04-77c1688635dc" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/EmployeeBenefitPlanSummaryofAccountingPolicyTables" xlink:type="simple" xlink:href="elv-20251231.xsd#EmployeeBenefitPlanSummaryofAccountingPolicyTables"/>
  <link:definitionLink xlink:role="http://www.elevancehealth.com/role/EmployeeBenefitPlanSummaryofAccountingPolicyTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanAccountingPolicyLineItems_019e97be-7aae-7b07-a340-3086ca5ee31c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanAccountingPolicyLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanAccountingPolicyTable_019e97be-7aae-7866-975d-a415188085da" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanAccountingPolicyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanAccountingPolicyLineItems_019e97be-7aae-7b07-a340-3086ca5ee31c" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanAccountingPolicyTable_019e97be-7aae-7866-975d-a415188085da" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_019e97be-7aae-79ca-bbc7-c3055f823ef0" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanAccountingPolicyTable_019e97be-7aae-7866-975d-a415188085da" xlink:to="loc_dei_LegalEntityAxis_019e97be-7aae-79ca-bbc7-c3055f823ef0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_019e97be-7aae-79ca-bbc7-c3055f823ef0_default" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_019e97be-7aae-79ca-bbc7-c3055f823ef0" xlink:to="loc_dei_EntityDomain_019e97be-7aae-79ca-bbc7-c3055f823ef0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_019e97be-7aae-793c-bb3b-494b00ca56a5" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_019e97be-7aae-79ca-bbc7-c3055f823ef0" xlink:to="loc_dei_EntityDomain_019e97be-7aae-793c-bb3b-494b00ca56a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_EBP003Member_019e97be-7aae-7ce4-8ac8-374c39f6d316" xlink:href="elv-20251231.xsd#elv_EBP003Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_019e97be-7aae-793c-bb3b-494b00ca56a5" xlink:to="loc_elv_EBP003Member_019e97be-7aae-7ce4-8ac8-374c39f6d316" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanSummaryOfAccountingPolicyTextBlock_019e97be-7aae-76be-8fd0-ef1c3511cf90" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanSummaryOfAccountingPolicyTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanAccountingPolicyLineItems_019e97be-7aae-7b07-a340-3086ca5ee31c" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanSummaryOfAccountingPolicyTextBlock_019e97be-7aae-76be-8fd0-ef1c3511cf90" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanBasisOfAccountingPolicyTextBlock_019ead70-38d4-7863-a86e-36b9dc97c372" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanBasisOfAccountingPolicyTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanAccountingPolicyLineItems_019e97be-7aae-7b07-a340-3086ca5ee31c" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanBasisOfAccountingPolicyTextBlock_019ead70-38d4-7863-a86e-36b9dc97c372" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanUseOfEstimatePolicyTextBlock_019ead72-ec2a-7a25-88e0-aef9e0268885" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanUseOfEstimatePolicyTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanAccountingPolicyLineItems_019e97be-7aae-7b07-a340-3086ca5ee31c" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanUseOfEstimatePolicyTextBlock_019ead72-ec2a-7a25-88e0-aef9e0268885" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentPolicyTextBlock_019ead73-9a53-7daf-bfd6-e76b1f235e17" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanInvestmentPolicyTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanAccountingPolicyLineItems_019e97be-7aae-7b07-a340-3086ca5ee31c" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentPolicyTextBlock_019ead73-9a53-7daf-bfd6-e76b1f235e17" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanNoteReceivableFromParticipantPolicyTextBlock_019ead73-f594-72d0-9df8-0c48030993e6" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanNoteReceivableFromParticipantPolicyTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanAccountingPolicyLineItems_019e97be-7aae-7b07-a340-3086ca5ee31c" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanNoteReceivableFromParticipantPolicyTextBlock_019ead73-f594-72d0-9df8-0c48030993e6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanPaymentToParticipantPolicyTextBlock_019ead74-4882-7b88-85c9-81d385fe550b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanPaymentToParticipantPolicyTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanAccountingPolicyLineItems_019e97be-7aae-7b07-a340-3086ca5ee31c" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanPaymentToParticipantPolicyTextBlock_019ead74-4882-7b88-85c9-81d385fe550b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanExpensePolicyTextBlock_019ead74-a1b1-73bb-ae1c-26eb41735f42" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanExpensePolicyTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanAccountingPolicyLineItems_019e97be-7aae-7b07-a340-3086ca5ee31c" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanExpensePolicyTextBlock_019ead74-a1b1-73bb-ae1c-26eb41735f42" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_EBPAccountingPolicyAdoptionPolicyTextBlock_019ead78-e63c-7d8f-a1ff-97f2436814ea" xlink:href="elv-20251231.xsd#elv_EBPAccountingPolicyAdoptionPolicyTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanAccountingPolicyLineItems_019e97be-7aae-7b07-a340-3086ca5ee31c" xlink:to="loc_elv_EBPAccountingPolicyAdoptionPolicyTextBlock_019ead78-e63c-7d8f-a1ff-97f2436814ea" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/EmployeeBenefitPlanReconciliationofFinancialStatementtoForm5500Tables" xlink:type="simple" xlink:href="elv-20251231.xsd#EmployeeBenefitPlanReconciliationofFinancialStatementtoForm5500Tables"/>
  <link:definitionLink xlink:role="http://www.elevancehealth.com/role/EmployeeBenefitPlanReconciliationofFinancialStatementtoForm5500Tables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500LineItems_019ddeca-b962-7f7b-b98a-8c917ff9cd2c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500LineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500Table_019ddeca-b962-7d1d-8976-5061ccdbe078" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500Table"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500LineItems_019ddeca-b962-7f7b-b98a-8c917ff9cd2c" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500Table_019ddeca-b962-7d1d-8976-5061ccdbe078" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_019ddeca-b962-789a-a213-8a16d4eea42e" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500Table_019ddeca-b962-7d1d-8976-5061ccdbe078" xlink:to="loc_dei_LegalEntityAxis_019ddeca-b962-789a-a213-8a16d4eea42e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_019ddeca-b962-789a-a213-8a16d4eea42e_default" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_019ddeca-b962-789a-a213-8a16d4eea42e" xlink:to="loc_dei_EntityDomain_019ddeca-b962-789a-a213-8a16d4eea42e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_019ddeca-b962-775f-b5b9-5ca50b5a81a5" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_019ddeca-b962-789a-a213-8a16d4eea42e" xlink:to="loc_dei_EntityDomain_019ddeca-b962-775f-b5b9-5ca50b5a81a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_EBP003Member_019ddeca-fec5-7899-97f9-fbeb00084e27" xlink:href="elv-20251231.xsd#elv_EBP003Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_019ddeca-b962-775f-b5b9-5ca50b5a81a5" xlink:to="loc_elv_EBP003Member_019ddeca-fec5-7899-97f9-fbeb00084e27" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500TextBlock_019e2bcd-9b4e-7e64-b61e-bdc4219d41a6" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500TextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500LineItems_019ddeca-b962-7f7b-b98a-8c917ff9cd2c" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500TextBlock_019e2bcd-9b4e-7e64-b61e-bdc4219d41a6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500TableTextBlock_019eadad-3a98-77f3-9474-2f7b9c9bcaad" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500TableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500LineItems_019ddeca-b962-7f7b-b98a-8c917ff9cd2c" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500TableTextBlock_019eadad-3a98-77f3-9474-2f7b9c9bcaad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanNetAssetAvailableForBenefit_019ddecd-1f10-7696-9e9e-af30c0bd30b7" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanNetAssetAvailableForBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500LineItems_019ddeca-b962-7f7b-b98a-8c917ff9cd2c" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanNetAssetAvailableForBenefit_019ddecd-1f10-7696-9e9e-af30c0bd30b7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500NetAssetAvailableForBenefitDeemedDistribution_019e1d73-920e-7aa2-aab6-e0d1ad76155b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500NetAssetAvailableForBenefitDeemedDistribution"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500LineItems_019ddeca-b962-7f7b-b98a-8c917ff9cd2c" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500NetAssetAvailableForBenefitDeemedDistribution_019e1d73-920e-7aa2-aab6-e0d1ad76155b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanForm5500CaptionNetAssetAvailableForBenefit_019ddecb-d510-7db5-b328-11736d30f5b7" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanForm5500CaptionNetAssetAvailableForBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500LineItems_019ddeca-b962-7f7b-b98a-8c917ff9cd2c" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanForm5500CaptionNetAssetAvailableForBenefit_019ddecb-d510-7db5-b328-11736d30f5b7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecrease_019dded3-4ecd-7950-bc10-91a7100edb46" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500LineItems_019ddeca-b962-7f7b-b98a-8c917ff9cd2c" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecrease_019dded3-4ecd-7950-bc10-91a7100edb46" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500PaymentToParticipantIncreaseDecreaseForDeemedDistribution_019ddeca-b962-7070-b971-d10e94ed4068" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500PaymentToParticipantIncreaseDecreaseForDeemedDistribution"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500LineItems_019ddeca-b962-7f7b-b98a-8c917ff9cd2c" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500PaymentToParticipantIncreaseDecreaseForDeemedDistribution_019ddeca-b962-7070-b971-d10e94ed4068" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanForm5500CaptionNetIncomeLoss_019ddecf-f211-7d61-be98-0025572bec23" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanForm5500CaptionNetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500LineItems_019ddeca-b962-7f7b-b98a-8c917ff9cd2c" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanForm5500CaptionNetIncomeLoss_019ddecf-f211-7d61-be98-0025572bec23" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/EmployeeBenefitPlanRelatedPartyandPartyinInterestTransactionsDetails" xlink:type="simple" xlink:href="elv-20251231.xsd#EmployeeBenefitPlanRelatedPartyandPartyinInterestTransactionsDetails"/>
  <link:definitionLink xlink:role="http://www.elevancehealth.com/role/EmployeeBenefitPlanRelatedPartyandPartyinInterestTransactionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsLineItems_019ddea1-5fc4-7f88-9c03-a19f3492204c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsTable_019ddea1-5fc4-7a61-9bec-d694617c232b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsLineItems_019ddea1-5fc4-7f88-9c03-a19f3492204c" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsTable_019ddea1-5fc4-7a61-9bec-d694617c232b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_019ddea1-5fc4-7c14-8b1d-d35db1ab3d41" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsTable_019ddea1-5fc4-7a61-9bec-d694617c232b" xlink:to="loc_dei_LegalEntityAxis_019ddea1-5fc4-7c14-8b1d-d35db1ab3d41" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_019ddea1-5fc4-7c14-8b1d-d35db1ab3d41_default" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_019ddea1-5fc4-7c14-8b1d-d35db1ab3d41" xlink:to="loc_dei_EntityDomain_019ddea1-5fc4-7c14-8b1d-d35db1ab3d41_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_019ddea1-5fc4-7aae-8b48-4b7b8cf73b4e" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_019ddea1-5fc4-7c14-8b1d-d35db1ab3d41" xlink:to="loc_dei_EntityDomain_019ddea1-5fc4-7aae-8b48-4b7b8cf73b4e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_EBP003Member_019ddea1-bacc-7b87-a506-60a4dd2e9cbf" xlink:href="elv-20251231.xsd#elv_EBP003Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_019ddea1-5fc4-7aae-8b48-4b7b8cf73b4e" xlink:to="loc_elv_EBP003Member_019ddea1-bacc-7b87-a506-60a4dd2e9cbf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestAxis_019ddea1-5fc4-7c0d-8d0a-2fc3df9e3316" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsTable_019ddea1-5fc4-7a61-9bec-d694617c232b" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestAxis_019ddea1-5fc4-7c0d-8d0a-2fc3df9e3316" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestDomain_019ddea1-5fc4-7c0d-8d0a-2fc3df9e3316_default" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestAxis_019ddea1-5fc4-7c0d-8d0a-2fc3df9e3316" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestDomain_019ddea1-5fc4-7c0d-8d0a-2fc3df9e3316_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestDomain_019ddea1-5fc4-73a9-9b03-4a71d7f6a866" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestAxis_019ddea1-5fc4-7c0d-8d0a-2fc3df9e3316" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestDomain_019ddea1-5fc4-73a9-9b03-4a71d7f6a866" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyMember_019ddec3-5e47-7b32-8e2c-d393322dcbcc" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RelatedPartyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestDomain_019ddea1-5fc4-73a9-9b03-4a71d7f6a866" xlink:to="loc_us-gaap_RelatedPartyMember_019ddec3-5e47-7b32-8e2c-d393322dcbcc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsTextBlock_019e2bc8-5155-7332-8c57-1114be2cd59e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsLineItems_019ddea1-5fc4-7f88-9c03-a19f3492204c" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsTextBlock_019e2bc8-5155-7332-8c57-1114be2cd59e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecreaseForAdministrativeExpense_019ddea1-5fc4-712c-b022-47faa2361594" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecreaseForAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsLineItems_019ddea1-5fc4-7f88-9c03-a19f3492204c" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecreaseForAdministrativeExpense_019ddea1-5fc4-712c-b022-47faa2361594" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentNumberOfShares_019ddea2-7de8-7cf7-b588-73f9fea23dbe" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanInvestmentNumberOfShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsLineItems_019ddea1-5fc4-7f88-9c03-a19f3492204c" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentNumberOfShares_019ddea2-7de8-7cf7-b588-73f9fea23dbe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentNumberOfSharesSold_019ddea4-0618-757d-8994-10d26bba9065" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanInvestmentNumberOfSharesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsLineItems_019ddea1-5fc4-7f88-9c03-a19f3492204c" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentNumberOfSharesSold_019ddea4-0618-757d-8994-10d26bba9065" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForDividendIncomeOnInvestment_019ddea5-2191-74bf-ba0d-c7bb26493cd2" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForDividendIncomeOnInvestment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsLineItems_019ddea1-5fc4-7f88-9c03-a19f3492204c" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForDividendIncomeOnInvestment_019ddea5-2191-74bf-ba0d-c7bb26493cd2" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/EmployeeBenefitPlanScheduleAssetHeldforInvestmentDetails" xlink:type="simple" xlink:href="elv-20251231.xsd#EmployeeBenefitPlanScheduleAssetHeldforInvestmentDetails"/>
  <link:definitionLink xlink:role="http://www.elevancehealth.com/role/EmployeeBenefitPlanScheduleAssetHeldforInvestmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentLineItems_019e0781-94f1-7e83-b780-415405724b10" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentTable_019dfed2-c440-7ff2-b3db-5d5b40a0dfec" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentLineItems_019e0781-94f1-7e83-b780-415405724b10" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentTable_019dfed2-c440-7ff2-b3db-5d5b40a0dfec" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIdentifierAxis_019dfa16-fa6e-7ebc-ada9-15a5712afcbc" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InvestmentIdentifierAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentTable_019dfed2-c440-7ff2-b3db-5d5b40a0dfec" xlink:to="loc_us-gaap_InvestmentIdentifierAxis_019dfa16-fa6e-7ebc-ada9-15a5712afcbc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_019dfed2-f489-70a8-ba74-403510695c12" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentTable_019dfed2-c440-7ff2-b3db-5d5b40a0dfec" xlink:to="loc_dei_LegalEntityAxis_019dfed2-f489-70a8-ba74-403510695c12" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_019dfed2-f489-70a8-ba74-403510695c12_default" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_019dfed2-f489-70a8-ba74-403510695c12" xlink:to="loc_dei_EntityDomain_019dfed2-f489-70a8-ba74-403510695c12_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_019dfed2-f489-72d2-8dcb-3919e8a53cbc" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_019dfed2-f489-70a8-ba74-403510695c12" xlink:to="loc_dei_EntityDomain_019dfed2-f489-72d2-8dcb-3919e8a53cbc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_EBP003Member_019dfed3-0976-7a8a-ad86-b550f594e324" xlink:href="elv-20251231.xsd#elv_EBP003Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_019dfed2-f489-72d2-8dcb-3919e8a53cbc" xlink:to="loc_elv_EBP003Member_019dfed3-0976-7a8a-ad86-b550f594e324" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_019e0784-eb32-7900-9084-98a8dc1c7bfb" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentTable_019dfed2-c440-7ff2-b3db-5d5b40a0dfec" xlink:to="loc_srt_RangeAxis_019e0784-eb32-7900-9084-98a8dc1c7bfb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019e0784-eb32-7900-9084-98a8dc1c7bfb_default" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_019e0784-eb32-7900-9084-98a8dc1c7bfb" xlink:to="loc_srt_RangeMember_019e0784-eb32-7900-9084-98a8dc1c7bfb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019e0784-eb32-72e3-b02b-cfcee1c23602" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_019e0784-eb32-7900-9084-98a8dc1c7bfb" xlink:to="loc_srt_RangeMember_019e0784-eb32-72e3-b02b-cfcee1c23602" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_019e0784-eb32-7fe9-a6aa-f7b7b7bd228a" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_019e0784-eb32-72e3-b02b-cfcee1c23602" xlink:to="loc_srt_MinimumMember_019e0784-eb32-7fe9-a6aa-f7b7b7bd228a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_019e0785-8a38-7211-986f-afca019bd681" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_019e0784-eb32-72e3-b02b-cfcee1c23602" xlink:to="loc_srt_MaximumMember_019e0785-8a38-7211-986f-afca019bd681" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentTableTextBlock_019eadb0-b6da-7143-a261-ce32a36af2b8" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentLineItems_019e0781-94f1-7e83-b780-415405724b10" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentTableTextBlock_019eadb0-b6da-7143-a261-ce32a36af2b8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanAssetHeldForInvestmentPartyInInterest_019e0781-94f1-7d4a-9884-11be345e1a59" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanAssetHeldForInvestmentPartyInInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentLineItems_019e0781-94f1-7e83-b780-415405724b10" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanAssetHeldForInvestmentPartyInInterest_019e0781-94f1-7d4a-9884-11be345e1a59" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentIssuerNameExtensibleEnumeration_019e0781-a8b6-74a1-bb4b-acce14246c96" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanInvestmentIssuerNameExtensibleEnumeration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentLineItems_019e0781-94f1-7e83-b780-415405724b10" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentIssuerNameExtensibleEnumeration_019e0781-a8b6-74a1-bb4b-acce14246c96" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentTypeExtensibleEnumeration_019e0781-b81a-731c-8121-9727e878d4e7" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanInvestmentTypeExtensibleEnumeration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentLineItems_019e0781-94f1-7e83-b780-415405724b10" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentTypeExtensibleEnumeration_019e0781-b81a-731c-8121-9727e878d4e7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanAssetHeldForInvestmentPlanInterestInMasterTrustParticipationStatusExtensibleEnumeration_019e0781-c87c-75e2-8431-c5fcd3f6bdbb" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanAssetHeldForInvestmentPlanInterestInMasterTrustParticipationStatusExtensibleEnumeration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentLineItems_019e0781-94f1-7e83-b780-415405724b10" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanAssetHeldForInvestmentPlanInterestInMasterTrustParticipationStatusExtensibleEnumeration_019e0781-c87c-75e2-8431-c5fcd3f6bdbb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentPlanInterestInMasterTrustFairValue_019e9488-cc66-7884-a920-81974336be17" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanInvestmentPlanInterestInMasterTrustFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentLineItems_019e0781-94f1-7e83-b780-415405724b10" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentPlanInterestInMasterTrustFairValue_019e9488-cc66-7884-a920-81974336be17" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanParticipantLoanInterestRate_019e0781-f5f1-7c54-a546-ca7fc84fed75" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanParticipantLoanInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentLineItems_019e0781-94f1-7e83-b780-415405724b10" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanParticipantLoanInterestRate_019e0781-f5f1-7c54-a546-ca7fc84fed75" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanParticipantLoanMaturityDate_019e0782-0c07-7da0-958e-692205db6641" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanParticipantLoanMaturityDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentLineItems_019e0781-94f1-7e83-b780-415405724b10" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanParticipantLoanMaturityDate_019e0782-0c07-7da0-958e-692205db6641" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanAssetHeldForInvestmentParticipantLoanAfterDeemedDistribution_019e0782-1cbd-703d-b8ba-5d9c154500c0" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanAssetHeldForInvestmentParticipantLoanAfterDeemedDistribution"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentLineItems_019e0781-94f1-7e83-b780-415405724b10" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanAssetHeldForInvestmentParticipantLoanAfterDeemedDistribution_019e0782-1cbd-703d-b8ba-5d9c154500c0" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_019e0788-8ff5-750a-a444-a265b2d31d21" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentLineItems_019e0781-94f1-7e83-b780-415405724b10" xlink:to="loc_dei_EntityTaxIdentificationNumber_019e0788-8ff5-750a-a444-a265b2d31d21" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanPlanNumber_019e0788-aeec-75a2-a23c-b98125901b9a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanPlanNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentLineItems_019e0781-94f1-7e83-b780-415405724b10" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanPlanNumber_019e0788-aeec-75a2-a23c-b98125901b9a" xlink:type="arc" order="10"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/EmployeeBenefitPlanScheduleAssetHeldforInvestmentDetails_1" xlink:type="simple" xlink:href="elv-20251231.xsd#EmployeeBenefitPlanScheduleAssetHeldforInvestmentDetails_1"/>
  <link:definitionLink xlink:role="http://www.elevancehealth.com/role/EmployeeBenefitPlanScheduleAssetHeldforInvestmentDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentLineItems_019e0781-94f1-7e83-b780-415405724b10" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentTable_019dfed2-c440-7ff2-b3db-5d5b40a0dfec" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentLineItems_019e0781-94f1-7e83-b780-415405724b10" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentTable_019dfed2-c440-7ff2-b3db-5d5b40a0dfec" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_019dfed2-f489-70a8-ba74-403510695c12" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentTable_019dfed2-c440-7ff2-b3db-5d5b40a0dfec" xlink:to="loc_dei_LegalEntityAxis_019dfed2-f489-70a8-ba74-403510695c12" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_019dfed2-f489-70a8-ba74-403510695c12_default" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_019dfed2-f489-70a8-ba74-403510695c12" xlink:to="loc_dei_EntityDomain_019dfed2-f489-70a8-ba74-403510695c12_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_019dfed2-f489-72d2-8dcb-3919e8a53cbc" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_019dfed2-f489-70a8-ba74-403510695c12" xlink:to="loc_dei_EntityDomain_019dfed2-f489-72d2-8dcb-3919e8a53cbc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_EBP003Member_019dfed3-0976-7a8a-ad86-b550f594e324" xlink:href="elv-20251231.xsd#elv_EBP003Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_019dfed2-f489-72d2-8dcb-3919e8a53cbc" xlink:to="loc_elv_EBP003Member_019dfed3-0976-7a8a-ad86-b550f594e324" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_019e0784-eb32-7900-9084-98a8dc1c7bfb" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentTable_019dfed2-c440-7ff2-b3db-5d5b40a0dfec" xlink:to="loc_srt_RangeAxis_019e0784-eb32-7900-9084-98a8dc1c7bfb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019e0784-eb32-7900-9084-98a8dc1c7bfb_default" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_019e0784-eb32-7900-9084-98a8dc1c7bfb" xlink:to="loc_srt_RangeMember_019e0784-eb32-7900-9084-98a8dc1c7bfb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019e0784-eb32-72e3-b02b-cfcee1c23602" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_019e0784-eb32-7900-9084-98a8dc1c7bfb" xlink:to="loc_srt_RangeMember_019e0784-eb32-72e3-b02b-cfcee1c23602" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_019e0784-eb32-7fe9-a6aa-f7b7b7bd228a" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_019e0784-eb32-72e3-b02b-cfcee1c23602" xlink:to="loc_srt_MinimumMember_019e0784-eb32-7fe9-a6aa-f7b7b7bd228a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_019e0785-8a38-7211-986f-afca019bd681" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_019e0784-eb32-72e3-b02b-cfcee1c23602" xlink:to="loc_srt_MaximumMember_019e0785-8a38-7211-986f-afca019bd681" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentTableTextBlock_019eadb0-b6da-7143-a261-ce32a36af2b8" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentLineItems_019e0781-94f1-7e83-b780-415405724b10" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentTableTextBlock_019eadb0-b6da-7143-a261-ce32a36af2b8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanAssetHeldForInvestmentPartyInInterest_019e0781-94f1-7d4a-9884-11be345e1a59" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanAssetHeldForInvestmentPartyInInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentLineItems_019e0781-94f1-7e83-b780-415405724b10" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanAssetHeldForInvestmentPartyInInterest_019e0781-94f1-7d4a-9884-11be345e1a59" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentIssuerNameExtensibleEnumeration_019e0781-a8b6-74a1-bb4b-acce14246c96" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanInvestmentIssuerNameExtensibleEnumeration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentLineItems_019e0781-94f1-7e83-b780-415405724b10" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentIssuerNameExtensibleEnumeration_019e0781-a8b6-74a1-bb4b-acce14246c96" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentTypeExtensibleEnumeration_019e0781-b81a-731c-8121-9727e878d4e7" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanInvestmentTypeExtensibleEnumeration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentLineItems_019e0781-94f1-7e83-b780-415405724b10" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentTypeExtensibleEnumeration_019e0781-b81a-731c-8121-9727e878d4e7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanAssetHeldForInvestmentPlanInterestInMasterTrustParticipationStatusExtensibleEnumeration_019e0781-c87c-75e2-8431-c5fcd3f6bdbb" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanAssetHeldForInvestmentPlanInterestInMasterTrustParticipationStatusExtensibleEnumeration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentLineItems_019e0781-94f1-7e83-b780-415405724b10" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanAssetHeldForInvestmentPlanInterestInMasterTrustParticipationStatusExtensibleEnumeration_019e0781-c87c-75e2-8431-c5fcd3f6bdbb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentPlanInterestInMasterTrustFairValue_019e9488-cc66-7884-a920-81974336be17" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanInvestmentPlanInterestInMasterTrustFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentLineItems_019e0781-94f1-7e83-b780-415405724b10" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentPlanInterestInMasterTrustFairValue_019e9488-cc66-7884-a920-81974336be17" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanParticipantLoanInterestRate_019e0781-f5f1-7c54-a546-ca7fc84fed75" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanParticipantLoanInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentLineItems_019e0781-94f1-7e83-b780-415405724b10" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanParticipantLoanInterestRate_019e0781-f5f1-7c54-a546-ca7fc84fed75" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanParticipantLoanMaturityDate_019e0782-0c07-7da0-958e-692205db6641" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanParticipantLoanMaturityDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentLineItems_019e0781-94f1-7e83-b780-415405724b10" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanParticipantLoanMaturityDate_019e0782-0c07-7da0-958e-692205db6641" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanAssetHeldForInvestmentParticipantLoanAfterDeemedDistribution_019e0782-1cbd-703d-b8ba-5d9c154500c0" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanAssetHeldForInvestmentParticipantLoanAfterDeemedDistribution"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentLineItems_019e0781-94f1-7e83-b780-415405724b10" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanAssetHeldForInvestmentParticipantLoanAfterDeemedDistribution_019e0782-1cbd-703d-b8ba-5d9c154500c0" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_019e0788-8ff5-750a-a444-a265b2d31d21" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentLineItems_019e0781-94f1-7e83-b780-415405724b10" xlink:to="loc_dei_EntityTaxIdentificationNumber_019e0788-8ff5-750a-a444-a265b2d31d21" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanPlanNumber_019e0788-aeec-75a2-a23c-b98125901b9a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanPlanNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentLineItems_019e0781-94f1-7e83-b780-415405724b10" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanPlanNumber_019e0788-aeec-75a2-a23c-b98125901b9a" xlink:type="arc" order="10"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/srt/role/srt-eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-roles-2026.xsd#eedm1"/>
  <link:definitionLink xlink:role="http://fasb.org/srt/role/srt-eedm/ExtensibleEnumerationLists" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIssuerNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InvestmentIssuerNameDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_JPMorganMember_019ed116-2478-7567-ab69-206437a90e43" xlink:href="elv-20251231.xsd#elv_JPMorganMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentIssuerNameDomain" xlink:to="loc_elv_JPMorganMember_019ed116-2478-7567-ab69-206437a90e43" xlink:type="arc" order="11"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>elv-20251231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019d97e9-6345-7c3e-aadc-cd30fd2ce9cd,g:dc9c1a7d-ae85-4e42-ad7d-8ea7d89a0d3f-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_EntityTaxIdentificationNumber_019dfed2-c440-7350-8c4f-7ce19e9f2a5f_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EIN</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValue_019d9d33-6a6c-7b05-914b-981a30eac4b4_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investments at fair value</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValue_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Investment, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValue" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForParticipantContributionRollover_019dcf2a-2090-7729-8827-19f7b168aa8d_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForParticipantContributionRollover" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contributions, Participant rollover</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForParticipantContributionRollover_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForParticipantContributionRollover" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Change in Net Asset Available for Benefit, Increase from Participant Contribution, Rollover</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForParticipantContributionRollover" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForParticipantContributionRollover"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForParticipantContributionRollover" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForParticipantContributionRollover" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_019ddfac-2fde-731d-96da-6b6a751137e8_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanForfeitedNonvestedAccountDecreaseForAdministrativeExpense_019e838d-4bfd-76dc-bafe-3b3c62e35ffb_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanForfeitedNonvestedAccountDecreaseForAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EBP, Forfeited Nonvested Account, Decrease from Administrative Expense</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanForfeitedNonvestedAccountDecreaseForAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanForfeitedNonvestedAccountDecreaseForAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Forfeited Nonvested Account, Decrease from Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanForfeitedNonvestedAccountDecreaseForAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanForfeitedNonvestedAccountDecreaseForAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanForfeitedNonvestedAccountDecreaseForAdministrativeExpense" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanForfeitedNonvestedAccountDecreaseForAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_EBPParticipantCatchUpContributionMinimumAge_019e41bb-5d61-7251-a210-7ffcf4246b89_terseLabel_en-US" xlink:label="lab_elv_EBPParticipantCatchUpContributionMinimumAge" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EBP Participant Catch Up Contribution Minimum Age</link:label>
    <link:label id="lab_elv_EBPParticipantCatchUpContributionMinimumAge_label_en-US" xlink:label="lab_elv_EBPParticipantCatchUpContributionMinimumAge" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Participant Catch Up Contribution Minimum Age</link:label>
    <link:label id="lab_elv_EBPParticipantCatchUpContributionMinimumAge_documentation_en-US" xlink:label="lab_elv_EBPParticipantCatchUpContributionMinimumAge" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">EBP, Participant Catch Up Contribution Minimum Age</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_EBPParticipantCatchUpContributionMinimumAge" xlink:href="elv-20251231.xsd#elv_EBPParticipantCatchUpContributionMinimumAge"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_EBPParticipantCatchUpContributionMinimumAge" xlink:to="lab_elv_EBPParticipantCatchUpContributionMinimumAge" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_019d9d14-9069-70e4-a422-33707534fde3_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_019ddf9d-77e2-7eeb-8e3a-5780acaaff0e_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanTable_019dde8f-405f-7f44-a362-324e6f248dd8_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EBP, Description of Plan [Table]</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanTable_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Description of Plan [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanTable" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanTable" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MutualFundMember_019dd9ed-f06f-7ad6-9166-d95d427e3976_terseLabel_en-US" xlink:label="lab_us-gaap_MutualFundMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Mutual Fund</link:label>
    <link:label id="lab_us-gaap_MutualFundMember_label_en-US" xlink:label="lab_us-gaap_MutualFundMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Mutual Fund [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MutualFundMember" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_MutualFundMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MutualFundMember" xlink:to="lab_us-gaap_MutualFundMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsTable_019ddea1-5fc4-7961-b7cb-43c5ab33567c_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EBP, Related Party and Party-in-Interest Transactions [Table]</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsTable_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Related Party and Party-in-Interest Transactions [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsTable" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_EBPEmployerMatchTrancheAxis_019e41ab-0f31-7ddb-9f6b-5ef8f5698cfa_terseLabel_en-US" xlink:label="lab_elv_EBPEmployerMatchTrancheAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EBP Employer Match Tranche [Axis]</link:label>
    <link:label id="lab_elv_EBPEmployerMatchTrancheAxis_label_en-US" xlink:label="lab_elv_EBPEmployerMatchTrancheAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Employer Match Tranche [Axis]</link:label>
    <link:label id="lab_elv_EBPEmployerMatchTrancheAxis_documentation_en-US" xlink:label="lab_elv_EBPEmployerMatchTrancheAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">EBP, Employer Match Tranche</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_EBPEmployerMatchTrancheAxis" xlink:href="elv-20251231.xsd#elv_EBPEmployerMatchTrancheAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_EBPEmployerMatchTrancheAxis" xlink:to="lab_elv_EBPEmployerMatchTrancheAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanSelfDirectedBrokerageAccountMember_019dd9ee-79e2-7d2f-a2b8-311a193a54bf_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanSelfDirectedBrokerageAccountMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Self-directed brokerage accounts</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanSelfDirectedBrokerageAccountMember_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanSelfDirectedBrokerageAccountMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Self-Directed Brokerage Account [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanSelfDirectedBrokerageAccountMember" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanSelfDirectedBrokerageAccountMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanSelfDirectedBrokerageAccountMember" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanSelfDirectedBrokerageAccountMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecrease_019e1ca1-e2f7-7052-bba0-c4300cdc3fe3_totalLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecrease" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total deductions</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecrease_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Change in Net Asset Available for Benefit, Decrease</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecrease" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavTextBlock_019e2bc0-61c5-7ba6-9a6c-6e9a507ba149_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EBP, Investment, Fair Value and NAV - Text Block</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavTextBlock_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Investment, Fair Value and NAV [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavTextBlock" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanNoteReceivableFromParticipantAccountMaximumBorrowingAmount_019e2838-b666-71f9-8488-d184b4c0f2ae_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanNoteReceivableFromParticipantAccountMaximumBorrowingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EBP, Note Receivable from Participant, Account, Maximum Borrowing, Amount</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanNoteReceivableFromParticipantAccountMaximumBorrowingAmount_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanNoteReceivableFromParticipantAccountMaximumBorrowingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Note Receivable from Participant, Account, Maximum Borrowing, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanNoteReceivableFromParticipantAccountMaximumBorrowingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanNoteReceivableFromParticipantAccountMaximumBorrowingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanNoteReceivableFromParticipantAccountMaximumBorrowingAmount" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanNoteReceivableFromParticipantAccountMaximumBorrowingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue_019dcf23-b453-79dd-a030-328fb7fab0f6_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EBP, Investment, Excluding Plan Interest in Master Trust, Fair Value</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Investment, Excluding Plan Interest in Master Trust, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedPlanInterestInMasterTrustMember_019dd9e4-37c4-7945-b725-1d2f133e2446_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedPlanInterestInMasterTrustMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EBP, Nonconsolidated, Plan Interest in Master Trust</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedPlanInterestInMasterTrustMember_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedPlanInterestInMasterTrustMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Nonconsolidated, Plan Interest in Master Trust [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedPlanInterestInMasterTrustMember" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedPlanInterestInMasterTrustMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedPlanInterestInMasterTrustMember" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedPlanInterestInMasterTrustMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_019ddabe-025b-732e-b4ac-b32d69608306_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500TableTextBlock_019eadad-0410-7a71-80bb-e210b1443dc6_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500TableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EBP, Reconciliation of Financial Statement to Form 5500 - Table Text Block</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500TableTextBlock_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500TableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Reconciliation of Financial Statement to Form 5500 [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500TableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500TableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500TableTextBlock" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500TableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_EBPAccountingPolicyAdoptionPolicyTextBlock_019ead78-e63c-7926-a844-6185797c431c_terseLabel_en-US" xlink:label="lab_elv_EBPAccountingPolicyAdoptionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EBP, Accounting Policy Adoption</link:label>
    <link:label id="lab_elv_EBPAccountingPolicyAdoptionPolicyTextBlock_label_en-US" xlink:label="lab_elv_EBPAccountingPolicyAdoptionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Accounting Policy Adoption [Policy Text Block]</link:label>
    <link:label id="lab_elv_EBPAccountingPolicyAdoptionPolicyTextBlock_documentation_en-US" xlink:label="lab_elv_EBPAccountingPolicyAdoptionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">EBP, Accounting Policy Adoption</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_EBPAccountingPolicyAdoptionPolicyTextBlock" xlink:href="elv-20251231.xsd#elv_EBPAccountingPolicyAdoptionPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_EBPAccountingPolicyAdoptionPolicyTextBlock" xlink:to="lab_elv_EBPAccountingPolicyAdoptionPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_EBPEmployerMatchTrancheOneMember_019e41ab-67ea-7bda-a63c-731b9fe9ccc9_terseLabel_en-US" xlink:label="lab_elv_EBPEmployerMatchTrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EBP Employer Match Tranche One</link:label>
    <link:label id="lab_elv_EBPEmployerMatchTrancheOneMember_label_en-US" xlink:label="lab_elv_EBPEmployerMatchTrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Employer Match Tranche One [Member]</link:label>
    <link:label id="lab_elv_EBPEmployerMatchTrancheOneMember_documentation_en-US" xlink:label="lab_elv_EBPEmployerMatchTrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">EBP, Employer Match Tranche One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_EBPEmployerMatchTrancheOneMember" xlink:href="elv-20251231.xsd#elv_EBPEmployerMatchTrancheOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_EBPEmployerMatchTrancheOneMember" xlink:to="lab_elv_EBPEmployerMatchTrancheOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavAbstract_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Investment, Fair Value and NAV [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavAbstract" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_019ddf9d-77e2-73df-94a5-349262ed7cd4_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanStatementOfChangeInNetAssetAvailableForBenefitTable_019d9d41-4c4a-7dde-a5ec-b6c8dfcd151d_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanStatementOfChangeInNetAssetAvailableForBenefitTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EBP, Statement of Change in Net Asset Available for Benefit [Table]</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanStatementOfChangeInNetAssetAvailableForBenefitTable_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanStatementOfChangeInNetAssetAvailableForBenefitTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Statement of Change in Net Asset Available for Benefit [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanStatementOfChangeInNetAssetAvailableForBenefitTable" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanStatementOfChangeInNetAssetAvailableForBenefitTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanStatementOfChangeInNetAssetAvailableForBenefitTable" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanStatementOfChangeInNetAssetAvailableForBenefitTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanPaymentToParticipantPolicyTextBlock_019ead74-4882-788a-bca9-e981eb43db16_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanPaymentToParticipantPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EBP, Payment to Participant</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanPaymentToParticipantPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanPaymentToParticipantPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Payment to Participant [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanPaymentToParticipantPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanPaymentToParticipantPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanPaymentToParticipantPolicyTextBlock" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanPaymentToParticipantPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanMasterTrustLineItems_019d97f4-4b8e-7ab5-8373-47b234db0781_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanMasterTrustLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EBP, Master Trust [Line Items]</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanMasterTrustLineItems_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanMasterTrustLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Master Trust [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanMasterTrustLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanMasterTrustLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanMasterTrustLineItems" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanMasterTrustLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500PaymentToParticipantIncreaseDecreaseForDeemedDistribution_019e83a5-15c6-7d82-ae0a-1a2a8f4d8cc7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500PaymentToParticipantIncreaseDecreaseForDeemedDistribution" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Deemed distributions of participant loans activity</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500PaymentToParticipantIncreaseDecreaseForDeemedDistribution_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500PaymentToParticipantIncreaseDecreaseForDeemedDistribution" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Reconciliation to Form 5500, Payment to Participant, Increase (Decrease) from Deemed Distribution</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500PaymentToParticipantIncreaseDecreaseForDeemedDistribution" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500PaymentToParticipantIncreaseDecreaseForDeemedDistribution"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500PaymentToParticipantIncreaseDecreaseForDeemedDistribution" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500PaymentToParticipantIncreaseDecreaseForDeemedDistribution" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_019e0874-aaae-7bad-83c7-e4d811da107b_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500NetAssetAvailableForBenefitDeemedDistribution_019e1d73-920e-77c2-b17c-41e3d83241bb_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500NetAssetAvailableForBenefitDeemedDistribution" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EBP, Reconciliation to Form 5500, Net Asset Available for Benefit, Deemed Distribution</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500NetAssetAvailableForBenefitDeemedDistribution_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500NetAssetAvailableForBenefitDeemedDistribution" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Reconciliation to Form 5500, Net Asset Available for Benefit, Deemed Distribution</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500NetAssetAvailableForBenefitDeemedDistribution" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500NetAssetAvailableForBenefitDeemedDistribution"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500NetAssetAvailableForBenefitDeemedDistribution" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500NetAssetAvailableForBenefitDeemedDistribution" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanBasisOfAccountingPolicyTextBlock_019ead70-38d4-7c4c-b62d-f7c0f69cb39b_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanBasisOfAccountingPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EBP, Basis of Accounting</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanBasisOfAccountingPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanBasisOfAccountingPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Basis of Accounting [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanBasisOfAccountingPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanBasisOfAccountingPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanBasisOfAccountingPolicyTextBlock" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanBasisOfAccountingPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentTable_019ddf9d-77e2-78e1-8b80-688fbc8f48ec_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EBP, Schedule of Asset Held for Investment [Table]</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentTable_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Schedule of Asset Held for Investment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentTable" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_EBPParticipantContributionIncrementalIncreaseOfAutomaticAnnualEscalation_019e41a5-a71e-7a7f-922c-6775d3548f2b_terseLabel_en-US" xlink:label="lab_elv_EBPParticipantContributionIncrementalIncreaseOfAutomaticAnnualEscalation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EBP, Participant Contribution, incremental increase of automatic annual escalation</link:label>
    <link:label id="lab_elv_EBPParticipantContributionIncrementalIncreaseOfAutomaticAnnualEscalation_label_en-US" xlink:label="lab_elv_EBPParticipantContributionIncrementalIncreaseOfAutomaticAnnualEscalation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Participant Contribution, incremental increase of automatic annual escalation</link:label>
    <link:label id="lab_elv_EBPParticipantContributionIncrementalIncreaseOfAutomaticAnnualEscalation_documentation_en-US" xlink:label="lab_elv_EBPParticipantContributionIncrementalIncreaseOfAutomaticAnnualEscalation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">EBP, Participant Contribution, incremental increase of automatic annual escalation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_EBPParticipantContributionIncrementalIncreaseOfAutomaticAnnualEscalation" xlink:href="elv-20251231.xsd#elv_EBPParticipantContributionIncrementalIncreaseOfAutomaticAnnualEscalation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_EBPParticipantContributionIncrementalIncreaseOfAutomaticAnnualEscalation" xlink:to="lab_elv_EBPParticipantContributionIncrementalIncreaseOfAutomaticAnnualEscalation" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_019e0863-63fd-791a-b8f0-212fee7d8d9c_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanInvestmentNumberOfShares_019ddaee-ea3c-7f69-907b-bf54e5a3a585_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanInvestmentNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investment number of shares/units</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanInvestmentNumberOfShares_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanInvestmentNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Investment, Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentNumberOfShares" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanInvestmentNumberOfShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentNumberOfShares" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanInvestmentNumberOfShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanAbstract_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Description of Plan and Accounting Change [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanAbstract" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavTableTextBlock_019eada8-dece-7fd0-a59a-58ff7859f504_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EBP, Investment, Fair Value and NAV - Table Text Block</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavTableTextBlock_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Investment, Fair Value and NAV [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavTableTextBlock" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_019dd9eb-7f9c-7525-ad5a-0dadb8dceb6e_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investments [Domain]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:to="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanMasterTrustAbstract_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanMasterTrustAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Master Trust [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanMasterTrustAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanMasterTrustAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanMasterTrustAbstract" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanMasterTrustAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanUseOfEstimatePolicyTextBlock_019ead72-ec2a-74a3-ae65-b63376e25f56_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanUseOfEstimatePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EBP, Use of Estimate</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanUseOfEstimatePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanUseOfEstimatePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Use of Estimate [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanUseOfEstimatePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanUseOfEstimatePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanUseOfEstimatePolicyTextBlock" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanUseOfEstimatePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentTableTextBlock_019eadb0-b6da-71a9-97bc-792c902f6fdc_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EBP, Schedule of Asset Held for Investment</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentTableTextBlock_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Schedule of Asset Held for Investment [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentTableTextBlock" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestDomain_019ddea1-5fc4-7463-8719-12b330c49a0a_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EBP, Related Party and Party-in-Interest [Domain]</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestDomain_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Related Party and Party-in-Interest [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestDomain" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForEmployerContributionCash_019dcf29-3cc4-75b7-84f8-5a80d915e1fe_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForEmployerContributionCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contributions, Employer</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForEmployerContributionCash_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForEmployerContributionCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Change in Net Asset Available for Benefit, Increase from Employer Contribution, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForEmployerContributionCash" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForEmployerContributionCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForEmployerContributionCash" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForEmployerContributionCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestAxis_019ddea1-5fc4-746b-acb9-77e2b3cf5de1_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EBP, Related Party and Party-in-Interest [Axis]</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestAxis_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Related Party and Party-in-Interest [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestAxis" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_019ddfaa-123c-7b99-9cc8-3aba1846b943_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_019e086b-d99d-7cc7-bc7e-79801c8b2193_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_019dd9eb-7f9c-7147-a98f-fa722703fa04_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeAxis" xlink:to="lab_us-gaap_InvestmentTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForInterestIncomeOnNoteReceivableFromParticipant_019dd4e4-3729-7320-996a-aaddbae8542a_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForInterestIncomeOnNoteReceivableFromParticipant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest income from notes receivable from participants</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForInterestIncomeOnNoteReceivableFromParticipant_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForInterestIncomeOnNoteReceivableFromParticipant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Change in Net Asset Available for Benefit, Increase from Interest Income on Note Receivable from Participant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForInterestIncomeOnNoteReceivableFromParticipant" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForInterestIncomeOnNoteReceivableFromParticipant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForInterestIncomeOnNoteReceivableFromParticipant" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForInterestIncomeOnNoteReceivableFromParticipant" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_EBPPlanRevenueCreditAccountDecreaseFromAdministrativeExpense_019ead66-65f1-75d1-bf1a-5ecdb827191c_terseLabel_en-US" xlink:label="lab_elv_EBPPlanRevenueCreditAccountDecreaseFromAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EBP, Plan Revenue Credit Account, Decrease from Administrative Expense</link:label>
    <link:label id="lab_elv_EBPPlanRevenueCreditAccountDecreaseFromAdministrativeExpense_label_en-US" xlink:label="lab_elv_EBPPlanRevenueCreditAccountDecreaseFromAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Plan Revenue Credit Account, Decrease from Administrative Expense</link:label>
    <link:label id="lab_elv_EBPPlanRevenueCreditAccountDecreaseFromAdministrativeExpense_documentation_en-US" xlink:label="lab_elv_EBPPlanRevenueCreditAccountDecreaseFromAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">EBP, Plan Revenue Credit Account, Decrease from Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_EBPPlanRevenueCreditAccountDecreaseFromAdministrativeExpense" xlink:href="elv-20251231.xsd#elv_EBPPlanRevenueCreditAccountDecreaseFromAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_EBPPlanRevenueCreditAccountDecreaseFromAdministrativeExpense" xlink:to="lab_elv_EBPPlanRevenueCreditAccountDecreaseFromAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForContribution_019dd4e0-91a0-7f8d-a57a-ffe914adf669_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForContribution" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total contributions</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForContribution_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForContribution" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Change in Net Asset Available for Benefit, Increase from Contribution</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForContribution" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForContribution"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForContribution" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForContribution" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForParticipantContributionExcludingRollover_019d9d3d-01a4-7999-87e8-631c1a814505_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForParticipantContributionExcludingRollover" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contributions, Participant</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForParticipantContributionExcludingRollover_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForParticipantContributionExcludingRollover" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Change in Net Asset Available for Benefit, Increase from Participant Contribution, Excluding Rollover</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForParticipantContributionExcludingRollover" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForParticipantContributionExcludingRollover"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForParticipantContributionExcludingRollover" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForParticipantContributionExcludingRollover" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForGainLossOnInvestment_019dda05-2dd2-79f0-a28f-4285155d5ee4_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForGainLossOnInvestment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net appreciation in fair value of investments</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForGainLossOnInvestment_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForGainLossOnInvestment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Change in Net Asset Available for Benefit, Increase (Decrease) from Gain (Loss) on Investment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForGainLossOnInvestment" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForGainLossOnInvestment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForGainLossOnInvestment" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForGainLossOnInvestment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForInterestAndDividendIncomeOnInvestment_019ddf44-5442-7e55-8ef6-888fed274b62_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForInterestAndDividendIncomeOnInvestment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest and dividends</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForInterestAndDividendIncomeOnInvestment_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForInterestAndDividendIncomeOnInvestment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Change in Net Asset Available for Benefit, Increase from Interest and Dividend Income on Investment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForInterestAndDividendIncomeOnInvestment" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForInterestAndDividendIncomeOnInvestment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForInterestAndDividendIncomeOnInvestment" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForInterestAndDividendIncomeOnInvestment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanLineItems_019dde8f-405f-7a2a-8a52-6ae0ee2f8e5a_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EBP, Description of Plan [Line Items]</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanLineItems_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Description of Plan [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanLineItems" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanPlanNumber_019dfed4-0a36-771a-afe8-61c643ace79d_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanPlanNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plan Number</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanPlanNumber_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanPlanNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Plan Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanPlanNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanPlanNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanPlanNumber" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanPlanNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavLineItems_019ddabe-025b-7537-962c-cebd9b2e7941_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EBP, Investment, Fair Value and NAV [Line Items]</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavLineItems_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Investment, Fair Value and NAV [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavLineItems" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanTextBlock_019e2bb6-60fa-79ba-a0f4-34fc466e0af1_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EBP, Description of Plan</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanTextBlock_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Description of Plan [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanTextBlock" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanInvestmentIssuerNameExtensibleEnumeration_019dfa1d-20f2-7213-82ec-69ab8224adc9_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanInvestmentIssuerNameExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investment issuer name</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanInvestmentIssuerNameExtensibleEnumeration_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanInvestmentIssuerNameExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Investment, Issuer Name [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentIssuerNameExtensibleEnumeration" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanInvestmentIssuerNameExtensibleEnumeration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentIssuerNameExtensibleEnumeration" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanInvestmentIssuerNameExtensibleEnumeration" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_EBPEmployerContributionVestingPercentage_019e41c0-1005-720a-95f7-ece683843bea_terseLabel_en-US" xlink:label="lab_elv_EBPEmployerContributionVestingPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EBP Employer Contribution Vesting Percentage</link:label>
    <link:label id="lab_elv_EBPEmployerContributionVestingPercentage_label_en-US" xlink:label="lab_elv_EBPEmployerContributionVestingPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Employer Contribution Vesting Percentage</link:label>
    <link:label id="lab_elv_EBPEmployerContributionVestingPercentage_documentation_en-US" xlink:label="lab_elv_EBPEmployerContributionVestingPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">EBP, Employer Contribution Vesting Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_EBPEmployerContributionVestingPercentage" xlink:href="elv-20251231.xsd#elv_EBPEmployerContributionVestingPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_EBPEmployerContributionVestingPercentage" xlink:to="lab_elv_EBPEmployerContributionVestingPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_EBPParticipantContributionMaximumContributionToEmployeeStockPlan_019e840e-7ede-71cf-bcfe-08b30bb5b5ff_terseLabel_en-US" xlink:label="lab_elv_EBPParticipantContributionMaximumContributionToEmployeeStockPlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EBP, Participant Contribution, Maximum Contribution to Employee Stock Plan</link:label>
    <link:label id="lab_elv_EBPParticipantContributionMaximumContributionToEmployeeStockPlan_label_en-US" xlink:label="lab_elv_EBPParticipantContributionMaximumContributionToEmployeeStockPlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Participant Contribution, Maximum Contribution to Employee Stock Plan</link:label>
    <link:label id="lab_elv_EBPParticipantContributionMaximumContributionToEmployeeStockPlan_documentation_en-US" xlink:label="lab_elv_EBPParticipantContributionMaximumContributionToEmployeeStockPlan" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">EBP, Participant Contribution, Maximum Contribution to Employee Stock Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_EBPParticipantContributionMaximumContributionToEmployeeStockPlan" xlink:href="elv-20251231.xsd#elv_EBPParticipantContributionMaximumContributionToEmployeeStockPlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_EBPParticipantContributionMaximumContributionToEmployeeStockPlan" xlink:to="lab_elv_EBPParticipantContributionMaximumContributionToEmployeeStockPlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanStatementOfChangeInNetAssetAvailableForBenefitLineItems_019d9d45-2c5a-7f94-ab40-d10026874d1d_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanStatementOfChangeInNetAssetAvailableForBenefitLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EBP, Statement of Change in Net Asset Available for Benefit [Abstract]</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanStatementOfChangeInNetAssetAvailableForBenefitLineItems_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanStatementOfChangeInNetAssetAvailableForBenefitLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Statement of Change in Net Asset Available for Benefit [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanStatementOfChangeInNetAssetAvailableForBenefitLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanStatementOfChangeInNetAssetAvailableForBenefitLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanStatementOfChangeInNetAssetAvailableForBenefitLineItems" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanStatementOfChangeInNetAssetAvailableForBenefitLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanStatementOfNetAssetAvailableForBenefitTable_019d97f4-4b8e-73b3-aa50-fabbccb69357_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanStatementOfNetAssetAvailableForBenefitTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EBP, Statement of Net Asset Available for Benefit [Table]</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanStatementOfNetAssetAvailableForBenefitTable_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanStatementOfNetAssetAvailableForBenefitTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Statement of Net Asset Available for Benefit [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanStatementOfNetAssetAvailableForBenefitTable" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanStatementOfNetAssetAvailableForBenefitTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanStatementOfNetAssetAvailableForBenefitTable" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanStatementOfNetAssetAvailableForBenefitTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentLineItems_019ddf9d-77e2-74c9-b3ea-bb6ea28cbbb0_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EBP, Schedule of Asset Held for Investment [Line Items]</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentLineItems_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Schedule of Asset Held for Investment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentLineItems" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustDomain_019dd9e0-74fb-71d5-b20f-61fa618f1b28_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EBP, Nonconsolidated, Master Trust and Plan Interest in Master Trust [Domain]</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustDomain_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Nonconsolidated, Master Trust and Plan Interest in Master Trust [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustDomain" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanEmployerCommonStockMember_019dd9ed-0e6a-7fec-ac62-567b48b90591_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanEmployerCommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Company common stock, at fair value</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanEmployerCommonStockMember_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanEmployerCommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Employer, Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanEmployerCommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanEmployerCommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanEmployerCommonStockMember" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanEmployerCommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentAbstract_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Schedule of Asset Held for Investment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentAbstract" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanAccountingPolicyTable_019e2be7-6920-7d48-b72f-2483b8437523_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanAccountingPolicyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EBP, Accounting Policy [Table]</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanAccountingPolicyTable_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanAccountingPolicyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Accounting Policy [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanAccountingPolicyTable" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanAccountingPolicyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanAccountingPolicyTable" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanAccountingPolicyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncrease_019e1c9b-ee3a-7e07-b4e4-865652de6c51_totalLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncrease" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total additions</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncrease_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Change in Net Asset Available for Benefit, Increase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncrease" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncrease" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncrease" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_019e086b-a0be-7354-a940-d5c24c20f27d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIdentifierAxis_019ddf9d-77e2-7ce2-b3d8-5e6773ae129e_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIdentifierAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investment, Identifier [Axis]</link:label>
    <link:label id="lab_us-gaap_InvestmentIdentifierAxis_label_en-US" xlink:label="lab_us-gaap_InvestmentIdentifierAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investment, Identifier [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIdentifierAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InvestmentIdentifierAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIdentifierAxis" xlink:to="lab_us-gaap_InvestmentIdentifierAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecreaseForAdministrativeExpense_019dd50c-b074-7800-ac50-9479ae526c1c_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecreaseForAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Administrative expenses</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecreaseForAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecreaseForAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Change in Net Asset Available for Benefit, Decrease from Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecreaseForAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecreaseForAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecreaseForAdministrativeExpense" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecreaseForAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_EBPParticipantContributionCapOfAutomaticAnnualEscalation_019e41a7-1681-76f6-8cd5-47fc9777e682_terseLabel_en-US" xlink:label="lab_elv_EBPParticipantContributionCapOfAutomaticAnnualEscalation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EBP, Participant Contribution, Cap Of Automatic Annual Escalation</link:label>
    <link:label id="lab_elv_EBPParticipantContributionCapOfAutomaticAnnualEscalation_label_en-US" xlink:label="lab_elv_EBPParticipantContributionCapOfAutomaticAnnualEscalation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Participant Contribution, Cap Of Automatic Annual Escalation</link:label>
    <link:label id="lab_elv_EBPParticipantContributionCapOfAutomaticAnnualEscalation_documentation_en-US" xlink:label="lab_elv_EBPParticipantContributionCapOfAutomaticAnnualEscalation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">EBP, Participant Contribution, Cap Of Automatic Annual Escalation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_EBPParticipantContributionCapOfAutomaticAnnualEscalation" xlink:href="elv-20251231.xsd#elv_EBPParticipantContributionCapOfAutomaticAnnualEscalation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_EBPParticipantContributionCapOfAutomaticAnnualEscalation" xlink:to="lab_elv_EBPParticipantContributionCapOfAutomaticAnnualEscalation" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationLineItems_019e0865-499a-72c2-9082-d70e4b6ef637_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:label id="lab_dei_DocumentInformationLineItems_label_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="lab_dei_DocumentInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanMasterTrustTextBlock_019e2bbe-d247-760f-b8cf-179ac0b09054_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanMasterTrustTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EBP, Master Trust - Text Block</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanMasterTrustTextBlock_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanMasterTrustTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Master Trust [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanMasterTrustTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanMasterTrustTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanMasterTrustTextBlock" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanMasterTrustTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_EBPEmployerMatchTrancheDomain_019e41ab-0f31-7d44-a791-4ccf469f82e0_terseLabel_en-US" xlink:label="lab_elv_EBPEmployerMatchTrancheDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EBP Employer Match Tranche [Domain]</link:label>
    <link:label id="lab_elv_EBPEmployerMatchTrancheDomain_label_en-US" xlink:label="lab_elv_EBPEmployerMatchTrancheDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Employer Match Tranche [Domain]</link:label>
    <link:label id="lab_elv_EBPEmployerMatchTrancheDomain_documentation_en-US" xlink:label="lab_elv_EBPEmployerMatchTrancheDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">EBP Employer Match Tranche [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_EBPEmployerMatchTrancheDomain" xlink:href="elv-20251231.xsd#elv_EBPEmployerMatchTrancheDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_EBPEmployerMatchTrancheDomain" xlink:to="lab_elv_EBPEmployerMatchTrancheDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_EBPAutomaticDistributionToParticipantThreshold_019e8f49-3614-7c28-8fb4-b1ce0271a463_terseLabel_en-US" xlink:label="lab_elv_EBPAutomaticDistributionToParticipantThreshold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EBP, Automatic Distribution to Participant Threshold</link:label>
    <link:label id="lab_elv_EBPAutomaticDistributionToParticipantThreshold_label_en-US" xlink:label="lab_elv_EBPAutomaticDistributionToParticipantThreshold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Automatic Distribution to Participant Threshold</link:label>
    <link:label id="lab_elv_EBPAutomaticDistributionToParticipantThreshold_documentation_en-US" xlink:label="lab_elv_EBPAutomaticDistributionToParticipantThreshold" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">EBP, Automatic Distribution to Participant Threshold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_EBPAutomaticDistributionToParticipantThreshold" xlink:href="elv-20251231.xsd#elv_EBPAutomaticDistributionToParticipantThreshold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_EBPAutomaticDistributionToParticipantThreshold" xlink:to="lab_elv_EBPAutomaticDistributionToParticipantThreshold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanEmployerContributionParticipantCompensationMatchedPercentage_019e2830-0092-7f3c-9232-077309952204_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanEmployerContributionParticipantCompensationMatchedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EBP, Employer Contribution, Participant Compensation Matched, Percentage</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanEmployerContributionParticipantCompensationMatchedPercentage_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanEmployerContributionParticipantCompensationMatchedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Employer Contribution, Participant Compensation Matched, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanEmployerContributionParticipantCompensationMatchedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanEmployerContributionParticipantCompensationMatchedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanEmployerContributionParticipantCompensationMatchedPercentage" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanEmployerContributionParticipantCompensationMatchedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanStatementOfChangeInNetAssetAvailableForBenefitAbstract_019d9d44-6798-7be1-8bab-39ee4dfab7d1_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanStatementOfChangeInNetAssetAvailableForBenefitAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EBP, Statement of Change in Net Asset Available for Benefit [Abstract]</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanStatementOfChangeInNetAssetAvailableForBenefitAbstract_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanStatementOfChangeInNetAssetAvailableForBenefitAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Statement of Change in Net Asset Available for Benefit [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanStatementOfChangeInNetAssetAvailableForBenefitAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanStatementOfChangeInNetAssetAvailableForBenefitAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanStatementOfChangeInNetAssetAvailableForBenefitAbstract" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanStatementOfChangeInNetAssetAvailableForBenefitAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_019dfdda-e908-7459-8c87-e7433f7c3034_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_019e0866-e587-7a48-af8f-05e71720c052_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanInvestmentNumberOfSharesSold_019ddaf1-d1ce-717d-bf40-3545ba006fee_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanInvestmentNumberOfSharesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employer common stock shares sold, net</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanInvestmentNumberOfSharesSold_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanInvestmentNumberOfSharesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Investment, Sold, Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentNumberOfSharesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanInvestmentNumberOfSharesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentNumberOfSharesSold" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanInvestmentNumberOfSharesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanParticipantLoanMaturityDate_019e077e-1ce7-7c2a-acce-1b38d1fedc49_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanParticipantLoanMaturityDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Participant Loans, maturities</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanParticipantLoanMaturityDate_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanParticipantLoanMaturityDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Asset Held for Investment, Participant Loan, Maturity Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanParticipantLoanMaturityDate" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanParticipantLoanMaturityDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanParticipantLoanMaturityDate" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanParticipantLoanMaturityDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanForm5500CaptionNetIncomeLoss_019e2c1f-71ba-7d26-be3e-013b9c44f5c3_totalLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanForm5500CaptionNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">EBP, Form 5500 Caption, Net Income (Loss), Total</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanForm5500CaptionNetIncomeLoss_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanForm5500CaptionNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Form 5500 Caption, Net Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanForm5500CaptionNetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanForm5500CaptionNetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanForm5500CaptionNetIncomeLoss" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanForm5500CaptionNetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_EBPEmployerContributionVestingPeriod_019e41c1-28d7-7eb6-abb1-50f5e9bed3d8_terseLabel_en-US" xlink:label="lab_elv_EBPEmployerContributionVestingPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EBP Employer Contribution Vesting Period</link:label>
    <link:label id="lab_elv_EBPEmployerContributionVestingPeriod_label_en-US" xlink:label="lab_elv_EBPEmployerContributionVestingPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Employer Contribution Vesting Period</link:label>
    <link:label id="lab_elv_EBPEmployerContributionVestingPeriod_documentation_en-US" xlink:label="lab_elv_EBPEmployerContributionVestingPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">EBP, Employer Contribution Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_EBPEmployerContributionVestingPeriod" xlink:href="elv-20251231.xsd#elv_EBPEmployerContributionVestingPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_EBPEmployerContributionVestingPeriod" xlink:to="lab_elv_EBPEmployerContributionVestingPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanTaxStatusTable_019e2be4-0402-762d-acbd-57bddf0c3d8b_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanTaxStatusTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EBP, Tax Status [Table]</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanTaxStatusTable_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanTaxStatusTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Tax Status [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanTaxStatusTable" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanTaxStatusTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanTaxStatusTable" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanTaxStatusTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecrease_019e1ca3-47c0-7774-9f99-c2d523ebbb92_totalLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net increase in net assets available for benefits</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecrease_019dd50f-6cc8-7ddd-b16a-60d109ae50e0_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net increase in net assets available for benefits</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Change in Net Asset Available for Benefit, Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecrease" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsTextBlock_019e2bc8-5155-7ea9-b1c2-5ae41910a0ee_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EBP, Related Party and Party-in-Interest Transactions</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsTextBlock_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Related Party and Party-in-Interest Transactions [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsTextBlock" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsAbstract_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Related Party and Party-in-Interest Transactions [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsAbstract" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanAccountingPolicyAbstract_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanAccountingPolicyAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Accounting Policy, Accounting Standard Update, and Change in Accounting Principle [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanAccountingPolicyAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanAccountingPolicyAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanAccountingPolicyAbstract" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanAccountingPolicyAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanReceivable_019e1c8e-aaac-7f0e-9a1f-7fd956271f08_totalLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanReceivable" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total receivables</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanReceivable_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanReceivable" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanEmployerContributionReceivable_019d9d34-d33a-7b58-908a-08b158db08d7_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanEmployerContributionReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Receivables, Employer contributions</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanEmployerContributionReceivable_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanEmployerContributionReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Employer Contribution, Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanEmployerContributionReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanEmployerContributionReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanEmployerContributionReceivable" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanEmployerContributionReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanParticipantContributionAutomaticDeferralRate_019e282d-5be3-7d46-b3d0-554c439cbb2a_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanParticipantContributionAutomaticDeferralRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EBP, Participant Contribution, Automatic, Deferral Rate</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanParticipantContributionAutomaticDeferralRate_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanParticipantContributionAutomaticDeferralRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Participant Contribution, Automatic, Deferral Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanParticipantContributionAutomaticDeferralRate" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanParticipantContributionAutomaticDeferralRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanParticipantContributionAutomaticDeferralRate" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanParticipantContributionAutomaticDeferralRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForDividendIncomeOnInvestment_019ddafa-1e87-7270-b949-14774b00134c_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForDividendIncomeOnInvestment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dividends on employer common stock</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForDividendIncomeOnInvestment_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForDividendIncomeOnInvestment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Change in Net Asset Available for Benefit, Increase from Dividend Income on Investment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForDividendIncomeOnInvestment" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForDividendIncomeOnInvestment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForDividendIncomeOnInvestment" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForDividendIncomeOnInvestment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecreaseForPaymentToParticipant_019dd50b-24c4-745f-8996-f5b5a22737fc_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecreaseForPaymentToParticipant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Benefits paid to participants</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecreaseForPaymentToParticipant_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecreaseForPaymentToParticipant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Change in Net Asset Available for Benefit, Decrease from Payment to Participant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecreaseForPaymentToParticipant" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecreaseForPaymentToParticipant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecreaseForPaymentToParticipant" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecreaseForPaymentToParticipant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanInvestmentPlanInterestInMasterTrustFairValue_019d9d2f-4462-767e-9af2-9c585d8e53eb_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanInvestmentPlanInterestInMasterTrustFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investments, at fair value, Interest in EH Master Trust</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanInvestmentPlanInterestInMasterTrustFairValue_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanInvestmentPlanInterestInMasterTrustFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Investment, Plan Interest in Master Trust, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentPlanInterestInMasterTrustFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanInvestmentPlanInterestInMasterTrustFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentPlanInterestInMasterTrustFairValue" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanInvestmentPlanInterestInMasterTrustFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019ddabe-025b-7119-9503-835b600e2c63_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyMember_019ddec3-5e47-7a30-974e-7e73aeeb5317_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party</link:label>
    <link:label id="lab_us-gaap_RelatedPartyMember_label_en-US" xlink:label="lab_us-gaap_RelatedPartyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyMember" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RelatedPartyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyMember" xlink:to="lab_us-gaap_RelatedPartyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanStatementOfNetAssetAvailableForBenefitAbstract_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanStatementOfNetAssetAvailableForBenefitAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Statement of Net Asset Available for Benefit [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanStatementOfNetAssetAvailableForBenefitAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanStatementOfNetAssetAvailableForBenefitAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanStatementOfNetAssetAvailableForBenefitAbstract" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanStatementOfNetAssetAvailableForBenefitAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanInvestmentTypeExtensibleEnumeration_019dfa31-4a7f-7675-a7b8-14d312aaccb0_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanInvestmentTypeExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investment type</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanInvestmentTypeExtensibleEnumeration_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanInvestmentTypeExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Investment, Current Value, Type [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentTypeExtensibleEnumeration" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanInvestmentTypeExtensibleEnumeration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentTypeExtensibleEnumeration" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanInvestmentTypeExtensibleEnumeration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanAccountingPolicyLineItems_019e2be7-6920-7c07-ab38-9cc25591af40_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanAccountingPolicyLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EBP, Accounting Policy [Line Items]</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanAccountingPolicyLineItems_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanAccountingPolicyLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Accounting Policy [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanAccountingPolicyLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanAccountingPolicyLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanAccountingPolicyLineItems" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanAccountingPolicyLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_EBPEligibilityServicePeriod_019e419e-07ba-7a04-90b3-07935843b98b_terseLabel_en-US" xlink:label="lab_elv_EBPEligibilityServicePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EBP eligibility service period</link:label>
    <link:label id="lab_elv_EBPEligibilityServicePeriod_label_en-US" xlink:label="lab_elv_EBPEligibilityServicePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Eligibility Service Period</link:label>
    <link:label id="lab_elv_EBPEligibilityServicePeriod_documentation_en-US" xlink:label="lab_elv_EBPEligibilityServicePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">EBP, Eligibility Service Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_EBPEligibilityServicePeriod" xlink:href="elv-20251231.xsd#elv_EBPEligibilityServicePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_EBPEligibilityServicePeriod" xlink:to="lab_elv_EBPEligibilityServicePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanTaxStatusAbstract_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanTaxStatusAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Tax Status [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanTaxStatusAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanTaxStatusAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanTaxStatusAbstract" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanTaxStatusAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_019e0863-bc8b-7aac-b051-0c319098b096_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500Table_019ddeca-b962-7f62-8088-6bf1c722a5e3_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500Table" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EBP, Reconciliation of Financial Statement to Form 5500 [Table]</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500Table_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500Table" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Reconciliation of Financial Statement to Form 5500 [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500Table" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500Table"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500Table" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500Table" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanAssetHeldForInvestmentPlanInterestInMasterTrustParticipationStatusExtensibleEnumeration_019e027f-faa7-7e03-8908-744b82448d5b_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanAssetHeldForInvestmentPlanInterestInMasterTrustParticipationStatusExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investment participation status</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanAssetHeldForInvestmentPlanInterestInMasterTrustParticipationStatusExtensibleEnumeration_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanAssetHeldForInvestmentPlanInterestInMasterTrustParticipationStatusExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Asset Held for Investment, Plan Interest in Master Trust, Participation Status [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanAssetHeldForInvestmentPlanInterestInMasterTrustParticipationStatusExtensibleEnumeration" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanAssetHeldForInvestmentPlanInterestInMasterTrustParticipationStatusExtensibleEnumeration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanAssetHeldForInvestmentPlanInterestInMasterTrustParticipationStatusExtensibleEnumeration" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanAssetHeldForInvestmentPlanInterestInMasterTrustParticipationStatusExtensibleEnumeration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForChangeInPlanInterestInMasterTrust_019dd4e2-9598-714c-b185-b6dc3c51eada_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForChangeInPlanInterestInMasterTrust" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest in EH Master Trust income</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForChangeInPlanInterestInMasterTrust_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForChangeInPlanInterestInMasterTrust" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Change in Net Asset Available for Benefit, Increase (Decrease) from Change in Plan Interest in Master Trust</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForChangeInPlanInterestInMasterTrust" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForChangeInPlanInterestInMasterTrust"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForChangeInPlanInterestInMasterTrust" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForChangeInPlanInterestInMasterTrust" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500LineItems_019ddeca-b962-77f2-8621-6185a45acb38_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500LineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EBP, Reconciliation of Financial Statement to Form 5500 [Line Items]</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500LineItems_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500LineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Reconciliation of Financial Statement to Form 5500 [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500LineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500LineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500LineItems" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500LineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EbpPlanName_019e0869-96ff-7a67-aea5-7b459471861d_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EbpPlanName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EBP, Plan Name</link:label>
    <link:label id="lab_us-gaap-ebp_EbpPlanName_label_en-US" xlink:label="lab_us-gaap-ebp_EbpPlanName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Plan Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EbpPlanName" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EbpPlanName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EbpPlanName" xlink:to="lab_us-gaap-ebp_EbpPlanName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanExpensePolicyTextBlock_019ead74-a1b1-7c91-a6cf-a65bbaadf9f9_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanExpensePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EBP, Expense</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanExpensePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanExpensePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Expense [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanExpensePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanExpensePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanExpensePolicyTextBlock" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanExpensePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500TextBlock_019e2bcd-9b4e-700a-81ec-dcf41a1fc6fc_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500TextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EBP, Reconciliation of Financial Statement to Form 5500 - Text Block</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500TextBlock_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500TextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Reconciliation of Financial Statement to Form 5500 [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500TextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500TextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500TextBlock" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500TextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_EBPParticipantContributionEligibleCompensationPercentage_019e418b-0348-7786-beea-d792cb7c36f1_terseLabel_en-US" xlink:label="lab_elv_EBPParticipantContributionEligibleCompensationPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EBP Participant Contribution Eligible Compensation Percentage</link:label>
    <link:label id="lab_elv_EBPParticipantContributionEligibleCompensationPercentage_label_en-US" xlink:label="lab_elv_EBPParticipantContributionEligibleCompensationPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Participant Contribution Eligible Compensation Percentage</link:label>
    <link:label id="lab_elv_EBPParticipantContributionEligibleCompensationPercentage_documentation_en-US" xlink:label="lab_elv_EBPParticipantContributionEligibleCompensationPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">EBP, Participant Contribution Eligible Compensation Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_EBPParticipantContributionEligibleCompensationPercentage" xlink:href="elv-20251231.xsd#elv_EBPParticipantContributionEligibleCompensationPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_EBPParticipantContributionEligibleCompensationPercentage" xlink:to="lab_elv_EBPParticipantContributionEligibleCompensationPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanAssetHeldForInvestmentParticipantLoanAfterDeemedDistribution_019ddfab-3308-70f0-885a-7a248d9e6bcb_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanAssetHeldForInvestmentParticipantLoanAfterDeemedDistribution" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Participant loans</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanAssetHeldForInvestmentParticipantLoanAfterDeemedDistribution_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanAssetHeldForInvestmentParticipantLoanAfterDeemedDistribution" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Asset Held for Investment, Participant Loan, after Deemed Distribution</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanAssetHeldForInvestmentParticipantLoanAfterDeemedDistribution" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanAssetHeldForInvestmentParticipantLoanAfterDeemedDistribution"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanAssetHeldForInvestmentParticipantLoanAfterDeemedDistribution" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanAssetHeldForInvestmentParticipantLoanAfterDeemedDistribution" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanInvestmentPolicyTextBlock_019ead73-9a53-708e-96a7-62230c5c7707_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanInvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EBP, Investment</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanInvestmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanInvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Investment [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanInvestmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentPolicyTextBlock" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanInvestmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanMasterTrustTable_019dd9de-bab9-75d8-a39c-e0927d539ee5_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanMasterTrustTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EBP, Master Trust [Table]</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanMasterTrustTable_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanMasterTrustTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Master Trust [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanMasterTrustTable" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanMasterTrustTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanMasterTrustTable" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanMasterTrustTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel12And3Member_019eb72a-b1aa-760a-8034-b3a88b1257ac_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel12And3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 1, Level 2, and Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel12And3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel12And3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 1, Level 2, and Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel12And3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FairValueInputsLevel12And3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel12And3Member" xlink:to="lab_us-gaap_FairValueInputsLevel12And3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanAssetHeldForInvestmentPartyInInterest_019dfa15-2b98-7ac0-9650-3d668b3686ae_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanAssetHeldForInvestmentPartyInInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investment party-in-interest</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanAssetHeldForInvestmentPartyInInterest_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanAssetHeldForInvestmentPartyInInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Asset Held for Investment, Party-in-Interest [true false]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanAssetHeldForInvestmentPartyInInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanAssetHeldForInvestmentPartyInInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanAssetHeldForInvestmentPartyInInterest" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanAssetHeldForInvestmentPartyInInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_019e0862-eb2f-7ad7-ad00-0edab052c1e8_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_019e0876-8b74-71c3-b740-8f1599019eac_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanParticipantLoanInterestRate_019ddf9d-77e2-74c4-b72e-bb64cd96260d_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanParticipantLoanInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Participant Loans, interest rates</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanParticipantLoanInterestRate_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanParticipantLoanInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Asset Held for Investment, Participant Loan, Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanParticipantLoanInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanParticipantLoanInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanParticipantLoanInterestRate" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanParticipantLoanInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500Abstract_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500Abstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Reconciliation of Financial Statement to Form 5500 [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500Abstract" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500Abstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500Abstract" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500Abstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanCommonCollectiveTrustMember_019dd9eb-a479-719e-9564-173d00717513_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanCommonCollectiveTrustMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Collective Trust</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanCommonCollectiveTrustMember_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanCommonCollectiveTrustMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Collective Trust [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCommonCollectiveTrustMember" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DefinedBenefitPlanCommonCollectiveTrustMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanCommonCollectiveTrustMember" xlink:to="lab_us-gaap_DefinedBenefitPlanCommonCollectiveTrustMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanTaxStatusLineItems_019e2be4-0402-7154-a6d4-0f6a6875091d_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanTaxStatusLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EBP, Tax Status [Line Items]</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanTaxStatusLineItems_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanTaxStatusLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Tax Status [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanTaxStatusLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanTaxStatusLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanTaxStatusLineItems" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanTaxStatusLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_EBPNoteReceivableFromParticipantGeneralLoanTerm_019e2842-bb70-7f60-a967-3950e998cf81_terseLabel_en-US" xlink:label="lab_elv_EBPNoteReceivableFromParticipantGeneralLoanTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EBP, Note receivable from participant, general loan term</link:label>
    <link:label id="lab_elv_EBPNoteReceivableFromParticipantGeneralLoanTerm_label_en-US" xlink:label="lab_elv_EBPNoteReceivableFromParticipantGeneralLoanTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Note receivable from participant, general loan term</link:label>
    <link:label id="lab_elv_EBPNoteReceivableFromParticipantGeneralLoanTerm_documentation_en-US" xlink:label="lab_elv_EBPNoteReceivableFromParticipantGeneralLoanTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">EBP, Note receivable from participant, general loan term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_EBPNoteReceivableFromParticipantGeneralLoanTerm" xlink:href="elv-20251231.xsd#elv_EBPNoteReceivableFromParticipantGeneralLoanTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_EBPNoteReceivableFromParticipantGeneralLoanTerm" xlink:to="lab_elv_EBPNoteReceivableFromParticipantGeneralLoanTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_EBPDistributionOfAccountBalanceStaysInPlanThreshold_019e8f5d-4a31-789d-a7e0-ba7acc918081_terseLabel_en-US" xlink:label="lab_elv_EBPDistributionOfAccountBalanceStaysInPlanThreshold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EBP, Distribution of Account Balance Stays in Plan Threshold</link:label>
    <link:label id="lab_elv_EBPDistributionOfAccountBalanceStaysInPlanThreshold_label_en-US" xlink:label="lab_elv_EBPDistributionOfAccountBalanceStaysInPlanThreshold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Distribution of Account Balance Stays in Plan Threshold</link:label>
    <link:label id="lab_elv_EBPDistributionOfAccountBalanceStaysInPlanThreshold_documentation_en-US" xlink:label="lab_elv_EBPDistributionOfAccountBalanceStaysInPlanThreshold" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">EBP, Distribution of Account Balance Stays in Plan Threshold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_EBPDistributionOfAccountBalanceStaysInPlanThreshold" xlink:href="elv-20251231.xsd#elv_EBPDistributionOfAccountBalanceStaysInPlanThreshold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_EBPDistributionOfAccountBalanceStaysInPlanThreshold" xlink:to="lab_elv_EBPDistributionOfAccountBalanceStaysInPlanThreshold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EbpSubsequentEventTable_019e2bea-dc69-7f8f-9084-81cc5c11dff5_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EbpSubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EBP, Subsequent Event [Table]</link:label>
    <link:label id="lab_us-gaap-ebp_EbpSubsequentEventTable_label_en-US" xlink:label="lab_us-gaap-ebp_EbpSubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Subsequent Event [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EbpSubsequentEventTable" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EbpSubsequentEventTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EbpSubsequentEventTable" xlink:to="lab_us-gaap-ebp_EbpSubsequentEventTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanForfeitedNonvestedAccountDecreaseForEmployerContribution_019e838c-7ed4-76a3-b76a-c9276eacf5b8_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanForfeitedNonvestedAccountDecreaseForEmployerContribution" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EBP, Forfeited Nonvested Account, Decrease from Employer Contribution</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanForfeitedNonvestedAccountDecreaseForEmployerContribution_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanForfeitedNonvestedAccountDecreaseForEmployerContribution" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Forfeited Nonvested Account, Decrease from Employer Contribution</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanForfeitedNonvestedAccountDecreaseForEmployerContribution" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanForfeitedNonvestedAccountDecreaseForEmployerContribution"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanForfeitedNonvestedAccountDecreaseForEmployerContribution" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanForfeitedNonvestedAccountDecreaseForEmployerContribution" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanNoteReceivableFromParticipant_019d9d33-e7a8-70ee-9b7a-5ca996b14b14_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanNoteReceivableFromParticipant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Notes receivable from participants</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanNoteReceivableFromParticipant_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanNoteReceivableFromParticipant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Note Receivable from Participant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanNoteReceivableFromParticipant" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanNoteReceivableFromParticipant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanNoteReceivableFromParticipant" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanNoteReceivableFromParticipant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedMasterTrustMember_019dd9e2-90ad-78a4-8533-1115c187f6a6_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedMasterTrustMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EBP, Nonconsolidated, Master Trust</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedMasterTrustMember_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedMasterTrustMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Nonconsolidated, Master Trust [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedMasterTrustMember" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedMasterTrustMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedMasterTrustMember" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedMasterTrustMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_019e086a-2c98-7db8-8cf5-317ca31b6001_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanSummaryOfAccountingPolicyTextBlock_019e2bb9-2d68-77af-bf9f-385ba91e3074_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanSummaryOfAccountingPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EBP, Summary of Accounting Policy</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanSummaryOfAccountingPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanSummaryOfAccountingPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Summary of Accounting Policy [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanSummaryOfAccountingPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanSummaryOfAccountingPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanSummaryOfAccountingPolicyTextBlock" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanSummaryOfAccountingPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_019ddabe-025b-7985-b624-669b322996f6_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanOtherAsset_019e0942-8213-76ae-bc22-9b504ce8a086_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanOtherAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Assets (Liabilities)</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanOtherAsset_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanOtherAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Other Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanOtherAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanOtherAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanOtherAsset" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanOtherAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_019e086c-0ace-7159-a4c3-5a2c2a39c431_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_019e0867-913c-7fb0-acd5-590428423766_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanMasterTrustTableTextBlock_019e9394-3809-72bb-9961-572828950edd_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanMasterTrustTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EBP, Master Trust - Table Text Block</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanMasterTrustTableTextBlock_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanMasterTrustTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Master Trust [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanMasterTrustTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanMasterTrustTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanMasterTrustTableTextBlock" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanMasterTrustTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_EBP003Member_019d9d15-1f35-7d9b-8624-5ec73d30e39d_terseLabel_en-US" xlink:label="lab_elv_EBP003Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EBP 003</link:label>
    <link:label id="lab_elv_EBP003Member_label_en-US" xlink:label="lab_elv_EBP003Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP 003 [Member]</link:label>
    <link:label id="lab_elv_EBP003Member_documentation_en-US" xlink:label="lab_elv_EBP003Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">EBP 003</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_EBP003Member" xlink:href="elv-20251231.xsd#elv_EBP003Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_EBP003Member" xlink:to="lab_elv_EBP003Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EbpSubsequentEventAbstract_label_en-US" xlink:label="lab_us-gaap-ebp_EbpSubsequentEventAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Subsequent Event [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EbpSubsequentEventAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EbpSubsequentEventAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EbpSubsequentEventAbstract" xlink:to="lab_us-gaap-ebp_EbpSubsequentEventAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanSubsequentEventTextBlock_019e2bcf-da28-7ea9-8bdc-09bc0f68de99_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanSubsequentEventTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EBP, Subsequent Event</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanSubsequentEventTextBlock_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanSubsequentEventTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Subsequent Event [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanSubsequentEventTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanSubsequentEventTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanSubsequentEventTextBlock" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanSubsequentEventTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanTaxStatusTextBlock_019e2bc9-3c4e-76ac-9603-a349f7df16b8_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanTaxStatusTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EBP, Tax Status</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanTaxStatusTextBlock_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanTaxStatusTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Tax Status [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanTaxStatusTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanTaxStatusTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanTaxStatusTextBlock" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanTaxStatusTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanNoteReceivableFromParticipantAccountMaximumBorrowingToTotalAccountPercentage_019e2834-65c4-7248-8853-27d94f0037a8_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanNoteReceivableFromParticipantAccountMaximumBorrowingToTotalAccountPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EBP, Note Receivable from Participant, Account, Maximum Borrowing, to Total Account, Percentage</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanNoteReceivableFromParticipantAccountMaximumBorrowingToTotalAccountPercentage_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanNoteReceivableFromParticipantAccountMaximumBorrowingToTotalAccountPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Note Receivable from Participant, Account, Maximum Borrowing, to Total Account, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanNoteReceivableFromParticipantAccountMaximumBorrowingToTotalAccountPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanNoteReceivableFromParticipantAccountMaximumBorrowingToTotalAccountPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanNoteReceivableFromParticipantAccountMaximumBorrowingToTotalAccountPercentage" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanNoteReceivableFromParticipantAccountMaximumBorrowingToTotalAccountPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EbpSubsequentEventLineItems_019e2bea-dc69-7706-8ec3-c913849e296e_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EbpSubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EBP, Subsequent Event [Line Items]</link:label>
    <link:label id="lab_us-gaap-ebp_EbpSubsequentEventLineItems_label_en-US" xlink:label="lab_us-gaap-ebp_EbpSubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Subsequent Event [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EbpSubsequentEventLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EbpSubsequentEventLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EbpSubsequentEventLineItems" xlink:to="lab_us-gaap-ebp_EbpSubsequentEventLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationTable_019e0865-499a-7df7-ae6f-0893eb406a5d_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Information [Table]</link:label>
    <link:label id="lab_dei_DocumentInformationTable_label_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentInformationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationTable" xlink:to="lab_dei_DocumentInformationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanNoteReceivableFromParticipantPolicyTextBlock_019ead73-f594-7ab5-9ba9-99ed330341f5_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanNoteReceivableFromParticipantPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EBP, Note Receivable from Participant</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanNoteReceivableFromParticipantPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanNoteReceivableFromParticipantPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Note Receivable from Participant [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanNoteReceivableFromParticipantPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanNoteReceivableFromParticipantPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanNoteReceivableFromParticipantPolicyTextBlock" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanNoteReceivableFromParticipantPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForIncomeLossOnInvestment_019ddf57-72a1-7870-95ff-c462719fd690_totalLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForIncomeLossOnInvestment" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total investment income</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForIncomeLossOnInvestment_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForIncomeLossOnInvestment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Change in Net Asset Available for Benefit, Increase (Decrease) from Income (Loss) on Investment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForIncomeLossOnInvestment" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForIncomeLossOnInvestment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForIncomeLossOnInvestment" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForIncomeLossOnInvestment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustAxis_019dd9e0-74fb-714c-9420-8a23d8783f62_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EBP, Nonconsolidated, Master Trust and Plan Interest in Master Trust [Axis]</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustAxis_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Nonconsolidated, Master Trust and Plan Interest in Master Trust [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustAxis" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsLineItems_019ddea1-5fc4-7125-a4b1-54490407b432_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EBP, Related Party and Party-in-Interest Transactions [Line Items]</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsLineItems_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Related Party and Party-in-Interest Transactions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsLineItems" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_019dfddb-faa2-7fe6-80e2-ce083ee539d0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanNetAssetAvailableForBenefit_019dd9f8-71be-7351-a563-b19b08a348aa_totalLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanNetAssetAvailableForBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">EBP, Net Asset Available for Benefit, Total</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanNetAssetAvailableForBenefit_019dd526-6afd-7dd5-a93d-16344a9b03f6_periodStartLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanNetAssetAvailableForBenefit" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">EBP, Net Asset Available for Benefit, Beginning Balance</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanNetAssetAvailableForBenefit_019dd526-4d85-76ca-940a-915167317205_periodEndLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanNetAssetAvailableForBenefit" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">EBP, Net Asset Available for Benefit, Ending Balance</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanNetAssetAvailableForBenefit_019d9d2a-4f37-7ee9-836c-89d3568eb69f_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanNetAssetAvailableForBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net assets available for benefits</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanNetAssetAvailableForBenefit_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanNetAssetAvailableForBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Net Asset Available for Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanNetAssetAvailableForBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanNetAssetAvailableForBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanNetAssetAvailableForBenefit" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanNetAssetAvailableForBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_019d9d14-9069-71c2-805c-1a7ca00b9c69_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanForfeitedNonvestedAccount_019e2833-3a42-732c-80d1-1147791775dc_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanForfeitedNonvestedAccount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forfeitures</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanForfeitedNonvestedAccount_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanForfeitedNonvestedAccount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Forfeited Nonvested Account</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanForfeitedNonvestedAccount" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanForfeitedNonvestedAccount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanForfeitedNonvestedAccount" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanForfeitedNonvestedAccount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanEmployerContributionMatchingPercentage_019e282e-b51f-7b31-a8f3-788298c686ca_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanEmployerContributionMatchingPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EBP, Employer Contribution, Matching Percentage</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanEmployerContributionMatchingPercentage_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanEmployerContributionMatchingPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Employer Contribution, Matching Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanEmployerContributionMatchingPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanEmployerContributionMatchingPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanEmployerContributionMatchingPercentage" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanEmployerContributionMatchingPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_EBPEmployerMatchTrancheTwoMember_019e41b3-293f-7144-a495-100073decaa1_terseLabel_en-US" xlink:label="lab_elv_EBPEmployerMatchTrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EBP Employer Match Tranche Two</link:label>
    <link:label id="lab_elv_EBPEmployerMatchTrancheTwoMember_label_en-US" xlink:label="lab_elv_EBPEmployerMatchTrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Employer Match Tranche Two [Member]</link:label>
    <link:label id="lab_elv_EBPEmployerMatchTrancheTwoMember_documentation_en-US" xlink:label="lab_elv_EBPEmployerMatchTrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">EBP, Employer Match Tranche Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_EBPEmployerMatchTrancheTwoMember" xlink:href="elv-20251231.xsd#elv_EBPEmployerMatchTrancheTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_EBPEmployerMatchTrancheTwoMember" xlink:to="lab_elv_EBPEmployerMatchTrancheTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanForm5500CaptionNetAssetAvailableForBenefit_019e2c1f-1d4d-715c-91a1-405dbe3040d9_totalLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanForm5500CaptionNetAssetAvailableForBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">EBP, Form 5500 Caption, Net Assets, Total</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanForm5500CaptionNetAssetAvailableForBenefit_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanForm5500CaptionNetAssetAvailableForBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Form 5500 Caption, Net Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanForm5500CaptionNetAssetAvailableForBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanForm5500CaptionNetAssetAvailableForBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanForm5500CaptionNetAssetAvailableForBenefit" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanForm5500CaptionNetAssetAvailableForBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_019eb72c-7fa1-7b80-8758-c5ab06f4e5ba_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measured at Net Asset Value Per Share</link:label>
    <link:label id="lab_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Measured at Net Asset Value Per Share [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember" xlink:to="lab_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavTable_019ddabe-025b-7e82-b2ba-ba3a3d6e8f24_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EBP, Investment, Fair Value and NAV [Table]</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavTable_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Investment, Fair Value and NAV [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavTable" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavTable" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanStatementOfNetAssetAvailableForBenefitLineItems_019d97f4-4b8e-7ec1-9229-ea6906527203_terseLabel_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanStatementOfNetAssetAvailableForBenefitLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EBP, Statement of Net Asset Available for Benefit [Line Items]</link:label>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanStatementOfNetAssetAvailableForBenefitLineItems_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanStatementOfNetAssetAvailableForBenefitLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Statement of Net Asset Available for Benefit [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanStatementOfNetAssetAvailableForBenefitLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanStatementOfNetAssetAvailableForBenefitLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanStatementOfNetAssetAvailableForBenefitLineItems" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanStatementOfNetAssetAvailableForBenefitLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_EBPDistributionOfAccountBalanceRolledIntoIRAThreshold_019e8f56-b397-7a08-b6dc-24ebc37d523b_terseLabel_en-US" xlink:label="lab_elv_EBPDistributionOfAccountBalanceRolledIntoIRAThreshold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EBP, Account Balance Rolled Into IRA Threshold</link:label>
    <link:label id="lab_elv_EBPDistributionOfAccountBalanceRolledIntoIRAThreshold_label_en-US" xlink:label="lab_elv_EBPDistributionOfAccountBalanceRolledIntoIRAThreshold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Distribution of Account Balance Rolled into IRA Threshold</link:label>
    <link:label id="lab_elv_EBPDistributionOfAccountBalanceRolledIntoIRAThreshold_documentation_en-US" xlink:label="lab_elv_EBPDistributionOfAccountBalanceRolledIntoIRAThreshold" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">EBP, Distribution of Account Balance Rolled into IRA Threshold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_EBPDistributionOfAccountBalanceRolledIntoIRAThreshold" xlink:href="elv-20251231.xsd#elv_EBPDistributionOfAccountBalanceRolledIntoIRAThreshold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_EBPDistributionOfAccountBalanceRolledIntoIRAThreshold" xlink:to="lab_elv_EBPDistributionOfAccountBalanceRolledIntoIRAThreshold" xlink:type="arc" order="1"/>
    <link:label id="lab_elv_JPMorganMember_label_en-US" xlink:label="lab_elv_JPMorganMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">JP Morgan [Member]</link:label>
    <link:label id="lab_elv_JPMorganMember_documentation_en-US" xlink:label="lab_elv_JPMorganMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">JP Morgan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_elv_JPMorganMember" xlink:href="elv-20251231.xsd#elv_JPMorganMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_elv_JPMorganMember" xlink:to="lab_elv_JPMorganMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MiscellaneousInvestmentsMember_label_en-US" xlink:label="lab_us-gaap_MiscellaneousInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Miscellaneous Investments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MiscellaneousInvestmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_MiscellaneousInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MiscellaneousInvestmentsMember" xlink:to="lab_us-gaap_MiscellaneousInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap-ebp_EmployeeBenefitPlanParticipantDirectedMember_label_en-US" xlink:label="lab_us-gaap-ebp_EmployeeBenefitPlanParticipantDirectedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBP, Participant-Directed [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanParticipantDirectedMember" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanParticipantDirectedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanParticipantDirectedMember" xlink:to="lab_us-gaap-ebp_EmployeeBenefitPlanParticipantDirectedMember" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>elv-20251231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019d97e9-6345-7c3e-aadc-cd30fd2ce9cd,g:dc9c1a7d-ae85-4e42-ad7d-8ea7d89a0d3f-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.elevancehealth.com/role/Cover" xlink:type="simple" xlink:href="elv-20251231.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_019dab99-ad71-7e0a-9e8a-ce8cd1dd6b84" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_019e0865-499a-7b3a-b68f-ecc2f6948192" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentInformationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019dab99-ad71-7e0a-9e8a-ce8cd1dd6b84" xlink:to="loc_dei_DocumentInformationTable_019e0865-499a-7b3a-b68f-ecc2f6948192" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_019e08b4-1860-7a41-92b5-49cf1ea69528" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_019e0865-499a-7b3a-b68f-ecc2f6948192" xlink:to="loc_dei_LegalEntityAxis_019e08b4-1860-7a41-92b5-49cf1ea69528" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_019e08b4-1860-766c-81aa-93489985b2d6" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_019e08b4-1860-7a41-92b5-49cf1ea69528" xlink:to="loc_dei_EntityDomain_019e08b4-1860-766c-81aa-93489985b2d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_EBP003Member_019e08b4-3001-7038-9799-1b3cdc740174" xlink:href="elv-20251231.xsd#elv_EBP003Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_019e08b4-1860-766c-81aa-93489985b2d6" xlink:to="loc_elv_EBP003Member_019e08b4-3001-7038-9799-1b3cdc740174" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_019e0865-499a-7561-9a54-f9868367e655" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_019e0865-499a-7b3a-b68f-ecc2f6948192" xlink:to="loc_dei_DocumentInformationLineItems_019e0865-499a-7561-9a54-f9868367e655" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_019e0862-eb2f-7d3a-8694-88ace06c1934" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019e0865-499a-7561-9a54-f9868367e655" xlink:to="loc_dei_DocumentType_019e0862-eb2f-7d3a-8694-88ace06c1934" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_019e0865-499a-74e6-b6e9-0b6bc2b430b0" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019e0865-499a-7561-9a54-f9868367e655" xlink:to="loc_dei_DocumentAnnualReport_019e0865-499a-74e6-b6e9-0b6bc2b430b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_019e0863-bc8b-749e-a65e-96b169bd79b6" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019e0865-499a-7561-9a54-f9868367e655" xlink:to="loc_dei_DocumentPeriodEndDate_019e0863-bc8b-749e-a65e-96b169bd79b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_019e0874-aaae-7497-b137-591604243a1c" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019e0865-499a-7561-9a54-f9868367e655" xlink:to="loc_dei_AmendmentFlag_019e0874-aaae-7497-b137-591604243a1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_019e0876-8b74-7344-b198-9d3538d2e704" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019e0865-499a-7561-9a54-f9868367e655" xlink:to="loc_dei_EntityCentralIndexKey_019e0876-8b74-7344-b198-9d3538d2e704" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_019e0866-e587-71e7-aaba-d69941f10885" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019e0865-499a-7561-9a54-f9868367e655" xlink:to="loc_dei_EntityFileNumber_019e0866-e587-71e7-aaba-d69941f10885" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EbpPlanName_019e0869-96ff-7454-93f5-20e148744e7a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EbpPlanName"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019e0865-499a-7561-9a54-f9868367e655" xlink:to="loc_us-gaap-ebp_EbpPlanName_019e0869-96ff-7454-93f5-20e148744e7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_019e0867-913c-723d-8340-e4bf9d0c2838" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019e0865-499a-7561-9a54-f9868367e655" xlink:to="loc_dei_EntityRegistrantName_019e0867-913c-723d-8340-e4bf9d0c2838" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_019e086a-2c98-7623-afd9-534ef74752b8" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019e0865-499a-7561-9a54-f9868367e655" xlink:to="loc_dei_EntityAddressAddressLine1_019e086a-2c98-7623-afd9-534ef74752b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_019e086b-a0be-71f3-a86e-021cd19820fb" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019e0865-499a-7561-9a54-f9868367e655" xlink:to="loc_dei_EntityAddressCityOrTown_019e086b-a0be-71f3-a86e-021cd19820fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_019e086b-d99d-702c-bc7e-401a515af2f1" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019e0865-499a-7561-9a54-f9868367e655" xlink:to="loc_dei_EntityAddressStateOrProvince_019e086b-d99d-702c-bc7e-401a515af2f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_019e086c-0ace-7832-aab6-1ba15519548d" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019e0865-499a-7561-9a54-f9868367e655" xlink:to="loc_dei_EntityAddressPostalZipCode_019e086c-0ace-7832-aab6-1ba15519548d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/EmployeeBenefitPlanStatementofNetAssetAvailableforBenefitStatement" xlink:type="simple" xlink:href="elv-20251231.xsd#EmployeeBenefitPlanStatementofNetAssetAvailableforBenefitStatement"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/EmployeeBenefitPlanStatementofNetAssetAvailableforBenefitStatement" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanStatementOfNetAssetAvailableForBenefitAbstract_019d9d27-cdc6-7c06-a7b2-f41054d13e49" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanStatementOfNetAssetAvailableForBenefitAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanStatementOfNetAssetAvailableForBenefitTable_019d9d2a-4f37-76fe-b419-6117e3205712" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanStatementOfNetAssetAvailableForBenefitTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanStatementOfNetAssetAvailableForBenefitAbstract_019d9d27-cdc6-7c06-a7b2-f41054d13e49" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanStatementOfNetAssetAvailableForBenefitTable_019d9d2a-4f37-76fe-b419-6117e3205712" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_019d9d2b-01b5-759d-a339-6c0dad06155e" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanStatementOfNetAssetAvailableForBenefitTable_019d9d2a-4f37-76fe-b419-6117e3205712" xlink:to="loc_dei_LegalEntityAxis_019d9d2b-01b5-759d-a339-6c0dad06155e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_019d9d2b-01b5-74e3-940b-94b245ffe2eb" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_019d9d2b-01b5-759d-a339-6c0dad06155e" xlink:to="loc_dei_EntityDomain_019d9d2b-01b5-74e3-940b-94b245ffe2eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_EBP003Member_019d9d2b-1211-721d-9c4b-3af537147d11" xlink:href="elv-20251231.xsd#elv_EBP003Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_019d9d2b-01b5-74e3-940b-94b245ffe2eb" xlink:to="loc_elv_EBP003Member_019d9d2b-1211-721d-9c4b-3af537147d11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanStatementOfNetAssetAvailableForBenefitLineItems_019d9d2a-4f37-7a23-9689-46e70f71a2e3" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanStatementOfNetAssetAvailableForBenefitLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanStatementOfNetAssetAvailableForBenefitTable_019d9d2a-4f37-76fe-b419-6117e3205712" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanStatementOfNetAssetAvailableForBenefitLineItems_019d9d2a-4f37-7a23-9689-46e70f71a2e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentPlanInterestInMasterTrustFairValue_019d9d2f-4462-7a3a-a8bc-24429aeb9ca1" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanInvestmentPlanInterestInMasterTrustFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanStatementOfNetAssetAvailableForBenefitLineItems_019d9d2a-4f37-7a23-9689-46e70f71a2e3" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentPlanInterestInMasterTrustFairValue_019d9d2f-4462-7a3a-a8bc-24429aeb9ca1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanNoteReceivableFromParticipant_019d9d33-e7a8-7216-99e0-08b0e0141cbf" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanNoteReceivableFromParticipant"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanStatementOfNetAssetAvailableForBenefitLineItems_019d9d2a-4f37-7a23-9689-46e70f71a2e3" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanNoteReceivableFromParticipant_019d9d33-e7a8-7216-99e0-08b0e0141cbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanEmployerContributionReceivable_019d9d34-d33a-7b19-adff-9862d0b460f7" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanEmployerContributionReceivable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanStatementOfNetAssetAvailableForBenefitLineItems_019d9d2a-4f37-7a23-9689-46e70f71a2e3" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanEmployerContributionReceivable_019d9d34-d33a-7b19-adff-9862d0b460f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanReceivable_019d9d36-1842-72ba-9c05-1b43668c2993" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanReceivable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanStatementOfNetAssetAvailableForBenefitLineItems_019d9d2a-4f37-7a23-9689-46e70f71a2e3" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanReceivable_019d9d36-1842-72ba-9c05-1b43668c2993" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanNetAssetAvailableForBenefit_019d9d2a-4f37-760c-8a70-d0c2f9299456" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanNetAssetAvailableForBenefit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanStatementOfNetAssetAvailableForBenefitLineItems_019d9d2a-4f37-7a23-9689-46e70f71a2e3" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanNetAssetAvailableForBenefit_019d9d2a-4f37-760c-8a70-d0c2f9299456" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/EmployeeBenefitPlanStatementofChangeinNetAssetAvailableforBenefitStatement" xlink:type="simple" xlink:href="elv-20251231.xsd#EmployeeBenefitPlanStatementofChangeinNetAssetAvailableforBenefitStatement"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/EmployeeBenefitPlanStatementofChangeinNetAssetAvailableforBenefitStatement" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanStatementOfChangeInNetAssetAvailableForBenefitAbstract_019d9d38-1ba9-7619-acb5-675110d8fe39" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanStatementOfChangeInNetAssetAvailableForBenefitAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanStatementOfChangeInNetAssetAvailableForBenefitTable_019d9d41-4c4a-7dac-b7ab-3e72eae70eab" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanStatementOfChangeInNetAssetAvailableForBenefitTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanStatementOfChangeInNetAssetAvailableForBenefitAbstract_019d9d38-1ba9-7619-acb5-675110d8fe39" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanStatementOfChangeInNetAssetAvailableForBenefitTable_019d9d41-4c4a-7dac-b7ab-3e72eae70eab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_019d9d42-6126-7f57-8401-d2136cee2a05" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanStatementOfChangeInNetAssetAvailableForBenefitTable_019d9d41-4c4a-7dac-b7ab-3e72eae70eab" xlink:to="loc_dei_LegalEntityAxis_019d9d42-6126-7f57-8401-d2136cee2a05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_019ddf9c-432c-7a61-bd9f-5462fe14b364" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_019d9d42-6126-7f57-8401-d2136cee2a05" xlink:to="loc_dei_EntityDomain_019ddf9c-432c-7a61-bd9f-5462fe14b364" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_EBP003Member_019ddf9c-5f25-725b-92b8-6ddbe2b6465b" xlink:href="elv-20251231.xsd#elv_EBP003Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_019ddf9c-432c-7a61-bd9f-5462fe14b364" xlink:to="loc_elv_EBP003Member_019ddf9c-5f25-725b-92b8-6ddbe2b6465b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanStatementOfChangeInNetAssetAvailableForBenefitLineItems_019d9d45-a194-7c7f-98eb-2cbe5d396653" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanStatementOfChangeInNetAssetAvailableForBenefitLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanStatementOfChangeInNetAssetAvailableForBenefitTable_019d9d41-4c4a-7dac-b7ab-3e72eae70eab" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanStatementOfChangeInNetAssetAvailableForBenefitLineItems_019d9d45-a194-7c7f-98eb-2cbe5d396653" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForParticipantContributionExcludingRollover_019d9d46-46c3-7356-be92-e0b1da7d56cf" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForParticipantContributionExcludingRollover"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanStatementOfChangeInNetAssetAvailableForBenefitLineItems_019d9d45-a194-7c7f-98eb-2cbe5d396653" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForParticipantContributionExcludingRollover_019d9d46-46c3-7356-be92-e0b1da7d56cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForEmployerContributionCash_019dcf29-3cc4-70e5-9aea-688ac1cd4898" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForEmployerContributionCash"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanStatementOfChangeInNetAssetAvailableForBenefitLineItems_019d9d45-a194-7c7f-98eb-2cbe5d396653" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForEmployerContributionCash_019dcf29-3cc4-70e5-9aea-688ac1cd4898" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForParticipantContributionRollover_019dcf2a-2090-7be8-9bf6-0560392789f4" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForParticipantContributionRollover"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanStatementOfChangeInNetAssetAvailableForBenefitLineItems_019d9d45-a194-7c7f-98eb-2cbe5d396653" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForParticipantContributionRollover_019dcf2a-2090-7be8-9bf6-0560392789f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForContribution_019dd4e0-91a0-7988-8a35-87d53074e118" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForContribution"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanStatementOfChangeInNetAssetAvailableForBenefitLineItems_019d9d45-a194-7c7f-98eb-2cbe5d396653" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForContribution_019dd4e0-91a0-7988-8a35-87d53074e118" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForChangeInPlanInterestInMasterTrust_019dd4e2-9598-76cc-867c-2e00b806da6c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForChangeInPlanInterestInMasterTrust"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanStatementOfChangeInNetAssetAvailableForBenefitLineItems_019d9d45-a194-7c7f-98eb-2cbe5d396653" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForChangeInPlanInterestInMasterTrust_019dd4e2-9598-76cc-867c-2e00b806da6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForInterestIncomeOnNoteReceivableFromParticipant_019dd4e4-3729-74a1-8159-d9ba09a158e6" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForInterestIncomeOnNoteReceivableFromParticipant"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanStatementOfChangeInNetAssetAvailableForBenefitLineItems_019d9d45-a194-7c7f-98eb-2cbe5d396653" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForInterestIncomeOnNoteReceivableFromParticipant_019dd4e4-3729-74a1-8159-d9ba09a158e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncrease_019dd500-ea3f-76a6-9553-852908fab41f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncrease"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanStatementOfChangeInNetAssetAvailableForBenefitLineItems_019d9d45-a194-7c7f-98eb-2cbe5d396653" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncrease_019dd500-ea3f-76a6-9553-852908fab41f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecreaseForPaymentToParticipant_019dd50b-24c4-7014-935c-67a580e105c9" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecreaseForPaymentToParticipant"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanStatementOfChangeInNetAssetAvailableForBenefitLineItems_019d9d45-a194-7c7f-98eb-2cbe5d396653" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecreaseForPaymentToParticipant_019dd50b-24c4-7014-935c-67a580e105c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecreaseForAdministrativeExpense_019dd50c-b074-7bdc-b63b-9ea328a48142" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecreaseForAdministrativeExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanStatementOfChangeInNetAssetAvailableForBenefitLineItems_019d9d45-a194-7c7f-98eb-2cbe5d396653" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecreaseForAdministrativeExpense_019dd50c-b074-7bdc-b63b-9ea328a48142" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecrease_019dd50d-908c-70e3-9ed7-ee38385450ed" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecrease"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanStatementOfChangeInNetAssetAvailableForBenefitLineItems_019d9d45-a194-7c7f-98eb-2cbe5d396653" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecrease_019dd50d-908c-70e3-9ed7-ee38385450ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecrease_019dd50f-6cc8-7944-ba40-649a2be2d578" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecrease"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanStatementOfChangeInNetAssetAvailableForBenefitLineItems_019d9d45-a194-7c7f-98eb-2cbe5d396653" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecrease_019dd50f-6cc8-7944-ba40-649a2be2d578" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanNetAssetAvailableForBenefit_019dd512-e097-701d-89f2-14e420d6f659" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanNetAssetAvailableForBenefit"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanStatementOfChangeInNetAssetAvailableForBenefitLineItems_019d9d45-a194-7c7f-98eb-2cbe5d396653" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanNetAssetAvailableForBenefit_019dd512-e097-701d-89f2-14e420d6f659" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanNetAssetAvailableForBenefit_019e1cf3-68b0-7a75-8dad-81fc56c03a73" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanNetAssetAvailableForBenefit"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanStatementOfChangeInNetAssetAvailableForBenefitLineItems_019d9d45-a194-7c7f-98eb-2cbe5d396653" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanNetAssetAvailableForBenefit_019e1cf3-68b0-7a75-8dad-81fc56c03a73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/EmployeeBenefitPlanDescriptionofPlanTables" xlink:type="simple" xlink:href="elv-20251231.xsd#EmployeeBenefitPlanDescriptionofPlanTables"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/EmployeeBenefitPlanDescriptionofPlanTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanAbstract_019dde8c-9e66-740e-acbb-285ca058a18f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanTable_019dde8f-d65f-7395-b54d-f0d9663a3a28" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanAbstract_019dde8c-9e66-740e-acbb-285ca058a18f" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanTable_019dde8f-d65f-7395-b54d-f0d9663a3a28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_019ead44-8285-70ce-94ab-e5b494bb37d3" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanTable_019dde8f-d65f-7395-b54d-f0d9663a3a28" xlink:to="loc_dei_LegalEntityAxis_019ead44-8285-70ce-94ab-e5b494bb37d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_019ead44-8285-72ac-ace4-d6ec12b37d51" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_019ead44-8285-70ce-94ab-e5b494bb37d3" xlink:to="loc_dei_EntityDomain_019ead44-8285-72ac-ace4-d6ec12b37d51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_EBP003Member_019ead44-8285-715b-a28d-4f4e8bfd7b2d" xlink:href="elv-20251231.xsd#elv_EBP003Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_019ead44-8285-72ac-ace4-d6ec12b37d51" xlink:to="loc_elv_EBP003Member_019ead44-8285-715b-a28d-4f4e8bfd7b2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_019e4194-f329-71f9-a97c-b7de812b9625" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanTable_019dde8f-d65f-7395-b54d-f0d9663a3a28" xlink:to="loc_srt_RangeAxis_019e4194-f329-71f9-a97c-b7de812b9625" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019e4194-f329-7212-9ccb-a590fb41ad02" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_019e4194-f329-71f9-a97c-b7de812b9625" xlink:to="loc_srt_RangeMember_019e4194-f329-7212-9ccb-a590fb41ad02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_019e4195-1300-7451-bc3f-ed046767e9df" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_019e4194-f329-7212-9ccb-a590fb41ad02" xlink:to="loc_srt_MinimumMember_019e4195-1300-7451-bc3f-ed046767e9df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_019e4195-f170-798d-b8e9-eda811ebd643" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_019e4194-f329-7212-9ccb-a590fb41ad02" xlink:to="loc_srt_MaximumMember_019e4195-f170-798d-b8e9-eda811ebd643" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_EBPEmployerMatchTrancheAxis_019e41ab-0f31-7e1a-8ab9-0e7c6c2623bb" xlink:href="elv-20251231.xsd#elv_EBPEmployerMatchTrancheAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanTable_019dde8f-d65f-7395-b54d-f0d9663a3a28" xlink:to="loc_elv_EBPEmployerMatchTrancheAxis_019e41ab-0f31-7e1a-8ab9-0e7c6c2623bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_EBPEmployerMatchTrancheDomain_019e41ab-0f31-763f-b038-1f5d2a95e056" xlink:href="elv-20251231.xsd#elv_EBPEmployerMatchTrancheDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_elv_EBPEmployerMatchTrancheAxis_019e41ab-0f31-7e1a-8ab9-0e7c6c2623bb" xlink:to="loc_elv_EBPEmployerMatchTrancheDomain_019e41ab-0f31-763f-b038-1f5d2a95e056" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_EBPEmployerMatchTrancheOneMember_019e41ab-67ea-779b-a6e3-f9da9059cd22" xlink:href="elv-20251231.xsd#elv_EBPEmployerMatchTrancheOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_elv_EBPEmployerMatchTrancheDomain_019e41ab-0f31-763f-b038-1f5d2a95e056" xlink:to="loc_elv_EBPEmployerMatchTrancheOneMember_019e41ab-67ea-779b-a6e3-f9da9059cd22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_EBPEmployerMatchTrancheTwoMember_019e82e6-2f9e-7629-a0af-5f625bb987dd" xlink:href="elv-20251231.xsd#elv_EBPEmployerMatchTrancheTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_elv_EBPEmployerMatchTrancheDomain_019e41ab-0f31-763f-b038-1f5d2a95e056" xlink:to="loc_elv_EBPEmployerMatchTrancheTwoMember_019e82e6-2f9e-7629-a0af-5f625bb987dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanLineItems_019dde8f-d65f-7e20-9cbc-29bf1fa671ee" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanTable_019dde8f-d65f-7395-b54d-f0d9663a3a28" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanLineItems_019dde8f-d65f-7e20-9cbc-29bf1fa671ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanTextBlock_019e9492-56e0-7788-b8e9-51cd91c62049" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanLineItems_019dde8f-d65f-7e20-9cbc-29bf1fa671ee" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanTextBlock_019e9492-56e0-7788-b8e9-51cd91c62049" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_EBPEligibilityServicePeriod_019e419e-07ba-7543-8e41-77106cdf67bb" xlink:href="elv-20251231.xsd#elv_EBPEligibilityServicePeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanLineItems_019dde8f-d65f-7e20-9cbc-29bf1fa671ee" xlink:to="loc_elv_EBPEligibilityServicePeriod_019e419e-07ba-7543-8e41-77106cdf67bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_EBPParticipantContributionEligibleCompensationPercentage_019e418b-0348-7a92-baa1-ff0d2d34118a" xlink:href="elv-20251231.xsd#elv_EBPParticipantContributionEligibleCompensationPercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanLineItems_019dde8f-d65f-7e20-9cbc-29bf1fa671ee" xlink:to="loc_elv_EBPParticipantContributionEligibleCompensationPercentage_019e418b-0348-7a92-baa1-ff0d2d34118a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanParticipantContributionAutomaticDeferralRate_019e282d-5be3-72cc-a94d-21cc11ba7da9" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanParticipantContributionAutomaticDeferralRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanLineItems_019dde8f-d65f-7e20-9cbc-29bf1fa671ee" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanParticipantContributionAutomaticDeferralRate_019e282d-5be3-72cc-a94d-21cc11ba7da9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_EBPParticipantContributionIncrementalIncreaseOfAutomaticAnnualEscalation_019e41a5-a71e-70dd-93ca-70bbf0c09bc8" xlink:href="elv-20251231.xsd#elv_EBPParticipantContributionIncrementalIncreaseOfAutomaticAnnualEscalation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanLineItems_019dde8f-d65f-7e20-9cbc-29bf1fa671ee" xlink:to="loc_elv_EBPParticipantContributionIncrementalIncreaseOfAutomaticAnnualEscalation_019e41a5-a71e-70dd-93ca-70bbf0c09bc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_EBPParticipantContributionCapOfAutomaticAnnualEscalation_019e41a7-1681-734a-99dc-e77e3f2b68c5" xlink:href="elv-20251231.xsd#elv_EBPParticipantContributionCapOfAutomaticAnnualEscalation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanLineItems_019dde8f-d65f-7e20-9cbc-29bf1fa671ee" xlink:to="loc_elv_EBPParticipantContributionCapOfAutomaticAnnualEscalation_019e41a7-1681-734a-99dc-e77e3f2b68c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanEmployerContributionMatchingPercentage_019e41aa-1df0-7af1-979f-8b0e2fbc2e92" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanEmployerContributionMatchingPercentage"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanLineItems_019dde8f-d65f-7e20-9cbc-29bf1fa671ee" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanEmployerContributionMatchingPercentage_019e41aa-1df0-7af1-979f-8b0e2fbc2e92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanEmployerContributionParticipantCompensationMatchedPercentage_019e41ab-ed5f-7497-aa3b-fd8c66f3f8cd" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanEmployerContributionParticipantCompensationMatchedPercentage"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanLineItems_019dde8f-d65f-7e20-9cbc-29bf1fa671ee" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanEmployerContributionParticipantCompensationMatchedPercentage_019e41ab-ed5f-7497-aa3b-fd8c66f3f8cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_EBPParticipantCatchUpContributionMinimumAge_019e41bb-5d61-7b5b-8b55-8063f43ec1e3" xlink:href="elv-20251231.xsd#elv_EBPParticipantCatchUpContributionMinimumAge"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanLineItems_019dde8f-d65f-7e20-9cbc-29bf1fa671ee" xlink:to="loc_elv_EBPParticipantCatchUpContributionMinimumAge_019e41bb-5d61-7b5b-8b55-8063f43ec1e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_EBPEmployerContributionVestingPercentage_019e41c0-1005-7cb2-968a-49fc9440a9c4" xlink:href="elv-20251231.xsd#elv_EBPEmployerContributionVestingPercentage"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanLineItems_019dde8f-d65f-7e20-9cbc-29bf1fa671ee" xlink:to="loc_elv_EBPEmployerContributionVestingPercentage_019e41c0-1005-7cb2-968a-49fc9440a9c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_EBPEmployerContributionVestingPeriod_019e41c1-28d7-7e58-b50e-6c8f969b31fb" xlink:href="elv-20251231.xsd#elv_EBPEmployerContributionVestingPeriod"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanLineItems_019dde8f-d65f-7e20-9cbc-29bf1fa671ee" xlink:to="loc_elv_EBPEmployerContributionVestingPeriod_019e41c1-28d7-7e58-b50e-6c8f969b31fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_EBPParticipantContributionMaximumContributionToEmployeeStockPlan_019e840e-7ede-714d-835e-962eaa87b249" xlink:href="elv-20251231.xsd#elv_EBPParticipantContributionMaximumContributionToEmployeeStockPlan"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanLineItems_019dde8f-d65f-7e20-9cbc-29bf1fa671ee" xlink:to="loc_elv_EBPParticipantContributionMaximumContributionToEmployeeStockPlan_019e840e-7ede-714d-835e-962eaa87b249" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_EBPAutomaticDistributionToParticipantThreshold_019e8f49-3614-7230-9e70-7565f0ef63b5" xlink:href="elv-20251231.xsd#elv_EBPAutomaticDistributionToParticipantThreshold"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanLineItems_019dde8f-d65f-7e20-9cbc-29bf1fa671ee" xlink:to="loc_elv_EBPAutomaticDistributionToParticipantThreshold_019e8f49-3614-7230-9e70-7565f0ef63b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_EBPDistributionOfAccountBalanceRolledIntoIRAThreshold_019e8f56-b397-7142-a1de-57e356a7856b" xlink:href="elv-20251231.xsd#elv_EBPDistributionOfAccountBalanceRolledIntoIRAThreshold"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanLineItems_019dde8f-d65f-7e20-9cbc-29bf1fa671ee" xlink:to="loc_elv_EBPDistributionOfAccountBalanceRolledIntoIRAThreshold_019e8f56-b397-7142-a1de-57e356a7856b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_EBPDistributionOfAccountBalanceStaysInPlanThreshold_019e8f5d-4a31-7491-8d60-28b1c1bdb34c" xlink:href="elv-20251231.xsd#elv_EBPDistributionOfAccountBalanceStaysInPlanThreshold"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanLineItems_019dde8f-d65f-7e20-9cbc-29bf1fa671ee" xlink:to="loc_elv_EBPDistributionOfAccountBalanceStaysInPlanThreshold_019e8f5d-4a31-7491-8d60-28b1c1bdb34c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanNoteReceivableFromParticipantAccountMaximumBorrowingToTotalAccountPercentage_019e2834-65c4-71ab-b9bd-ff32747007f6" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanNoteReceivableFromParticipantAccountMaximumBorrowingToTotalAccountPercentage"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanLineItems_019dde8f-d65f-7e20-9cbc-29bf1fa671ee" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanNoteReceivableFromParticipantAccountMaximumBorrowingToTotalAccountPercentage_019e2834-65c4-71ab-b9bd-ff32747007f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanNoteReceivableFromParticipantAccountMaximumBorrowingAmount_019e2838-b666-7ef4-96aa-4536054295f1" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanNoteReceivableFromParticipantAccountMaximumBorrowingAmount"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanLineItems_019dde8f-d65f-7e20-9cbc-29bf1fa671ee" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanNoteReceivableFromParticipantAccountMaximumBorrowingAmount_019e2838-b666-7ef4-96aa-4536054295f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_EBPNoteReceivableFromParticipantGeneralLoanTerm_019e2842-bb70-7a81-9f7e-4c5cc1ebd485" xlink:href="elv-20251231.xsd#elv_EBPNoteReceivableFromParticipantGeneralLoanTerm"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanLineItems_019dde8f-d65f-7e20-9cbc-29bf1fa671ee" xlink:to="loc_elv_EBPNoteReceivableFromParticipantGeneralLoanTerm_019e2842-bb70-7a81-9f7e-4c5cc1ebd485" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanForfeitedNonvestedAccount_019e2833-3a42-7730-b6ce-073f195ddb18" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanForfeitedNonvestedAccount"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanLineItems_019dde8f-d65f-7e20-9cbc-29bf1fa671ee" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanForfeitedNonvestedAccount_019e2833-3a42-7730-b6ce-073f195ddb18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanForfeitedNonvestedAccountDecreaseForEmployerContribution_019e838c-7ed4-7294-b680-d2257e327882" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanForfeitedNonvestedAccountDecreaseForEmployerContribution"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanLineItems_019dde8f-d65f-7e20-9cbc-29bf1fa671ee" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanForfeitedNonvestedAccountDecreaseForEmployerContribution_019e838c-7ed4-7294-b680-d2257e327882" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanForfeitedNonvestedAccountDecreaseForAdministrativeExpense_019e838d-4bfd-702d-bfd2-cf55f485f4a9" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanForfeitedNonvestedAccountDecreaseForAdministrativeExpense"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanLineItems_019dde8f-d65f-7e20-9cbc-29bf1fa671ee" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanForfeitedNonvestedAccountDecreaseForAdministrativeExpense_019e838d-4bfd-702d-bfd2-cf55f485f4a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_EBPPlanRevenueCreditAccountDecreaseFromAdministrativeExpense_019ead66-65f1-789e-afd9-c0688416762c" xlink:href="elv-20251231.xsd#elv_EBPPlanRevenueCreditAccountDecreaseFromAdministrativeExpense"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanLineItems_019dde8f-d65f-7e20-9cbc-29bf1fa671ee" xlink:to="loc_elv_EBPPlanRevenueCreditAccountDecreaseFromAdministrativeExpense_019ead66-65f1-789e-afd9-c0688416762c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/EmployeeBenefitPlanMasterTrustTables" xlink:type="simple" xlink:href="elv-20251231.xsd#EmployeeBenefitPlanMasterTrustTables"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/EmployeeBenefitPlanMasterTrustTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanMasterTrustAbstract_019dd9da-1699-7ff8-b955-e0429f2865be" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanMasterTrustAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanMasterTrustTable_019dd9de-bab9-7fef-ae90-b422974c2ade" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanMasterTrustTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanMasterTrustAbstract_019dd9da-1699-7ff8-b955-e0429f2865be" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanMasterTrustTable_019dd9de-bab9-7fef-ae90-b422974c2ade" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustAxis_019dd9e0-74fb-73ce-a8ce-96df102732bb" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanMasterTrustTable_019dd9de-bab9-7fef-ae90-b422974c2ade" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustAxis_019dd9e0-74fb-73ce-a8ce-96df102732bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustDomain_019dd9e0-74fb-7364-b61e-1965c4706b4c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustAxis_019dd9e0-74fb-73ce-a8ce-96df102732bb" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustDomain_019dd9e0-74fb-7364-b61e-1965c4706b4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedMasterTrustMember_019dd9e2-90ad-72b3-b715-43d429a49e18" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedMasterTrustMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustDomain_019dd9e0-74fb-7364-b61e-1965c4706b4c" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedMasterTrustMember_019dd9e2-90ad-72b3-b715-43d429a49e18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedPlanInterestInMasterTrustMember_019dd9e4-37c4-7a1c-9576-58f759b5d647" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedPlanInterestInMasterTrustMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustDomain_019dd9e0-74fb-7364-b61e-1965c4706b4c" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedPlanInterestInMasterTrustMember_019dd9e4-37c4-7a1c-9576-58f759b5d647" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_019dd9eb-7f9c-7ddd-970d-084380a28bf8" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanMasterTrustTable_019dd9de-bab9-7fef-ae90-b422974c2ade" xlink:to="loc_us-gaap_InvestmentTypeAxis_019dd9eb-7f9c-7ddd-970d-084380a28bf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_019dd9eb-7f9c-74f1-938b-bb5701c2a390" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_019dd9eb-7f9c-7ddd-970d-084380a28bf8" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_019dd9eb-7f9c-74f1-938b-bb5701c2a390" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCommonCollectiveTrustMember_019dd9eb-a479-7a9a-bfb5-b95949a46134" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DefinedBenefitPlanCommonCollectiveTrustMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_019dd9eb-7f9c-74f1-938b-bb5701c2a390" xlink:to="loc_us-gaap_DefinedBenefitPlanCommonCollectiveTrustMember_019dd9eb-a479-7a9a-bfb5-b95949a46134" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanEmployerCommonStockMember_019dd9ed-0e6a-79f9-8ba0-329633b639d7" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanEmployerCommonStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_019dd9eb-7f9c-74f1-938b-bb5701c2a390" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanEmployerCommonStockMember_019dd9ed-0e6a-79f9-8ba0-329633b639d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MutualFundMember_019dd9ed-f06f-7f7b-bfd0-d9cf60b8b981" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_MutualFundMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_019dd9eb-7f9c-74f1-938b-bb5701c2a390" xlink:to="loc_us-gaap_MutualFundMember_019dd9ed-f06f-7f7b-bfd0-d9cf60b8b981" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanSelfDirectedBrokerageAccountMember_019dd9ee-79e2-7856-af77-464eca85fc5c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanSelfDirectedBrokerageAccountMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_019dd9eb-7f9c-74f1-938b-bb5701c2a390" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanSelfDirectedBrokerageAccountMember_019dd9ee-79e2-7856-af77-464eca85fc5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_019dd9e1-371d-77aa-9041-a98bf06808cf" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanMasterTrustTable_019dd9de-bab9-7fef-ae90-b422974c2ade" xlink:to="loc_dei_LegalEntityAxis_019dd9e1-371d-77aa-9041-a98bf06808cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_019dd9e1-371d-76e6-a82a-700778cfb442" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_019dd9e1-371d-77aa-9041-a98bf06808cf" xlink:to="loc_dei_EntityDomain_019dd9e1-371d-76e6-a82a-700778cfb442" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_EBP003Member_019dd9e1-ce0b-725d-bd62-ed090227be8d" xlink:href="elv-20251231.xsd#elv_EBP003Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_019dd9e1-371d-76e6-a82a-700778cfb442" xlink:to="loc_elv_EBP003Member_019dd9e1-ce0b-725d-bd62-ed090227be8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanMasterTrustLineItems_019dd9de-bab9-784d-ac4f-12bbd0c85439" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanMasterTrustLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanMasterTrustTable_019dd9de-bab9-7fef-ae90-b422974c2ade" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanMasterTrustLineItems_019dd9de-bab9-784d-ac4f-12bbd0c85439" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanMasterTrustTextBlock_019e2bbe-d247-7997-be57-d85beeed0fe9" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanMasterTrustTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanMasterTrustLineItems_019dd9de-bab9-784d-ac4f-12bbd0c85439" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanMasterTrustTextBlock_019e2bbe-d247-7997-be57-d85beeed0fe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanMasterTrustTableTextBlock_019eada7-04c6-7f93-a64a-c31721f36e86" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanMasterTrustTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanMasterTrustLineItems_019dd9de-bab9-784d-ac4f-12bbd0c85439" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanMasterTrustTableTextBlock_019eada7-04c6-7f93-a64a-c31721f36e86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValue_019dd9e5-b675-7f66-9443-cac157fb38d2" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanMasterTrustLineItems_019dd9de-bab9-784d-ac4f-12bbd0c85439" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValue_019dd9e5-b675-7f66-9443-cac157fb38d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanOtherAsset_019e0942-8213-7fcc-8095-251e0dbd2d4c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanOtherAsset"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanMasterTrustLineItems_019dd9de-bab9-784d-ac4f-12bbd0c85439" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanOtherAsset_019e0942-8213-7fcc-8095-251e0dbd2d4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanNetAssetAvailableForBenefit_019dd9de-bab9-7059-8384-e81f5f313d57" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanNetAssetAvailableForBenefit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanMasterTrustLineItems_019dd9de-bab9-784d-ac4f-12bbd0c85439" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanNetAssetAvailableForBenefit_019dd9de-bab9-7059-8384-e81f5f313d57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForGainLossOnInvestment_019dda08-88c1-74f0-8e54-7e0c35b31f72" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForGainLossOnInvestment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanMasterTrustLineItems_019dd9de-bab9-784d-ac4f-12bbd0c85439" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForGainLossOnInvestment_019dda08-88c1-74f0-8e54-7e0c35b31f72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForInterestAndDividendIncomeOnInvestment_019ddf44-fc44-7bd4-8ee2-cc85d206d433" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForInterestAndDividendIncomeOnInvestment"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanMasterTrustLineItems_019dd9de-bab9-784d-ac4f-12bbd0c85439" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForInterestAndDividendIncomeOnInvestment_019ddf44-fc44-7bd4-8ee2-cc85d206d433" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForIncomeLossOnInvestment_019dda06-80c3-7824-92a1-067d69f2f4a7" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForIncomeLossOnInvestment"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanMasterTrustLineItems_019dd9de-bab9-784d-ac4f-12bbd0c85439" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForIncomeLossOnInvestment_019dda06-80c3-7824-92a1-067d69f2f4a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/EmployeeBenefitPlanFairValueandNAVTables" xlink:type="simple" xlink:href="elv-20251231.xsd#EmployeeBenefitPlanFairValueandNAVTables"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/EmployeeBenefitPlanFairValueandNAVTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavAbstract_019ecb4b-0b32-7dba-9ed2-1be9289c2dea" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavTable_019ecb4b-0b32-7e75-85ba-62e79ca53f2d" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavAbstract_019ecb4b-0b32-7dba-9ed2-1be9289c2dea" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavTable_019ecb4b-0b32-7e75-85ba-62e79ca53f2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_019ecb4b-0b32-7574-b77c-6555a8a7e143" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavTable_019ecb4b-0b32-7e75-85ba-62e79ca53f2d" xlink:to="loc_dei_LegalEntityAxis_019ecb4b-0b32-7574-b77c-6555a8a7e143" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_019ecb4b-0b32-72f3-b837-0cdc20f76b33" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_019ecb4b-0b32-7574-b77c-6555a8a7e143" xlink:to="loc_dei_EntityDomain_019ecb4b-0b32-72f3-b837-0cdc20f76b33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_EBP003Member_019ecb4b-0b32-7824-a590-2337c18dda69" xlink:href="elv-20251231.xsd#elv_EBP003Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_019ecb4b-0b32-72f3-b837-0cdc20f76b33" xlink:to="loc_elv_EBP003Member_019ecb4b-0b32-7824-a590-2337c18dda69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_019ecb2e-fd4b-752d-a70b-9d2b50fa37e5" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavTable_019ecb4b-0b32-7e75-85ba-62e79ca53f2d" xlink:to="loc_us-gaap_InvestmentTypeAxis_019ecb2e-fd4b-752d-a70b-9d2b50fa37e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_019ecb2e-fd4b-7602-a7de-3c04d96131fe" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_019ecb2e-fd4b-752d-a70b-9d2b50fa37e5" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_019ecb2e-fd4b-7602-a7de-3c04d96131fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanEmployerCommonStockMember_019ecb75-eb5c-7cc8-aeb7-c1bad5e65a10" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanEmployerCommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_019ecb2e-fd4b-7602-a7de-3c04d96131fe" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanEmployerCommonStockMember_019ecb75-eb5c-7cc8-aeb7-c1bad5e65a10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MutualFundMember_019ecb76-5e02-719e-be60-27de7d9958ff" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_MutualFundMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_019ecb2e-fd4b-7602-a7de-3c04d96131fe" xlink:to="loc_us-gaap_MutualFundMember_019ecb76-5e02-719e-be60-27de7d9958ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanSelfDirectedBrokerageAccountMember_019ecb3a-92bf-7be1-8ab4-278f2dc19d1a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanSelfDirectedBrokerageAccountMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_019ecb2e-fd4b-7602-a7de-3c04d96131fe" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanSelfDirectedBrokerageAccountMember_019ecb3a-92bf-7be1-8ab4-278f2dc19d1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_019ecb38-555b-7080-8f98-f457b137ee26" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavTable_019ecb4b-0b32-7e75-85ba-62e79ca53f2d" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_019ecb38-555b-7080-8f98-f457b137ee26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019ecb38-555b-7285-9735-96d144e3138e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_019ecb38-555b-7080-8f98-f457b137ee26" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019ecb38-555b-7285-9735-96d144e3138e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel12And3Member_019ecb38-8dee-7cf2-96a5-e12290732899" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FairValueInputsLevel12And3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019ecb38-555b-7285-9735-96d144e3138e" xlink:to="loc_us-gaap_FairValueInputsLevel12And3Member_019ecb38-8dee-7cf2-96a5-e12290732899" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_019ecb70-55d2-79e8-90a5-f540d56bfc26" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019ecb38-555b-7285-9735-96d144e3138e" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_019ecb70-55d2-79e8-90a5-f540d56bfc26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_019ecb70-aeec-757c-864a-7979b3012cc3" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019ecb38-555b-7285-9735-96d144e3138e" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_019ecb70-aeec-757c-864a-7979b3012cc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_019ecb70-f85e-70f4-958c-6cb1fe65b719" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019ecb38-555b-7285-9735-96d144e3138e" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_019ecb70-f85e-70f4-958c-6cb1fe65b719" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_019ecb5d-e184-7a3c-a3bf-edb3fb0bd3e8" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019ecb38-555b-7285-9735-96d144e3138e" xlink:to="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_019ecb5d-e184-7a3c-a3bf-edb3fb0bd3e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavLineItems_019ecb4b-0b32-71fa-9342-c77f90c9c54e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavTable_019ecb4b-0b32-7e75-85ba-62e79ca53f2d" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavLineItems_019ecb4b-0b32-71fa-9342-c77f90c9c54e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavTextBlock_019ecb4b-0b32-79f8-8c7f-309244f2a599" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavLineItems_019ecb4b-0b32-71fa-9342-c77f90c9c54e" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavTextBlock_019ecb4b-0b32-79f8-8c7f-309244f2a599" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavTableTextBlock_019eada8-dece-7033-bcf7-f06b779d9e63" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavLineItems_019ecb4b-0b32-71fa-9342-c77f90c9c54e" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavTableTextBlock_019eada8-dece-7033-bcf7-f06b779d9e63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue_019ecb38-20c9-73cd-8dc0-fc06f1ffb847" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavLineItems_019ecb4b-0b32-71fa-9342-c77f90c9c54e" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue_019ecb38-20c9-73cd-8dc0-fc06f1ffb847" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/EmployeeBenefitPlanTaxStatusTables" xlink:type="simple" xlink:href="elv-20251231.xsd#EmployeeBenefitPlanTaxStatusTables"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/EmployeeBenefitPlanTaxStatusTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanTaxStatusAbstract_019e2bc9-3c4e-7d67-847b-4beb0f89ef72" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanTaxStatusAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanTaxStatusTextBlock_019e2bc9-3c4e-794b-a28a-9ebb2710a8e5" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanTaxStatusTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanTaxStatusAbstract_019e2bc9-3c4e-7d67-847b-4beb0f89ef72" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanTaxStatusTextBlock_019e2bc9-3c4e-794b-a28a-9ebb2710a8e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanTaxStatusTable_019e2be4-0402-75c4-926a-6ea162bb5f40" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanTaxStatusTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanTaxStatusAbstract_019e2bc9-3c4e-7d67-847b-4beb0f89ef72" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanTaxStatusTable_019e2be4-0402-75c4-926a-6ea162bb5f40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_019e2be4-0402-719b-b193-4a5cc51047c9" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanTaxStatusTable_019e2be4-0402-75c4-926a-6ea162bb5f40" xlink:to="loc_dei_LegalEntityAxis_019e2be4-0402-719b-b193-4a5cc51047c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_019e2be4-0402-7364-8331-2ca494b51231" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_019e2be4-0402-719b-b193-4a5cc51047c9" xlink:to="loc_dei_EntityDomain_019e2be4-0402-7364-8331-2ca494b51231" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_EBP003Member_019e2be4-0402-7739-bf61-e912926b9a2d" xlink:href="elv-20251231.xsd#elv_EBP003Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_019e2be4-0402-7364-8331-2ca494b51231" xlink:to="loc_elv_EBP003Member_019e2be4-0402-7739-bf61-e912926b9a2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanTaxStatusLineItems_019e2be4-0402-7cbb-bea6-b1fc44a75618" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanTaxStatusLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanTaxStatusTable_019e2be4-0402-75c4-926a-6ea162bb5f40" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanTaxStatusLineItems_019e2be4-0402-7cbb-bea6-b1fc44a75618" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanTaxStatusTextBlock_019e2be4-0402-7cec-b28b-bc15f6187595" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanTaxStatusTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanTaxStatusLineItems_019e2be4-0402-7cbb-bea6-b1fc44a75618" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanTaxStatusTextBlock_019e2be4-0402-7cec-b28b-bc15f6187595" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/EmployeeBenefitPlanSubsequentEventTables" xlink:type="simple" xlink:href="elv-20251231.xsd#EmployeeBenefitPlanSubsequentEventTables"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/EmployeeBenefitPlanSubsequentEventTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EbpSubsequentEventAbstract_019e2bcf-da28-75a5-98b2-095674b967a9" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EbpSubsequentEventAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EbpSubsequentEventTable_019e2bea-dc69-7e36-b056-096037f53277" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EbpSubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EbpSubsequentEventAbstract_019e2bcf-da28-75a5-98b2-095674b967a9" xlink:to="loc_us-gaap-ebp_EbpSubsequentEventTable_019e2bea-dc69-7e36-b056-096037f53277" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_019e2bea-dc69-7e74-b9a4-25d17dbb0232" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EbpSubsequentEventTable_019e2bea-dc69-7e36-b056-096037f53277" xlink:to="loc_dei_LegalEntityAxis_019e2bea-dc69-7e74-b9a4-25d17dbb0232" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_019e2bea-dc69-7a9a-b9b1-55a9e860d421" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_019e2bea-dc69-7e74-b9a4-25d17dbb0232" xlink:to="loc_dei_EntityDomain_019e2bea-dc69-7a9a-b9b1-55a9e860d421" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_EBP003Member_019e2bea-dc69-786c-9056-801000c614a8" xlink:href="elv-20251231.xsd#elv_EBP003Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_019e2bea-dc69-7a9a-b9b1-55a9e860d421" xlink:to="loc_elv_EBP003Member_019e2bea-dc69-786c-9056-801000c614a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EbpSubsequentEventLineItems_019e2bea-dc69-79bc-a3ec-f2a8cd3012c0" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EbpSubsequentEventLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EbpSubsequentEventTable_019e2bea-dc69-7e36-b056-096037f53277" xlink:to="loc_us-gaap-ebp_EbpSubsequentEventLineItems_019e2bea-dc69-79bc-a3ec-f2a8cd3012c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanSubsequentEventTextBlock_019e2bea-dc69-79d1-8e04-77c1688635dc" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanSubsequentEventTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EbpSubsequentEventLineItems_019e2bea-dc69-79bc-a3ec-f2a8cd3012c0" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanSubsequentEventTextBlock_019e2bea-dc69-79d1-8e04-77c1688635dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/EmployeeBenefitPlanSummaryofAccountingPolicyTables" xlink:type="simple" xlink:href="elv-20251231.xsd#EmployeeBenefitPlanSummaryofAccountingPolicyTables"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/EmployeeBenefitPlanSummaryofAccountingPolicyTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanAccountingPolicyAbstract_019eb751-ff63-7df7-bd36-fec736306789" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanAccountingPolicyAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanAccountingPolicyTable_019e97be-7aae-7866-975d-a415188085da" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanAccountingPolicyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanAccountingPolicyAbstract_019eb751-ff63-7df7-bd36-fec736306789" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanAccountingPolicyTable_019e97be-7aae-7866-975d-a415188085da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_019e97be-7aae-79ca-bbc7-c3055f823ef0" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanAccountingPolicyTable_019e97be-7aae-7866-975d-a415188085da" xlink:to="loc_dei_LegalEntityAxis_019e97be-7aae-79ca-bbc7-c3055f823ef0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_019e97be-7aae-793c-bb3b-494b00ca56a5" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_019e97be-7aae-79ca-bbc7-c3055f823ef0" xlink:to="loc_dei_EntityDomain_019e97be-7aae-793c-bb3b-494b00ca56a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_EBP003Member_019e97be-7aae-7ce4-8ac8-374c39f6d316" xlink:href="elv-20251231.xsd#elv_EBP003Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_019e97be-7aae-793c-bb3b-494b00ca56a5" xlink:to="loc_elv_EBP003Member_019e97be-7aae-7ce4-8ac8-374c39f6d316" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanAccountingPolicyLineItems_019e97be-7aae-7b07-a340-3086ca5ee31c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanAccountingPolicyLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanAccountingPolicyTable_019e97be-7aae-7866-975d-a415188085da" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanAccountingPolicyLineItems_019e97be-7aae-7b07-a340-3086ca5ee31c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanSummaryOfAccountingPolicyTextBlock_019e97be-7aae-76be-8fd0-ef1c3511cf90" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanSummaryOfAccountingPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanAccountingPolicyLineItems_019e97be-7aae-7b07-a340-3086ca5ee31c" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanSummaryOfAccountingPolicyTextBlock_019e97be-7aae-76be-8fd0-ef1c3511cf90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanBasisOfAccountingPolicyTextBlock_019ead70-38d4-7863-a86e-36b9dc97c372" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanBasisOfAccountingPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanAccountingPolicyLineItems_019e97be-7aae-7b07-a340-3086ca5ee31c" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanBasisOfAccountingPolicyTextBlock_019ead70-38d4-7863-a86e-36b9dc97c372" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanUseOfEstimatePolicyTextBlock_019ead72-ec2a-7a25-88e0-aef9e0268885" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanUseOfEstimatePolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanAccountingPolicyLineItems_019e97be-7aae-7b07-a340-3086ca5ee31c" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanUseOfEstimatePolicyTextBlock_019ead72-ec2a-7a25-88e0-aef9e0268885" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentPolicyTextBlock_019ead73-9a53-7daf-bfd6-e76b1f235e17" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanInvestmentPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanAccountingPolicyLineItems_019e97be-7aae-7b07-a340-3086ca5ee31c" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentPolicyTextBlock_019ead73-9a53-7daf-bfd6-e76b1f235e17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanNoteReceivableFromParticipantPolicyTextBlock_019ead73-f594-72d0-9df8-0c48030993e6" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanNoteReceivableFromParticipantPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanAccountingPolicyLineItems_019e97be-7aae-7b07-a340-3086ca5ee31c" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanNoteReceivableFromParticipantPolicyTextBlock_019ead73-f594-72d0-9df8-0c48030993e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanPaymentToParticipantPolicyTextBlock_019ead74-4882-7b88-85c9-81d385fe550b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanPaymentToParticipantPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanAccountingPolicyLineItems_019e97be-7aae-7b07-a340-3086ca5ee31c" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanPaymentToParticipantPolicyTextBlock_019ead74-4882-7b88-85c9-81d385fe550b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanExpensePolicyTextBlock_019ead74-a1b1-73bb-ae1c-26eb41735f42" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanExpensePolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanAccountingPolicyLineItems_019e97be-7aae-7b07-a340-3086ca5ee31c" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanExpensePolicyTextBlock_019ead74-a1b1-73bb-ae1c-26eb41735f42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_EBPAccountingPolicyAdoptionPolicyTextBlock_019ead78-e63c-7d8f-a1ff-97f2436814ea" xlink:href="elv-20251231.xsd#elv_EBPAccountingPolicyAdoptionPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanAccountingPolicyLineItems_019e97be-7aae-7b07-a340-3086ca5ee31c" xlink:to="loc_elv_EBPAccountingPolicyAdoptionPolicyTextBlock_019ead78-e63c-7d8f-a1ff-97f2436814ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/EmployeeBenefitPlanReconciliationofFinancialStatementtoForm5500Tables" xlink:type="simple" xlink:href="elv-20251231.xsd#EmployeeBenefitPlanReconciliationofFinancialStatementtoForm5500Tables"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/EmployeeBenefitPlanReconciliationofFinancialStatementtoForm5500Tables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500Abstract_019ddeca-b962-7fea-82a0-8ac7eaf5e218" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500Abstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500Table_019ddeca-b962-7d1d-8976-5061ccdbe078" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500Table"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500Abstract_019ddeca-b962-7fea-82a0-8ac7eaf5e218" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500Table_019ddeca-b962-7d1d-8976-5061ccdbe078" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_019ddeca-b962-789a-a213-8a16d4eea42e" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500Table_019ddeca-b962-7d1d-8976-5061ccdbe078" xlink:to="loc_dei_LegalEntityAxis_019ddeca-b962-789a-a213-8a16d4eea42e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_019ddeca-b962-775f-b5b9-5ca50b5a81a5" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_019ddeca-b962-789a-a213-8a16d4eea42e" xlink:to="loc_dei_EntityDomain_019ddeca-b962-775f-b5b9-5ca50b5a81a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_EBP003Member_019ddeca-fec5-7899-97f9-fbeb00084e27" xlink:href="elv-20251231.xsd#elv_EBP003Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_019ddeca-b962-775f-b5b9-5ca50b5a81a5" xlink:to="loc_elv_EBP003Member_019ddeca-fec5-7899-97f9-fbeb00084e27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500LineItems_019ddeca-b962-7f7b-b98a-8c917ff9cd2c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500LineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500Table_019ddeca-b962-7d1d-8976-5061ccdbe078" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500LineItems_019ddeca-b962-7f7b-b98a-8c917ff9cd2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500TextBlock_019e2bcd-9b4e-7e64-b61e-bdc4219d41a6" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500TextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500LineItems_019ddeca-b962-7f7b-b98a-8c917ff9cd2c" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500TextBlock_019e2bcd-9b4e-7e64-b61e-bdc4219d41a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500TableTextBlock_019eadad-3a98-77f3-9474-2f7b9c9bcaad" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500TableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500LineItems_019ddeca-b962-7f7b-b98a-8c917ff9cd2c" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500TableTextBlock_019eadad-3a98-77f3-9474-2f7b9c9bcaad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanNetAssetAvailableForBenefit_019ddecd-1f10-7696-9e9e-af30c0bd30b7" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanNetAssetAvailableForBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500LineItems_019ddeca-b962-7f7b-b98a-8c917ff9cd2c" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanNetAssetAvailableForBenefit_019ddecd-1f10-7696-9e9e-af30c0bd30b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500NetAssetAvailableForBenefitDeemedDistribution_019e1d73-920e-7aa2-aab6-e0d1ad76155b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500NetAssetAvailableForBenefitDeemedDistribution"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500LineItems_019ddeca-b962-7f7b-b98a-8c917ff9cd2c" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500NetAssetAvailableForBenefitDeemedDistribution_019e1d73-920e-7aa2-aab6-e0d1ad76155b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanForm5500CaptionNetAssetAvailableForBenefit_019ddecb-d510-7db5-b328-11736d30f5b7" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanForm5500CaptionNetAssetAvailableForBenefit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500LineItems_019ddeca-b962-7f7b-b98a-8c917ff9cd2c" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanForm5500CaptionNetAssetAvailableForBenefit_019ddecb-d510-7db5-b328-11736d30f5b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecrease_019dded3-4ecd-7950-bc10-91a7100edb46" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecrease"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500LineItems_019ddeca-b962-7f7b-b98a-8c917ff9cd2c" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecrease_019dded3-4ecd-7950-bc10-91a7100edb46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500PaymentToParticipantIncreaseDecreaseForDeemedDistribution_019ddeca-b962-7070-b971-d10e94ed4068" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500PaymentToParticipantIncreaseDecreaseForDeemedDistribution"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500LineItems_019ddeca-b962-7f7b-b98a-8c917ff9cd2c" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500PaymentToParticipantIncreaseDecreaseForDeemedDistribution_019ddeca-b962-7070-b971-d10e94ed4068" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanForm5500CaptionNetIncomeLoss_019ddecf-f211-7d61-be98-0025572bec23" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanForm5500CaptionNetIncomeLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500LineItems_019ddeca-b962-7f7b-b98a-8c917ff9cd2c" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanForm5500CaptionNetIncomeLoss_019ddecf-f211-7d61-be98-0025572bec23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/EmployeeBenefitPlanSubsequentEventTables_1" xlink:type="simple" xlink:href="elv-20251231.xsd#EmployeeBenefitPlanSubsequentEventTables_1"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/EmployeeBenefitPlanSubsequentEventTables_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EbpSubsequentEventAbstract_019eb752-9d2a-767c-aaf1-8026c4d435ad" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EbpSubsequentEventAbstract"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/EmployeeBenefitPlanMasterTrustDetails" xlink:type="simple" xlink:href="elv-20251231.xsd#EmployeeBenefitPlanMasterTrustDetails"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/EmployeeBenefitPlanMasterTrustDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanMasterTrustAbstract_019dd9da-1699-7bb1-ac3f-3090e242999f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanMasterTrustAbstract"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/EmployeeBenefitPlanFairValueandNAVDetails" xlink:type="simple" xlink:href="elv-20251231.xsd#EmployeeBenefitPlanFairValueandNAVDetails"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/EmployeeBenefitPlanFairValueandNAVDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavAbstract_019e1d28-ff17-7083-9f54-1a4896212480" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavAbstract"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/EmployeeBenefitPlanRelatedPartyandPartyinInterestTransactionsDetails" xlink:type="simple" xlink:href="elv-20251231.xsd#EmployeeBenefitPlanRelatedPartyandPartyinInterestTransactionsDetails"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/EmployeeBenefitPlanRelatedPartyandPartyinInterestTransactionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsAbstract_019ddea1-5fc4-755e-840c-bce21937a970" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsTable_019ddea1-5fc4-7a61-9bec-d694617c232b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsAbstract_019ddea1-5fc4-755e-840c-bce21937a970" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsTable_019ddea1-5fc4-7a61-9bec-d694617c232b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_019ddea1-5fc4-7c14-8b1d-d35db1ab3d41" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsTable_019ddea1-5fc4-7a61-9bec-d694617c232b" xlink:to="loc_dei_LegalEntityAxis_019ddea1-5fc4-7c14-8b1d-d35db1ab3d41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_019ddea1-5fc4-7aae-8b48-4b7b8cf73b4e" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_019ddea1-5fc4-7c14-8b1d-d35db1ab3d41" xlink:to="loc_dei_EntityDomain_019ddea1-5fc4-7aae-8b48-4b7b8cf73b4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_EBP003Member_019ddea1-bacc-7b87-a506-60a4dd2e9cbf" xlink:href="elv-20251231.xsd#elv_EBP003Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_019ddea1-5fc4-7aae-8b48-4b7b8cf73b4e" xlink:to="loc_elv_EBP003Member_019ddea1-bacc-7b87-a506-60a4dd2e9cbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestAxis_019ddea1-5fc4-7c0d-8d0a-2fc3df9e3316" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsTable_019ddea1-5fc4-7a61-9bec-d694617c232b" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestAxis_019ddea1-5fc4-7c0d-8d0a-2fc3df9e3316" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestDomain_019ddea1-5fc4-73a9-9b03-4a71d7f6a866" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestAxis_019ddea1-5fc4-7c0d-8d0a-2fc3df9e3316" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestDomain_019ddea1-5fc4-73a9-9b03-4a71d7f6a866" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyMember_019ddec3-5e47-7b32-8e2c-d393322dcbcc" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RelatedPartyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestDomain_019ddea1-5fc4-73a9-9b03-4a71d7f6a866" xlink:to="loc_us-gaap_RelatedPartyMember_019ddec3-5e47-7b32-8e2c-d393322dcbcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsLineItems_019ddea1-5fc4-7f88-9c03-a19f3492204c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsTable_019ddea1-5fc4-7a61-9bec-d694617c232b" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsLineItems_019ddea1-5fc4-7f88-9c03-a19f3492204c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsTextBlock_019e2bc8-5155-7332-8c57-1114be2cd59e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsLineItems_019ddea1-5fc4-7f88-9c03-a19f3492204c" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsTextBlock_019e2bc8-5155-7332-8c57-1114be2cd59e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecreaseForAdministrativeExpense_019ddea1-5fc4-712c-b022-47faa2361594" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecreaseForAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsLineItems_019ddea1-5fc4-7f88-9c03-a19f3492204c" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecreaseForAdministrativeExpense_019ddea1-5fc4-712c-b022-47faa2361594" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentNumberOfShares_019ddea2-7de8-7cf7-b588-73f9fea23dbe" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanInvestmentNumberOfShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsLineItems_019ddea1-5fc4-7f88-9c03-a19f3492204c" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentNumberOfShares_019ddea2-7de8-7cf7-b588-73f9fea23dbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentNumberOfSharesSold_019ddea4-0618-757d-8994-10d26bba9065" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanInvestmentNumberOfSharesSold"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsLineItems_019ddea1-5fc4-7f88-9c03-a19f3492204c" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentNumberOfSharesSold_019ddea4-0618-757d-8994-10d26bba9065" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForDividendIncomeOnInvestment_019ddea5-2191-74bf-ba0d-c7bb26493cd2" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForDividendIncomeOnInvestment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsLineItems_019ddea1-5fc4-7f88-9c03-a19f3492204c" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForDividendIncomeOnInvestment_019ddea5-2191-74bf-ba0d-c7bb26493cd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/EmployeeBenefitPlanReconciliationofFinancialStatementtoForm5500Details" xlink:type="simple" xlink:href="elv-20251231.xsd#EmployeeBenefitPlanReconciliationofFinancialStatementtoForm5500Details"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/EmployeeBenefitPlanReconciliationofFinancialStatementtoForm5500Details" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500Abstract_019ddeca-b962-7e0d-8d10-0181d1600003" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500Abstract"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.elevancehealth.com/role/EmployeeBenefitPlanScheduleAssetHeldforInvestmentDetails" xlink:type="simple" xlink:href="elv-20251231.xsd#EmployeeBenefitPlanScheduleAssetHeldforInvestmentDetails"/>
  <link:presentationLink xlink:role="http://www.elevancehealth.com/role/EmployeeBenefitPlanScheduleAssetHeldforInvestmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentAbstract_019ddf9d-77e2-76cb-899d-502b9a3b4356" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentTable_019dfed2-c440-7ff2-b3db-5d5b40a0dfec" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentAbstract_019ddf9d-77e2-76cb-899d-502b9a3b4356" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentTable_019dfed2-c440-7ff2-b3db-5d5b40a0dfec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIdentifierAxis_019dfa16-fa6e-7ebc-ada9-15a5712afcbc" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InvestmentIdentifierAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentTable_019dfed2-c440-7ff2-b3db-5d5b40a0dfec" xlink:to="loc_us-gaap_InvestmentIdentifierAxis_019dfa16-fa6e-7ebc-ada9-15a5712afcbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_019dfed2-f489-70a8-ba74-403510695c12" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentTable_019dfed2-c440-7ff2-b3db-5d5b40a0dfec" xlink:to="loc_dei_LegalEntityAxis_019dfed2-f489-70a8-ba74-403510695c12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_019dfed2-f489-72d2-8dcb-3919e8a53cbc" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_019dfed2-f489-70a8-ba74-403510695c12" xlink:to="loc_dei_EntityDomain_019dfed2-f489-72d2-8dcb-3919e8a53cbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_elv_EBP003Member_019dfed3-0976-7a8a-ad86-b550f594e324" xlink:href="elv-20251231.xsd#elv_EBP003Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_019dfed2-f489-72d2-8dcb-3919e8a53cbc" xlink:to="loc_elv_EBP003Member_019dfed3-0976-7a8a-ad86-b550f594e324" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_019e0784-eb32-7900-9084-98a8dc1c7bfb" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentTable_019dfed2-c440-7ff2-b3db-5d5b40a0dfec" xlink:to="loc_srt_RangeAxis_019e0784-eb32-7900-9084-98a8dc1c7bfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019e0784-eb32-72e3-b02b-cfcee1c23602" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_019e0784-eb32-7900-9084-98a8dc1c7bfb" xlink:to="loc_srt_RangeMember_019e0784-eb32-72e3-b02b-cfcee1c23602" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_019e0784-eb32-7fe9-a6aa-f7b7b7bd228a" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_019e0784-eb32-72e3-b02b-cfcee1c23602" xlink:to="loc_srt_MinimumMember_019e0784-eb32-7fe9-a6aa-f7b7b7bd228a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_019e0785-8a38-7211-986f-afca019bd681" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_019e0784-eb32-72e3-b02b-cfcee1c23602" xlink:to="loc_srt_MaximumMember_019e0785-8a38-7211-986f-afca019bd681" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentLineItems_019e0781-94f1-7e83-b780-415405724b10" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentTable_019dfed2-c440-7ff2-b3db-5d5b40a0dfec" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentLineItems_019e0781-94f1-7e83-b780-415405724b10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentTableTextBlock_019eadb0-b6da-7143-a261-ce32a36af2b8" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentLineItems_019e0781-94f1-7e83-b780-415405724b10" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentTableTextBlock_019eadb0-b6da-7143-a261-ce32a36af2b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanAssetHeldForInvestmentPartyInInterest_019e0781-94f1-7d4a-9884-11be345e1a59" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanAssetHeldForInvestmentPartyInInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentLineItems_019e0781-94f1-7e83-b780-415405724b10" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanAssetHeldForInvestmentPartyInInterest_019e0781-94f1-7d4a-9884-11be345e1a59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentIssuerNameExtensibleEnumeration_019e0781-a8b6-74a1-bb4b-acce14246c96" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanInvestmentIssuerNameExtensibleEnumeration"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentLineItems_019e0781-94f1-7e83-b780-415405724b10" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentIssuerNameExtensibleEnumeration_019e0781-a8b6-74a1-bb4b-acce14246c96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentTypeExtensibleEnumeration_019e0781-b81a-731c-8121-9727e878d4e7" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanInvestmentTypeExtensibleEnumeration"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentLineItems_019e0781-94f1-7e83-b780-415405724b10" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentTypeExtensibleEnumeration_019e0781-b81a-731c-8121-9727e878d4e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanAssetHeldForInvestmentPlanInterestInMasterTrustParticipationStatusExtensibleEnumeration_019e0781-c87c-75e2-8431-c5fcd3f6bdbb" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanAssetHeldForInvestmentPlanInterestInMasterTrustParticipationStatusExtensibleEnumeration"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentLineItems_019e0781-94f1-7e83-b780-415405724b10" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanAssetHeldForInvestmentPlanInterestInMasterTrustParticipationStatusExtensibleEnumeration_019e0781-c87c-75e2-8431-c5fcd3f6bdbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentPlanInterestInMasterTrustFairValue_019e9488-cc66-7884-a920-81974336be17" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanInvestmentPlanInterestInMasterTrustFairValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentLineItems_019e0781-94f1-7e83-b780-415405724b10" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanInvestmentPlanInterestInMasterTrustFairValue_019e9488-cc66-7884-a920-81974336be17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanParticipantLoanInterestRate_019e0781-f5f1-7c54-a546-ca7fc84fed75" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanParticipantLoanInterestRate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentLineItems_019e0781-94f1-7e83-b780-415405724b10" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanParticipantLoanInterestRate_019e0781-f5f1-7c54-a546-ca7fc84fed75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanParticipantLoanMaturityDate_019e0782-0c07-7da0-958e-692205db6641" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanParticipantLoanMaturityDate"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentLineItems_019e0781-94f1-7e83-b780-415405724b10" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanParticipantLoanMaturityDate_019e0782-0c07-7da0-958e-692205db6641" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanAssetHeldForInvestmentParticipantLoanAfterDeemedDistribution_019e0782-1cbd-703d-b8ba-5d9c154500c0" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanAssetHeldForInvestmentParticipantLoanAfterDeemedDistribution"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentLineItems_019e0781-94f1-7e83-b780-415405724b10" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanAssetHeldForInvestmentParticipantLoanAfterDeemedDistribution_019e0782-1cbd-703d-b8ba-5d9c154500c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_019e0788-8ff5-750a-a444-a265b2d31d21" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentLineItems_019e0781-94f1-7e83-b780-415405724b10" xlink:to="loc_dei_EntityTaxIdentificationNumber_019e0788-8ff5-750a-a444-a265b2d31d21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap-ebp_EmployeeBenefitPlanPlanNumber_019e0788-aeec-75a2-a23c-b98125901b9a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd#us-gaap-ebp_EmployeeBenefitPlanPlanNumber"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentLineItems_019e0781-94f1-7e83-b780-415405724b10" xlink:to="loc_us-gaap-ebp_EmployeeBenefitPlanPlanNumber_019e0788-aeec-75a2-a23c-b98125901b9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">11-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001156039<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Elevance Health, Inc.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=elv_EBP003Member', window );">EBP 003</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">11-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-16751<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EbpPlanName', window );">EBP, Plan Name</a></td>
<td class="text">ELEVANCE HEALTH 401(k) PLAN<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Elevance Health, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">220 Virginia Avenue<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Indianapolis<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">IN<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">46204<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EbpPlanName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of employee stock purchase, saving, or similar plan (employee benefit plan (EBP)).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EbpPlanName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap-ebp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=elv_EBP003Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=elv_EBP003Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Employee Benefit Plan, Statement of Net Asset Available for Benefit (Statement) - EBP 003 - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanStatementOfNetAssetAvailableForBenefitLineItems', window );"><strong>EBP, Statement of Net Asset Available for Benefit [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanInvestmentPlanInterestInMasterTrustFairValue', window );">Investments, at fair value, Interest in EH Master Trust</a></td>
<td class="nump">$ 13,065,058,854<span></span>
</td>
<td class="nump">$ 11,861,354,869<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanNoteReceivableFromParticipant', window );">Notes receivable from participants</a></td>
<td class="nump">238,395,440<span></span>
</td>
<td class="nump">234,538,393<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanEmployerContributionReceivable', window );">Receivables, Employer contributions</a></td>
<td class="nump">9,458,553<span></span>
</td>
<td class="nump">14,692,281<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanReceivable', window );">Total receivables</a></td>
<td class="nump">247,853,993<span></span>
</td>
<td class="nump">249,230,674<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanNetAssetAvailableForBenefit', window );">EBP, Net Asset Available for Benefit, Total</a></td>
<td class="nump">$ 13,312,912,847<span></span>
</td>
<td class="nump">$ 12,110,585,543<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EmployeeBenefitPlanEmployerContributionReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution receivable from employer of participant in employee stock purchase, saving, or similar plan (employee benefit plan (EBP)).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478873/962-325-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-05(a)(Schedule II))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478642/962-310-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EmployeeBenefitPlanEmployerContributionReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap-ebp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EmployeeBenefitPlanInvestmentPlanInterestInMasterTrustFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of plan interest in master trust held by employee stock purchase, saving, or similar plan (employee benefit plan (EBP)).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478873/962-325-55-18<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-05(a)(Schedule II))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-03(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477063/962-205-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EmployeeBenefitPlanInvestmentPlanInterestInMasterTrustFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap-ebp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EmployeeBenefitPlanNetAssetAvailableForBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset less liability available to pay benefit of participant in employee stock purchase, saving, or similar plan (employee benefit plan (EBP)), including, but not limited to, aggregation of participants' individual account balances.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477509/962-325-45-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478873/962-325-55-18<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478873/962-325-55-17<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-05(a)(Schedule II))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479750/962-40-25-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-04(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-04(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-03(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477063/962-205-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EmployeeBenefitPlanNetAssetAvailableForBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap-ebp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EmployeeBenefitPlanNoteReceivableFromParticipant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unpaid principal plus accrued but unpaid interest for loan from participant in employee stock purchase, saving, or similar plan (employee benefit plan (EBP)).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478873/962-325-55-17<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-05(a)(Schedule II))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478642/962-310-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EmployeeBenefitPlanNoteReceivableFromParticipant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap-ebp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EmployeeBenefitPlanReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of receivable of employee stock purchase, saving, or similar plan (employee benefit plan (EBP)).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478873/962-325-55-17<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-05(a)(Schedule II))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EmployeeBenefitPlanReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap-ebp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EmployeeBenefitPlanStatementOfNetAssetAvailableForBenefitLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477509/962-325-45-8<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477509/962-325-45-5<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477509/962-325-45-5<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (j)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477509/962-325-45-5<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-03(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477509/962-325-45-5<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-03(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477509/962-325-45-5<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-03(6)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-03(7)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (k)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477509/962-325-45-5<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477509/962-325-45-5<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477509/962-325-45-5<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477509/962-325-45-5<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477509/962-325-45-5<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477509/962-325-45-5<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-03(2)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-03(2)(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-03(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-03(6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-03(7)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EmployeeBenefitPlanStatementOfNetAssetAvailableForBenefitLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap-ebp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=elv_EBP003Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=elv_EBP003Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefit Plan, Statement of Change in Net Asset Available for Benefit (Statement) - EBP 003<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanStatementOfChangeInNetAssetAvailableForBenefitLineItems', window );"><strong>EBP, Statement of Change in Net Asset Available for Benefit [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForParticipantContributionExcludingRollover', window );">Contributions, Participant</a></td>
<td class="nump">$ 555,710,479<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForEmployerContributionCash', window );">Contributions, Employer</a></td>
<td class="nump">292,872,276<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForParticipantContributionRollover', window );">Contributions, Participant rollover</a></td>
<td class="nump">88,135,249<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForContribution', window );">Total contributions</a></td>
<td class="nump">936,718,004<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForChangeInPlanInterestInMasterTrust', window );">Interest in EH Master Trust income</a></td>
<td class="nump">1,817,823,441<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForInterestIncomeOnNoteReceivableFromParticipant', window );">Interest income from notes receivable from participants</a></td>
<td class="nump">19,589,802<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncrease', window );">Total additions</a></td>
<td class="nump">2,774,131,247<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecreaseForPaymentToParticipant', window );">Benefits paid to participants</a></td>
<td class="nump">1,565,382,437<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecreaseForAdministrativeExpense', window );">Administrative expenses</a></td>
<td class="nump">6,421,506<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecrease', window );">Total deductions</a></td>
<td class="nump">1,571,803,943<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecrease', window );">Net increase in net assets available for benefits</a></td>
<td class="nump">1,202,327,304<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanNetAssetAvailableForBenefit', window );">EBP, Net Asset Available for Benefit, Beginning Balance</a></td>
<td class="nump">12,110,585,543<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanNetAssetAvailableForBenefit', window );">EBP, Net Asset Available for Benefit, Ending Balance</a></td>
<td class="nump">$ 13,312,912,847<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in net asset available for benefit to participant in employee stock purchase, saving, or similar plan (employee benefit plan (EBP)).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478873/962-325-55-17<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-05(a)(Schedule III))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap-ebp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecreaseForAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in net asset available for benefit from administrative expense incurred by employee stock purchase, saving, or similar plan (employee benefit plan (EBP)).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478873/962-325-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-05(a)(Schedule III))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477063/962-205-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecreaseForAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap-ebp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecreaseForPaymentToParticipant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in net asset available for benefit from payment of benefit to participant in employee stock purchase, saving, or similar plan (employee benefit plan (EBP)), including, but not limited to, withdrawal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478873/962-325-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-05(a)(Schedule III))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-04(5)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477783/962-325-50-2B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477063/962-205-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecreaseForPaymentToParticipant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap-ebp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in net asset available for benefit to participant in employee stock purchase, saving, or similar plan (employee benefit plan (EBP)).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478873/962-325-55-17<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-05(a)(Schedule III))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap-ebp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in net asset available for benefit to participant in employee stock purchase, saving, or similar plan (employee benefit plan (EBP)).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478873/962-325-55-17<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-05(a)(Schedule III))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477509/962-325-45-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap-ebp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForChangeInPlanInterestInMasterTrust">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in net asset available for benefit from increase (decrease) in plan interest in master trust held by employee stock purchase, saving, or similar plan (employee benefit plan (EBP)).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477063/962-205-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForChangeInPlanInterestInMasterTrust</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap-ebp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForContribution">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in net asset available for benefit from contribution to employee stock purchase, saving, or similar plan (employee benefit plan (EBP)).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478873/962-325-55-17<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-05(a)(Schedule III))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForContribution</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap-ebp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForEmployerContributionCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in net asset available for benefit from cash contribution from employer of participant in employee stock purchase, saving, or similar plan (employee benefit plan (EBP)).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478873/962-325-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477063/962-205-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForEmployerContributionCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap-ebp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForInterestIncomeOnNoteReceivableFromParticipant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in net asset available for benefit from interest income on note receivable from participant in employee stock purchase, saving, or similar plan (employee benefit plan (EBP)).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478873/962-325-55-17<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-05(a)(Schedule III))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForInterestIncomeOnNoteReceivableFromParticipant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap-ebp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForParticipantContributionExcludingRollover">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding rollover, of increase in net asset available for benefit from contribution by participant in employee stock purchase, saving, or similar plan (employee benefit plan (EBP)).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478873/962-325-55-17<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-04(4)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-04(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-05(a)(Schedule III))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477783/962-325-50-2B<br><br>Reference 6: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477063/962-205-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForParticipantContributionExcludingRollover</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap-ebp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForParticipantContributionRollover">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in net asset available for benefit from contribution transferred from another qualified plan or from individual retirement account of participant in employee stock purchase, saving, or similar plan (employee benefit plan (EBP)). Excludes contribution for participant transmitted by employer of participant in EBP.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478873/962-325-55-17<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-04(4)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-04(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-05(a)(Schedule III))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477783/962-325-50-2B<br><br>Reference 6: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477063/962-205-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForParticipantContributionRollover</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap-ebp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EmployeeBenefitPlanNetAssetAvailableForBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset less liability available to pay benefit of participant in employee stock purchase, saving, or similar plan (employee benefit plan (EBP)), including, but not limited to, aggregation of participants' individual account balances.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477509/962-325-45-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478873/962-325-55-18<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478873/962-325-55-17<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-05(a)(Schedule II))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479750/962-40-25-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-04(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-04(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-03(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477063/962-205-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EmployeeBenefitPlanNetAssetAvailableForBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap-ebp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EmployeeBenefitPlanStatementOfChangeInNetAssetAvailableForBenefitLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477509/962-325-45-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-04(2)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-04(2)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-04(2)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EmployeeBenefitPlanStatementOfChangeInNetAssetAvailableForBenefitLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap-ebp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=elv_EBP003Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=elv_EBP003Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefit Plan, Description of Plan (Tables) - EBP 003<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanLineItems', window );"><strong>EBP, Description of Plan [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanTextBlock', window );">EBP, Description of Plan</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">1. Description of the Plan</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following description of the Elevance Health 401(k) Plan (the &#8220;Plan&#8221;) provides only general information. More detailed information concerning the Plan may be found by consulting the summary plan description.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">General </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Plan is a qualified defined contribution plan which provides savings opportunities for eligible employees of Elevance Health, Inc. (&#8220;Elevance Health&#8221;) and certain of its subsidiaries (the &#8220;Participating Employers&#8221;) and is subject to the provisions of the Employee Retirement Income Security Act of 1974, as amended  ("ERISA"). Employees of the Participating Employers are generally eligible to participate in the Plan 30 days after their date of hire. The net assets of the Plan, excluding notes receivable from participants, are held in the Elevance Health Defined Contribution Master Trust (the "EH Master Trust"). Fidelity Management Trust Company serves as the trustee for the EH Master Trust and Fidelity Workplace Services LLC serves as the recordkeeper (collectively, "Fidelity"). The Plan Sponsor is ATH Holding Company, LLC, a wholly owned subsidiary of Elevance Health. The Retirement Committee of ATH Holding Company, LLC is the Plan Administrator.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Participant Accounts</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">An individual account is maintained by the Plan for each eligible employee who participates in the Plan.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Each participant&#8217;s account is credited with the participant&#8217;s contributions, rollover contributions, allocations of the Plan Sponsor&#8217;s contributions, and an allocation of investment earnings or losses, reduced by participant withdrawals and certain administrative expenses. The benefit to which a participant is entitled is the benefit that can be provided from the participant&#8217;s account.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Contributions</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Participants may make voluntary contributions of 1% to 80% of eligible compensation, as defined in the Plan document, subject to limitations imposed by applicable Internal Revenue Service (&#8220;IRS&#8221;) regulations. Participants may make pretax contributions to a traditional 401(k) account, after-tax contributions to a Roth 401(k) account or a combination of the two through automatic payroll deduction. Participants are automatically enrolled in the Plan at an initial pretax deferral rate of 6%, with an annual automatic increase of the rate of 1%, up to 15% of the participant's eligible compensation, unless the participant directs otherwise.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Plan Sponsor provides a matching contribution of 100% on the first 4% of the participant's eligible compensation, plus 50% of the next 2% of the participant's eligible compensation contributed, for a total potential Plan Sponsor matching contribution of 5%. Additionally, the Plan provides for a true-up matching contribution to ensure that eligible participants who elected to contribute the maximum contribution allowed by the Plan receive the maximum matching contribution of eligible compensation determined as of the end of the plan year. The Plan permits additional Plan Sponsor discretionary contributions to be made, but no such discretionary contributions were made during the 2025 plan year. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Participants who attain age 50 by the end of the plan year may contribute additional "catch up" contributions to their account beyond the regular annual IRS limit, in accordance with applicable law and the Plan's terms. Catch-up contributions are eligible for matching contributions.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Rollover Contributions</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Plan may accept rollover contributions. Rollover contributions represent distributions received from other qualified retirement plans, as defined in Section 401(a)(31)(E) of the Internal Revenue Code (the "Code"), including </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">any such distributions contributed via a "conduit" individual retirement account. Distributions from other plans are subject to certain conditions to be eligible for rollover into the Plan.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Vesting</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Participants have a 100% vested interest in the Plan Sponsor match after completing a two-year period of service. Nonvested account balances of terminated employees are forfeited (subject to reinstatement upon reemployment as required by applicable law and the Plan's terms).</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Investments</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Participants direct their elective contributions and employer matching contributions into various investment options offered by the Plan, including target date funds, several mutual and collective investment trust funds, all of which are subject to change from time to time by the Plan Administrator, and the Elevance Health Stock Fund, which is provided for in the Plan document and overseen by an independent fiduciary. The Plan also provides access to a self-directed brokerage option. If a participant has not elected an investment option, their contributions will automatically be invested in the Plan&#8217;s qualified default investment alternative, which is the target date fund aligned with the year the participant turns 65.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Elevance Health Stock Fund is a unitized fund, which means participants do not actually own shares of Elevance Health common stock but rather own an interest in the unitized fund. A portion of the fund may be invested in short-term reserves to accommodate daily transactions. Investment in the Elevance Health Stock Fund is limited to no more than 20% of a participant's total account balance. Each participant is entitled to exercise voting rights attributable to the shares allocated to his or her account. Any cash dividends paid to the participant&#8217;s account will be reinvested in the Elevance Health Stock Fund unless the participant elects to receive the dividend in cash paid directly to the participant. Participants may change their election to receive dividends in cash or to reinvest dividends at least quarterly. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Benefit Payments and Withdrawals</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">A participant may make a withdrawal of voluntary after-tax contributions made to a traditional 401(k) account prior to January 1, 2012, or take a qualified distribution of Roth 401(k) contributions, as defined by the IRS, at any time. Additionally, after attaining age 59&#189;, a participant may withdraw participant and Plan Sponsor matching contributions for any reason. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Subject to the provisions and conditions specified in the Plan document, an active participant in the Plan may make certain hardship withdrawals of amounts held in the participant&#8217;s account attributable to the participant&#8217;s contributions, vested Plan Sponsor matching contributions, rollovers, pre-2006 employer match, and income allocated to the contributions account.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Upon termination of employment, the participant is entitled to receive the fully vested current value of his or her account. If the current value of the vested account is $1,000 or less, the account is paid in a lump-sum payment. If the vested account value is $1,000 or more, but less than $5,000, the account will be rolled over into an individual retirement account unless the participant elects otherwise. If the vested account value is $5,000 or more, the account will remain in the Plan unless the participant elects otherwise. The participant may elect to have the entire portion, if any, of the account held in the Elevance Health Stock Fund paid in whole shares of Elevance Health common stock, with fractional shares and any uninvested funds paid in cash. Distribution of participant accounts must commence by the later of retirement or the latest date permitted under Section 401(a)(9) of the Code, as amended by federal legislation known as the SECURE Act and SECURE 2.0 (including regulatory guidance issued thereunder). Upon death, payments are made to the participant&#8217;s beneficiary in the form of a lump-sum payment or in installments.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Notes Receivable from Participants</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Participants may request a loan not in excess of the lesser of: (1) 50% of the vested account balance, or (2) $50,000, less the highest outstanding loan balance during the preceding year. A participant may not have more than two loans outstanding at any one time and must wait 30 days from when a loan is paid off before requesting a new loan. Repayment of loans shall not exceed five years except for loans used to acquire the participant&#8217;s principal residence. Each loan bears interest in accordance with the Plan's loan policy and applicable regulations. Repayments are made by payroll deduction or remitted directly to Fidelity. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Forfeitures and Certain Plan Expenses</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Forfeited nonvested account balances totaled $3,875,557 and $506,167 as of December 31, 2025 and 2024, respectively. Forfeitures may be used to offset employer contributions or to pay certain administrative expenses, as determined by the Plan Sponsor. During the year ended December&#160;31, 2025, forfeitures of $6,093,646 were used to offset employer contributions and forfeitures of $73,579 were used to pay Plan administrative expenses.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In addition, Fidelity maintains, on behalf of the Plan, a</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">plan revenue credit account in connection with net float earnings received from certain investment managers and amounts (if any) owed by Fidelity with respect to performance guarantees under the recordkeeping agreement.</span><span style="color:#ff0000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During the plan year ended December&#160;31, 2025,</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">the plan</span><span style="color:#e97132;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">revenue credit account was used to pay Plan administrative expenses totaling $360,106.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Plan Termination</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Although it has not expressed any intent to do so, the Plan Sponsor has the right to terminate the Plan subject to the terms of the Plan and the provisions of ERISA. In the event the Plan is terminated, each participant&#8217;s account shall be non-forfeitable with respect to both the participant&#8217;s and the Plan Sponsor&#8217;s contributions. The Plan Sponsor has the right to amend the Plan or to suspend matching contributions to the Plan at any time, either permanently or temporarily, for any length of time.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_EBPEligibilityServicePeriod', window );">EBP eligibility service period</a></td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanParticipantContributionAutomaticDeferralRate', window );">EBP, Participant Contribution, Automatic, Deferral Rate</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_EBPParticipantContributionIncrementalIncreaseOfAutomaticAnnualEscalation', window );">EBP, Participant Contribution, incremental increase of automatic annual escalation</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_EBPParticipantContributionCapOfAutomaticAnnualEscalation', window );">EBP, Participant Contribution, Cap Of Automatic Annual Escalation</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanEmployerContributionParticipantCompensationMatchedPercentage', window );">EBP, Employer Contribution, Participant Compensation Matched, Percentage</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_EBPParticipantCatchUpContributionMinimumAge', window );">EBP Participant Catch Up Contribution Minimum Age</a></td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_EBPEmployerContributionVestingPercentage', window );">EBP Employer Contribution Vesting Percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_EBPEmployerContributionVestingPeriod', window );">EBP Employer Contribution Vesting Period</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_EBPParticipantContributionMaximumContributionToEmployeeStockPlan', window );">EBP, Participant Contribution, Maximum Contribution to Employee Stock Plan</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_EBPAutomaticDistributionToParticipantThreshold', window );">EBP, Automatic Distribution to Participant Threshold</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_EBPDistributionOfAccountBalanceStaysInPlanThreshold', window );">EBP, Distribution of Account Balance Stays in Plan Threshold</a></td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanNoteReceivableFromParticipantAccountMaximumBorrowingToTotalAccountPercentage', window );">EBP, Note Receivable from Participant, Account, Maximum Borrowing, to Total Account, Percentage</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanNoteReceivableFromParticipantAccountMaximumBorrowingAmount', window );">EBP, Note Receivable from Participant, Account, Maximum Borrowing, Amount</a></td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_EBPNoteReceivableFromParticipantGeneralLoanTerm', window );">EBP, Note receivable from participant, general loan term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanForfeitedNonvestedAccount', window );">Forfeitures</a></td>
<td class="nump">$ 3,875,557<span></span>
</td>
<td class="nump">$ 506,167<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanForfeitedNonvestedAccountDecreaseForEmployerContribution', window );">EBP, Forfeited Nonvested Account, Decrease from Employer Contribution</a></td>
<td class="nump">6,093,646<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanForfeitedNonvestedAccountDecreaseForAdministrativeExpense', window );">EBP, Forfeited Nonvested Account, Decrease from Administrative Expense</a></td>
<td class="nump">73,579<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_EBPPlanRevenueCreditAccountDecreaseFromAdministrativeExpense', window );">EBP, Plan Revenue Credit Account, Decrease from Administrative Expense</a></td>
<td class="nump">$ 360,106<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=elv_EBP003Member', window );">EBP Employer Match Tranche One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanLineItems', window );"><strong>EBP, Description of Plan [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanEmployerContributionMatchingPercentage', window );">EBP, Employer Contribution, Matching Percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanEmployerContributionParticipantCompensationMatchedPercentage', window );">EBP, Employer Contribution, Participant Compensation Matched, Percentage</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=elv_EBP003Member', window );">EBP Employer Match Tranche Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanLineItems', window );"><strong>EBP, Description of Plan [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanEmployerContributionMatchingPercentage', window );">EBP, Employer Contribution, Matching Percentage</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanEmployerContributionParticipantCompensationMatchedPercentage', window );">EBP, Employer Contribution, Participant Compensation Matched, Percentage</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=elv_EBP003Member', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanLineItems', window );"><strong>EBP, Description of Plan [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_EBPParticipantContributionEligibleCompensationPercentage', window );">EBP Participant Contribution Eligible Compensation Percentage</a></td>
<td class="nump">0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_EBPDistributionOfAccountBalanceRolledIntoIRAThreshold', window );">EBP, Account Balance Rolled Into IRA Threshold</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=elv_EBP003Member', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanLineItems', window );"><strong>EBP, Description of Plan [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_EBPParticipantContributionEligibleCompensationPercentage', window );">EBP Participant Contribution Eligible Compensation Percentage</a></td>
<td class="nump">0.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_EBPDistributionOfAccountBalanceRolledIntoIRAThreshold', window );">EBP, Account Balance Rolled Into IRA Threshold</a></td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elv_EBPAutomaticDistributionToParticipantThreshold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>EBP, Automatic Distribution to Participant Threshold</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elv_EBPAutomaticDistributionToParticipantThreshold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elv_EBPDistributionOfAccountBalanceRolledIntoIRAThreshold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>EBP, Distribution of Account Balance Rolled into IRA Threshold</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elv_EBPDistributionOfAccountBalanceRolledIntoIRAThreshold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elv_EBPDistributionOfAccountBalanceStaysInPlanThreshold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>EBP, Distribution of Account Balance Stays in Plan Threshold</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elv_EBPDistributionOfAccountBalanceStaysInPlanThreshold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elv_EBPEligibilityServicePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>EBP, Eligibility Service Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elv_EBPEligibilityServicePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elv_EBPEmployerContributionVestingPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>EBP, Employer Contribution Vesting Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elv_EBPEmployerContributionVestingPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elv_EBPEmployerContributionVestingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>EBP, Employer Contribution Vesting Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elv_EBPEmployerContributionVestingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elv_EBPNoteReceivableFromParticipantGeneralLoanTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>EBP, Note receivable from participant, general loan term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elv_EBPNoteReceivableFromParticipantGeneralLoanTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elv_EBPParticipantCatchUpContributionMinimumAge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>EBP, Participant Catch Up Contribution Minimum Age</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elv_EBPParticipantCatchUpContributionMinimumAge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elv_EBPParticipantContributionCapOfAutomaticAnnualEscalation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>EBP, Participant Contribution, Cap Of Automatic Annual Escalation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elv_EBPParticipantContributionCapOfAutomaticAnnualEscalation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elv_EBPParticipantContributionEligibleCompensationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>EBP, Participant Contribution Eligible Compensation Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elv_EBPParticipantContributionEligibleCompensationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elv_EBPParticipantContributionIncrementalIncreaseOfAutomaticAnnualEscalation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>EBP, Participant Contribution, incremental increase of automatic annual escalation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elv_EBPParticipantContributionIncrementalIncreaseOfAutomaticAnnualEscalation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elv_EBPParticipantContributionMaximumContributionToEmployeeStockPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>EBP, Participant Contribution, Maximum Contribution to Employee Stock Plan</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elv_EBPParticipantContributionMaximumContributionToEmployeeStockPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elv_EBPPlanRevenueCreditAccountDecreaseFromAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>EBP, Plan Revenue Credit Account, Decrease from Administrative Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elv_EBPPlanRevenueCreditAccountDecreaseFromAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478416/962-205-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap-ebp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for description of employee stock purchase, saving, or similar plan (employee benefit plan (EBP)). Includes, but is not limited to, vesting and allocation provisions and disposition of forfeiture.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 11.M.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480530/250-10-S99-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SAB Topic 11.M)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480530/250-10-S99-6<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478873/962-325-55-17<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478416/962-205-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap-ebp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EmployeeBenefitPlanEmployerContributionMatchingPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of employer matching contribution on eligible participant contribution to employee stock purchase, saving, or similar plan (employee benefit plan (EBP)).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478873/962-325-55-17<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EmployeeBenefitPlanEmployerContributionMatchingPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap-ebp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EmployeeBenefitPlanEmployerContributionParticipantCompensationMatchedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of participant compensation eligible for employer matching contribution for participant in employee stock purchase, saving, or similar plan (employee benefit plan (EBP)).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478873/962-325-55-17<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EmployeeBenefitPlanEmployerContributionParticipantCompensationMatchedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap-ebp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EmployeeBenefitPlanForfeitedNonvestedAccount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of plan asset, in forfeited nonvested account, no longer allocated to participant in employee stock purchase, saving, or similar plan (employee benefit plan (EBP)).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478873/962-325-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478416/962-205-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EmployeeBenefitPlanForfeitedNonvestedAccount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap-ebp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EmployeeBenefitPlanForfeitedNonvestedAccountDecreaseForAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in forfeited nonvested account of employee stock purchase, saving, or similar plan (employee benefit plan (EBP)) from administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478416/962-205-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-04(5)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EmployeeBenefitPlanForfeitedNonvestedAccountDecreaseForAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap-ebp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EmployeeBenefitPlanForfeitedNonvestedAccountDecreaseForEmployerContribution">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in forfeited nonvested account of employee stock purchase, saving, or similar plan (employee benefit plan (EBP)) from employer contribution.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478873/962-325-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478416/962-205-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-04(5)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EmployeeBenefitPlanForfeitedNonvestedAccountDecreaseForEmployerContribution</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap-ebp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EmployeeBenefitPlanNoteReceivableFromParticipantAccountMaximumBorrowingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of maximum account balance that participant in employee stock purchase, saving, or similar plan (employee benefit plan (EBP)) can borrow.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478873/962-325-55-17<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EmployeeBenefitPlanNoteReceivableFromParticipantAccountMaximumBorrowingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap-ebp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EmployeeBenefitPlanNoteReceivableFromParticipantAccountMaximumBorrowingToTotalAccountPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of maximum account balance that participant in employee stock purchase, saving, or similar plan (employee benefit plan (EBP)) can borrow to total participant account balance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478873/962-325-55-17<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EmployeeBenefitPlanNoteReceivableFromParticipantAccountMaximumBorrowingToTotalAccountPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap-ebp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EmployeeBenefitPlanParticipantContributionAutomaticDeferralRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of eligible compensation contributed for participant automatically enrolled in employee stock purchase, saving, or similar plan (employee benefit plan (EBP)).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478873/962-325-55-17<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EmployeeBenefitPlanParticipantContributionAutomaticDeferralRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap-ebp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=elv_EBP003Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=elv_EBP003Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elv_EBPEmployerMatchTrancheAxis=elv_EBPEmployerMatchTrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elv_EBPEmployerMatchTrancheAxis=elv_EBPEmployerMatchTrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elv_EBPEmployerMatchTrancheAxis=elv_EBPEmployerMatchTrancheTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elv_EBPEmployerMatchTrancheAxis=elv_EBPEmployerMatchTrancheTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefit Plan, Master Trust (Tables) - EBP 003 - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanMasterTrustLineItems', window );"><strong>EBP, Master Trust [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanMasterTrustTextBlock', window );">EBP, Master Trust - Text Block</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">3. Plan's Interest in EH Master Trust</span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Elevance Health Defined Contribution Master Trust was established on January 1, 2024 pursuant to a trust agreement between the Plan Administrator and Fidelity in order to facilitate the administration of transactions in certain investment options offered in both this Plan and the Elevance Health Puerto Rico Retirement Savings Plan (together, the "Participating Plans"). Each Participating Plan has a divided interest in specific investment assets held in the EH Master Trust. </span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the net assets of the EH Master Trust and the Plan's interest in the net assets of the EH Master Trust as of December&#160;31, 2025 is as follows:</span></div><div style="margin-bottom:9pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.188%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.747%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.596%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.664%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.436%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.664%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.436%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.664%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.436%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.669%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">EH Master Trust Balances</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Plan's Interest in EH Master Trust Balances</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">EH Master Trust Balances</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Plan's Interest in EH Master Trust Balances</span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Investments at fair value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Collective investment trusts</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$12,095,039,709&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$12,093,468,072&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$10,874,772,817&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$10,873,336,349&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Elevance Health common stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">352,309,761&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">352,194,754&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">408,045,086&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">408,004,931&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Mutual funds</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">302,657,683&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">302,656,679&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">329,248,156&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">329,247,804&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Self-directed brokerage accounts</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">316,803,497&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">316,803,497&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">250,803,504&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">250,803,504&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total investments at fair value</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">13,066,810,650&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">13,065,123,002&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">11,862,869,563&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">11,861,392,588&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other assets (liabilities)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(64,169)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(64,148)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(37,723)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(37,719)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Total net assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$13,066,746,481&#160;</span></td><td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$13,065,058,854&#160;</span></td><td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$11,862,831,840&#160;</span></td><td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$11,861,354,869&#160;</span></td><td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2025, the EH Master Trust net investment income was comprised of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:82.874%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.926%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">EH Master Trust Balances</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net appreciation in fair value of investments</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$1,774,360,282&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Interest and dividends</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">43,516,628&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total EH Master Trust net investment income</span></div></td><td colspan="2" style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$1,817,876,910&#160;</span></td><td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanMasterTrustTableTextBlock', window );">EBP, Master Trust - Table Text Block</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the net assets of the EH Master Trust and the Plan's interest in the net assets of the EH Master Trust as of December&#160;31, 2025 is as follows:</span></div><div style="margin-bottom:9pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.188%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.747%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.596%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.664%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.436%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.664%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.436%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.664%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.436%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.669%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">EH Master Trust Balances</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Plan's Interest in EH Master Trust Balances</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">EH Master Trust Balances</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Plan's Interest in EH Master Trust Balances</span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Investments at fair value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Collective investment trusts</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$12,095,039,709&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$12,093,468,072&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$10,874,772,817&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$10,873,336,349&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Elevance Health common stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">352,309,761&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">352,194,754&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">408,045,086&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">408,004,931&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Mutual funds</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">302,657,683&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">302,656,679&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">329,248,156&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">329,247,804&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Self-directed brokerage accounts</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">316,803,497&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">316,803,497&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">250,803,504&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">250,803,504&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total investments at fair value</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">13,066,810,650&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">13,065,123,002&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">11,862,869,563&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">11,861,392,588&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other assets (liabilities)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(64,169)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(64,148)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(37,723)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(37,719)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Total net assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$13,066,746,481&#160;</span></td><td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$13,065,058,854&#160;</span></td><td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$11,862,831,840&#160;</span></td><td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$11,861,354,869&#160;</span></td><td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2025, the EH Master Trust net investment income was comprised of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:82.874%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.926%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">EH Master Trust Balances</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net appreciation in fair value of investments</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$1,774,360,282&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Interest and dividends</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">43,516,628&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total EH Master Trust net investment income</span></div></td><td colspan="2" style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$1,817,876,910&#160;</span></td><td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanNetAssetAvailableForBenefit', window );">Net assets available for benefits</a></td>
<td class="nump">$ 13,312,912,847<span></span>
</td>
<td class="nump">$ 12,110,585,543<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForGainLossOnInvestment', window );">Net appreciation in fair value of investments</a></td>
<td class="nump">1,774,360,282<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForInterestAndDividendIncomeOnInvestment', window );">Interest and dividends</a></td>
<td class="nump">43,516,628<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForIncomeLossOnInvestment', window );">Total investment income</a></td>
<td class="nump">1,817,876,910<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustAxis=us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedMasterTrustMember', window );">EBP, Nonconsolidated, Master Trust</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanMasterTrustLineItems', window );"><strong>EBP, Master Trust [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValue', window );">Investments at fair value</a></td>
<td class="nump">13,066,810,650<span></span>
</td>
<td class="nump">11,862,869,563<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanOtherAsset', window );">Other Assets (Liabilities)</a></td>
<td class="num">(64,169)<span></span>
</td>
<td class="num">(37,723)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanNetAssetAvailableForBenefit', window );">Net assets available for benefits</a></td>
<td class="nump">13,066,746,481<span></span>
</td>
<td class="nump">11,862,831,840<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustAxis=us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedMasterTrustMember', window );">EBP, Nonconsolidated, Master Trust | Common Collective Trust</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanMasterTrustLineItems', window );"><strong>EBP, Master Trust [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValue', window );">Investments at fair value</a></td>
<td class="nump">12,095,039,709<span></span>
</td>
<td class="nump">10,874,772,817<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustAxis=us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedMasterTrustMember', window );">EBP, Nonconsolidated, Master Trust | Company common stock, at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanMasterTrustLineItems', window );"><strong>EBP, Master Trust [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValue', window );">Investments at fair value</a></td>
<td class="nump">352,309,761<span></span>
</td>
<td class="nump">408,045,086<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustAxis=us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedMasterTrustMember', window );">EBP, Nonconsolidated, Master Trust | Mutual Fund</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanMasterTrustLineItems', window );"><strong>EBP, Master Trust [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValue', window );">Investments at fair value</a></td>
<td class="nump">302,657,683<span></span>
</td>
<td class="nump">329,248,156<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustAxis=us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedMasterTrustMember', window );">EBP, Nonconsolidated, Master Trust | Self-directed brokerage accounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanMasterTrustLineItems', window );"><strong>EBP, Master Trust [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValue', window );">Investments at fair value</a></td>
<td class="nump">316,803,497<span></span>
</td>
<td class="nump">250,803,504<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustAxis=us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedPlanInterestInMasterTrustMember', window );">EBP, Nonconsolidated, Plan Interest in Master Trust</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanMasterTrustLineItems', window );"><strong>EBP, Master Trust [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValue', window );">Investments at fair value</a></td>
<td class="nump">13,065,123,002<span></span>
</td>
<td class="nump">11,861,392,588<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanOtherAsset', window );">Other Assets (Liabilities)</a></td>
<td class="num">(64,148)<span></span>
</td>
<td class="num">(37,719)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanNetAssetAvailableForBenefit', window );">Net assets available for benefits</a></td>
<td class="nump">13,065,058,854<span></span>
</td>
<td class="nump">11,861,354,869<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustAxis=us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedPlanInterestInMasterTrustMember', window );">EBP, Nonconsolidated, Plan Interest in Master Trust | Common Collective Trust</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanMasterTrustLineItems', window );"><strong>EBP, Master Trust [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValue', window );">Investments at fair value</a></td>
<td class="nump">12,093,468,072<span></span>
</td>
<td class="nump">10,873,336,349<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustAxis=us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedPlanInterestInMasterTrustMember', window );">EBP, Nonconsolidated, Plan Interest in Master Trust | Company common stock, at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanMasterTrustLineItems', window );"><strong>EBP, Master Trust [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValue', window );">Investments at fair value</a></td>
<td class="nump">352,194,754<span></span>
</td>
<td class="nump">408,004,931<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustAxis=us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedPlanInterestInMasterTrustMember', window );">EBP, Nonconsolidated, Plan Interest in Master Trust | Mutual Fund</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanMasterTrustLineItems', window );"><strong>EBP, Master Trust [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValue', window );">Investments at fair value</a></td>
<td class="nump">302,656,679<span></span>
</td>
<td class="nump">329,247,804<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustAxis=us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedPlanInterestInMasterTrustMember', window );">EBP, Nonconsolidated, Plan Interest in Master Trust | Self-directed brokerage accounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanMasterTrustLineItems', window );"><strong>EBP, Master Trust [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValue', window );">Investments at fair value</a></td>
<td class="nump">$ 316,803,497<span></span>
</td>
<td class="nump">$ 250,803,504<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForGainLossOnInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in net asset available for benefit from realized and unrealized gain (loss) on investment held by employee stock purchase, saving, or similar plan (employee benefit plan (EBP)).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478873/962-325-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477783/962-325-50-7<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477063/962-205-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForGainLossOnInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap-ebp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForIncomeLossOnInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in net asset available for benefit from income (loss) on investment held by employee stock purchase, saving, or similar plan (employee benefit plan (EBP)). Includes, but is not limited to, realized and unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478873/962-325-55-17<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForIncomeLossOnInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap-ebp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForInterestAndDividendIncomeOnInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in net asset available for benefit from interest and dividend income on investment held by employee stock purchase, saving, or similar plan (employee benefit plan (EBP)).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477783/962-325-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForInterestAndDividendIncomeOnInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap-ebp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment held by employee stock purchase, saving, or similar plan (employee benefit plan (EBP)). Includes, but is not limited to, derivative, investment measured at net asset value per share as practical expedient, and insurance contract not meeting fully-benefit responsive investment criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4B<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4B<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477783/962-325-50-5<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478873/962-325-55-18<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477783/962-325-50-8A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4K<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4K<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-7A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-05(a)(Schedule II))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-03(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477509/962-325-45-5<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-03(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477783/962-325-50-8A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-02(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477783/962-325-50-8B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477783/962-325-50-8A<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Subparagraph (j)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477783/962-325-50-8A<br><br>Reference 24: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477783/962-325-50-8A<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477783/962-325-50-8A<br><br>Reference 26: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477783/962-325-50-8A<br><br>Reference 27: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477783/962-325-50-8A<br><br>Reference 28: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477783/962-325-50-8A<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-03(2)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-03(2)(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-03(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477783/962-325-50-8A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap-ebp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EmployeeBenefitPlanMasterTrustLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478873/962-325-55-18<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477783/962-325-50-8A<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477783/962-325-50-8A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477783/962-325-50-8A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477783/962-325-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477783/962-325-50-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477783/962-325-50-8B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477783/962-325-50-8A<br><br>Reference 21: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Subparagraph (j)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477783/962-325-50-8A<br><br>Reference 22: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477783/962-325-50-8A<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477783/962-325-50-8A<br><br>Reference 24: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477783/962-325-50-8A<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477783/962-325-50-8A<br><br>Reference 26: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477783/962-325-50-8A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477783/962-325-50-8C<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EmployeeBenefitPlanMasterTrustLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap-ebp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EmployeeBenefitPlanMasterTrustTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of master trust arrangement in which employee stock purchase, saving, or similar plan (employee benefit plan (EBP)) participates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477783/962-325-50-8A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478873/962-325-55-18<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477783/962-325-50-8B<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477783/962-325-50-8C<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477783/962-325-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EmployeeBenefitPlanMasterTrustTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap-ebp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EmployeeBenefitPlanMasterTrustTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for master trust arrangement in which employee stock purchase, saving, or similar plan (employee benefit plan (EBP)) participates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478873/962-325-55-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477783/962-325-50-8B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477783/962-325-50-8A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477783/962-325-50-8C<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477783/962-325-50-8<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477783/962-325-50-7<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EmployeeBenefitPlanMasterTrustTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap-ebp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EmployeeBenefitPlanNetAssetAvailableForBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset less liability available to pay benefit of participant in employee stock purchase, saving, or similar plan (employee benefit plan (EBP)), including, but not limited to, aggregation of participants' individual account balances.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477509/962-325-45-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478873/962-325-55-18<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478873/962-325-55-17<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-05(a)(Schedule II))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479750/962-40-25-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-04(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-04(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-03(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477063/962-205-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EmployeeBenefitPlanNetAssetAvailableForBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap-ebp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EmployeeBenefitPlanOtherAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset held by employee stock purchase, saving, or similar plan (employee benefit plan (EBP)), classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477783/962-325-50-8C<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-03(6)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-03(6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-03(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EmployeeBenefitPlanOtherAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap-ebp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=elv_EBP003Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=elv_EBP003Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustAxis=us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedMasterTrustMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustAxis=us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedMasterTrustMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_DefinedBenefitPlanCommonCollectiveTrustMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_DefinedBenefitPlanCommonCollectiveTrustMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap-ebp_EmployeeBenefitPlanEmployerCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap-ebp_EmployeeBenefitPlanEmployerCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_MutualFundMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_MutualFundMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap-ebp_EmployeeBenefitPlanSelfDirectedBrokerageAccountMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap-ebp_EmployeeBenefitPlanSelfDirectedBrokerageAccountMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustAxis=us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedPlanInterestInMasterTrustMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustAxis=us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedPlanInterestInMasterTrustMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefit Plan, Fair Value and NAV (Tables) - EBP 003 - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavLineItems', window );"><strong>EBP, Investment, Fair Value and NAV [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavTextBlock', window );">EBP, Investment, Fair Value and NAV - Text Block</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">4. Fair Value Measurements</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The framework for measuring fair value provides a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. Level inputs, as defined by the Financial Accounting Standards Board guidance for fair value measurements and disclosures, are as follows: Level 1, inputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date; Level 2, inputs other than quoted prices included in Level 1 that are observable for the asset or liability through corroboration with market data; and Level 3, unobservable inputs that reflect management's best estimate of what market participants would use in pricing the asset or liability. Assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following methods and assumptions were used to determine the fair value of investments recorded at fair value in the statements of net assets available for benefits.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Elevance Health common stock: </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Valued at the closing price on the New York Stock Exchange on the last business day of the plan year.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mutual funds:</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Valued at quoted market prices, which represent net asset value ("NAV") of shares held by the Plan.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Self-directed brokerage accounts: </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The self-directed brokerage account allows participants the opportunity to invest in a wide array of individual securities including stocks, mutual funds, exchange-traded funds, unit investment trusts, corporate bonds, U.S. Treasury securities, and certificates of deposits, which are primarily valued using quoted prices in active markets.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Collective investment trusts (CITs):</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Valued based on the NAV of the units of a collective trust. The NAV, as provided by the trustee, is used as a practical expedient to estimate fair value. The NAV is based on the fair value of the underlying investments held by the trust less its liabilities. There are no restrictions on redemptions from the CITs and no unfunded commitments.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth by level within the fair value hierarchy a summary of the EH Master Trust investments by general types measured at fair value on a recurring basis as of December&#160;31, 2025:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.203%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.845%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;3</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Elevance Health common stock</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">352,309,761&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">352,309,761&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Mutual funds</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">302,657,683&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">302,657,683&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Self-directed brokerage accounts</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">316,803,497&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">312,048,032&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,544,392&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">211,073&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Investments measured at fair value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">971,770,941&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">967,015,476&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,544,392&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">211,073&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Investments measured at NAV</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">12,095,039,709&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total investments at fair value</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">13,066,810,650&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth by level within the fair value hierarchy a summary of the EH Master Trust investments by general types measured at fair value on a recurring basis as of December&#160;31, 2024:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.198%"><tr><td style="width:1.0%"></td><td style="width:32.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.738%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.893%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.954%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.738%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.954%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.959%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;3</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Elevance Health common stock</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">408,045,086&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">408,045,086&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Mutual funds</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">329,248,156&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">329,248,156&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Self-directed brokerage accounts</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">250,803,504&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">246,848,476&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,920,987&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">34,041&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Investments measured at fair value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">988,096,746&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">984,141,718&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,920,987&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">34,041&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Investments measured at NAV</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10,874,772,817&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total investments at fair value</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">11,862,869,563&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our Level 3 securities as of December&#160;31, 2025 and December&#160;31, 2024 primarily consisted of certain corporate fixed maturity securities for which observable inputs were not always available. The fair values of these securities were estimated using inputs including, but not limited to, credit spreads, default rates and benchmark yields. There were no material transfers in or out of Level 3 during either the year ended December&#160;31, 2025 or the year ended  December&#160;31, 2024.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavTableTextBlock', window );">EBP, Investment, Fair Value and NAV - Table Text Block</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth by level within the fair value hierarchy a summary of the EH Master Trust investments by general types measured at fair value on a recurring basis as of December&#160;31, 2025:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.203%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.845%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;3</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Elevance Health common stock</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">352,309,761&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">352,309,761&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Mutual funds</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">302,657,683&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">302,657,683&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Self-directed brokerage accounts</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">316,803,497&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">312,048,032&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,544,392&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">211,073&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Investments measured at fair value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">971,770,941&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">967,015,476&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,544,392&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">211,073&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Investments measured at NAV</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">12,095,039,709&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total investments at fair value</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">13,066,810,650&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth by level within the fair value hierarchy a summary of the EH Master Trust investments by general types measured at fair value on a recurring basis as of December&#160;31, 2024:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.198%"><tr><td style="width:1.0%"></td><td style="width:32.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.738%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.893%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.954%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.738%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.954%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.959%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;3</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Elevance Health common stock</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">408,045,086&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">408,045,086&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Mutual funds</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">329,248,156&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">329,248,156&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Self-directed brokerage accounts</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">250,803,504&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">246,848,476&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,920,987&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">34,041&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Investments measured at fair value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">988,096,746&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">984,141,718&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,920,987&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">34,041&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Investments measured at NAV</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10,874,772,817&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total investments at fair value</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">11,862,869,563&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue', window );">EBP, Investment, Excluding Plan Interest in Master Trust, Fair Value</a></td>
<td class="nump">$ 13,066,810,650<span></span>
</td>
<td class="nump">$ 11,862,869,563<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=elv_EBP003Member', window );">Fair Value, Inputs, Level 1, Level 2, and Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavLineItems', window );"><strong>EBP, Investment, Fair Value and NAV [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue', window );">EBP, Investment, Excluding Plan Interest in Master Trust, Fair Value</a></td>
<td class="nump">971,770,941<span></span>
</td>
<td class="nump">988,096,746<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=elv_EBP003Member', window );">Fair Value, Inputs, Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavLineItems', window );"><strong>EBP, Investment, Fair Value and NAV [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue', window );">EBP, Investment, Excluding Plan Interest in Master Trust, Fair Value</a></td>
<td class="nump">967,015,476<span></span>
</td>
<td class="nump">984,141,718<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=elv_EBP003Member', window );">Fair Value, Inputs, Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavLineItems', window );"><strong>EBP, Investment, Fair Value and NAV [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue', window );">EBP, Investment, Excluding Plan Interest in Master Trust, Fair Value</a></td>
<td class="nump">4,544,392<span></span>
</td>
<td class="nump">3,920,987<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=elv_EBP003Member', window );">Fair Value, Inputs, Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavLineItems', window );"><strong>EBP, Investment, Fair Value and NAV [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue', window );">EBP, Investment, Excluding Plan Interest in Master Trust, Fair Value</a></td>
<td class="nump">211,073<span></span>
</td>
<td class="nump">34,041<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=elv_EBP003Member', window );">Fair Value Measured at Net Asset Value Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavLineItems', window );"><strong>EBP, Investment, Fair Value and NAV [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue', window );">EBP, Investment, Excluding Plan Interest in Master Trust, Fair Value</a></td>
<td class="nump">12,095,039,709<span></span>
</td>
<td class="nump">10,874,772,817<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=elv_EBP003Member', window );">Company common stock, at fair value | Fair Value, Inputs, Level 1, Level 2, and Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavLineItems', window );"><strong>EBP, Investment, Fair Value and NAV [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue', window );">EBP, Investment, Excluding Plan Interest in Master Trust, Fair Value</a></td>
<td class="nump">352,309,761<span></span>
</td>
<td class="nump">408,045,086<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=elv_EBP003Member', window );">Company common stock, at fair value | Fair Value, Inputs, Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavLineItems', window );"><strong>EBP, Investment, Fair Value and NAV [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue', window );">EBP, Investment, Excluding Plan Interest in Master Trust, Fair Value</a></td>
<td class="nump">352,309,761<span></span>
</td>
<td class="nump">408,045,086<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=elv_EBP003Member', window );">Company common stock, at fair value | Fair Value, Inputs, Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavLineItems', window );"><strong>EBP, Investment, Fair Value and NAV [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue', window );">EBP, Investment, Excluding Plan Interest in Master Trust, Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=elv_EBP003Member', window );">Company common stock, at fair value | Fair Value, Inputs, Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavLineItems', window );"><strong>EBP, Investment, Fair Value and NAV [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue', window );">EBP, Investment, Excluding Plan Interest in Master Trust, Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=elv_EBP003Member', window );">Mutual Fund | Fair Value, Inputs, Level 1, Level 2, and Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavLineItems', window );"><strong>EBP, Investment, Fair Value and NAV [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue', window );">EBP, Investment, Excluding Plan Interest in Master Trust, Fair Value</a></td>
<td class="nump">302,657,683<span></span>
</td>
<td class="nump">329,248,156<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=elv_EBP003Member', window );">Mutual Fund | Fair Value, Inputs, Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavLineItems', window );"><strong>EBP, Investment, Fair Value and NAV [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue', window );">EBP, Investment, Excluding Plan Interest in Master Trust, Fair Value</a></td>
<td class="nump">302,657,683<span></span>
</td>
<td class="nump">329,248,156<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=elv_EBP003Member', window );">Mutual Fund | Fair Value, Inputs, Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavLineItems', window );"><strong>EBP, Investment, Fair Value and NAV [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue', window );">EBP, Investment, Excluding Plan Interest in Master Trust, Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=elv_EBP003Member', window );">Mutual Fund | Fair Value, Inputs, Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavLineItems', window );"><strong>EBP, Investment, Fair Value and NAV [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue', window );">EBP, Investment, Excluding Plan Interest in Master Trust, Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=elv_EBP003Member', window );">Self-directed brokerage accounts | Fair Value, Inputs, Level 1, Level 2, and Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavLineItems', window );"><strong>EBP, Investment, Fair Value and NAV [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue', window );">EBP, Investment, Excluding Plan Interest in Master Trust, Fair Value</a></td>
<td class="nump">316,803,497<span></span>
</td>
<td class="nump">250,803,504<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=elv_EBP003Member', window );">Self-directed brokerage accounts | Fair Value, Inputs, Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavLineItems', window );"><strong>EBP, Investment, Fair Value and NAV [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue', window );">EBP, Investment, Excluding Plan Interest in Master Trust, Fair Value</a></td>
<td class="nump">312,048,032<span></span>
</td>
<td class="nump">246,848,476<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=elv_EBP003Member', window );">Self-directed brokerage accounts | Fair Value, Inputs, Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavLineItems', window );"><strong>EBP, Investment, Fair Value and NAV [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue', window );">EBP, Investment, Excluding Plan Interest in Master Trust, Fair Value</a></td>
<td class="nump">4,544,392<span></span>
</td>
<td class="nump">3,920,987<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=elv_EBP003Member', window );">Self-directed brokerage accounts | Fair Value, Inputs, Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavLineItems', window );"><strong>EBP, Investment, Fair Value and NAV [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue', window );">EBP, Investment, Excluding Plan Interest in Master Trust, Fair Value</a></td>
<td class="nump">$ 211,073<span></span>
</td>
<td class="nump">$ 34,041<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment, excluding plan interest in master trust, held by employee stock purchase, saving, or similar plan (employee benefit plan (EBP)). Includes, but is not limited to, derivative, investment measured at net asset value per share as practical expedient, and insurance contract not meeting fully-benefit responsive investment criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4B<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4B<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478873/962-325-55-17<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477509/962-325-45-5<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4K<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4K<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477509/962-325-45-5<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (j)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477509/962-325-45-5<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-7A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477509/962-325-45-5<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477509/962-325-45-5<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (k)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477509/962-325-45-5<br><br>Reference 18: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477509/962-325-45-5<br><br>Reference 19: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477509/962-325-45-5<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477509/962-325-45-5<br><br>Reference 21: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477509/962-325-45-5<br><br>Reference 22: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477509/962-325-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap-ebp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477509/962-325-45-5<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477509/962-325-45-5<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (j)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477509/962-325-45-5<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477509/962-325-45-5<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-04(2)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (k)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477509/962-325-45-5<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477509/962-325-45-5<br><br>Reference 18: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477509/962-325-45-5<br><br>Reference 19: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477509/962-325-45-5<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477509/962-325-45-5<br><br>Reference 21: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477509/962-325-45-5<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-02(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap-ebp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of fair value of investment held by employee stock purchase, saving, or similar plan (employee benefit plan (EBP)), including, but not limited to, fair value measured at net asset value per share as practical expedient (NAV).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477509/962-325-45-5<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478873/962-325-55-17<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477509/962-325-45-6<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477783/962-325-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-8<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap-ebp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for fair value of investment held by employee stock purchase, saving, or similar plan (employee benefit plan (EBP)), including, but not limited to, fair value measured at net asset value per share as practical expedient (NAV).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478873/962-325-55-17<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477509/962-325-45-5<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-04(2)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-04(3)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-02(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 23<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-23<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477509/962-325-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap-ebp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=elv_EBP003Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=elv_EBP003Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel12And3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel12And3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap-ebp_EmployeeBenefitPlanEmployerCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap-ebp_EmployeeBenefitPlanEmployerCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_MutualFundMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_MutualFundMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap-ebp_EmployeeBenefitPlanSelfDirectedBrokerageAccountMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap-ebp_EmployeeBenefitPlanSelfDirectedBrokerageAccountMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefit Plan, Tax Status (Tables) - EBP 003<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanTaxStatusAbstract', window );"><strong>EBP, Tax Status [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanTaxStatusTextBlock', window );">EBP, Tax Status</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">6. Income Tax Status</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Plan has received a determination letter from the IRS dated October 24, 2017, stating the Plan is qualified under Section 401(a) of the Code and, therefore, exempt from taxation. Although the Plan has been restated and amended since receiving the determination letter, the Plan Sponsor believes the Plan is designed and being operated in compliance with the applicable requirements of the Code. The Plan's EH Master Trust is intended to be considered as an organization as described in Section 401(a) of the Code and exempt under Section 501(a) of the Code. </span></div>GAAP requires Plan management to evaluate tax positions taken by the Plan and recognize a tax liability if the Plan has taken an uncertain tax position that more likely than not would not be sustained upon examination by the IRS. Plan management has analyzed the tax positions taken by the Plan and has concluded there are no uncertain positions taken or expected to be taken. The Plan is subject to routine audits by taxing jurisdictions; however, there are currently no audits for any tax periods in progress.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanTaxStatusLineItems', window );"><strong>EBP, Tax Status [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanTaxStatusTextBlock', window );">EBP, Tax Status</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">6. Income Tax Status</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Plan has received a determination letter from the IRS dated October 24, 2017, stating the Plan is qualified under Section 401(a) of the Code and, therefore, exempt from taxation. Although the Plan has been restated and amended since receiving the determination letter, the Plan Sponsor believes the Plan is designed and being operated in compliance with the applicable requirements of the Code. The Plan's EH Master Trust is intended to be considered as an organization as described in Section 401(a) of the Code and exempt under Section 501(a) of the Code. </span></div>GAAP requires Plan management to evaluate tax positions taken by the Plan and recognize a tax liability if the Plan has taken an uncertain tax position that more likely than not would not be sustained upon examination by the IRS. Plan management has analyzed the tax positions taken by the Plan and has concluded there are no uncertain positions taken or expected to be taken. The Plan is subject to routine audits by taxing jurisdictions; however, there are currently no audits for any tax periods in progress.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EmployeeBenefitPlanTaxStatusAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EmployeeBenefitPlanTaxStatusAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap-ebp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EmployeeBenefitPlanTaxStatusLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478416/962-205-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EmployeeBenefitPlanTaxStatusLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap-ebp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EmployeeBenefitPlanTaxStatusTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for tax status of employee stock purchase, saving, or similar plan (employee benefit plan (EBP)). Includes, but is not limited to, information concerning whether tax ruling or determination letter was obtained and principal assumption on which plan relied in not making provision for federal income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478873/962-325-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478416/962-205-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-02(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EmployeeBenefitPlanTaxStatusTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap-ebp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=elv_EBP003Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=elv_EBP003Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefit Plan, Subsequent Event (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=elv_EBP003Member', window );">EBP 003</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EbpSubsequentEventLineItems', window );"><strong>EBP, Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanSubsequentEventTextBlock', window );">EBP, Subsequent Event</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">8. Subsequent Events</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Plan Sponsor has evaluated the impact of subsequent events through June&#160;17, 2026, the date the financial statements were issued. No subsequent events have been recognized or required additional disclosure in the financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EbpSubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EbpSubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap-ebp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EmployeeBenefitPlanSubsequentEventTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for subsequent event in financial statement of employee stock purchase, saving, or similar plan (employee benefit plan (EBP)).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 962<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479143/962-235-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EmployeeBenefitPlanSubsequentEventTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap-ebp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=elv_EBP003Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=elv_EBP003Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefit Plan, Summary of Accounting Policy (Tables) - EBP 003<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanAccountingPolicyLineItems', window );"><strong>EBP, Accounting Policy [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanSummaryOfAccountingPolicyTextBlock', window );">EBP, Summary of Accounting Policy</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">2. Significant Accounting Policies</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying financial statements of the Plan have been prepared on the accrual basis of accounting and are in conformity with U.S. generally accepted accounting principles (&#8220;GAAP&#8221;).</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in accordance with GAAP requires the use of estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results may differ from those estimates.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Investment Valuation and Income Recognition</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The EH Master Trust's investments are stated at fair value. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. See Note&#160;4, "Fair Value Measurements", for further discussion.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Plan's interest in the net investment income of the EH Master Trust consists of the Plan's allocation of realized gains and losses on investments that were sold during the period, unrealized appreciation and depreciation of the underlying investments held at year end, and net investment income/loss based upon the total of each Plan participant's share of the EH Master Trust.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Purchases and sales of securities are recorded on a trade-date basis and interest income is recorded on the accrual basis. Dividends are recorded on the ex-dividend date. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Investment securities are exposed to various risks, such as interest rate, market, and credit risks. Due to the level of risk associated with certain investment securities, it is reasonably possible that changes in the values of investment securities will occur in the near term and that such changes could materially affect the amounts reported in the statements of net assets available for benefits, participant accounts and the statement of changes in net assets available for benefits.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Notes Receivable from Participants</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Notes receivable from participants represent participant loans that are recorded at their unpaid principal balance plus any accrued but unpaid interest. Interest income on notes receivable from participants is recorded when it is earned. Related fees are recorded as administrative expenses and are expensed when they are incurred. Delinquent participant loans are recorded as distributions based on the terms of the Plan document. No allowance for credit losses has been recorded as of December&#160;31, 2025 or 2024. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Benefits Paid to Participants</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Benefit payments to participants are recorded upon distribution.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Administrative Expenses</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Certain administrative expenses of maintaining the Plan are paid from Plan assets. The Plan Sponsor may bear certain costs associated with administering the Plan; these costs are not included in the accompanying financial statements and constitute exempt party-in-interest transactions. Certain transaction fees, such as those related to loan processing, are paid from individual participant accounts and are included in administrative expenses. Investment related expenses are included in the Plan's interest in EH Master Trust net investment income.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">There have been no recently adopted or issued accounting standards that had, or will have, a material impact on the financial statements.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanBasisOfAccountingPolicyTextBlock', window );">EBP, Basis of Accounting</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying financial statements of the Plan have been prepared on the accrual basis of accounting and are in conformity with U.S. generally accepted accounting principles (&#8220;GAAP&#8221;).</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanUseOfEstimatePolicyTextBlock', window );">EBP, Use of Estimate</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in accordance with GAAP requires the use of estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results may differ from those estimates.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanInvestmentPolicyTextBlock', window );">EBP, Investment</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Investment Valuation and Income Recognition</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The EH Master Trust's investments are stated at fair value. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. See Note&#160;4, "Fair Value Measurements", for further discussion.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Plan's interest in the net investment income of the EH Master Trust consists of the Plan's allocation of realized gains and losses on investments that were sold during the period, unrealized appreciation and depreciation of the underlying investments held at year end, and net investment income/loss based upon the total of each Plan participant's share of the EH Master Trust.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Purchases and sales of securities are recorded on a trade-date basis and interest income is recorded on the accrual basis. Dividends are recorded on the ex-dividend date. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Investment securities are exposed to various risks, such as interest rate, market, and credit risks. Due to the level of risk associated with certain investment securities, it is reasonably possible that changes in the values of investment securities will occur in the near term and that such changes could materially affect the amounts reported in the statements of net assets available for benefits, participant accounts and the statement of changes in net assets available for benefits.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanNoteReceivableFromParticipantPolicyTextBlock', window );">EBP, Note Receivable from Participant</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Notes Receivable from Participants</span></div>Notes receivable from participants represent participant loans that are recorded at their unpaid principal balance plus any accrued but unpaid interest. Interest income on notes receivable from participants is recorded when it is earned. Related fees are recorded as administrative expenses and are expensed when they are incurred. Delinquent participant loans are recorded as distributions based on the terms of the Plan document. No allowance for credit losses has been recorded as of December&#160;31, 2025 or 2024.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanPaymentToParticipantPolicyTextBlock', window );">EBP, Payment to Participant</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Benefits Paid to Participants</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Benefit payments to participants are recorded upon distribution.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanExpensePolicyTextBlock', window );">EBP, Expense</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Administrative Expenses</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Certain administrative expenses of maintaining the Plan are paid from Plan assets. The Plan Sponsor may bear certain costs associated with administering the Plan; these costs are not included in the accompanying financial statements and constitute exempt party-in-interest transactions. Certain transaction fees, such as those related to loan processing, are paid from individual participant accounts and are included in administrative expenses. Investment related expenses are included in the Plan's interest in EH Master Trust net investment income.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_elv_EBPAccountingPolicyAdoptionPolicyTextBlock', window );">EBP, Accounting Policy Adoption</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">There have been no recently adopted or issued accounting standards that had, or will have, a material impact on the financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_elv_EBPAccountingPolicyAdoptionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>EBP, Accounting Policy Adoption</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">elv_EBPAccountingPolicyAdoptionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>elv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EmployeeBenefitPlanAccountingPolicyLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 962<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479143/962-235-S50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EmployeeBenefitPlanAccountingPolicyLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap-ebp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EmployeeBenefitPlanBasisOfAccountingPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting used to prepare financial statements of employee stock purchase, saving, or similar plan (employee benefit plan (EBP)).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 962<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479143/962-235-S50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EmployeeBenefitPlanBasisOfAccountingPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap-ebp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EmployeeBenefitPlanExpensePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for expense incurred by employee stock purchase, saving, or similar plan (employee benefit plan (EBP)).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478873/962-325-55-17<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EmployeeBenefitPlanExpensePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap-ebp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EmployeeBenefitPlanInvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment held by employee stock purchase, saving, or similar plan (employee benefit plan (EBP)).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478873/962-325-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477783/962-325-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477783/962-325-50-2A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478844/962-325-35-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EmployeeBenefitPlanInvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap-ebp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EmployeeBenefitPlanNoteReceivableFromParticipantPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for note receivable from participant in employee stock purchase, saving, or similar plan (employee benefit plan (EBP)).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478873/962-325-55-17<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EmployeeBenefitPlanNoteReceivableFromParticipantPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap-ebp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EmployeeBenefitPlanPaymentToParticipantPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for payment of benefit to participant in employee stock purchase, saving, or similar plan (employee benefit plan (EBP)).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478873/962-325-55-17<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EmployeeBenefitPlanPaymentToParticipantPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap-ebp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EmployeeBenefitPlanSummaryOfAccountingPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for summary of accounting policy used to prepare financial statement of employee stock purchase, saving, or similar plan (employee benefit plan (EBP)).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 11.M.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480530/250-10-S99-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SAB Topic 11.M)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480530/250-10-S99-6<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478873/962-325-55-17<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EmployeeBenefitPlanSummaryOfAccountingPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap-ebp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EmployeeBenefitPlanUseOfEstimatePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for use of estimate in preparation of financial statement of employee stock purchase, saving, or similar plan (employee benefit plan (EBP)).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478873/962-325-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EmployeeBenefitPlanUseOfEstimatePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap-ebp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=elv_EBP003Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=elv_EBP003Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefit Plan, Reconciliation of Financial Statement to Form 5500 (Tables) - EBP 003 - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500LineItems', window );"><strong>EBP, Reconciliation of Financial Statement to Form 5500 [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500TextBlock', window );">EBP, Reconciliation of Financial Statement to Form 5500 - Text Block</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">7. Reconciliation to Form 5500</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Reconciliation of net assets available for benefits per the financial statements to the Form 5500 as of December&#160;31, 2025 and 2024, is as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.047%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.925%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.927%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net assets available for benefits per the financial statements</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">13,312,912,847&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">12,110,585,543&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Less: deemed distributions of participant loans</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">776,730&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">721,481&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net assets available for benefits per the Form 5500</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">13,312,136,117&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">12,109,864,062&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Reconciliation of the increase in net assets available for benefits per the financial statements to the net income (loss) per the Form 5500 for the year ended December&#160;31, 2025 is as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:82.874%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.926%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Increase in net assets available for benefits per the financial statements</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,202,327,304&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Deemed distributions of participant loans activity</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(55,249)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) per the Form 5500</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,202,272,055&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500TableTextBlock', window );">EBP, Reconciliation of Financial Statement to Form 5500 - Table Text Block</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Reconciliation of net assets available for benefits per the financial statements to the Form 5500 as of December&#160;31, 2025 and 2024, is as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.047%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.925%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.927%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net assets available for benefits per the financial statements</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">13,312,912,847&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">12,110,585,543&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Less: deemed distributions of participant loans</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">776,730&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">721,481&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net assets available for benefits per the Form 5500</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">13,312,136,117&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">12,109,864,062&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Reconciliation of the increase in net assets available for benefits per the financial statements to the net income (loss) per the Form 5500 for the year ended December&#160;31, 2025 is as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:82.874%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.926%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Increase in net assets available for benefits per the financial statements</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,202,327,304&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Deemed distributions of participant loans activity</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(55,249)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) per the Form 5500</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,202,272,055&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanNetAssetAvailableForBenefit', window );">Net assets available for benefits</a></td>
<td class="nump">$ 13,312,912,847<span></span>
</td>
<td class="nump">$ 12,110,585,543<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500NetAssetAvailableForBenefitDeemedDistribution', window );">EBP, Reconciliation to Form 5500, Net Asset Available for Benefit, Deemed Distribution</a></td>
<td class="nump">776,730<span></span>
</td>
<td class="nump">721,481<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanForm5500CaptionNetAssetAvailableForBenefit', window );">EBP, Form 5500 Caption, Net Assets, Total</a></td>
<td class="nump">13,312,136,117<span></span>
</td>
<td class="nump">$ 12,109,864,062<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecrease', window );">Net increase in net assets available for benefits</a></td>
<td class="nump">1,202,327,304<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500PaymentToParticipantIncreaseDecreaseForDeemedDistribution', window );">Deemed distributions of participant loans activity</a></td>
<td class="num">(55,249)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanForm5500CaptionNetIncomeLoss', window );">EBP, Form 5500 Caption, Net Income (Loss), Total</a></td>
<td class="nump">$ 1,202,272,055<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in net asset available for benefit to participant in employee stock purchase, saving, or similar plan (employee benefit plan (EBP)).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478873/962-325-55-17<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-05(a)(Schedule III))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477509/962-325-45-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap-ebp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EmployeeBenefitPlanForm5500CaptionNetAssetAvailableForBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of net asset available for benefit as reported in Form 5500 caption for employee stock purchase, saving, or similar plan (employee benefit plan (EBP)). Form 5500 is form provided by Department of the Treasury, Internal Revenue Service (IRS); Department of Labor (DOL), Employee Benefit Security Administration (EBSA); and Pension Benefit Guaranty Corporation (PBGC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478873/962-325-55-17<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478416/962-205-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EmployeeBenefitPlanForm5500CaptionNetAssetAvailableForBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap-ebp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EmployeeBenefitPlanForm5500CaptionNetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in net asset available for benefit from net income (loss) as reported in Form 5500 caption for employee stock purchase, saving, or similar plan (employee benefit plan (EBP)). Form 5500 is form provided by Department of the Treasury, Internal Revenue Service (IRS); Department of Labor (DOL), Employee Benefit Security Administration (EBSA); and Pension Benefit Guaranty Corporation (PBGC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Employee Retirement Income Security Act of 1974<br> -Number 2520<br> -Section 103<br> -Subsection 1<br> -Paragraph b<br> -Subparagraph (3)<br> -Publisher DOL-EBSA<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478416/962-205-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EmployeeBenefitPlanForm5500CaptionNetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap-ebp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EmployeeBenefitPlanNetAssetAvailableForBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset less liability available to pay benefit of participant in employee stock purchase, saving, or similar plan (employee benefit plan (EBP)), including, but not limited to, aggregation of participants' individual account balances.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477509/962-325-45-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478873/962-325-55-18<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478873/962-325-55-17<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-05(a)(Schedule II))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479750/962-40-25-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-04(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-04(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-03(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477063/962-205-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EmployeeBenefitPlanNetAssetAvailableForBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap-ebp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500LineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478416/962-205-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500LineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap-ebp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500NetAssetAvailableForBenefitDeemedDistribution">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deemed distribution to participant in employee stock purchase, saving, or similar plan (employee benefit plan (EBP)) to reconcile net asset available for benefit per financial statement to Form 5500 caption. Form 5500 is form provided by Department of the Treasury, Internal Revenue Service (IRS); Department of Labor (DOL), Employee Benefit Security Administration (EBSA); and Pension Benefit Guaranty Corporation (PBGC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Employee Retirement Income Security Act of 1974<br> -Number 2520<br> -Section 103<br> -Subsection 1<br> -Paragraph b<br> -Subparagraph (3)<br> -Publisher DOL-EBSA<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478416/962-205-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500NetAssetAvailableForBenefitDeemedDistribution</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap-ebp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500PaymentToParticipantIncreaseDecreaseForDeemedDistribution">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in benefit payment from deemed distribution to participant in employee stock purchase, saving, or similar plan (employee benefit plan (EBP)) to reconcile benefit payment per financial statement to Form 5500 caption. Form 5500 is form provided by Department of the Treasury, Internal Revenue Service (IRS); Department of Labor (DOL), Employee Benefit Security Administration (EBSA); and Pension Benefit Guaranty Corporation (PBGC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Employee Retirement Income Security Act of 1974<br> -Number 2520<br> -Section 103<br> -Subsection 1<br> -Paragraph b<br> -Subparagraph (3)<br> -Publisher DOL-EBSA<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478416/962-205-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500PaymentToParticipantIncreaseDecreaseForDeemedDistribution</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap-ebp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500TableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of reconciliation of financial statement to Form 5500 for employee stock purchase, saving, or similar plan (employee benefit plan (EBP)). Form 5500 is form provided by Department of the Treasury, Internal Revenue Service (IRS); Department of Labor (DOL), Employee Benefit Security Administration (EBSA); and Pension Benefit Guaranty Corporation (PBGC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478873/962-325-55-17<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500TableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap-ebp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500TextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reconciliation of financial statement to Form 5500 for employee stock purchase, saving, or similar plan (employee benefit plan (EBP)). Form 5500 is form provided by Department of the Treasury, Internal Revenue Service (IRS); Department of Labor (DOL), Employee Benefit Security Administration (EBSA); and Pension Benefit Guaranty Corporation (PBGC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478873/962-325-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478416/962-205-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500TextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap-ebp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=elv_EBP003Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=elv_EBP003Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefit Plan, Related-Party and Party-in-Interest Transactions (Details) - EBP 003 - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsLineItems', window );"><strong>EBP, Related Party and Party-in-Interest Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsTextBlock', window );">EBP, Related Party and Party-in-Interest Transactions</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">5. Exempt Related Party and Party-In-Interest Transactions</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Parties-in-interest are defined under Department of Labor regulations as any fiduciary of the Plan, any party rendering services to the Plan, the employer, and certain others. Certain administrative functions are performed by officers and employees of the Plan Sponsor or affiliates of the Plan Sponsor. No such officer or employee is compensated from the Plan.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2025, the Plan reimbursed the Plan Sponsor $59,943 for administrative expenses. This reimbursement is included in administrative expenses in the statement of changes in net assets available for benefits.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Transactions in shares of Elevance Health common stock qualify as exempt party-in-interest transactions under the provisions of ERISA. The Plan owned approximately 1,004,692 and 1,105,902 shares of Elevance Health common stock as of December&#160;31, 2025 and 2024, respectively. During the year ended December&#160;31, 2025, the Plan had net sales of Elevance Health common stock totaling $38,322,881 and the total dividends on Elevance Health common stock in the Elevance Health Stock Fund were $7,148,373.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Certain Plan investments include funds that are managed by affiliates of Fidelity, which constitute party-in-interest transactions. In addition, certain investments in the self-directed brokerage accounts are issued by Fidelity.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Notes receivable from participants also reflect exempt party-in-interest transactions.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecreaseForAdministrativeExpense', window );">Administrative expenses</a></td>
<td class="nump">$ 6,421,506<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=elv_EBP003Member', window );">Related Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsLineItems', window );"><strong>EBP, Related Party and Party-in-Interest Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecreaseForAdministrativeExpense', window );">Administrative expenses</a></td>
<td class="nump">$ 59,943<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanInvestmentNumberOfShares', window );">Investment number of shares/units</a></td>
<td class="nump">1,004,692<span></span>
</td>
<td class="nump">1,105,902<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanInvestmentNumberOfSharesSold', window );">Employer common stock shares sold, net</a></td>
<td class="nump">38,322,881<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForDividendIncomeOnInvestment', window );">Dividends on employer common stock</a></td>
<td class="nump">$ 7,148,373<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecreaseForAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in net asset available for benefit from administrative expense incurred by employee stock purchase, saving, or similar plan (employee benefit plan (EBP)).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478873/962-325-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-05(a)(Schedule III))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477063/962-205-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecreaseForAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap-ebp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForDividendIncomeOnInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in net asset available for benefit from dividend income on investment held by employee stock purchase, saving, or similar plan (employee benefit plan (EBP)).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478873/962-325-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-04(1)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477783/962-325-50-7<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477063/962-205-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForDividendIncomeOnInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap-ebp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EmployeeBenefitPlanInvestmentNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares or units of investment held by employee stock purchase, saving, or similar plan (employee benefit plan (EBP)).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-05(a)(Schedule I))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Employee Retirement Income Security Act of 1974<br> -Number 2520<br> -Section 103<br> -Subsection 10<br> -Paragraph b<br> -Subparagraph (3)<br> -Publisher DOL-EBSA<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Employee Retirement Income Security Act of 1974<br> -Number 2520<br> -Section 103<br> -Subsection 10<br> -Paragraph b<br> -Subparagraph (4)<br> -Publisher DOL-EBSA<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Employee Retirement Income Security Act of 1974<br> -Number 2520<br> -Section 103<br> -Subsection 10<br> -Paragraph b<br> -Subparagraph (1)(i)(B)<br> -Publisher DOL-EBSA<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Employee Retirement Income Security Act of 1974<br> -Number 2520<br> -Section 103<br> -Subsection 10<br> -Paragraph b<br> -Subparagraph (2)(i)(B)<br> -Publisher DOL-EBSA<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Employee Retirement Income Security Act of 1974<br> -Number 2520<br> -Section 103<br> -Subsection 6<br> -Paragraph d<br> -Subparagraph (1)(ii)<br> -Publisher DOL-EBSA<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-02(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EmployeeBenefitPlanInvestmentNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap-ebp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EmployeeBenefitPlanInvestmentNumberOfSharesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares or units of investment sold by employee stock purchase, saving, or similar plan (employee benefit plan (EBP)).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-04(2)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EmployeeBenefitPlanInvestmentNumberOfSharesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap-ebp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 962<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479143/962-235-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap-ebp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party and party-in-interest transactions with employee stock purchase, saving, or similar plan (employee benefit plan (EBP)).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478873/962-325-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap-ebp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=elv_EBP003Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=elv_EBP003Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestAxis=us-gaap_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestAxis=us-gaap_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefit Plan, Schedule, Asset Held for Investment (Details) - EBP 003 - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentLineItems', window );"><strong>EBP, Schedule of Asset Held for Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentTableTextBlock', window );">EBP, Schedule of Asset Held for Investment</a></td>
<td class="text"><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Elevance Health 401(k) Plan</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Schedule H, Line 4i&#8212;Schedule of Assets (Held at End of Year)</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Plan Sponsor: ATH Holding Company, LLC.     EIN #11-3713086     Plan #003</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:81.805%"><tr><td style="width:1.0%"></td><td style="width:2.125%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.648%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.857%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.648%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.499%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.200%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.125%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.596%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.988%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.521%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.479%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.714%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">(b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">(c)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">(d)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">(e)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Identity of issuer, borrower,<br/>lessor, or similar party</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Description of&#160;investment including maturity date, <br/>interest rate, collateral and par or maturity value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Cost**</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Current<br/>value</span></td></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">*</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-168">JP Morgan</span></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-169">Plan's interest in EH Master Trust</span></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-170">&#8212;</span>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">13,065,058,854&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Notes receivable from participants</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Interest rates range from</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.25%</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">to</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.50%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">237,618,710&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">maturing at various dates through</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5/26/2045</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanInvestmentPlanInterestInMasterTrustFairValue', window );">Investments, at fair value, Interest in EH Master Trust</a></td>
<td class="nump">$ 13,065,058,854<span></span>
</td>
<td class="nump">$ 11,861,354,869<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanAssetHeldForInvestmentParticipantLoanAfterDeemedDistribution', window );">Participant loans</a></td>
<td class="nump">$ 237,618,710<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">EIN</a></td>
<td class="text">11-3713086<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanPlanNumber', window );">Plan Number</a></td>
<td class="text">003<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=elv_EBP003Member', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentLineItems', window );"><strong>EBP, Schedule of Asset Held for Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanParticipantLoanInterestRate', window );">Participant Loans, interest rates</a></td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=elv_EBP003Member', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentLineItems', window );"><strong>EBP, Schedule of Asset Held for Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanParticipantLoanInterestRate', window );">Participant Loans, interest rates</a></td>
<td class="nump">10.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanParticipantLoanMaturityDate', window );">Participant Loans, maturities</a></td>
<td class="text">May 26,  2045<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIdentifierAxis=JP Morgan', window );">Investment, Identifier [Axis]: JP Morgan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentLineItems', window );"><strong>EBP, Schedule of Asset Held for Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanAssetHeldForInvestmentPartyInInterest', window );">Investment party-in-interest</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanInvestmentIssuerNameExtensibleEnumeration', window );">Investment issuer name</a></td>
<td class="text">JP Morgan [Member]<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanInvestmentTypeExtensibleEnumeration', window );">Investment type</a></td>
<td class="text">Miscellaneous Investments [Member]<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap-ebp_EmployeeBenefitPlanAssetHeldForInvestmentPlanInterestInMasterTrustParticipationStatusExtensibleEnumeration', window );">Investment participation status</a></td>
<td class="text">EBP, Participant-Directed [Member]<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EmployeeBenefitPlanAssetHeldForInvestmentParticipantLoanAfterDeemedDistribution">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deemed distribution, of participant loan in schedule of asset held for investment of employee stock purchase, saving, or similar plan (employee benefit plan (EBP)).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Employee Retirement Income Security Act of 1974<br> -Number 2520<br> -Section 103<br> -Subsection 10<br> -Paragraph b<br> -Subparagraph (1)(i)(D)<br> -Publisher DOL-EBSA<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-05(a)(Schedule I))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EmployeeBenefitPlanAssetHeldForInvestmentParticipantLoanAfterDeemedDistribution</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap-ebp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EmployeeBenefitPlanAssetHeldForInvestmentPartyInInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates (true false) whether asset held for investment of employee stock purchase, saving, or similar plan (employee benefit plan (EBP)) was transacted with party-in-interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-05(a)(Schedule I))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Employee Retirement Income Security Act of 1974<br> -Number 2520<br> -Section 103<br> -Subsection 10<br> -Paragraph b<br> -Subparagraph (1)(i)(A)<br> -Publisher DOL-EBSA<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EmployeeBenefitPlanAssetHeldForInvestmentPartyInInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap-ebp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EmployeeBenefitPlanAssetHeldForInvestmentPlanInterestInMasterTrustParticipationStatusExtensibleEnumeration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates status of participation by participant for plan interest in master trust in schedule of asset held for investment of employee stock purchase, saving, or similar plan (employee benefit plan (EBP)).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-05(a)(Schedule I))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Employee Retirement Income Security Act of 1974<br> -Number 2520<br> -Section 103<br> -Subsection 10<br> -Paragraph b<br> -Subparagraph (1)(ii)<br> -Publisher DOL-EBSA<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EmployeeBenefitPlanAssetHeldForInvestmentPlanInterestInMasterTrustParticipationStatusExtensibleEnumeration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap-ebp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EmployeeBenefitPlanInvestmentIssuerNameExtensibleEnumeration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates name of issuer of investment held by employee stock purchase, saving, or similar plan (employee benefit plan (EBP)).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-05(a)(Schedule I))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Employee Retirement Income Security Act of 1974<br> -Number 2520<br> -Section 103<br> -Subsection 10<br> -Paragraph b<br> -Subparagraph (1)(i)(A)<br> -Publisher DOL-EBSA<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Employee Retirement Income Security Act of 1974<br> -Number 2520<br> -Section 103<br> -Subsection 10<br> -Paragraph b<br> -Subparagraph (2)(i)(A)<br> -Publisher DOL-EBSA<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Employee Retirement Income Security Act of 1974<br> -Number 2520<br> -Section 103<br> -Subsection 6<br> -Paragraph d<br> -Subparagraph (1)(i)<br> -Publisher DOL-EBSA<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EmployeeBenefitPlanInvestmentIssuerNameExtensibleEnumeration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap-ebp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EmployeeBenefitPlanInvestmentPlanInterestInMasterTrustFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of plan interest in master trust held by employee stock purchase, saving, or similar plan (employee benefit plan (EBP)).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 962<br> -SubTopic 325<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478873/962-325-55-18<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-05(a)(Schedule II))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-03(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477063/962-205-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EmployeeBenefitPlanInvestmentPlanInterestInMasterTrustFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap-ebp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EmployeeBenefitPlanInvestmentTypeExtensibleEnumeration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates type of investment at current value held by employee stock purchase, saving, or similar plan (employee benefit plan (EBP)).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-05(a)(Schedule I))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Employee Retirement Income Security Act of 1974<br> -Number 2520<br> -Section 103<br> -Subsection 10<br> -Paragraph b<br> -Subparagraph (1)(i)(A)<br> -Publisher DOL-EBSA<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Employee Retirement Income Security Act of 1974<br> -Number 2520<br> -Section 103<br> -Subsection 10<br> -Paragraph b<br> -Subparagraph (2)(i)(A)<br> -Publisher DOL-EBSA<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EmployeeBenefitPlanInvestmentTypeExtensibleEnumeration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap-ebp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EmployeeBenefitPlanParticipantLoanInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest rate on participant loan in schedule of asset held for investment of employee stock purchase, saving, or similar plan (employee benefit plan (EBP)).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Employee Retirement Income Security Act of 1974<br> -Number 2520<br> -Section 103<br> -Subsection 10<br> -Paragraph b<br> -Subparagraph (1)(i)(D)<br> -Publisher DOL-EBSA<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-05(a)(Schedule I))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EmployeeBenefitPlanParticipantLoanInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap-ebp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EmployeeBenefitPlanParticipantLoanMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maturity date of participant loan in schedule of asset held for investment of employee stock purchase, saving, or similar plan (employee benefit plan (EBP)), in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Employee Retirement Income Security Act of 1974<br> -Number 2520<br> -Section 103<br> -Subsection 10<br> -Paragraph b<br> -Subparagraph (1)(i)(D)<br> -Publisher DOL-EBSA<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-05(a)(Schedule I))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EmployeeBenefitPlanParticipantLoanMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap-ebp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EmployeeBenefitPlanPlanNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Plan number of employee stock purchase, saving, or similar plan (employee benefit plan (EBP)), in three-digit numeric format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-05(a)(Schedule I))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-05(a)(Schedule II))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Employee Retirement Income Security Act of 1974<br> -Number 2520<br> -Section 103<br> -Subsection 10<br> -Paragraph b<br> -Subparagraph (1)<br> -Publisher DOL-EBSA<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-05(a)(Schedule III))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Employee Retirement Income Security Act of 1974<br> -Number 2520<br> -Section 103<br> -Subsection 10<br> -Paragraph b<br> -Subparagraph (3)<br> -Publisher DOL-EBSA<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Employee Retirement Income Security Act of 1974<br> -Number 2520<br> -Section 103<br> -Subsection 10<br> -Paragraph b<br> -Subparagraph (4)<br> -Publisher DOL-EBSA<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Employee Retirement Income Security Act of 1974<br> -Number 2520<br> -Section 103<br> -Subsection 6<br> -Paragraph d<br> -Subparagraph (1)<br> -Publisher DOL-EBSA<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Employee Retirement Income Security Act of 1974<br> -Number 2520<br> -Section 103<br> -Subsection 6<br> -Paragraph d<br> -Subparagraph (2)<br> -Publisher DOL-EBSA<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Employee Retirement Income Security Act of 1974<br> -Number 2520<br> -Section 103<br> -Subsection 10<br> -Paragraph b<br> -Subparagraph (2)<br> -Publisher DOL-EBSA<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EmployeeBenefitPlanPlanNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap-ebp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>us-types:threeDigitItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Employee Retirement Income Security Act of 1974<br> -Number 2520<br> -Section 103<br> -Subsection 10<br> -Paragraph b<br> -Subparagraph (1)(i)(D)<br> -Publisher DOL-EBSA<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-05(a)(Schedule I))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Employee Retirement Income Security Act of 1974<br> -Number 2520<br> -Section 103<br> -Subsection 10<br> -Paragraph b<br> -Subparagraph (1)(i)(A)<br> -Publisher DOL-EBSA<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Employee Retirement Income Security Act of 1974<br> -Number 2520<br> -Section 103<br> -Subsection 10<br> -Paragraph b<br> -Subparagraph (1)(i)(C)<br> -Publisher DOL-EBSA<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Employee Retirement Income Security Act of 1974<br> -Number 2520<br> -Section 103<br> -Subsection 10<br> -Paragraph b<br> -Subparagraph (1)(i)(B)<br> -Publisher DOL-EBSA<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap-ebp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for schedule of asset held for investment for employee stock purchase, saving, or similar plan (employee benefit plan (EBP)).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 962<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6A-05(a)(Schedule I))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477804/962-205-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Employee Retirement Income Security Act of 1974<br> -Number 2520<br> -Section 103<br> -Subsection 10<br> -Paragraph b<br> -Subparagraph (1)(i)<br> -Publisher DOL-EBSA<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap-ebp_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=elv_EBP003Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=elv_EBP003Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIdentifierAxis=JP Morgan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIdentifierAxis=JP Morgan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.26.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>69</ContextCount>
  <ElementCount>90</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>18</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="elv-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="elv-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Statement - Employee Benefit Plan, Statement of Net Asset Available for Benefit (Statement)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/EmployeeBenefitPlanStatementofNetAssetAvailableforBenefitStatement</Role>
      <ShortName>Employee Benefit Plan, Statement of Net Asset Available for Benefit (Statement)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="elv-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - Employee Benefit Plan, Statement of Change in Net Asset Available for Benefit (Statement)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/EmployeeBenefitPlanStatementofChangeinNetAssetAvailableforBenefitStatement</Role>
      <ShortName>Employee Benefit Plan, Statement of Change in Net Asset Available for Benefit (Statement)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="elv-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Disclosure - Employee Benefit Plan, Description of Plan (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/EmployeeBenefitPlanDescriptionofPlanTables</Role>
      <ShortName>Employee Benefit Plan, Description of Plan (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="elv-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Disclosure - Employee Benefit Plan, Master Trust (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/EmployeeBenefitPlanMasterTrustTables</Role>
      <ShortName>Employee Benefit Plan, Master Trust (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="elv-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Disclosure - Employee Benefit Plan, Fair Value and NAV (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/EmployeeBenefitPlanFairValueandNAVTables</Role>
      <ShortName>Employee Benefit Plan, Fair Value and NAV (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="elv-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Disclosure - Employee Benefit Plan, Tax Status (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/EmployeeBenefitPlanTaxStatusTables</Role>
      <ShortName>Employee Benefit Plan, Tax Status (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="elv-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Disclosure - Employee Benefit Plan, Subsequent Event (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/EmployeeBenefitPlanSubsequentEventTables</Role>
      <ShortName>Employee Benefit Plan, Subsequent Event (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="elv-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Disclosure - Employee Benefit Plan, Summary of Accounting Policy (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/EmployeeBenefitPlanSummaryofAccountingPolicyTables</Role>
      <ShortName>Employee Benefit Plan, Summary of Accounting Policy (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="elv-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - Employee Benefit Plan, Reconciliation of Financial Statement to Form 5500 (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/EmployeeBenefitPlanReconciliationofFinancialStatementtoForm5500Tables</Role>
      <ShortName>Employee Benefit Plan, Reconciliation of Financial Statement to Form 5500 (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="elv-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - Employee Benefit Plan, Related-Party and Party-in-Interest Transactions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/EmployeeBenefitPlanRelatedPartyandPartyinInterestTransactionsDetails</Role>
      <ShortName>Employee Benefit Plan, Related-Party and Party-in-Interest Transactions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="elv-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - Employee Benefit Plan, Schedule, Asset Held for Investment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.elevancehealth.com/role/EmployeeBenefitPlanScheduleAssetHeldforInvestmentDetails</Role>
      <ShortName>Employee Benefit Plan, Schedule, Asset Held for Investment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="11-K" isDefinitelyFs="true" isUsgaap="true" original="elv-20251231.htm">elv-20251231.htm</File>
    <File>elv-20251231.xsd</File>
    <File>elv-20251231_cal.xml</File>
    <File>elv-20251231_def.xml</File>
    <File>elv-20251231_lab.xml</File>
    <File>elv-20251231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="145">http://fasb.org/us-gaap-ebp/2026</BaseTaxonomy>
    <BaseTaxonomy items="14">http://xbrl.sec.gov/dei/2026</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>26
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "elv-20251231.htm": {
   "nsprefix": "elv",
   "nsuri": "http://www.elevancehealth.com/20251231",
   "dts": {
    "inline": {
     "local": [
      "elv-20251231.htm"
     ]
    },
    "schema": {
     "local": [
      "elv-20251231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/2023/calculation-1.1.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd",
      "https://xbrl.fasb.org/srt/2026/elts/srt-roles-2026.xsd",
      "https://xbrl.fasb.org/srt/2026/elts/srt-types-2026.xsd",
      "https://xbrl.fasb.org/us-gaap/2026/ebp/elts/us-gaap-ebp-2026.xsd",
      "https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd",
      "https://xbrl.fasb.org/us-gaap/2026/elts/us-roles-2026.xsd",
      "https://xbrl.fasb.org/us-gaap/2026/elts/us-types-2026.xsd",
      "https://xbrl.sec.gov/country/2026/country-2026.xsd",
      "https://xbrl.sec.gov/dei/2026/dei-2026.xsd",
      "https://xbrl.sec.gov/stpr/2026/stpr-2026.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "elv-20251231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "elv-20251231_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "elv-20251231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "elv-20251231_pre.xml"
     ]
    }
   },
   "keyStandard": 76,
   "keyCustom": 14,
   "axisStandard": 7,
   "axisCustom": 1,
   "memberStandard": 15,
   "memberCustom": 3,
   "hidden": {
    "total": 7,
    "http://fasb.org/us-gaap-ebp/2026": 3,
    "http://xbrl.sec.gov/dei/2026": 4
   },
   "contextCount": 69,
   "entityCount": 1,
   "segmentCount": 18,
   "elementCount": 158,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap-ebp/2026": 145,
    "http://xbrl.sec.gov/dei/2026": 14
   },
   "report": {
    "R1": {
     "role": "http://www.elevancehealth.com/role/Cover",
     "longName": "0000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "elv-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "elv-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://www.elevancehealth.com/role/EmployeeBenefitPlanStatementofNetAssetAvailableforBenefitStatement",
     "longName": "0000002 - Statement - Employee Benefit Plan, Statement of Net Asset Available for Benefit (Statement)",
     "shortName": "Employee Benefit Plan, Statement of Net Asset Available for Benefit (Statement)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap-ebp:EmployeeBenefitPlanInvestmentPlanInterestInMasterTrustFairValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "elv-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap-ebp:EmployeeBenefitPlanNoteReceivableFromParticipant",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "elv-20251231.htm",
      "unique": true
     }
    },
    "R3": {
     "role": "http://www.elevancehealth.com/role/EmployeeBenefitPlanStatementofChangeinNetAssetAvailableforBenefitStatement",
     "longName": "0000003 - Statement - Employee Benefit Plan, Statement of Change in Net Asset Available for Benefit (Statement)",
     "shortName": "Employee Benefit Plan, Statement of Change in Net Asset Available for Benefit (Statement)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap-ebp:EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForParticipantContributionExcludingRollover",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "elv-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap-ebp:EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForParticipantContributionExcludingRollover",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "elv-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R4": {
     "role": "http://www.elevancehealth.com/role/EmployeeBenefitPlanDescriptionofPlanTables",
     "longName": "0000004 - Disclosure - Employee Benefit Plan, Description of Plan (Tables)",
     "shortName": "Employee Benefit Plan, Description of Plan (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "4",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap-ebp:EmployeeBenefitPlanDescriptionOfPlanTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "elv-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap-ebp:EmployeeBenefitPlanDescriptionOfPlanTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "elv-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R5": {
     "role": "http://www.elevancehealth.com/role/EmployeeBenefitPlanMasterTrustTables",
     "longName": "0000005 - Disclosure - Employee Benefit Plan, Master Trust (Tables)",
     "shortName": "Employee Benefit Plan, Master Trust (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "5",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap-ebp:EmployeeBenefitPlanMasterTrustTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "elv-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap-ebp:EmployeeBenefitPlanMasterTrustTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "elv-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R6": {
     "role": "http://www.elevancehealth.com/role/EmployeeBenefitPlanFairValueandNAVTables",
     "longName": "0000006 - Disclosure - Employee Benefit Plan, Fair Value and NAV (Tables)",
     "shortName": "Employee Benefit Plan, Fair Value and NAV (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "6",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap-ebp:EmployeeBenefitPlanInvestmentFairValueAndNavTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "elv-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap-ebp:EmployeeBenefitPlanInvestmentFairValueAndNavTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "elv-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R7": {
     "role": "http://www.elevancehealth.com/role/EmployeeBenefitPlanTaxStatusTables",
     "longName": "0000007 - Disclosure - Employee Benefit Plan, Tax Status (Tables)",
     "shortName": "Employee Benefit Plan, Tax Status (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "7",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap-ebp:EmployeeBenefitPlanTaxStatusTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "elv-20251231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R8": {
     "role": "http://www.elevancehealth.com/role/EmployeeBenefitPlanSubsequentEventTables",
     "longName": "0000008 - Disclosure - Employee Benefit Plan, Subsequent Event (Tables)",
     "shortName": "Employee Benefit Plan, Subsequent Event (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "8",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap-ebp:EmployeeBenefitPlanSubsequentEventTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "elv-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap-ebp:EmployeeBenefitPlanSubsequentEventTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "elv-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://www.elevancehealth.com/role/EmployeeBenefitPlanSummaryofAccountingPolicyTables",
     "longName": "0000009 - Disclosure - Employee Benefit Plan, Summary of Accounting Policy (Tables)",
     "shortName": "Employee Benefit Plan, Summary of Accounting Policy (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "9",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap-ebp:EmployeeBenefitPlanSummaryOfAccountingPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "elv-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap-ebp:EmployeeBenefitPlanSummaryOfAccountingPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "elv-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://www.elevancehealth.com/role/EmployeeBenefitPlanReconciliationofFinancialStatementtoForm5500Tables",
     "longName": "0000010 - Disclosure - Employee Benefit Plan, Reconciliation of Financial Statement to Form 5500 (Tables)",
     "shortName": "Employee Benefit Plan, Reconciliation of Financial Statement to Form 5500 (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "10",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap-ebp:EmployeeBenefitPlanReconciliationToForm5500TextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "elv-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap-ebp:EmployeeBenefitPlanReconciliationToForm5500TextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "elv-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://www.elevancehealth.com/role/EmployeeBenefitPlanRelatedPartyandPartyinInterestTransactionsDetails",
     "longName": "0000014 - Disclosure - Employee Benefit Plan, Related-Party and Party-in-Interest Transactions (Details)",
     "shortName": "Employee Benefit Plan, Related-Party and Party-in-Interest Transactions (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "11",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap-ebp:EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "elv-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap-ebp:EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "elv-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://www.elevancehealth.com/role/EmployeeBenefitPlanScheduleAssetHeldforInvestmentDetails",
     "longName": "0000016 - Disclosure - Employee Benefit Plan, Schedule, Asset Held for Investment (Details)",
     "shortName": "Employee Benefit Plan, Schedule, Asset Held for Investment (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "12",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap-ebp:EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "elv-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap-ebp:EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "elv-20251231.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.elevancehealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedBenefitPlanCommonCollectiveTrustMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "DefinedBenefitPlanCommonCollectiveTrustMember",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanMasterTrustTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Collective Trust",
        "label": "Common Collective Trust [Member]"
       }
      }
     },
     "auth_ref": [
      "r113",
      "r122",
      "r125",
      "r132"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://www.elevancehealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Annual Report",
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r136",
      "r137",
      "r138"
     ]
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://www.elevancehealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Information [Line Items]",
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentInformationTable",
     "presentation": [
      "http://www.elevancehealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Information [Table]",
        "label": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.elevancehealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentType",
     "presentation": [
      "http://www.elevancehealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "elv_EBP003Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.elevancehealth.com/20251231",
     "localname": "EBP003Member",
     "presentation": [
      "http://www.elevancehealth.com/role/Cover",
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanDescriptionofPlanTables",
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanFairValueandNAVTables",
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanMasterTrustTables",
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanReconciliationofFinancialStatementtoForm5500Tables",
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanRelatedPartyandPartyinInterestTransactionsDetails",
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanScheduleAssetHeldforInvestmentDetails",
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanStatementofChangeinNetAssetAvailableforBenefitStatement",
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanStatementofNetAssetAvailableforBenefitStatement",
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanSubsequentEventTables",
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanSummaryofAccountingPolicyTables",
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanTaxStatusTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EBP 003",
        "label": "EBP 003 [Member]",
        "documentation": "EBP 003"
       }
      }
     },
     "auth_ref": []
    },
    "elv_EBPAccountingPolicyAdoptionPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.elevancehealth.com/20251231",
     "localname": "EBPAccountingPolicyAdoptionPolicyTextBlock",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanSummaryofAccountingPolicyTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EBP, Accounting Policy Adoption",
        "label": "EBP, Accounting Policy Adoption [Policy Text Block]",
        "documentation": "EBP, Accounting Policy Adoption"
       }
      }
     },
     "auth_ref": []
    },
    "elv_EBPAutomaticDistributionToParticipantThreshold": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.elevancehealth.com/20251231",
     "localname": "EBPAutomaticDistributionToParticipantThreshold",
     "crdr": "debit",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanDescriptionofPlanTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EBP, Automatic Distribution to Participant Threshold",
        "label": "EBP, Automatic Distribution to Participant Threshold",
        "documentation": "EBP, Automatic Distribution to Participant Threshold"
       }
      }
     },
     "auth_ref": []
    },
    "elv_EBPDistributionOfAccountBalanceRolledIntoIRAThreshold": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.elevancehealth.com/20251231",
     "localname": "EBPDistributionOfAccountBalanceRolledIntoIRAThreshold",
     "crdr": "debit",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanDescriptionofPlanTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EBP, Account Balance Rolled Into IRA Threshold",
        "label": "EBP, Distribution of Account Balance Rolled into IRA Threshold",
        "documentation": "EBP, Distribution of Account Balance Rolled into IRA Threshold"
       }
      }
     },
     "auth_ref": []
    },
    "elv_EBPDistributionOfAccountBalanceStaysInPlanThreshold": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.elevancehealth.com/20251231",
     "localname": "EBPDistributionOfAccountBalanceStaysInPlanThreshold",
     "crdr": "debit",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanDescriptionofPlanTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EBP, Distribution of Account Balance Stays in Plan Threshold",
        "label": "EBP, Distribution of Account Balance Stays in Plan Threshold",
        "documentation": "EBP, Distribution of Account Balance Stays in Plan Threshold"
       }
      }
     },
     "auth_ref": []
    },
    "elv_EBPEligibilityServicePeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.elevancehealth.com/20251231",
     "localname": "EBPEligibilityServicePeriod",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanDescriptionofPlanTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EBP eligibility service period",
        "label": "EBP, Eligibility Service Period",
        "documentation": "EBP, Eligibility Service Period"
       }
      }
     },
     "auth_ref": []
    },
    "elv_EBPEmployerContributionVestingPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.elevancehealth.com/20251231",
     "localname": "EBPEmployerContributionVestingPercentage",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanDescriptionofPlanTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EBP Employer Contribution Vesting Percentage",
        "label": "EBP, Employer Contribution Vesting Percentage",
        "documentation": "EBP, Employer Contribution Vesting Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "elv_EBPEmployerContributionVestingPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.elevancehealth.com/20251231",
     "localname": "EBPEmployerContributionVestingPeriod",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanDescriptionofPlanTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EBP Employer Contribution Vesting Period",
        "label": "EBP, Employer Contribution Vesting Period",
        "documentation": "EBP, Employer Contribution Vesting Period"
       }
      }
     },
     "auth_ref": []
    },
    "elv_EBPEmployerMatchTrancheAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.elevancehealth.com/20251231",
     "localname": "EBPEmployerMatchTrancheAxis",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanDescriptionofPlanTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EBP Employer Match Tranche [Axis]",
        "label": "EBP, Employer Match Tranche [Axis]",
        "documentation": "EBP, Employer Match Tranche"
       }
      }
     },
     "auth_ref": []
    },
    "elv_EBPEmployerMatchTrancheDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.elevancehealth.com/20251231",
     "localname": "EBPEmployerMatchTrancheDomain",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanDescriptionofPlanTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EBP Employer Match Tranche [Domain]",
        "label": "EBP, Employer Match Tranche [Domain]",
        "documentation": "EBP Employer Match Tranche [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "elv_EBPEmployerMatchTrancheOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.elevancehealth.com/20251231",
     "localname": "EBPEmployerMatchTrancheOneMember",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanDescriptionofPlanTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EBP Employer Match Tranche One",
        "label": "EBP, Employer Match Tranche One [Member]",
        "documentation": "EBP, Employer Match Tranche One"
       }
      }
     },
     "auth_ref": []
    },
    "elv_EBPEmployerMatchTrancheTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.elevancehealth.com/20251231",
     "localname": "EBPEmployerMatchTrancheTwoMember",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanDescriptionofPlanTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EBP Employer Match Tranche Two",
        "label": "EBP, Employer Match Tranche Two [Member]",
        "documentation": "EBP, Employer Match Tranche Two"
       }
      }
     },
     "auth_ref": []
    },
    "elv_EBPNoteReceivableFromParticipantGeneralLoanTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.elevancehealth.com/20251231",
     "localname": "EBPNoteReceivableFromParticipantGeneralLoanTerm",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanDescriptionofPlanTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EBP, Note receivable from participant, general loan term",
        "label": "EBP, Note receivable from participant, general loan term",
        "documentation": "EBP, Note receivable from participant, general loan term"
       }
      }
     },
     "auth_ref": []
    },
    "elv_EBPParticipantCatchUpContributionMinimumAge": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.elevancehealth.com/20251231",
     "localname": "EBPParticipantCatchUpContributionMinimumAge",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanDescriptionofPlanTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EBP Participant Catch Up Contribution Minimum Age",
        "label": "EBP, Participant Catch Up Contribution Minimum Age",
        "documentation": "EBP, Participant Catch Up Contribution Minimum Age"
       }
      }
     },
     "auth_ref": []
    },
    "elv_EBPParticipantContributionCapOfAutomaticAnnualEscalation": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.elevancehealth.com/20251231",
     "localname": "EBPParticipantContributionCapOfAutomaticAnnualEscalation",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanDescriptionofPlanTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EBP, Participant Contribution, Cap Of Automatic Annual Escalation",
        "label": "EBP, Participant Contribution, Cap Of Automatic Annual Escalation",
        "documentation": "EBP, Participant Contribution, Cap Of Automatic Annual Escalation"
       }
      }
     },
     "auth_ref": []
    },
    "elv_EBPParticipantContributionEligibleCompensationPercentage": {
     "xbrltype": "pureItemType",
     "nsuri": "http://www.elevancehealth.com/20251231",
     "localname": "EBPParticipantContributionEligibleCompensationPercentage",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanDescriptionofPlanTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EBP Participant Contribution Eligible Compensation Percentage",
        "label": "EBP, Participant Contribution Eligible Compensation Percentage",
        "documentation": "EBP, Participant Contribution Eligible Compensation Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "elv_EBPParticipantContributionIncrementalIncreaseOfAutomaticAnnualEscalation": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.elevancehealth.com/20251231",
     "localname": "EBPParticipantContributionIncrementalIncreaseOfAutomaticAnnualEscalation",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanDescriptionofPlanTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EBP, Participant Contribution, incremental increase of automatic annual escalation",
        "label": "EBP, Participant Contribution, incremental increase of automatic annual escalation",
        "documentation": "EBP, Participant Contribution, incremental increase of automatic annual escalation"
       }
      }
     },
     "auth_ref": []
    },
    "elv_EBPParticipantContributionMaximumContributionToEmployeeStockPlan": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.elevancehealth.com/20251231",
     "localname": "EBPParticipantContributionMaximumContributionToEmployeeStockPlan",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanDescriptionofPlanTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EBP, Participant Contribution, Maximum Contribution to Employee Stock Plan",
        "label": "EBP, Participant Contribution, Maximum Contribution to Employee Stock Plan",
        "documentation": "EBP, Participant Contribution, Maximum Contribution to Employee Stock Plan"
       }
      }
     },
     "auth_ref": []
    },
    "elv_EBPPlanRevenueCreditAccountDecreaseFromAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.elevancehealth.com/20251231",
     "localname": "EBPPlanRevenueCreditAccountDecreaseFromAdministrativeExpense",
     "crdr": "credit",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanDescriptionofPlanTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EBP, Plan Revenue Credit Account, Decrease from Administrative Expense",
        "label": "EBP, Plan Revenue Credit Account, Decrease from Administrative Expense",
        "documentation": "EBP, Plan Revenue Credit Account, Decrease from Administrative Expense"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap-ebp_EbpPlanName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EbpPlanName",
     "presentation": [
      "http://www.elevancehealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EBP, Plan Name",
        "label": "EBP, Plan Name",
        "documentation": "Name of employee stock purchase, saving, or similar plan (employee benefit plan (EBP))."
       }
      }
     },
     "auth_ref": [
      "r179"
     ]
    },
    "us-gaap-ebp_EbpSubsequentEventAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EbpSubsequentEventAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "EBP, Subsequent Event [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap-ebp_EbpSubsequentEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EbpSubsequentEventLineItems",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanSubsequentEventTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EBP, Subsequent Event [Line Items]",
        "label": "EBP, Subsequent Event [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r48",
      "r140"
     ]
    },
    "us-gaap-ebp_EbpSubsequentEventTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EbpSubsequentEventTable",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanSubsequentEventTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EBP, Subsequent Event [Table]",
        "label": "EBP, Subsequent Event [Table]",
        "documentation": "Disclosure of information about subsequent event for employee stock purchase, saving, or similar plan (employee benefit plan (EBP))."
       }
      }
     },
     "auth_ref": [
      "r48",
      "r140"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanAccountingPolicyAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanAccountingPolicyAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "EBP, Accounting Policy, Accounting Standard Update, and Change in Accounting Principle [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap-ebp_EmployeeBenefitPlanAccountingPolicyLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanAccountingPolicyLineItems",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanSummaryofAccountingPolicyTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EBP, Accounting Policy [Line Items]",
        "label": "EBP, Accounting Policy [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r180",
      "r190"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanAccountingPolicyTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanAccountingPolicyTable",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanSummaryofAccountingPolicyTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EBP, Accounting Policy [Table]",
        "label": "EBP, Accounting Policy [Table]",
        "documentation": "Disclosure of information about accounting policy for employee stock purchase, saving, or similar plan (employee benefit plan (EBP))."
       }
      }
     },
     "auth_ref": [
      "r180",
      "r190"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanAssetHeldForInvestmentParticipantLoanAfterDeemedDistribution": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanAssetHeldForInvestmentParticipantLoanAfterDeemedDistribution",
     "crdr": "debit",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanScheduleAssetHeldforInvestmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Participant loans",
        "label": "EBP, Asset Held for Investment, Participant Loan, after Deemed Distribution",
        "documentation": "Amount, after deemed distribution, of participant loan in schedule of asset held for investment of employee stock purchase, saving, or similar plan (employee benefit plan (EBP))."
       }
      }
     },
     "auth_ref": [
      "r87",
      "r150"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanAssetHeldForInvestmentPartyInInterest": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanAssetHeldForInvestmentPartyInInterest",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanScheduleAssetHeldforInvestmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment party-in-interest",
        "label": "EBP, Asset Held for Investment, Party-in-Interest [true false]",
        "documentation": "Indicates (true false) whether asset held for investment of employee stock purchase, saving, or similar plan (employee benefit plan (EBP)) was transacted with party-in-interest."
       }
      }
     },
     "auth_ref": [
      "r87",
      "r147"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanAssetHeldForInvestmentPlanInterestInMasterTrustParticipationStatusExtensibleEnumeration": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanAssetHeldForInvestmentPlanInterestInMasterTrustParticipationStatusExtensibleEnumeration",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanScheduleAssetHeldforInvestmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment participation status",
        "label": "EBP, Asset Held for Investment, Plan Interest in Master Trust, Participation Status [Extensible Enumeration]",
        "documentation": "Indicates status of participation by participant for plan interest in master trust in schedule of asset held for investment of employee stock purchase, saving, or similar plan (employee benefit plan (EBP))."
       }
      }
     },
     "auth_ref": [
      "r151",
      "r187"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanBasisOfAccountingPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanBasisOfAccountingPolicyTextBlock",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanSummaryofAccountingPolicyTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EBP, Basis of Accounting",
        "label": "EBP, Basis of Accounting [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for basis of accounting used to prepare financial statements of employee stock purchase, saving, or similar plan (employee benefit plan (EBP))."
       }
      }
     },
     "auth_ref": [
      "r180",
      "r190"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecrease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecrease",
     "crdr": "credit",
     "calculation": {
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanStatementofChangeinNetAssetAvailableforBenefitStatement": {
       "parentTag": "us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecrease",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanStatementofChangeinNetAssetAvailableforBenefitStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total deductions",
        "label": "EBP, Change in Net Asset Available for Benefit, Decrease",
        "documentation": "Amount of decrease in net asset available for benefit to participant in employee stock purchase, saving, or similar plan (employee benefit plan (EBP))."
       }
      }
     },
     "auth_ref": [
      "r133",
      "r189"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecreaseForAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecreaseForAdministrativeExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanStatementofChangeinNetAssetAvailableforBenefitStatement": {
       "parentTag": "us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecrease",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanRelatedPartyandPartyinInterestTransactionsDetails",
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanStatementofChangeinNetAssetAvailableforBenefitStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Administrative expenses",
        "label": "EBP, Change in Net Asset Available for Benefit, Decrease from Administrative Expense",
        "documentation": "Amount of decrease in net asset available for benefit from administrative expense incurred by employee stock purchase, saving, or similar plan (employee benefit plan (EBP))."
       }
      }
     },
     "auth_ref": [
      "r55",
      "r89",
      "r133"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecreaseForPaymentToParticipant": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecreaseForPaymentToParticipant",
     "crdr": "credit",
     "calculation": {
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanStatementofChangeinNetAssetAvailableforBenefitStatement": {
       "parentTag": "us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecrease",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanStatementofChangeinNetAssetAvailableforBenefitStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Benefits paid to participants",
        "label": "EBP, Change in Net Asset Available for Benefit, Decrease from Payment to Participant",
        "documentation": "Amount of decrease in net asset available for benefit from payment of benefit to participant in employee stock purchase, saving, or similar plan (employee benefit plan (EBP)), including, but not limited to, withdrawal."
       }
      }
     },
     "auth_ref": [
      "r54",
      "r83",
      "r89",
      "r98",
      "r133"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncrease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncrease",
     "crdr": "debit",
     "calculation": {
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanStatementofChangeinNetAssetAvailableforBenefitStatement": {
       "parentTag": "us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecrease",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanStatementofChangeinNetAssetAvailableforBenefitStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total additions",
        "label": "EBP, Change in Net Asset Available for Benefit, Increase",
        "documentation": "Amount of increase in net asset available for benefit to participant in employee stock purchase, saving, or similar plan (employee benefit plan (EBP))."
       }
      }
     },
     "auth_ref": [
      "r133",
      "r189"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecrease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecrease",
     "crdr": "debit",
     "calculation": {
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanReconciliationofFinancialStatementtoForm5500Details": {
       "parentTag": "us-gaap-ebp_EmployeeBenefitPlanForm5500CaptionNetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanStatementofChangeinNetAssetAvailableforBenefitStatement": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanReconciliationofFinancialStatementtoForm5500Tables",
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanStatementofChangeinNetAssetAvailableforBenefitStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net increase in net assets available for benefits",
        "terseLabel": "Net increase in net assets available for benefits",
        "label": "EBP, Change in Net Asset Available for Benefit, Increase (Decrease)",
        "documentation": "Amount of increase (decrease) in net asset available for benefit to participant in employee stock purchase, saving, or similar plan (employee benefit plan (EBP))."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r89",
      "r133",
      "r193"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForChangeInPlanInterestInMasterTrust": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForChangeInPlanInterestInMasterTrust",
     "crdr": "debit",
     "calculation": {
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanStatementofChangeinNetAssetAvailableforBenefitStatement": {
       "parentTag": "us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncrease",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanStatementofChangeinNetAssetAvailableforBenefitStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest in EH Master Trust income",
        "label": "EBP, Change in Net Asset Available for Benefit, Increase (Decrease) from Change in Plan Interest in Master Trust",
        "documentation": "Amount of increase (decrease) in net asset available for benefit from increase (decrease) in plan interest in master trust held by employee stock purchase, saving, or similar plan (employee benefit plan (EBP))."
       }
      }
     },
     "auth_ref": [
      "r50"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForGainLossOnInvestment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForGainLossOnInvestment",
     "crdr": "debit",
     "calculation": {
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanMasterTrustDetails": {
       "parentTag": "us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForIncomeLossOnInvestment",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanMasterTrustTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net appreciation in fair value of investments",
        "label": "EBP, Change in Net Asset Available for Benefit, Increase (Decrease) from Gain (Loss) on Investment",
        "documentation": "Amount of increase (decrease) in net asset available for benefit from realized and unrealized gain (loss) on investment held by employee stock purchase, saving, or similar plan (employee benefit plan (EBP))."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r52",
      "r102",
      "r133"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForIncomeLossOnInvestment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForIncomeLossOnInvestment",
     "crdr": "debit",
     "calculation": {
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanMasterTrustDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanMasterTrustTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total investment income",
        "label": "EBP, Change in Net Asset Available for Benefit, Increase (Decrease) from Income (Loss) on Investment",
        "documentation": "Amount of increase (decrease) in net asset available for benefit from income (loss) on investment held by employee stock purchase, saving, or similar plan (employee benefit plan (EBP)). Includes, but is not limited to, realized and unrealized gain (loss) on investment."
       }
      }
     },
     "auth_ref": [
      "r133"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForContribution": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForContribution",
     "crdr": "debit",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanStatementofChangeinNetAssetAvailableforBenefitStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total contributions",
        "label": "EBP, Change in Net Asset Available for Benefit, Increase from Contribution",
        "documentation": "Amount of increase in net asset available for benefit from contribution to employee stock purchase, saving, or similar plan (employee benefit plan (EBP))."
       }
      }
     },
     "auth_ref": [
      "r133",
      "r189"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForDividendIncomeOnInvestment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForDividendIncomeOnInvestment",
     "crdr": "debit",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanRelatedPartyandPartyinInterestTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividends on employer common stock",
        "label": "EBP, Change in Net Asset Available for Benefit, Increase from Dividend Income on Investment",
        "documentation": "Amount of increase in net asset available for benefit from dividend income on investment held by employee stock purchase, saving, or similar plan (employee benefit plan (EBP))."
       }
      }
     },
     "auth_ref": [
      "r77",
      "r133",
      "r175",
      "r197"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForEmployerContributionCash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForEmployerContributionCash",
     "crdr": "debit",
     "calculation": {
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanStatementofChangeinNetAssetAvailableforBenefitStatement": {
       "parentTag": "us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncrease",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanStatementofChangeinNetAssetAvailableforBenefitStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contributions, Employer",
        "label": "EBP, Change in Net Asset Available for Benefit, Increase from Employer Contribution, Cash",
        "documentation": "Amount of increase in net asset available for benefit from cash contribution from employer of participant in employee stock purchase, saving, or similar plan (employee benefit plan (EBP))."
       }
      }
     },
     "auth_ref": [
      "r53",
      "r133"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForInterestAndDividendIncomeOnInvestment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForInterestAndDividendIncomeOnInvestment",
     "crdr": "debit",
     "calculation": {
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanMasterTrustDetails": {
       "parentTag": "us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForIncomeLossOnInvestment",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanMasterTrustTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest and dividends",
        "label": "EBP, Change in Net Asset Available for Benefit, Increase from Interest and Dividend Income on Investment",
        "documentation": "Amount of increase in net asset available for benefit from interest and dividend income on investment held by employee stock purchase, saving, or similar plan (employee benefit plan (EBP))."
       }
      }
     },
     "auth_ref": [
      "r103"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForInterestIncomeOnNoteReceivableFromParticipant": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForInterestIncomeOnNoteReceivableFromParticipant",
     "crdr": "debit",
     "calculation": {
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanStatementofChangeinNetAssetAvailableforBenefitStatement": {
       "parentTag": "us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncrease",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanStatementofChangeinNetAssetAvailableforBenefitStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest income from notes receivable from participants",
        "label": "EBP, Change in Net Asset Available for Benefit, Increase from Interest Income on Note Receivable from Participant",
        "documentation": "Amount of increase in net asset available for benefit from interest income on note receivable from participant in employee stock purchase, saving, or similar plan (employee benefit plan (EBP))."
       }
      }
     },
     "auth_ref": [
      "r133",
      "r189"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForParticipantContributionExcludingRollover": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForParticipantContributionExcludingRollover",
     "crdr": "debit",
     "calculation": {
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanStatementofChangeinNetAssetAvailableforBenefitStatement": {
       "parentTag": "us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncrease",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanStatementofChangeinNetAssetAvailableforBenefitStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contributions, Participant",
        "label": "EBP, Change in Net Asset Available for Benefit, Increase from Participant Contribution, Excluding Rollover",
        "documentation": "Amount, excluding rollover, of increase in net asset available for benefit from contribution by participant in employee stock purchase, saving, or similar plan (employee benefit plan (EBP))."
       }
      }
     },
     "auth_ref": [
      "r133",
      "r141",
      "r142",
      "r143",
      "r185",
      "r186"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForParticipantContributionRollover": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForParticipantContributionRollover",
     "crdr": "debit",
     "calculation": {
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanStatementofChangeinNetAssetAvailableforBenefitStatement": {
       "parentTag": "us-gaap-ebp_EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncrease",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanStatementofChangeinNetAssetAvailableforBenefitStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contributions, Participant rollover",
        "label": "EBP, Change in Net Asset Available for Benefit, Increase from Participant Contribution, Rollover",
        "documentation": "Amount of increase in net asset available for benefit from contribution transferred from another qualified plan or from individual retirement account of participant in employee stock purchase, saving, or similar plan (employee benefit plan (EBP)). Excludes contribution for participant transmitted by employer of participant in EBP."
       }
      }
     },
     "auth_ref": [
      "r133",
      "r141",
      "r142",
      "r143",
      "r185",
      "r186"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanDescriptionOfPlanAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "EBP, Description of Plan and Accounting Change [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanDescriptionOfPlanLineItems",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanDescriptionofPlanTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EBP, Description of Plan [Line Items]",
        "label": "EBP, Description of Plan [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r176"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanDescriptionOfPlanTable",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanDescriptionofPlanTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EBP, Description of Plan [Table]",
        "label": "EBP, Description of Plan [Table]",
        "documentation": "Disclosure of information about description of employee stock purchase, saving, or similar plan (employee benefit plan (EBP))."
       }
      }
     },
     "auth_ref": [
      "r176"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanDescriptionOfPlanTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanDescriptionOfPlanTextBlock",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanDescriptionofPlanTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EBP, Description of Plan",
        "label": "EBP, Description of Plan [Text Block]",
        "documentation": "The entire disclosure for description of employee stock purchase, saving, or similar plan (employee benefit plan (EBP)). Includes, but is not limited to, vesting and allocation provisions and disposition of forfeiture."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r3",
      "r4",
      "r56",
      "r133"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanEmployerCommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanEmployerCommonStockMember",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanFairValueandNAVTables",
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanMasterTrustTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company common stock, at fair value",
        "label": "EBP, Employer, Common Stock [Member]",
        "documentation": "Common stock issued by employer of participant in employee stock purchase, saving, or similar plan (employee benefit plan (EBP))."
       }
      }
     },
     "auth_ref": [
      "r117",
      "r173",
      "r181",
      "r182",
      "r183",
      "r194",
      "r199",
      "r200"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanEmployerContributionMatchingPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanEmployerContributionMatchingPercentage",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanDescriptionofPlanTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EBP, Employer Contribution, Matching Percentage",
        "label": "EBP, Employer Contribution, Matching Percentage",
        "documentation": "Percentage of employer matching contribution on eligible participant contribution to employee stock purchase, saving, or similar plan (employee benefit plan (EBP))."
       }
      }
     },
     "auth_ref": [
      "r133"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanEmployerContributionParticipantCompensationMatchedPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanEmployerContributionParticipantCompensationMatchedPercentage",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanDescriptionofPlanTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EBP, Employer Contribution, Participant Compensation Matched, Percentage",
        "label": "EBP, Employer Contribution, Participant Compensation Matched, Percentage",
        "documentation": "Percentage of participant compensation eligible for employer matching contribution for participant in employee stock purchase, saving, or similar plan (employee benefit plan (EBP))."
       }
      }
     },
     "auth_ref": [
      "r133"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanEmployerContributionReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanEmployerContributionReceivable",
     "crdr": "debit",
     "calculation": {
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanStatementofNetAssetAvailableforBenefitStatement": {
       "parentTag": "us-gaap-ebp_EmployeeBenefitPlanReceivable",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanStatementofNetAssetAvailableforBenefitStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Receivables, Employer contributions",
        "label": "EBP, Employer Contribution, Receivable",
        "documentation": "Amount of contribution receivable from employer of participant in employee stock purchase, saving, or similar plan (employee benefit plan (EBP))."
       }
      }
     },
     "auth_ref": [
      "r88",
      "r90",
      "r133"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanExpensePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanExpensePolicyTextBlock",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanSummaryofAccountingPolicyTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EBP, Expense",
        "label": "EBP, Expense [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for expense incurred by employee stock purchase, saving, or similar plan (employee benefit plan (EBP))."
       }
      }
     },
     "auth_ref": [
      "r133"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanForfeitedNonvestedAccount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanForfeitedNonvestedAccount",
     "crdr": "debit",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanDescriptionofPlanTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forfeitures",
        "label": "EBP, Forfeited Nonvested Account",
        "documentation": "Amount of plan asset, in forfeited nonvested account, no longer allocated to participant in employee stock purchase, saving, or similar plan (employee benefit plan (EBP))."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r133"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanForfeitedNonvestedAccountDecreaseForAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanForfeitedNonvestedAccountDecreaseForAdministrativeExpense",
     "crdr": "credit",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanDescriptionofPlanTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EBP, Forfeited Nonvested Account, Decrease from Administrative Expense",
        "label": "EBP, Forfeited Nonvested Account, Decrease from Administrative Expense",
        "documentation": "Amount of decrease in forfeited nonvested account of employee stock purchase, saving, or similar plan (employee benefit plan (EBP)) from administrative expense."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r84"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanForfeitedNonvestedAccountDecreaseForEmployerContribution": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanForfeitedNonvestedAccountDecreaseForEmployerContribution",
     "crdr": "credit",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanDescriptionofPlanTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EBP, Forfeited Nonvested Account, Decrease from Employer Contribution",
        "label": "EBP, Forfeited Nonvested Account, Decrease from Employer Contribution",
        "documentation": "Amount of decrease in forfeited nonvested account of employee stock purchase, saving, or similar plan (employee benefit plan (EBP)) from employer contribution."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r84",
      "r133"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanForm5500CaptionNetAssetAvailableForBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanForm5500CaptionNetAssetAvailableForBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanReconciliationofFinancialStatementtoForm5500Details": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanReconciliationofFinancialStatementtoForm5500Tables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "EBP, Form 5500 Caption, Net Assets, Total",
        "label": "EBP, Form 5500 Caption, Net Assets",
        "documentation": "Amount of net asset available for benefit as reported in Form 5500 caption for employee stock purchase, saving, or similar plan (employee benefit plan (EBP)). Form 5500 is form provided by Department of the Treasury, Internal Revenue Service (IRS); Department of Labor (DOL), Employee Benefit Security Administration (EBSA); and Pension Benefit Guaranty Corporation (PBGC)."
       }
      }
     },
     "auth_ref": [
      "r133",
      "r178"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanForm5500CaptionNetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanForm5500CaptionNetIncomeLoss",
     "crdr": "debit",
     "calculation": {
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanReconciliationofFinancialStatementtoForm5500Details": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanReconciliationofFinancialStatementtoForm5500Tables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "EBP, Form 5500 Caption, Net Income (Loss), Total",
        "label": "EBP, Form 5500 Caption, Net Income (Loss)",
        "documentation": "Amount of increase (decrease) in net asset available for benefit from net income (loss) as reported in Form 5500 caption for employee stock purchase, saving, or similar plan (employee benefit plan (EBP)). Form 5500 is form provided by Department of the Treasury, Internal Revenue Service (IRS); Department of Labor (DOL), Employee Benefit Security Administration (EBSA); and Pension Benefit Guaranty Corporation (PBGC)."
       }
      }
     },
     "auth_ref": [
      "r144",
      "r178"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue",
     "crdr": "debit",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanFairValueandNAVTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EBP, Investment, Excluding Plan Interest in Master Trust, Fair Value",
        "label": "EBP, Investment, Excluding Plan Interest in Master Trust, Fair Value",
        "documentation": "Fair value of investment, excluding plan interest in master trust, held by employee stock purchase, saving, or similar plan (employee benefit plan (EBP)). Includes, but is not limited to, derivative, investment measured at net asset value per share as practical expedient, and insurance contract not meeting fully-benefit responsive investment criteria."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14",
      "r21",
      "r22",
      "r24",
      "r25",
      "r32",
      "r33",
      "r35",
      "r93",
      "r111",
      "r112",
      "r113",
      "r114",
      "r115",
      "r116",
      "r117",
      "r118",
      "r119",
      "r120",
      "r133"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanInvestmentFairValue",
     "crdr": "debit",
     "calculation": {
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanMasterTrustDetails": {
       "parentTag": "us-gaap-ebp_EmployeeBenefitPlanNetAssetAvailableForBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanMasterTrustTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investments at fair value",
        "label": "EBP, Investment, Fair Value",
        "documentation": "Fair value of investment held by employee stock purchase, saving, or similar plan (employee benefit plan (EBP)). Includes, but is not limited to, derivative, investment measured at net asset value per share as practical expedient, and insurance contract not meeting fully-benefit responsive investment criteria."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14",
      "r21",
      "r22",
      "r24",
      "r25",
      "r32",
      "r33",
      "r35",
      "r63",
      "r64",
      "r65",
      "r66",
      "r67",
      "r68",
      "r69",
      "r93",
      "r100",
      "r105",
      "r106",
      "r107",
      "r123",
      "r124",
      "r126",
      "r127",
      "r128",
      "r129",
      "r130",
      "r131",
      "r134",
      "r188"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanInvestmentFairValueAndNavAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "EBP, Investment, Fair Value and NAV [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanInvestmentFairValueAndNavLineItems",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanFairValueandNAVTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EBP, Investment, Fair Value and NAV [Line Items]",
        "label": "EBP, Investment, Fair Value and NAV [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r27",
      "r28",
      "r32",
      "r33",
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r60",
      "r81",
      "r111",
      "r112",
      "r113",
      "r114",
      "r115",
      "r116",
      "r117",
      "r118",
      "r119",
      "r120"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanInvestmentFairValueAndNavTable",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanFairValueandNAVTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EBP, Investment, Fair Value and NAV [Table]",
        "label": "EBP, Investment, Fair Value and NAV [Table]",
        "documentation": "Disclosure of information about fair value of investment held by employee stock purchase, saving, or similar plan (employee benefit plan (EBP)), including, but not limited to, fair value measured at net asset value per share as practical expedient (NAV)."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r26",
      "r27",
      "r28",
      "r32",
      "r33",
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r60",
      "r81",
      "r96",
      "r111",
      "r112",
      "r113",
      "r114",
      "r115",
      "r116",
      "r117",
      "r118",
      "r119",
      "r120"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanInvestmentFairValueAndNavTableTextBlock",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanFairValueandNAVTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EBP, Investment, Fair Value and NAV - Table Text Block",
        "label": "EBP, Investment, Fair Value and NAV [Table Text Block]",
        "documentation": "Tabular disclosure of fair value of investment held by employee stock purchase, saving, or similar plan (employee benefit plan (EBP)), including, but not limited to, fair value measured at net asset value per share as practical expedient (NAV)."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r31",
      "r33",
      "r34",
      "r42",
      "r133",
      "r191",
      "r192",
      "r195"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanInvestmentFairValueAndNavTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanInvestmentFairValueAndNavTextBlock",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanFairValueandNAVTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EBP, Investment, Fair Value and NAV - Text Block",
        "label": "EBP, Investment, Fair Value and NAV [Text Block]",
        "documentation": "The entire disclosure for fair value of investment held by employee stock purchase, saving, or similar plan (employee benefit plan (EBP)), including, but not limited to, fair value measured at net asset value per share as practical expedient (NAV)."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r28",
      "r29",
      "r32",
      "r33",
      "r35",
      "r38",
      "r39",
      "r40",
      "r41",
      "r60",
      "r81",
      "r82",
      "r93",
      "r94",
      "r133",
      "r139"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanInvestmentIssuerNameExtensibleEnumeration": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanInvestmentIssuerNameExtensibleEnumeration",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanScheduleAssetHeldforInvestmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment issuer name",
        "label": "EBP, Investment, Issuer Name [Extensible Enumeration]",
        "documentation": "Indicates name of issuer of investment held by employee stock purchase, saving, or similar plan (employee benefit plan (EBP))."
       }
      }
     },
     "auth_ref": [
      "r87",
      "r147",
      "r153",
      "r160"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanInvestmentNumberOfShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanInvestmentNumberOfShares",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanRelatedPartyandPartyinInterestTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment number of shares/units",
        "label": "EBP, Investment, Number of Shares",
        "documentation": "Number of shares or units of investment held by employee stock purchase, saving, or similar plan (employee benefit plan (EBP))."
       }
      }
     },
     "auth_ref": [
      "r61",
      "r87",
      "r148",
      "r154",
      "r157",
      "r158",
      "r161"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanInvestmentNumberOfSharesSold": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanInvestmentNumberOfSharesSold",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanRelatedPartyandPartyinInterestTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employer common stock shares sold, net",
        "label": "EBP, Investment, Sold, Number of Shares",
        "documentation": "Number of shares or units of investment sold by employee stock purchase, saving, or similar plan (employee benefit plan (EBP))."
       }
      }
     },
     "auth_ref": [
      "r184"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanInvestmentPlanInterestInMasterTrustFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanInvestmentPlanInterestInMasterTrustFairValue",
     "crdr": "debit",
     "calculation": {
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanStatementofNetAssetAvailableforBenefitStatement": {
       "parentTag": "us-gaap-ebp_EmployeeBenefitPlanNetAssetAvailableForBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanScheduleAssetHeldforInvestmentDetails",
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanStatementofNetAssetAvailableforBenefitStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investments, at fair value, Interest in EH Master Trust",
        "label": "EBP, Investment, Plan Interest in Master Trust, Fair Value",
        "documentation": "Fair value of plan interest in master trust held by employee stock purchase, saving, or similar plan (employee benefit plan (EBP))."
       }
      }
     },
     "auth_ref": [
      "r50",
      "r69",
      "r134",
      "r188"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanInvestmentPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanInvestmentPolicyTextBlock",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanSummaryofAccountingPolicyTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EBP, Investment",
        "label": "EBP, Investment [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for investment held by employee stock purchase, saving, or similar plan (employee benefit plan (EBP))."
       }
      }
     },
     "auth_ref": [
      "r92",
      "r96",
      "r97",
      "r133"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanInvestmentTypeExtensibleEnumeration": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanInvestmentTypeExtensibleEnumeration",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanScheduleAssetHeldforInvestmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment type",
        "label": "EBP, Investment, Current Value, Type [Extensible Enumeration]",
        "documentation": "Indicates type of investment at current value held by employee stock purchase, saving, or similar plan (employee benefit plan (EBP))."
       }
      }
     },
     "auth_ref": [
      "r87",
      "r147",
      "r153"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanMasterTrustAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanMasterTrustAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "EBP, Master Trust [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap-ebp_EmployeeBenefitPlanMasterTrustLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanMasterTrustLineItems",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanMasterTrustTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EBP, Master Trust [Line Items]",
        "label": "EBP, Master Trust [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r25",
      "r26",
      "r27",
      "r28",
      "r32",
      "r33",
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r102",
      "r103",
      "r105",
      "r107",
      "r108",
      "r123",
      "r124",
      "r125",
      "r126",
      "r127",
      "r128",
      "r129",
      "r130",
      "r131",
      "r134"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanMasterTrustTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanMasterTrustTable",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanMasterTrustTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EBP, Master Trust [Table]",
        "label": "EBP, Master Trust [Table]",
        "documentation": "Disclosure of information about master trust arrangement in which employee stock purchase, saving, or similar plan (employee benefit plan (EBP)) participates."
       }
      }
     },
     "auth_ref": [
      "r32",
      "r33",
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r102",
      "r103",
      "r105",
      "r107",
      "r108",
      "r123",
      "r124",
      "r125",
      "r126",
      "r127",
      "r128",
      "r129",
      "r130",
      "r131",
      "r134"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanMasterTrustTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanMasterTrustTableTextBlock",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanMasterTrustTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EBP, Master Trust - Table Text Block",
        "label": "EBP, Master Trust [Table Text Block]",
        "documentation": "Tabular disclosure of master trust arrangement in which employee stock purchase, saving, or similar plan (employee benefit plan (EBP)) participates."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r31",
      "r33",
      "r134",
      "r196",
      "r198",
      "r200",
      "r201"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanMasterTrustTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanMasterTrustTextBlock",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanMasterTrustTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EBP, Master Trust - Text Block",
        "label": "EBP, Master Trust [Text Block]",
        "documentation": "The entire disclosure for master trust arrangement in which employee stock purchase, saving, or similar plan (employee benefit plan (EBP)) participates."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r28",
      "r29",
      "r30",
      "r32",
      "r33",
      "r35",
      "r38",
      "r39",
      "r40",
      "r41",
      "r101",
      "r104",
      "r105",
      "r107",
      "r108",
      "r134"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanNetAssetAvailableForBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanNetAssetAvailableForBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanReconciliationofFinancialStatementtoForm5500Details": {
       "parentTag": "us-gaap-ebp_EmployeeBenefitPlanForm5500CaptionNetAssetAvailableForBenefit",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanStatementofNetAssetAvailableforBenefitStatement": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanMasterTrustDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanMasterTrustTables",
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanReconciliationofFinancialStatementtoForm5500Tables",
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanStatementofChangeinNetAssetAvailableforBenefitStatement",
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanStatementofNetAssetAvailableforBenefitStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "EBP, Net Asset Available for Benefit, Total",
        "periodStartLabel": "EBP, Net Asset Available for Benefit, Beginning Balance",
        "periodEndLabel": "EBP, Net Asset Available for Benefit, Ending Balance",
        "terseLabel": "Net assets available for benefits",
        "label": "EBP, Net Asset Available for Benefit",
        "documentation": "Amount of asset less liability available to pay benefit of participant in employee stock purchase, saving, or similar plan (employee benefit plan (EBP)), including, but not limited to, aggregation of participants' individual account balances."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r51",
      "r75",
      "r85",
      "r86",
      "r95",
      "r109",
      "r133",
      "r134",
      "r188"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustAxis",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanMasterTrustTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EBP, Nonconsolidated, Master Trust and Plan Interest in Master Trust [Axis]",
        "label": "EBP, Nonconsolidated, Master Trust and Plan Interest in Master Trust [Axis]",
        "documentation": "Information by master trust and plan interest in master trust for employee stock purchase, saving, or similar plan (employee benefit plan (EBP)) reported in note to financial statement. Excludes plan interest in master trust information reported in statement of net asset available for benefit and statement of change in net asset available for benefit."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r25",
      "r26",
      "r27",
      "r28",
      "r32",
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r102",
      "r103",
      "r105",
      "r107",
      "r108",
      "r123",
      "r124",
      "r125",
      "r126",
      "r127",
      "r128",
      "r129",
      "r130",
      "r131",
      "r134"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustDomain",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanMasterTrustTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EBP, Nonconsolidated, Master Trust and Plan Interest in Master Trust [Domain]",
        "label": "EBP, Nonconsolidated, Master Trust and Plan Interest in Master Trust [Domain]",
        "documentation": "Master trust and plan interest in master trust for employee stock purchase, saving, or similar plan (employee benefit plan (EBP)) reported in note to financial statement. Excludes plan interest in master trust information reported in statement of net asset available for benefit and statement of change in net asset available for benefit."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r25",
      "r26",
      "r27",
      "r28",
      "r32",
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r102",
      "r103",
      "r105",
      "r107",
      "r108",
      "r123",
      "r124",
      "r125",
      "r126",
      "r127",
      "r128",
      "r129",
      "r130",
      "r131",
      "r134"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedMasterTrustMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanNonconsolidatedMasterTrustMember",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanMasterTrustTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EBP, Nonconsolidated, Master Trust",
        "label": "EBP, Nonconsolidated, Master Trust [Member]",
        "documentation": "Master trust in which employee stock purchase, saving, or similar plan (employee benefit plan (EBP)) participates that is reported in note to financial statement. Excludes plan interest in master trust information reported in statement of net asset available for benefit and statement of change in net asset available for benefit."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r25",
      "r26",
      "r27",
      "r28",
      "r32",
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r102",
      "r103",
      "r105",
      "r108",
      "r123",
      "r124",
      "r125",
      "r126",
      "r127",
      "r128",
      "r129",
      "r130",
      "r131",
      "r134"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanNonconsolidatedPlanInterestInMasterTrustMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanNonconsolidatedPlanInterestInMasterTrustMember",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanMasterTrustTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EBP, Nonconsolidated, Plan Interest in Master Trust",
        "label": "EBP, Nonconsolidated, Plan Interest in Master Trust [Member]",
        "documentation": "Plan interest in master trust for employee stock purchase, saving, or similar plan (employee benefit plan (EBP)) that is reported in note to financial statement. Excludes plan interest in master trust information reported in statement of net asset available for benefit and statement of change in net asset available for benefit."
       }
      }
     },
     "auth_ref": [
      "r32",
      "r107",
      "r108",
      "r134"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanNoteReceivableFromParticipant": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanNoteReceivableFromParticipant",
     "crdr": "debit",
     "calculation": {
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanStatementofNetAssetAvailableforBenefitStatement": {
       "parentTag": "us-gaap-ebp_EmployeeBenefitPlanReceivable",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanStatementofNetAssetAvailableforBenefitStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Notes receivable from participants",
        "label": "EBP, Note Receivable from Participant",
        "documentation": "Amount of unpaid principal plus accrued but unpaid interest for loan from participant in employee stock purchase, saving, or similar plan (employee benefit plan (EBP))."
       }
      }
     },
     "auth_ref": [
      "r91",
      "r133",
      "r188"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanNoteReceivableFromParticipantAccountMaximumBorrowingAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanNoteReceivableFromParticipantAccountMaximumBorrowingAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanDescriptionofPlanTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EBP, Note Receivable from Participant, Account, Maximum Borrowing, Amount",
        "label": "EBP, Note Receivable from Participant, Account, Maximum Borrowing, Amount",
        "documentation": "Amount of maximum account balance that participant in employee stock purchase, saving, or similar plan (employee benefit plan (EBP)) can borrow."
       }
      }
     },
     "auth_ref": [
      "r133"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanNoteReceivableFromParticipantAccountMaximumBorrowingToTotalAccountPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanNoteReceivableFromParticipantAccountMaximumBorrowingToTotalAccountPercentage",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanDescriptionofPlanTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EBP, Note Receivable from Participant, Account, Maximum Borrowing, to Total Account, Percentage",
        "label": "EBP, Note Receivable from Participant, Account, Maximum Borrowing, to Total Account, Percentage",
        "documentation": "Percentage of maximum account balance that participant in employee stock purchase, saving, or similar plan (employee benefit plan (EBP)) can borrow to total participant account balance."
       }
      }
     },
     "auth_ref": [
      "r133"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanNoteReceivableFromParticipantPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanNoteReceivableFromParticipantPolicyTextBlock",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanSummaryofAccountingPolicyTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EBP, Note Receivable from Participant",
        "label": "EBP, Note Receivable from Participant [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for note receivable from participant in employee stock purchase, saving, or similar plan (employee benefit plan (EBP))."
       }
      }
     },
     "auth_ref": [
      "r133"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanOtherAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanOtherAsset",
     "crdr": "debit",
     "calculation": {
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanMasterTrustDetails": {
       "parentTag": "us-gaap-ebp_EmployeeBenefitPlanNetAssetAvailableForBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanMasterTrustTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Assets (Liabilities)",
        "label": "EBP, Other Asset",
        "documentation": "Amount of asset held by employee stock purchase, saving, or similar plan (employee benefit plan (EBP)), classified as other."
       }
      }
     },
     "auth_ref": [
      "r70",
      "r71",
      "r72",
      "r201"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanParticipantContributionAutomaticDeferralRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanParticipantContributionAutomaticDeferralRate",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanDescriptionofPlanTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EBP, Participant Contribution, Automatic, Deferral Rate",
        "label": "EBP, Participant Contribution, Automatic, Deferral Rate",
        "documentation": "Percentage of eligible compensation contributed for participant automatically enrolled in employee stock purchase, saving, or similar plan (employee benefit plan (EBP))."
       }
      }
     },
     "auth_ref": [
      "r133"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanParticipantLoanInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanParticipantLoanInterestRate",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanScheduleAssetHeldforInvestmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Participant Loans, interest rates",
        "label": "EBP, Asset Held for Investment, Participant Loan, Interest Rate",
        "documentation": "Interest rate on participant loan in schedule of asset held for investment of employee stock purchase, saving, or similar plan (employee benefit plan (EBP))."
       }
      }
     },
     "auth_ref": [
      "r87",
      "r150"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanParticipantLoanMaturityDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanParticipantLoanMaturityDate",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanScheduleAssetHeldforInvestmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Participant Loans, maturities",
        "label": "EBP, Asset Held for Investment, Participant Loan, Maturity Date",
        "documentation": "Maturity date of participant loan in schedule of asset held for investment of employee stock purchase, saving, or similar plan (employee benefit plan (EBP)), in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": [
      "r87",
      "r150"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanPaymentToParticipantPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanPaymentToParticipantPolicyTextBlock",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanSummaryofAccountingPolicyTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EBP, Payment to Participant",
        "label": "EBP, Payment to Participant [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for payment of benefit to participant in employee stock purchase, saving, or similar plan (employee benefit plan (EBP))."
       }
      }
     },
     "auth_ref": [
      "r133"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanPlanNumber": {
     "xbrltype": "threeDigitItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanPlanNumber",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanScheduleAssetHeldforInvestmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan Number",
        "label": "EBP, Plan Number",
        "documentation": "Plan number of employee stock purchase, saving, or similar plan (employee benefit plan (EBP)), in three-digit numeric format."
       }
      }
     },
     "auth_ref": [
      "r145",
      "r152",
      "r157",
      "r158",
      "r159",
      "r167",
      "r187",
      "r188",
      "r189"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanReceivable",
     "crdr": "debit",
     "calculation": {
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanStatementofNetAssetAvailableforBenefitStatement": {
       "parentTag": "us-gaap-ebp_EmployeeBenefitPlanNetAssetAvailableForBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanStatementofNetAssetAvailableforBenefitStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total receivables",
        "label": "EBP, Receivable",
        "documentation": "Amount of receivable of employee stock purchase, saving, or similar plan (employee benefit plan (EBP))."
       }
      }
     },
     "auth_ref": [
      "r133",
      "r188"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500Abstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanReconciliationToForm5500Abstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "EBP, Reconciliation of Financial Statement to Form 5500 [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500LineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanReconciliationToForm5500LineItems",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanReconciliationofFinancialStatementtoForm5500Tables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EBP, Reconciliation of Financial Statement to Form 5500 [Line Items]",
        "label": "EBP, Reconciliation of Financial Statement to Form 5500 [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r178"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500NetAssetAvailableForBenefitDeemedDistribution": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanReconciliationToForm5500NetAssetAvailableForBenefitDeemedDistribution",
     "crdr": "credit",
     "calculation": {
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanReconciliationofFinancialStatementtoForm5500Details": {
       "parentTag": "us-gaap-ebp_EmployeeBenefitPlanForm5500CaptionNetAssetAvailableForBenefit",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanReconciliationofFinancialStatementtoForm5500Tables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EBP, Reconciliation to Form 5500, Net Asset Available for Benefit, Deemed Distribution",
        "label": "EBP, Reconciliation to Form 5500, Net Asset Available for Benefit, Deemed Distribution",
        "documentation": "Amount of deemed distribution to participant in employee stock purchase, saving, or similar plan (employee benefit plan (EBP)) to reconcile net asset available for benefit per financial statement to Form 5500 caption. Form 5500 is form provided by Department of the Treasury, Internal Revenue Service (IRS); Department of Labor (DOL), Employee Benefit Security Administration (EBSA); and Pension Benefit Guaranty Corporation (PBGC)."
       }
      }
     },
     "auth_ref": [
      "r144",
      "r178"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500PaymentToParticipantIncreaseDecreaseForDeemedDistribution": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanReconciliationToForm5500PaymentToParticipantIncreaseDecreaseForDeemedDistribution",
     "crdr": "credit",
     "calculation": {
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanReconciliationofFinancialStatementtoForm5500Details": {
       "parentTag": "us-gaap-ebp_EmployeeBenefitPlanForm5500CaptionNetIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanReconciliationofFinancialStatementtoForm5500Tables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Deemed distributions of participant loans activity",
        "label": "EBP, Reconciliation to Form 5500, Payment to Participant, Increase (Decrease) from Deemed Distribution",
        "documentation": "Amount of increase (decrease) in benefit payment from deemed distribution to participant in employee stock purchase, saving, or similar plan (employee benefit plan (EBP)) to reconcile benefit payment per financial statement to Form 5500 caption. Form 5500 is form provided by Department of the Treasury, Internal Revenue Service (IRS); Department of Labor (DOL), Employee Benefit Security Administration (EBSA); and Pension Benefit Guaranty Corporation (PBGC)."
       }
      }
     },
     "auth_ref": [
      "r144",
      "r178"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500Table": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanReconciliationToForm5500Table",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanReconciliationofFinancialStatementtoForm5500Tables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EBP, Reconciliation of Financial Statement to Form 5500 [Table]",
        "label": "EBP, Reconciliation of Financial Statement to Form 5500 [Table]",
        "documentation": "Disclosure of information about reconciliation of financial statement to Form 5500 for employee stock purchase, saving, or similar plan (employee benefit plan (EBP)). Form 5500 is form provided by Department of the Treasury, Internal Revenue Service (IRS); Department of Labor (DOL), Employee Benefit Security Administration (EBSA); and Pension Benefit Guaranty Corporation (PBGC)."
       }
      }
     },
     "auth_ref": [
      "r178"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500TableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanReconciliationToForm5500TableTextBlock",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanReconciliationofFinancialStatementtoForm5500Tables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EBP, Reconciliation of Financial Statement to Form 5500 - Table Text Block",
        "label": "EBP, Reconciliation of Financial Statement to Form 5500 [Table Text Block]",
        "documentation": "Tabular disclosure of reconciliation of financial statement to Form 5500 for employee stock purchase, saving, or similar plan (employee benefit plan (EBP)). Form 5500 is form provided by Department of the Treasury, Internal Revenue Service (IRS); Department of Labor (DOL), Employee Benefit Security Administration (EBSA); and Pension Benefit Guaranty Corporation (PBGC)."
       }
      }
     },
     "auth_ref": [
      "r133"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanReconciliationToForm5500TextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanReconciliationToForm5500TextBlock",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanReconciliationofFinancialStatementtoForm5500Tables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EBP, Reconciliation of Financial Statement to Form 5500 - Text Block",
        "label": "EBP, Reconciliation of Financial Statement to Form 5500 [Text Block]",
        "documentation": "The entire disclosure for reconciliation of financial statement to Form 5500 for employee stock purchase, saving, or similar plan (employee benefit plan (EBP)). Form 5500 is form provided by Department of the Treasury, Internal Revenue Service (IRS); Department of Labor (DOL), Employee Benefit Security Administration (EBSA); and Pension Benefit Guaranty Corporation (PBGC)."
       }
      }
     },
     "auth_ref": [
      "r58",
      "r133"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanRelatedPartyAndPartyInInterestAxis",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanRelatedPartyandPartyinInterestTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EBP, Related Party and Party-in-Interest [Axis]",
        "label": "EBP, Related Party and Party-in-Interest [Axis]",
        "documentation": "Information by related party and party-in-interest to employee stock purchase, saving, or similar plan (employee benefit plan (EBP))."
       }
      }
     },
     "auth_ref": [
      "r46",
      "r70",
      "r71",
      "r133"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanRelatedPartyAndPartyInInterestDomain",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanRelatedPartyandPartyinInterestTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EBP, Related Party and Party-in-Interest [Domain]",
        "label": "EBP, Related Party and Party-in-Interest [Domain]",
        "documentation": "Related party and party-in-interest to employee stock purchase, saving, or similar plan (employee benefit plan (EBP))."
       }
      }
     },
     "auth_ref": [
      "r46",
      "r70",
      "r71",
      "r133"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "EBP, Related Party and Party-in-Interest Transactions [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsLineItems",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanRelatedPartyandPartyinInterestTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EBP, Related Party and Party-in-Interest Transactions [Line Items]",
        "label": "EBP, Related Party and Party-in-Interest Transactions [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r46",
      "r180",
      "r190"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsTable",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanRelatedPartyandPartyinInterestTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EBP, Related Party and Party-in-Interest Transactions [Table]",
        "label": "EBP, Related Party and Party-in-Interest Transactions [Table]",
        "documentation": "Disclosure of information about related party and party-in-interest transactions with employee stock purchase, saving, or similar plan (employee benefit plan (EBP))."
       }
      }
     },
     "auth_ref": [
      "r46",
      "r180",
      "r190"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsTextBlock",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanRelatedPartyandPartyinInterestTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EBP, Related Party and Party-in-Interest Transactions",
        "label": "EBP, Related Party and Party-in-Interest Transactions [Text Block]",
        "documentation": "The entire disclosure for related party and party-in-interest transactions with employee stock purchase, saving, or similar plan (employee benefit plan (EBP))."
       }
      }
     },
     "auth_ref": [
      "r43",
      "r44",
      "r45",
      "r46",
      "r133"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "EBP, Schedule of Asset Held for Investment [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentLineItems",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanScheduleAssetHeldforInvestmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EBP, Schedule of Asset Held for Investment [Line Items]",
        "label": "EBP, Schedule of Asset Held for Investment [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r87",
      "r147",
      "r148",
      "r149",
      "r150"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentTable",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanScheduleAssetHeldforInvestmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EBP, Schedule of Asset Held for Investment [Table]",
        "label": "EBP, Schedule of Asset Held for Investment [Table]",
        "documentation": "Disclosure of information about schedule of asset held for investment of employee stock purchase, saving, or similar plan (employee benefit plan (EBP))."
       }
      }
     },
     "auth_ref": [
      "r87",
      "r147",
      "r148",
      "r149",
      "r150"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentTableTextBlock",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanScheduleAssetHeldforInvestmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EBP, Schedule of Asset Held for Investment",
        "label": "EBP, Schedule of Asset Held for Investment [Text Block]",
        "documentation": "The entire disclosure for schedule of asset held for investment for employee stock purchase, saving, or similar plan (employee benefit plan (EBP))."
       }
      }
     },
     "auth_ref": [
      "r146",
      "r187"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanSelfDirectedBrokerageAccountMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanSelfDirectedBrokerageAccountMember",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanFairValueandNAVTables",
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanMasterTrustTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Self-directed brokerage accounts",
        "label": "EBP, Self-Directed Brokerage Account [Member]",
        "documentation": "Investment fund option allowing participant to select investment outside core option offered by employee stock purchase, saving, or similar plan (employee benefit plan (EBP))."
       }
      }
     },
     "auth_ref": [
      "r120",
      "r122",
      "r131",
      "r132",
      "r133"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanStatementOfChangeInNetAssetAvailableForBenefitAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanStatementOfChangeInNetAssetAvailableForBenefitAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EBP, Statement of Change in Net Asset Available for Benefit [Abstract]",
        "label": "EBP, Statement of Change in Net Asset Available for Benefit [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap-ebp_EmployeeBenefitPlanStatementOfChangeInNetAssetAvailableForBenefitLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanStatementOfChangeInNetAssetAvailableForBenefitLineItems",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanStatementofChangeinNetAssetAvailableforBenefitStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EBP, Statement of Change in Net Asset Available for Benefit [Abstract]",
        "label": "EBP, Statement of Change in Net Asset Available for Benefit [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r78",
      "r79",
      "r80",
      "r95"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanStatementOfChangeInNetAssetAvailableForBenefitTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanStatementOfChangeInNetAssetAvailableForBenefitTable",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanStatementofChangeinNetAssetAvailableforBenefitStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EBP, Statement of Change in Net Asset Available for Benefit [Table]",
        "label": "EBP, Statement of Change in Net Asset Available for Benefit [Table]",
        "documentation": "Presentation of information about change in net asset available for benefit for employee stock purchase, saving, or similar plan (employee benefit plan (EBP))."
       }
      }
     },
     "auth_ref": [
      "r78",
      "r79",
      "r80",
      "r95"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanStatementOfNetAssetAvailableForBenefitAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanStatementOfNetAssetAvailableForBenefitAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "EBP, Statement of Net Asset Available for Benefit [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap-ebp_EmployeeBenefitPlanStatementOfNetAssetAvailableForBenefitLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanStatementOfNetAssetAvailableForBenefitLineItems",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanStatementofNetAssetAvailableforBenefitStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EBP, Statement of Net Asset Available for Benefit [Line Items]",
        "label": "EBP, Statement of Net Asset Available for Benefit [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r64",
      "r65",
      "r66",
      "r67",
      "r68",
      "r69",
      "r70",
      "r71",
      "r73",
      "r74",
      "r93",
      "r95",
      "r111",
      "r112",
      "r113",
      "r114",
      "r115",
      "r116",
      "r117",
      "r118",
      "r119",
      "r120"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanStatementOfNetAssetAvailableForBenefitTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanStatementOfNetAssetAvailableForBenefitTable",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanStatementofNetAssetAvailableforBenefitStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EBP, Statement of Net Asset Available for Benefit [Table]",
        "label": "EBP, Statement of Net Asset Available for Benefit [Table]",
        "documentation": "Presentation of information about net asset available for benefit for employee stock purchase, saving, or similar plan (employee benefit plan (EBP))."
       }
      }
     },
     "auth_ref": [
      "r64",
      "r65",
      "r66",
      "r67",
      "r68",
      "r69",
      "r70",
      "r71",
      "r73",
      "r74",
      "r93",
      "r95",
      "r111",
      "r112",
      "r113",
      "r114",
      "r115",
      "r116",
      "r117",
      "r118",
      "r119"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanSubsequentEventTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanSubsequentEventTextBlock",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanSubsequentEventTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EBP, Subsequent Event",
        "label": "EBP, Subsequent Event [Text Block]",
        "documentation": "The entire disclosure for subsequent event in financial statement of employee stock purchase, saving, or similar plan (employee benefit plan (EBP))."
       }
      }
     },
     "auth_ref": [
      "r47",
      "r49",
      "r180",
      "r190"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanSummaryOfAccountingPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanSummaryOfAccountingPolicyTextBlock",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanSummaryofAccountingPolicyTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EBP, Summary of Accounting Policy",
        "label": "EBP, Summary of Accounting Policy [Text Block]",
        "documentation": "The entire disclosure for summary of accounting policy used to prepare financial statement of employee stock purchase, saving, or similar plan (employee benefit plan (EBP))."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r3",
      "r133"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanTaxStatusAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanTaxStatusAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "EBP, Tax Status [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap-ebp_EmployeeBenefitPlanTaxStatusLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanTaxStatusLineItems",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanTaxStatusTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EBP, Tax Status [Line Items]",
        "label": "EBP, Tax Status [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r177"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanTaxStatusTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanTaxStatusTable",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanTaxStatusTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EBP, Tax Status [Table]",
        "label": "EBP, Tax Status [Table]",
        "documentation": "Disclosure of information about tax status of employee stock purchase, saving, or similar plan (employee benefit plan (EBP)). Includes, but is not limited to, information concerning whether tax ruling or determination letter was obtained and principal assumption on which plan relied in not making provision for federal income tax."
       }
      }
     },
     "auth_ref": [
      "r177"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanTaxStatusTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanTaxStatusTextBlock",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanTaxStatusTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EBP, Tax Status",
        "label": "EBP, Tax Status [Text Block]",
        "documentation": "The entire disclosure for tax status of employee stock purchase, saving, or similar plan (employee benefit plan (EBP)). Includes, but is not limited to, information concerning whether tax ruling or determination letter was obtained and principal assumption on which plan relied in not making provision for federal income tax."
       }
      }
     },
     "auth_ref": [
      "r57",
      "r62",
      "r133"
     ]
    },
    "us-gaap-ebp_EmployeeBenefitPlanUseOfEstimatePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap-ebp/2026",
     "localname": "EmployeeBenefitPlanUseOfEstimatePolicyTextBlock",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanSummaryofAccountingPolicyTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EBP, Use of Estimate",
        "label": "EBP, Use of Estimate [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for use of estimate in preparation of financial statement of employee stock purchase, saving, or similar plan (employee benefit plan (EBP))."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r6",
      "r7",
      "r8",
      "r9",
      "r10",
      "r133"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.elevancehealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.elevancehealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.elevancehealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.elevancehealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.elevancehealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r135"
     ]
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityDomain",
     "presentation": [
      "http://www.elevancehealth.com/role/Cover",
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanDescriptionofPlanTables",
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanFairValueandNAVTables",
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanMasterTrustTables",
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanReconciliationofFinancialStatementtoForm5500Tables",
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanRelatedPartyandPartyinInterestTransactionsDetails",
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanScheduleAssetHeldforInvestmentDetails",
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanStatementofChangeinNetAssetAvailableforBenefitStatement",
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanStatementofNetAssetAvailableforBenefitStatement",
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanSubsequentEventTables",
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanSummaryofAccountingPolicyTables",
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanTaxStatusTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity [Domain]",
        "label": "Entity [Domain]",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.elevancehealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.elevancehealth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r135"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanScheduleAssetHeldforInvestmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EIN",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r135"
     ]
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanFairValueandNAVTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]",
        "label": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "auth_ref": [
      "r25",
      "r26",
      "r27",
      "r28",
      "r32",
      "r33",
      "r35",
      "r94",
      "r133"
     ]
    },
    "us-gaap_FairValueInputsLevel12And3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "FairValueInputsLevel12And3Member",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanFairValueandNAVTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Inputs, Level 1, Level 2, and Level 3",
        "label": "Fair Value, Inputs, Level 1, Level 2, and Level 3 [Member]"
       }
      }
     },
     "auth_ref": [
      "r174",
      "r192",
      "r194"
     ]
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "FairValueInputsLevel1Member",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanFairValueandNAVTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Inputs, Level 1",
        "label": "Fair Value, Inputs, Level 1 [Member]"
       }
      }
     },
     "auth_ref": [
      "r25",
      "r32",
      "r121",
      "r133"
     ]
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "FairValueInputsLevel2Member",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanFairValueandNAVTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Inputs, Level 2",
        "label": "Fair Value, Inputs, Level 2 [Member]"
       }
      }
     },
     "auth_ref": [
      "r25",
      "r26",
      "r32",
      "r121",
      "r133"
     ]
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "FairValueInputsLevel3Member",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanFairValueandNAVTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Inputs, Level 3",
        "label": "Fair Value, Inputs, Level 3 [Member]"
       }
      }
     },
     "auth_ref": [
      "r25",
      "r26",
      "r27",
      "r28",
      "r32",
      "r33",
      "r121",
      "r133"
     ]
    },
    "us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "FairValueMeasuredAtNetAssetValuePerShareMember",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanFairValueandNAVTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measured at Net Asset Value Per Share",
        "label": "Fair Value Measured at Net Asset Value Per Share [Member]"
       }
      }
     },
     "auth_ref": [
      "r35",
      "r121"
     ]
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanFairValueandNAVTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]",
        "label": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "auth_ref": [
      "r25",
      "r26",
      "r27",
      "r28",
      "r32",
      "r33",
      "r35",
      "r94",
      "r133"
     ]
    },
    "us-gaap_InvestmentIdentifierAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "InvestmentIdentifierAxis",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanScheduleAssetHeldforInvestmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment, Identifier [Axis]",
        "label": "Investment, Identifier [Axis]"
       }
      }
     },
     "auth_ref": [
      "r87",
      "r147",
      "r148",
      "r149",
      "r150",
      "r153",
      "r154",
      "r155",
      "r156",
      "r157",
      "r158",
      "r160",
      "r161",
      "r162",
      "r163",
      "r164",
      "r165",
      "r166",
      "r168",
      "r169",
      "r170",
      "r171",
      "r172"
     ]
    },
    "us-gaap_InvestmentTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "InvestmentTypeAxis",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanFairValueandNAVTables",
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanMasterTrustTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment Type [Axis]",
        "label": "Investment Type [Axis]"
       }
      }
     },
     "auth_ref": [
      "r11",
      "r12",
      "r13",
      "r14",
      "r15",
      "r16",
      "r17",
      "r18",
      "r19",
      "r20",
      "r21",
      "r24",
      "r25",
      "r26",
      "r27",
      "r28",
      "r32",
      "r33",
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r60",
      "r64",
      "r65",
      "r66",
      "r67",
      "r68",
      "r69",
      "r76",
      "r78",
      "r79",
      "r80",
      "r81",
      "r87",
      "r93",
      "r99",
      "r105",
      "r107",
      "r110",
      "r111",
      "r112",
      "r113",
      "r114",
      "r115",
      "r116",
      "r117",
      "r118",
      "r119",
      "r120",
      "r123",
      "r124",
      "r125",
      "r126",
      "r127",
      "r128",
      "r129",
      "r130",
      "r131",
      "r133",
      "r134",
      "r150",
      "r173",
      "r188"
     ]
    },
    "us-gaap_InvestmentTypeCategorizationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "InvestmentTypeCategorizationMember",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanFairValueandNAVTables",
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanMasterTrustTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investments [Domain]",
        "label": "Investments [Domain]"
       }
      }
     },
     "auth_ref": [
      "r11",
      "r12",
      "r13",
      "r14",
      "r15",
      "r16",
      "r17",
      "r18",
      "r19",
      "r20",
      "r21",
      "r24",
      "r25",
      "r26",
      "r27",
      "r28",
      "r32",
      "r33",
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r60",
      "r64",
      "r65",
      "r66",
      "r67",
      "r68",
      "r69",
      "r76",
      "r78",
      "r79",
      "r80",
      "r81",
      "r87",
      "r93",
      "r99",
      "r105",
      "r107",
      "r110",
      "r111",
      "r112",
      "r113",
      "r114",
      "r115",
      "r116",
      "r117",
      "r118",
      "r119",
      "r120",
      "r123",
      "r124",
      "r125",
      "r126",
      "r127",
      "r128",
      "r129",
      "r130",
      "r131",
      "r133",
      "r134",
      "r150",
      "r173",
      "r188"
     ]
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://www.elevancehealth.com/role/Cover",
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanDescriptionofPlanTables",
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanFairValueandNAVTables",
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanMasterTrustTables",
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanReconciliationofFinancialStatementtoForm5500Tables",
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanRelatedPartyandPartyinInterestTransactionsDetails",
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanScheduleAssetHeldforInvestmentDetails",
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanStatementofChangeinNetAssetAvailableforBenefitStatement",
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanStatementofNetAssetAvailableforBenefitStatement",
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanSubsequentEventTables",
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanSummaryofAccountingPolicyTables",
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanTaxStatusTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Legal Entity [Axis]",
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2026",
     "localname": "MaximumMember",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanDescriptionofPlanTables",
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanScheduleAssetHeldforInvestmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum",
        "label": "Maximum [Member]"
       }
      }
     },
     "auth_ref": [
      "r28",
      "r133",
      "r150",
      "r187"
     ]
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2026",
     "localname": "MinimumMember",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanDescriptionofPlanTables",
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanScheduleAssetHeldforInvestmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Minimum",
        "label": "Minimum [Member]"
       }
      }
     },
     "auth_ref": [
      "r28",
      "r133",
      "r150",
      "r187"
     ]
    },
    "us-gaap_MutualFundMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "MutualFundMember",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanFairValueandNAVTables",
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanMasterTrustTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Mutual Fund",
        "label": "Mutual Fund [Member]"
       }
      }
     },
     "auth_ref": [
      "r111",
      "r122",
      "r123",
      "r132",
      "r133",
      "r134"
     ]
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2026",
     "localname": "RangeAxis",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanDescriptionofPlanTables",
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanScheduleAssetHeldforInvestmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Axis]",
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r28",
      "r133",
      "r150",
      "r187"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2026",
     "localname": "RangeMember",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanDescriptionofPlanTables",
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanScheduleAssetHeldforInvestmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Domain]",
        "label": "Statistical Measurement [Domain]"
       }
      }
     },
     "auth_ref": [
      "r28",
      "r133",
      "r150",
      "r187"
     ]
    },
    "us-gaap_RelatedPartyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "RelatedPartyMember",
     "presentation": [
      "http://www.elevancehealth.com/role/EmployeeBenefitPlanRelatedPartyandPartyinInterestTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party",
        "label": "Related Party [Member]"
       }
      }
     },
     "auth_ref": []
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480530/250-10-S99-5"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SAB Topic 11.M)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480530/250-10-S99-6"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-11"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-11"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-12"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-4"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4K",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4K"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4K",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4K"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4K",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4K"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4K",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4K"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4K",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4K"
  },
  "r20": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4K",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4K"
  },
  "r21": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4K",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4K"
  },
  "r22": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-7A"
  },
  "r23": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r24": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r25": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r26": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r27": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r28": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r29": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r30": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r31": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r32": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r33": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r34": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r35": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r36": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r37": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r38": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r39": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r40": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r41": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r42": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-8"
  },
  "r43": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r44": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r45": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r46": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r47": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r48": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r49": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-3"
  },
  "r50": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "962",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477063/962-205-45-10"
  },
  "r51": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "962",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477063/962-205-45-2"
  },
  "r52": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "962",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477063/962-205-45-7"
  },
  "r53": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "962",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477063/962-205-45-7"
  },
  "r54": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "962",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477063/962-205-45-7"
  },
  "r55": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "962",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477063/962-205-45-7"
  },
  "r56": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "962",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478416/962-205-50-1"
  },
  "r57": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "962",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478416/962-205-50-1"
  },
  "r58": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "962",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478416/962-205-50-1"
  },
  "r59": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "962",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478416/962-205-50-1"
  },
  "r60": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "962",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6A-02(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1"
  },
  "r61": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "962",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6A-02(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1"
  },
  "r62": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "962",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6A-02(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1"
  },
  "r63": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "962",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6A-02(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1"
  },
  "r64": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "962",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6A-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1"
  },
  "r65": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "962",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6A-03(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1"
  },
  "r66": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "962",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6A-03(2)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1"
  },
  "r67": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "962",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6A-03(2)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1"
  },
  "r68": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "962",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6A-03(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1"
  },
  "r69": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "962",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6A-03(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1"
  },
  "r70": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "962",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6A-03(6)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1"
  },
  "r71": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "962",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6A-03(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1"
  },
  "r72": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "962",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6A-03(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1"
  },
  "r73": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "962",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6A-03(7)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1"
  },
  "r74": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "962",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6A-03(7)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1"
  },
  "r75": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "962",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6A-03(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1"
  },
  "r76": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "962",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6A-04(1)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1"
  },
  "r77": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "962",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6A-04(1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1"
  },
  "r78": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "962",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6A-04(2)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1"
  },
  "r79": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "962",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6A-04(2)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1"
  },
  "r80": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "962",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6A-04(2)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1"
  },
  "r81": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "962",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6A-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1"
  },
  "r82": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "962",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6A-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1"
  },
  "r83": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "962",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6A-04(5)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1"
  },
  "r84": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "962",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6A-04(5)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1"
  },
  "r85": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "962",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6A-04(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1"
  },
  "r86": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "962",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6A-04(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1"
  },
  "r87": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "962",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6A-05(a)(Schedule I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1"
  },
  "r88": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "962",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6A-05(a)(Schedule II))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1"
  },
  "r89": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "962",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6A-05(a)(Schedule III))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1"
  },
  "r90": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "962",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478642/962-310-45-1"
  },
  "r91": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "962",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478642/962-310-45-2"
  },
  "r92": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "962",
   "SubTopic": "325",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478844/962-325-35-1B"
  },
  "r93": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "962",
   "SubTopic": "325",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477509/962-325-45-5"
  },
  "r94": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "962",
   "SubTopic": "325",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477509/962-325-45-6"
  },
  "r95": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "962",
   "SubTopic": "325",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477509/962-325-45-8"
  },
  "r96": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "962",
   "SubTopic": "325",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477783/962-325-50-1"
  },
  "r97": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "962",
   "SubTopic": "325",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477783/962-325-50-2A"
  },
  "r98": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "962",
   "SubTopic": "325",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477783/962-325-50-2B"
  },
  "r99": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "962",
   "SubTopic": "325",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477783/962-325-50-3"
  },
  "r100": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "962",
   "SubTopic": "325",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477783/962-325-50-5"
  },
  "r101": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "962",
   "SubTopic": "325",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477783/962-325-50-7"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "962",
   "SubTopic": "325",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477783/962-325-50-7"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "962",
   "SubTopic": "325",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477783/962-325-50-7"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "962",
   "SubTopic": "325",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477783/962-325-50-8"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "962",
   "SubTopic": "325",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477783/962-325-50-8A"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "962",
   "SubTopic": "325",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477783/962-325-50-8A"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "962",
   "SubTopic": "325",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477783/962-325-50-8B"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "962",
   "SubTopic": "325",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477783/962-325-50-8C"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "962",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479750/962-40-25-1"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4L",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4L"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "962",
   "SubTopic": "325",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477509/962-325-45-5"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "962",
   "SubTopic": "325",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477509/962-325-45-5"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "962",
   "SubTopic": "325",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477509/962-325-45-5"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "962",
   "SubTopic": "325",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477509/962-325-45-5"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "962",
   "SubTopic": "325",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477509/962-325-45-5"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "962",
   "SubTopic": "325",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477509/962-325-45-5"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "962",
   "SubTopic": "325",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477509/962-325-45-5"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "962",
   "SubTopic": "325",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477509/962-325-45-5"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "962",
   "SubTopic": "325",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477509/962-325-45-5"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "962",
   "SubTopic": "325",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(k)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477509/962-325-45-5"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "962",
   "SubTopic": "325",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477509/962-325-45-6"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "962",
   "SubTopic": "325",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477783/962-325-50-1"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "962",
   "SubTopic": "325",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477783/962-325-50-8A"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "962",
   "SubTopic": "325",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477783/962-325-50-8A"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "962",
   "SubTopic": "325",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477783/962-325-50-8A"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "962",
   "SubTopic": "325",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477783/962-325-50-8A"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "962",
   "SubTopic": "325",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8A",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477783/962-325-50-8A"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "962",
   "SubTopic": "325",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8A",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477783/962-325-50-8A"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "962",
   "SubTopic": "325",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8A",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477783/962-325-50-8A"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "962",
   "SubTopic": "325",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8A",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477783/962-325-50-8A"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "962",
   "SubTopic": "325",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8A",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477783/962-325-50-8A"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "962",
   "SubTopic": "325",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477783/962-325-50-8B"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "962",
   "SubTopic": "325",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478873/962-325-55-17"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "962",
   "SubTopic": "325",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478873/962-325-55-18"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-23"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-3"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "962",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477063/962-205-45-7"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "962",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6A-05(a)(Schedule III))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "962",
   "SubTopic": "325",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477783/962-325-50-2B"
  },
  "r144": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Employee Retirement Income Security Act of 1974",
   "Number": "2520",
   "Section": "103",
   "Subsection": "1",
   "Paragraph": "b",
   "Subparagraph": "(3)",
   "Publisher": "DOL-EBSA"
  },
  "r145": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Employee Retirement Income Security Act of 1974",
   "Number": "2520",
   "Section": "103",
   "Subsection": "10",
   "Paragraph": "b",
   "Subparagraph": "(1)",
   "Publisher": "DOL-EBSA"
  },
  "r146": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Employee Retirement Income Security Act of 1974",
   "Number": "2520",
   "Section": "103",
   "Subsection": "10",
   "Paragraph": "b",
   "Subparagraph": "(1)(i)",
   "Publisher": "DOL-EBSA"
  },
  "r147": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Employee Retirement Income Security Act of 1974",
   "Number": "2520",
   "Section": "103",
   "Subsection": "10",
   "Paragraph": "b",
   "Subparagraph": "(1)(i)(A)",
   "Publisher": "DOL-EBSA"
  },
  "r148": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Employee Retirement Income Security Act of 1974",
   "Number": "2520",
   "Section": "103",
   "Subsection": "10",
   "Paragraph": "b",
   "Subparagraph": "(1)(i)(B)",
   "Publisher": "DOL-EBSA"
  },
  "r149": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Employee Retirement Income Security Act of 1974",
   "Number": "2520",
   "Section": "103",
   "Subsection": "10",
   "Paragraph": "b",
   "Subparagraph": "(1)(i)(C)",
   "Publisher": "DOL-EBSA"
  },
  "r150": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Employee Retirement Income Security Act of 1974",
   "Number": "2520",
   "Section": "103",
   "Subsection": "10",
   "Paragraph": "b",
   "Subparagraph": "(1)(i)(D)",
   "Publisher": "DOL-EBSA"
  },
  "r151": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Employee Retirement Income Security Act of 1974",
   "Number": "2520",
   "Section": "103",
   "Subsection": "10",
   "Paragraph": "b",
   "Subparagraph": "(1)(ii)",
   "Publisher": "DOL-EBSA"
  },
  "r152": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Employee Retirement Income Security Act of 1974",
   "Number": "2520",
   "Section": "103",
   "Subsection": "10",
   "Paragraph": "b",
   "Subparagraph": "(2)",
   "Publisher": "DOL-EBSA"
  },
  "r153": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Employee Retirement Income Security Act of 1974",
   "Number": "2520",
   "Section": "103",
   "Subsection": "10",
   "Paragraph": "b",
   "Subparagraph": "(2)(i)(A)",
   "Publisher": "DOL-EBSA"
  },
  "r154": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Employee Retirement Income Security Act of 1974",
   "Number": "2520",
   "Section": "103",
   "Subsection": "10",
   "Paragraph": "b",
   "Subparagraph": "(2)(i)(B)",
   "Publisher": "DOL-EBSA"
  },
  "r155": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Employee Retirement Income Security Act of 1974",
   "Number": "2520",
   "Section": "103",
   "Subsection": "10",
   "Paragraph": "b",
   "Subparagraph": "(2)(i)(C)",
   "Publisher": "DOL-EBSA"
  },
  "r156": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Employee Retirement Income Security Act of 1974",
   "Number": "2520",
   "Section": "103",
   "Subsection": "10",
   "Paragraph": "b",
   "Subparagraph": "(2)(i)(D)",
   "Publisher": "DOL-EBSA"
  },
  "r157": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Employee Retirement Income Security Act of 1974",
   "Number": "2520",
   "Section": "103",
   "Subsection": "10",
   "Paragraph": "b",
   "Subparagraph": "(3)",
   "Publisher": "DOL-EBSA"
  },
  "r158": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Employee Retirement Income Security Act of 1974",
   "Number": "2520",
   "Section": "103",
   "Subsection": "10",
   "Paragraph": "b",
   "Subparagraph": "(4)",
   "Publisher": "DOL-EBSA"
  },
  "r159": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Employee Retirement Income Security Act of 1974",
   "Number": "2520",
   "Section": "103",
   "Subsection": "6",
   "Paragraph": "d",
   "Subparagraph": "(1)",
   "Publisher": "DOL-EBSA"
  },
  "r160": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Employee Retirement Income Security Act of 1974",
   "Number": "2520",
   "Section": "103",
   "Subsection": "6",
   "Paragraph": "d",
   "Subparagraph": "(1)(i)",
   "Publisher": "DOL-EBSA"
  },
  "r161": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Employee Retirement Income Security Act of 1974",
   "Number": "2520",
   "Section": "103",
   "Subsection": "6",
   "Paragraph": "d",
   "Subparagraph": "(1)(ii)",
   "Publisher": "DOL-EBSA"
  },
  "r162": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Employee Retirement Income Security Act of 1974",
   "Number": "2520",
   "Section": "103",
   "Subsection": "6",
   "Paragraph": "d",
   "Subparagraph": "(1)(iii)",
   "Publisher": "DOL-EBSA"
  },
  "r163": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Employee Retirement Income Security Act of 1974",
   "Number": "2520",
   "Section": "103",
   "Subsection": "6",
   "Paragraph": "d",
   "Subparagraph": "(1)(iv)",
   "Publisher": "DOL-EBSA"
  },
  "r164": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Employee Retirement Income Security Act of 1974",
   "Number": "2520",
   "Section": "103",
   "Subsection": "6",
   "Paragraph": "d",
   "Subparagraph": "(1)(v)",
   "Publisher": "DOL-EBSA"
  },
  "r165": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Employee Retirement Income Security Act of 1974",
   "Number": "2520",
   "Section": "103",
   "Subsection": "6",
   "Paragraph": "d",
   "Subparagraph": "(1)(vi)",
   "Publisher": "DOL-EBSA"
  },
  "r166": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Employee Retirement Income Security Act of 1974",
   "Number": "2520",
   "Section": "103",
   "Subsection": "6",
   "Paragraph": "d",
   "Subparagraph": "(1)(vii)",
   "Publisher": "DOL-EBSA"
  },
  "r167": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Employee Retirement Income Security Act of 1974",
   "Number": "2520",
   "Section": "103",
   "Subsection": "6",
   "Paragraph": "d",
   "Subparagraph": "(2)",
   "Publisher": "DOL-EBSA"
  },
  "r168": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Employee Retirement Income Security Act of 1974",
   "Number": "2520",
   "Section": "103",
   "Subsection": "6",
   "Paragraph": "d",
   "Subparagraph": "(2)(i)",
   "Publisher": "DOL-EBSA"
  },
  "r169": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Employee Retirement Income Security Act of 1974",
   "Number": "2520",
   "Section": "103",
   "Subsection": "6",
   "Paragraph": "d",
   "Subparagraph": "(2)(ii)",
   "Publisher": "DOL-EBSA"
  },
  "r170": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Employee Retirement Income Security Act of 1974",
   "Number": "2520",
   "Section": "103",
   "Subsection": "6",
   "Paragraph": "d",
   "Subparagraph": "(2)(iii)",
   "Publisher": "DOL-EBSA"
  },
  "r171": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Employee Retirement Income Security Act of 1974",
   "Number": "2520",
   "Section": "103",
   "Subsection": "6",
   "Paragraph": "d",
   "Subparagraph": "(2)(iv)",
   "Publisher": "DOL-EBSA"
  },
  "r172": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Employee Retirement Income Security Act of 1974",
   "Number": "2520",
   "Section": "103",
   "Subsection": "6",
   "Paragraph": "d",
   "Subparagraph": "(2)(v)",
   "Publisher": "DOL-EBSA"
  },
  "r173": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r174": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r175": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "962",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477063/962-205-45-7"
  },
  "r176": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "962",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478416/962-205-50-1"
  },
  "r177": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "962",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478416/962-205-50-1"
  },
  "r178": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "962",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478416/962-205-50-1"
  },
  "r179": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "962",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6A-01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1"
  },
  "r180": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "962",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6A-02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1"
  },
  "r181": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "962",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6A-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1"
  },
  "r182": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "962",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6A-04(1)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1"
  },
  "r183": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "962",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6A-04(2)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1"
  },
  "r184": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "962",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6A-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1"
  },
  "r185": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "962",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6A-04(4)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1"
  },
  "r186": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "962",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6A-04(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1"
  },
  "r187": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "962",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6A-05(a)(Schedule I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1"
  },
  "r188": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "962",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6A-05(a)(Schedule II))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1"
  },
  "r189": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "962",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6A-05(a)(Schedule III))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477804/962-205-S99-1"
  },
  "r190": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "962",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479143/962-235-S50-1"
  },
  "r191": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "962",
   "SubTopic": "325",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477509/962-325-45-5"
  },
  "r192": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "962",
   "SubTopic": "325",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477509/962-325-45-6"
  },
  "r193": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "962",
   "SubTopic": "325",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477509/962-325-45-8"
  },
  "r194": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "962",
   "SubTopic": "325",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477783/962-325-50-1"
  },
  "r195": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "962",
   "SubTopic": "325",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477783/962-325-50-3"
  },
  "r196": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "962",
   "SubTopic": "325",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477783/962-325-50-7"
  },
  "r197": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "962",
   "SubTopic": "325",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477783/962-325-50-7"
  },
  "r198": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "962",
   "SubTopic": "325",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477783/962-325-50-8A"
  },
  "r199": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "962",
   "SubTopic": "325",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8A",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477783/962-325-50-8A"
  },
  "r200": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "962",
   "SubTopic": "325",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477783/962-325-50-8B"
  },
  "r201": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "962",
   "SubTopic": "325",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477783/962-325-50-8C"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>27
<FILENAME>0001156039-26-000052-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001156039-26-000052-xbrl.zip
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MN$Q$KMQ-2Q%K[DL41J;S,7*M@T'4 T'-$M4#K7(W2D>*F@?)0\M$U+V\1SM
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MKOHI[S)PK<R#KYR+=[?%^JZ90Y7T3!^F=OF_5TE1O2PNI)\M_[SA3/WP TS
M0Q45%?Y/QDF^2\[.FCV:08[XFXV0HW*^VAHY%IA!B5&LW<IY1NOS?E7F7SEG
M9"GG'3Y-F57$UW25K)1/]%O\B&-/;#C,6^\G<UN6-S%M]^QOWZ4OGG]GNK^=
MK'HL65QJ%54B\<JY .LCWY7(/[$?3X&1>9$_9 '_=<Q,BQ9OV?=GO\%?A#;V
M8* ;1E\962-FZ-9 ,4;=]M#L*VJ;]<V!9OPO.GQF[P3ADP/X,['=YIC9=^/P
MM*=-PW</MA6.3U5%^5,C^YSIW\&C R\,O<FI 4_B^IJF8]^YI_^* CBO)W@C
MF)H ZX%_ E/QG_F,B_.N&F_(D'V+X>(WAI[C^:>_*/3?NQ$ J#DR)[;S=/KK
M+6!3('UE#](UG+;[JQP -$?\F<#^-SM5^S !_?H@]@I#.+;+XKVK&F[XQ]>K
MV\L/TLWM^>WE378#55_ZS>7%C^NKVZO+&^G\ZP?I\I\7G\Z__O52NOCVY<O5
MS<W5MZ]5V8]6:#__,(.Q[=Z%GBM+'UH7+4E3.KKQPCV$YL!A\2L#SP<R:L)>
M'',:L-/XAW>6'4P=\PE8."V+7GJ7G: #$]PS/[2'IB,FH?GXUX*(=+W5[ZE(
M1R%0:VC%$PL2:\$V3Q8_-_HM0\G_2FFI]/D)C>?'7PJXM:=A@]Z!C2"4?F^T
M&W-[%:M7IZ%$]<BE^ BGIF4!M$\5";Y+ICBAK3\+[1X 0WP2>E-^P!6@B(_?
MKK](OP&_=#WW:S2!08:28*O7;$3=M!N2:Z(01?'VP1M&\=U6@SCJ"!XX4]7F
M?Q/7G8UR5A +B\)EZUC94X\ *PV:N#2<4PKAW)LOIO]3^N:RMS&.;/=P06ZW
M%"Z[USE=K=7I=U8>;F$\Z;0T=?50 D^6(45\Z-KT$8\]33$.&RW"P)L6/^9_
MP, X>  ';+I!\]E3UN=/F<-V;:9R[KJ1Z5RSJ>>'#6GD^1,S!)4-=@9*^^G
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M]#T^.QPS*P(E>0K,!-'* K7#9[8KC4W0'@:,N?C5U/3A&_C4' Y!C28(/M@
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M=!]!I[$##+(@A8-RL1:J<?$ 9XXI(JJ'OSZV*8@'T2)1I<]!.1^: 2KGR'^
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M94&2+%8OV;YL4;4Y0*7^'OLS-\$=:P[@#'\VS1&L\Y1;J.@P2&\0=I>&9C%
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M+LPI3O!RW:N?V"%JNPLZV&9V2(6SEVJBJXGNA4*Z=*(SN,&C&'*_J\M*=S'
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M;:;!=9=K<"<#SWJ"?\;AQ#G[_U!+ P04    "  CC]%<O/O9Y(@'  !+/@
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M'M4W1MWNLO(G$:'KL/^M)_I\XW56;5JL*"^.D+P5%>KUS=&=A781>BI](BM
M>6,!.3."RQ#TMM^!W[B.O7]#8=M6L%L6=6TC=]%\),6+$8)BE,<S9DGL0.5U
M&AE$H7G"MOPV\/K"[ZS C]M=J,@2%84&;2,!V@MI8^T(Q"V'Q+7Q^1Y"WT9H
MNNYON&QHF7<5\![<Q+S'/9%&4@K5'ED*0)%;@^*11\V85WK+[R5M1*_O,+!M
MD^/;Y\Z:A?JLO?UH?\/N[:O_ U!+ P04    "  CC]%<\U*P5W\G  #B)0(
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M)OZ8G#B61-(T\F27@%F:5UB0IL&FT8SM5-^WWW]CV/20YZ$_&3^?>^J]I==
M>>3&+J'@A_86^P_@C^%+;YSFE,%D'H\$C:D#2:@'11F"P&S4'CFBZ'X[?*N>
M^LAM6T29#XTK]S?NA?>C,![?_B]+B6>@#!"7%@HI" 43O09.68B224YL"0NO
M>/3)F'E?M3ZTM2IFZQ?IY?O1I^%?L[T88<$@FYP_'!,D)0(@@IU/7@)!T9:S
M]/V#3\W..ZKTH95U,2O_,4E1VOO1A]'PNC=PX1Z7U]J#1,2ER$T&8 @;CKF)
M).)RIEYZ^JG9>Q_EKMCLV&LK:P'8A^%X8OK_M_?MQ=#?P7* C$M<5)1D5U$
MM@9SCC5GRI>S^<*S3\WBNRMVA;UOU[F_/U]23L+\YWY9%:\NO_6'/T+X+0S2
MMTZR$SGE:E;.,/X>)A?C<?KGVO3Z^<0R:>OVDW>?VB$EH\!#B^5SE%; GLD@
M"TY] [3W#Z&]OH.V0&6O/3' (DVQGTDNA!9* Q,IC(\2&Q)HE\'6WA(4B3YW
M17%W2#^O0Q$#6(8U"(QEH 1QB9N250ZFPRH)+P?DZ\HXN)ZICS29)N.W@+#E
M:>5*OH6A-.%WR!N/1%IK5N3R/9YDFD.9NCGUIK7*.T[7V(CC-%-OVJN_(6]C
M:]U5M"4+:19DR*9_+&$\QD!"B2C[>%)OBINP464=I][<X, $8Y $>]".6: F
M<BHQDQ[C#=[Q<:7>M-=J0^I-:Y44S-K8L%:\&5R'\61Z3#W]:1)2U);BP7=F
MG%Y^&EV-)Z]-;_0OT[^Z6RPB,"9(<DNH :.L \(8T298[4S37D@'+N V\.L1
MZ/B]P<[,7H^YOP\G*<QWH7<]U5M2_@<SFO1<[YL93&XQ4PI!&I5'FP"M P*D
M+ H(,^QLK$O51KQG;G9AV((KW ;,MV^-7J3@9M2S5]EV]S+,0#-(P'.">W*P
MC8\1M!+$(\M$4E5=-C8#/M.Q$],6S.?: /HA0 %8L31[$VN2WX$X8,NH$,H1
MK2OO?9UY5M!D!7/+-LW+ZQ7S8!L!.5!&(LA'\5$GO(PW)8EVL=RN1WMF77FC
MKDV!JWY8\^*K&7P)O8>2U3BTV>KAE0YO=E=(M4.<&XAOFMBX/ H8!X,U ^ED
M7FR#!>)LX)YJ(?CA#G.VD:3[0YT6:.:W@1D&YECR8KQQ8*6Q0(,DP:39)9BF
MK;:#Z_3(#GDZX_/VASV=4.!X#WV2OR0P$2 CEZ 8PN )IL*%0 S:+TGZT1SZ
M=&/RC8<_[53?_8%!,XZ3/?QIJ?[FDX/M=->U+7W4#A@E+OFZ H/U.@)G@L2
MF:6B1#G+41W^%#!A6Y5U??@SQ<$CX2E\Y387D2L0WMM K&""VPU>]I$=_K36
M:M/A3UN5U-M";[%0O!FX43#C_,[<+NS\7MBK[ZY_E3O"?1SV^[DKT(S,(L6E
MCH*D7( -FD! %GLC/1>N\MY[-X(>XS["H3W/(Z#4L8Z?51O)+\SXZU0X%XD&
MZEPR PH<M D&1"[HQ\XSI9OJ1@X^7M8)=AX?1T&9>J=@10;_PIA/,IK$6HU
MVJ! VR@ <8&H)E+IV.0!'GQ8;)#O/#J.B4#UCN:VDW%>L!LOD@4$&ILDD%8*
ME*$<5%H *9(L8'S4"\6\,&?Z'XP:]8X,MQ#H9;@7[/:OUJ8FS:0EH/FT)-0Y
M4$(Z( $AJY#P1C3U+CGL0-A&TO,H.4Y2%>SX471.N)?,#2_#^Q:Y5$EB!E0F
M5U(R@T%AKL%K:Y VF*M0^=2^0VG/0^EXR=55OY6])+Z1@",$P="8)@0CTM3
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MK>H5'ZW?NU@H%Y[;O] Q^5].1J!($\8B,7P7+[B;',>CJ_8^MHS'G:Q:K]5
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M::G5YGR5=BJIF230M%ZL)";*UWLA R0ZZJ,.]$&[DL,Z@D]T5:YKZ)IGMDW
MURQ=JZ"W6/:K<_40_D-EHI2@YQY6KI?5LHL(U.@TLE&^.T=B+Z,P2AS59'H
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M8^X)_H*QY>-B\TKL-^L+?C];S-:;E;Q2/HG7WQ[$8MU<]42551QR6G- )6=
M22T@HQDK4Y$5=4T=V%G6"OIVYJB3>Z]<M-<NVJKW+-HIV)[5QSI&6R6=F%WV
M:SC*Q JR,A;FE+]%<64TC48NC(%DK^84C*'1(&L:/N/EF!&ZF#_])G_/NQ84
MV;"OOSYT#:FW4IP\.5Y\:7DZ3RB%@I<)H+1(@*2)O!G7-:OS-"]IA75XVE"N
M?_H]OOXH7:)?'X[N0=%6G4CJH\>TIN .$ZA'R"QX<0)P\6U\0^.;O@5L1PK<
M C[M(\02A/9DD%]6+%\D:1NL\&^FHP4A<,LI[GC9]NMF=*L>5]Z(+V3>OK"\
M^#9;;U\YDAQP7&) L<B!Y&D*689B5&2YO&MFN@^2)V-[ILU&6K1]I/NL!/9?
MR:["</T1<L3DS C.9%Y&+XT],[!Z6SP=*]AK8L\DNN^'?1\Q=\!\4'Z@(_<+
MEM=#)%) 0E"H1$:@0%5,&"%U'0M=]TMG7,^;Y*,Z'M:25.2OU%MIP3VN1!.4
M]_G5\I[,%IH[YA2+ZSX9RQF:[13KR1EY:"Y,981_ICM:,._,A2ET?3.7_MFI
M9^:56+/5[$$=8N]K]8-/RIO:;BE1U9#'12V-^%R>/5DISYXT%V6=YA7G6AY-
M*^DA?"H=R=&R5@&OB^AS(UUSX]GA.LH5,AXM"WO>!BA7'HSA"8=Q3_3H, 7?
MPS \FHZ%*X-8D<UO;Q\WCV3^\^."=X]H+#C4<2GYA/ 2<%*6P''!\Q2)#*/2
M@$_.!/A^*&G$14J>$3N< Z%% *.F9_AT<IB9P^>3:_/0W[K=;7NZ9<^'#[DK
M>R=WLO'Z/^?T(/\@YDT8L[RG?G^Q:/_W;G&WD+_M8KWYM"*+-6%-:$;WA"<)
M%#7+ >$R 8H8A3QC!:%95I2(.3CA#=4*<?1O56I<+=\CLMC^"68+V.D5=15S
M:A>8+M,H@\$C^!:6A'/<79D9EC"%L3],E9N"86()J*;%8CNZU0/(5O[JK7+Z
MJ;'95['SSHD\(13B.DL <4X!UR6%0M15792X8C4Q>/#HDQ/@@6,G.FID1UOA
M1GZ[:V!I/6"X@,""E@),W^A!P@4,(QX@+L/A[*7AVNR&7Q9ZOQWR)>':%$Y>
M#JY^W*D9^%',ZU>SE6"2(7]:+?\E5N2+V#X5']_%A#3ZE+N4IS60E%:0)0E)
M<$:*G&HE.HW6Q+>#52H ?*M!1'<J1*358>W$GM/ >Y0)YQ9%"WIL4-QI$.U5
MV,6ZN+\TCD<BC&&FH<\4;#%]V#3-+X,!0^=O[&)A&N,L8?)R*](: 8J+%"@E
M,; \BV/&65:KI]-]1JK'\/^=2D9<UY.1.[!5F^S:B O^V%J^H1(M]HB/(CE/
M.%JPG4&2Q$ZC*20_G*(SF=2&O6)3H$(+(-VE)9R-[#M+5EZ-WY&G3^+;YB>)
MS;\:3DPIBZ%,6 &(DA*P2I\M!29%+/^>Y%H1>J,U">'CNYPGVCB=WKWX9P21
MTB9JU/&56GN*_RB&=(NJ!3%> ?3S 4__EJ ^&#=+SCW59PKTIP^;?>INWX!.
MR>[=<B,^""9F3PW%ROEWHO-VEFB;U/+3<K5:_CY;?'EQKW[:DF"554#+L@24
MU!BJO*J )U5.<Q;7*=$*%?*F80AR5-I%!_7.LCR?'1(9=IE5>RWEOS5Z.F'-
M$0LYBDW#+(\%RWI=&5?T.QZ],+0\0L\IT/5XF#5IW($@3[;LZV]L_JC*&+8_
M;A]X[A9OR5K^\=/J<7U2$X;5:08T+S) F',@<19#EE8U136A<6T28>)4N= 6
M[UZU-EQK_[HJK[6M>E&CGU8)%?\KY\@P]K0>(VUEETOAWGZVP"RT26VBXA1H
M>Q2XQH:WC0S'MOA"XK5>SF>\>93O4^/X[2F'##511WD!%*4%)#RMDRP3:9Z[
M8&DSK<+8W$<:/1NF T?6M='2C+2H?0%N946;8!WN!<L.I%#&LI%N4V!:.SBU
MC6*KP>W"I?<<?;=X>-RLWX@G,4^ZC"F_!7%:4$!9*J2%2QC0+.4E+N,JBXTB
MIP=D>>;!@X6C3"0E_%G4B(\2LZ#J(;BT6,P5"&;<-#!_#Z'7&E-T%(4])"EH
M0+;&E$]CLW6^XCA,6TUF-I\UH5F?EC\O5_=%$<=-J.+Q8PWAA$.<JR(*!"50
MQ92"2).8)GF><>;"3M+3)DQ0=E<3E6GT\VQ!Y$_(/%+)A&WZX&:IZJ[<1TI'
M]8C3.,D</^5HKM H<\D][A9FD@7DGT\1#Q&<;0)5J)AL+9VF8"29P:<=@6TT
MJ%7@]=;QJ*ZVT@ACWU_P99.DUO[ME"E1!:+,F+Q1IB60*L^A3*H"87G+S!*M
M/!8SL2$H\:!*U$J/=LH8127K CE,:/[@L6"N?F2BS]L?Z%#4&+2,0KH]H#8B
MPMOB]\HTRMMPPL-!W[J#A8P!-YS@24BXZ;>=9:Z\7W1J9K3I*R42!!#E!$A#
MH%E"<2TP8\RD7M>@,/]DV9?$(548G<%QP$R+(9TA8<&+_2A<OV":PS$ZJ\4*
M%N>I+8._)"[26\ZF:9[C<ACBUHDN9Y/1R'8Y_TZ8V,<75-5"9".#1:X.?^/(
MNYT:-XR[.T7BQF%W>W6F< '3!FULT-W9>)9%M?:UYSHEM3)> \Y) 5DN+UBI
MX(AQK0X[1Z-ZM@-Z:TX99'(>HS#,&]9S,R,!RVF9%]*Z4GG.J(Q6N*3,B^J?
ME=#RF'"Y\Y2]KS6R  ZU-S#/$\A93E3NN !2" :T9!6O&4^*Q$7S& O50O@U
M#K[%9:V?<..T"H?-HHTR(CPOA859X6D5G&5[V@,6*/W30L$IV",C@-5-$!TA
MP2DU_T*^*S4^+3OQK#WNXQSRJI*&3E41H(Q@$+A*!,TS3A,7#VT:JH2@WJT:
MZE&GHX@32M4!>Q2%.H;0@C(OHV?D<G9%CP9@A*%#'86F0'\&P&G2G<F(3NFM
M$X7T9K80=Y)TMT7#42WYC%8"$*$%5!G*($<TS7).8U0E#OCLDNP0!'8<N*=$
M1XUL-V;A141'D=98G"Q8RAPB5Z0T--DP+'11@RG0SA TFCPS.$20&*5+3+?K
MMM=I0_-*2.N/OU*-:+;M$;9=O$@!2<%*>>&5IA81,8&$I*2J<UXQAG[;-8KW
M%M5DK;_6CL7MCCV;A?;N;>5&O"-XK2YG#QU;8[XD\H>JO-W3;//=:[R3_6J/
M8LS;+)ZS**INN%2?Q=AIL/KC3O4_M[F>V]^!KOXWB[ :C?AM@['LU9_"@>%M
M44:&>(V7;]X8YX64R)L7CSGYTIPE<25O[(00H>J8<&GA,@1"'B-)PDD2(ZV.
MD&<C>[9?][(B)4R_'\[Q[(>Y==2<S,A/<SI&;7 NJF[5!.=XI& M<"Y.H-L
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MF3FJQ*PA,&A!9GT 3NLR&WS35TZEF_O$A0$]GZ['^7_A+@L#,PV>_#>I"\(
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M#\WL$K^S9N6/EO?B_>+=<B,^""9F3\U7Y'P[R>7MQLY%#AE*Y;TZ2V/ N"1
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M"&#=5ZT]D^#TK/P@YJK-D7+!?E<-CM3_WNU['*D\N35A35WKT[1^R<%%4A2
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MF7?>$#;+3J< EU5\AQ=AU$'O#%J+0]\#J@[K ER')5BI@ %5IF Q:(&E7U!
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MP%=!&MMLS@_?7.I;]Y9LV%=5Y?PTS3(50(ND!D2S!$A59X"J*L45*RMY8W-
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M;PTZLM+;J&S>A?S&5KS[?A_AF>IU G@$;Y)%PIVA-/FH1*--NX<4OSGH.(M
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M6;J0EMT@;WV$G#G30A.B\\"=TKMDKYDUG/@93ZUP>5H6='9>WKT6 (:+JO0
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M=C9R!637<UO'JAP?LY]N_-Q??MR\_(\)\K4(7WZ\2=_2=,-EX08P $99$D/
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M+_PR_==%V6_[5DH..MQBNO_1_6XT-6"GR^TF_W5GP-U0+$/$Z!QG22?!&L^
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M@3-9'R;Z)+R?EEAJNOG0J6+K1? O;CE9/L2FBQJE::(HLP('9U0"KKR-P>K
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MV+4!P+Q3;8R/I^,7H]V3S1M!9F/ !A2DHS9S81DC8O#RK4=S46GR=>6NP?&
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M,#(U,3(S,2YH=&U02P$"% ,4    "  CC]%<O/O9Y(@'  !+/@  $
M        @ &F3@  96QV+3(P,C4Q,C,Q+GAS9%!+ 0(4 Q0    ( "./T5Q:
M7SU_Z@<  )-0   4              "  5Q6  !E;'8M,C R-3$R,S%?8V%L
M+GAM;%!+ 0(4 Q0    ( "./T5SS4K!7?R<  .(E @ 4              "
M 7A>  !E;'8M,C R-3$R,S%?9&5F+GAM;%!+ 0(4 Q0    ( "./T5S_!U$U
M?ST  )C_ @ 4              "  2F&  !E;'8M,C R-3$R,S%?;&%B+GAM
M;%!+ 0(4 Q0    ( "./T5RKN,FK6R@  +(; @ 4              "  =K#
L  !E;'8M,C R-3$R,S%?<')E+GAM;%!+!08     !@ & (0!  !G[      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>elv-20251231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2026"
  xmlns:elv="http://www.elevancehealth.com/20251231"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2026"
  xmlns:us-gaap="http://fasb.org/us-gaap/2026"
  xmlns:us-gaap-ebp="http://fasb.org/us-gaap-ebp/2026"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="elv-20251231.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="elv:EBPEmployerMatchTrancheAxis">elv:EBPEmployerMatchTrancheOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="elv:EBPEmployerMatchTrancheAxis">elv:EBPEmployerMatchTrancheTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap-ebp:EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustAxis">us-gaap-ebp:EmployeeBenefitPlanNonconsolidatedMasterTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DefinedBenefitPlanCommonCollectiveTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap-ebp:EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustAxis">us-gaap-ebp:EmployeeBenefitPlanNonconsolidatedPlanInterestInMasterTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DefinedBenefitPlanCommonCollectiveTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap-ebp:EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustAxis">us-gaap-ebp:EmployeeBenefitPlanNonconsolidatedMasterTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DefinedBenefitPlanCommonCollectiveTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap-ebp:EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustAxis">us-gaap-ebp:EmployeeBenefitPlanNonconsolidatedPlanInterestInMasterTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DefinedBenefitPlanCommonCollectiveTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap-ebp:EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustAxis">us-gaap-ebp:EmployeeBenefitPlanNonconsolidatedMasterTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap-ebp:EmployeeBenefitPlanEmployerCommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap-ebp:EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustAxis">us-gaap-ebp:EmployeeBenefitPlanNonconsolidatedPlanInterestInMasterTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap-ebp:EmployeeBenefitPlanEmployerCommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap-ebp:EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustAxis">us-gaap-ebp:EmployeeBenefitPlanNonconsolidatedMasterTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap-ebp:EmployeeBenefitPlanEmployerCommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap-ebp:EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustAxis">us-gaap-ebp:EmployeeBenefitPlanNonconsolidatedPlanInterestInMasterTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap-ebp:EmployeeBenefitPlanEmployerCommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap-ebp:EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustAxis">us-gaap-ebp:EmployeeBenefitPlanNonconsolidatedMasterTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap-ebp:EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustAxis">us-gaap-ebp:EmployeeBenefitPlanNonconsolidatedPlanInterestInMasterTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap-ebp:EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustAxis">us-gaap-ebp:EmployeeBenefitPlanNonconsolidatedMasterTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap-ebp:EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustAxis">us-gaap-ebp:EmployeeBenefitPlanNonconsolidatedPlanInterestInMasterTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap-ebp:EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustAxis">us-gaap-ebp:EmployeeBenefitPlanNonconsolidatedMasterTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap-ebp:EmployeeBenefitPlanSelfDirectedBrokerageAccountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap-ebp:EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustAxis">us-gaap-ebp:EmployeeBenefitPlanNonconsolidatedPlanInterestInMasterTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap-ebp:EmployeeBenefitPlanSelfDirectedBrokerageAccountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap-ebp:EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustAxis">us-gaap-ebp:EmployeeBenefitPlanNonconsolidatedMasterTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap-ebp:EmployeeBenefitPlanSelfDirectedBrokerageAccountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap-ebp:EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustAxis">us-gaap-ebp:EmployeeBenefitPlanNonconsolidatedPlanInterestInMasterTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap-ebp:EmployeeBenefitPlanSelfDirectedBrokerageAccountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap-ebp:EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustAxis">us-gaap-ebp:EmployeeBenefitPlanNonconsolidatedMasterTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap-ebp:EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustAxis">us-gaap-ebp:EmployeeBenefitPlanNonconsolidatedPlanInterestInMasterTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap-ebp:EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustAxis">us-gaap-ebp:EmployeeBenefitPlanNonconsolidatedMasterTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap-ebp:EmployeeBenefitPlanNonconsolidatedMasterTrustAndPlanInterestInMasterTrustAxis">us-gaap-ebp:EmployeeBenefitPlanNonconsolidatedPlanInterestInMasterTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap-ebp:EmployeeBenefitPlanEmployerCommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap-ebp:EmployeeBenefitPlanEmployerCommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap-ebp:EmployeeBenefitPlanEmployerCommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap-ebp:EmployeeBenefitPlanEmployerCommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap-ebp:EmployeeBenefitPlanSelfDirectedBrokerageAccountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap-ebp:EmployeeBenefitPlanSelfDirectedBrokerageAccountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap-ebp:EmployeeBenefitPlanSelfDirectedBrokerageAccountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap-ebp:EmployeeBenefitPlanSelfDirectedBrokerageAccountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap-ebp:EmployeeBenefitPlanEmployerCommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap-ebp:EmployeeBenefitPlanEmployerCommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap-ebp:EmployeeBenefitPlanEmployerCommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap-ebp:EmployeeBenefitPlanEmployerCommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap-ebp:EmployeeBenefitPlanSelfDirectedBrokerageAccountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap-ebp:EmployeeBenefitPlanSelfDirectedBrokerageAccountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap-ebp:EmployeeBenefitPlanSelfDirectedBrokerageAccountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap-ebp:EmployeeBenefitPlanSelfDirectedBrokerageAccountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap-ebp:EmployeeBenefitPlanRelatedPartyAndPartyInInterestAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap-ebp:EmployeeBenefitPlanRelatedPartyAndPartyInInterestAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap-ebp:EmployeeBenefitPlanRelatedPartyAndPartyInInterestAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:limitedToken.domain>JP Morgan</us-gaap:limitedToken.domain>
                </xbrldi:typedMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156039</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:InvestmentIdentifierAxis">
                    <us-gaap:limitedToken.domain>JP Morgan</us-gaap:limitedToken.domain>
                </xbrldi:typedMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">elv:EBP003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <dei:AmendmentFlag contextRef="c-2" id="f-11">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="c-2" id="f-12">0001156039</dei:EntityCentralIndexKey>
    <dei:EntityRegistrantName contextRef="c-2" id="f-13">Elevance Health, Inc.</dei:EntityRegistrantName>
    <dei:DocumentType contextRef="c-2" id="f-14">11-K</dei:DocumentType>
    <us-gaap-ebp:EmployeeBenefitPlanInvestmentIssuerNameExtensibleEnumeration contextRef="c-69" id="f-168">http://www.elevancehealth.com/20251231#JPMorganMember</us-gaap-ebp:EmployeeBenefitPlanInvestmentIssuerNameExtensibleEnumeration>
    <us-gaap-ebp:EmployeeBenefitPlanInvestmentTypeExtensibleEnumeration contextRef="c-69" id="f-169">http://fasb.org/us-gaap/2026#MiscellaneousInvestmentsMember</us-gaap-ebp:EmployeeBenefitPlanInvestmentTypeExtensibleEnumeration>
    <us-gaap-ebp:EmployeeBenefitPlanAssetHeldForInvestmentPlanInterestInMasterTrustParticipationStatusExtensibleEnumeration contextRef="c-68" id="f-170">http://fasb.org/us-gaap-ebp/2026#EmployeeBenefitPlanParticipantDirectedMember</us-gaap-ebp:EmployeeBenefitPlanAssetHeldForInvestmentPlanInterestInMasterTrustParticipationStatusExtensibleEnumeration>
    <dei:DocumentType contextRef="c-1" id="f-1">11-K</dei:DocumentType>
    <dei:DocumentAnnualReport contextRef="c-1" id="f-2">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-3">2025-12-31</dei:DocumentPeriodEndDate>
    <dei:EntityFileNumber contextRef="c-1" id="f-4">001-16751</dei:EntityFileNumber>
    <us-gaap-ebp:EbpPlanName contextRef="c-1" id="f-5">ELEVANCE HEALTH 401(k) PLAN</us-gaap-ebp:EbpPlanName>
    <dei:EntityRegistrantName contextRef="c-1" id="f-6">Elevance Health, Inc.</dei:EntityRegistrantName>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-7">220 Virginia Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-8">Indianapolis</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-9">IN</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-10">46204</dei:EntityAddressPostalZipCode>
    <us-gaap-ebp:EmployeeBenefitPlanInvestmentPlanInterestInMasterTrustFairValue contextRef="c-3" decimals="0" id="f-15" unitRef="usd">13065058854</us-gaap-ebp:EmployeeBenefitPlanInvestmentPlanInterestInMasterTrustFairValue>
    <us-gaap-ebp:EmployeeBenefitPlanInvestmentPlanInterestInMasterTrustFairValue contextRef="c-4" decimals="0" id="f-16" unitRef="usd">11861354869</us-gaap-ebp:EmployeeBenefitPlanInvestmentPlanInterestInMasterTrustFairValue>
    <us-gaap-ebp:EmployeeBenefitPlanNoteReceivableFromParticipant contextRef="c-3" decimals="0" id="f-17" unitRef="usd">238395440</us-gaap-ebp:EmployeeBenefitPlanNoteReceivableFromParticipant>
    <us-gaap-ebp:EmployeeBenefitPlanNoteReceivableFromParticipant contextRef="c-4" decimals="0" id="f-18" unitRef="usd">234538393</us-gaap-ebp:EmployeeBenefitPlanNoteReceivableFromParticipant>
    <us-gaap-ebp:EmployeeBenefitPlanEmployerContributionReceivable contextRef="c-3" decimals="0" id="f-19" unitRef="usd">9458553</us-gaap-ebp:EmployeeBenefitPlanEmployerContributionReceivable>
    <us-gaap-ebp:EmployeeBenefitPlanEmployerContributionReceivable contextRef="c-4" decimals="0" id="f-20" unitRef="usd">14692281</us-gaap-ebp:EmployeeBenefitPlanEmployerContributionReceivable>
    <us-gaap-ebp:EmployeeBenefitPlanReceivable contextRef="c-3" decimals="0" id="f-21" unitRef="usd">247853993</us-gaap-ebp:EmployeeBenefitPlanReceivable>
    <us-gaap-ebp:EmployeeBenefitPlanReceivable contextRef="c-4" decimals="0" id="f-22" unitRef="usd">249230674</us-gaap-ebp:EmployeeBenefitPlanReceivable>
    <us-gaap-ebp:EmployeeBenefitPlanNetAssetAvailableForBenefit contextRef="c-3" decimals="0" id="f-23" unitRef="usd">13312912847</us-gaap-ebp:EmployeeBenefitPlanNetAssetAvailableForBenefit>
    <us-gaap-ebp:EmployeeBenefitPlanNetAssetAvailableForBenefit contextRef="c-4" decimals="0" id="f-24" unitRef="usd">12110585543</us-gaap-ebp:EmployeeBenefitPlanNetAssetAvailableForBenefit>
    <us-gaap-ebp:EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForParticipantContributionExcludingRollover contextRef="c-1" decimals="0" id="f-25" unitRef="usd">555710479</us-gaap-ebp:EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForParticipantContributionExcludingRollover>
    <us-gaap-ebp:EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForEmployerContributionCash contextRef="c-1" decimals="0" id="f-26" unitRef="usd">292872276</us-gaap-ebp:EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForEmployerContributionCash>
    <us-gaap-ebp:EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForParticipantContributionRollover contextRef="c-1" decimals="0" id="f-27" unitRef="usd">88135249</us-gaap-ebp:EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForParticipantContributionRollover>
    <us-gaap-ebp:EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForContribution contextRef="c-1" decimals="0" id="f-28" unitRef="usd">936718004</us-gaap-ebp:EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForContribution>
    <us-gaap-ebp:EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForChangeInPlanInterestInMasterTrust contextRef="c-1" decimals="0" id="f-29" unitRef="usd">1817823441</us-gaap-ebp:EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForChangeInPlanInterestInMasterTrust>
    <us-gaap-ebp:EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForInterestIncomeOnNoteReceivableFromParticipant contextRef="c-1" decimals="0" id="f-30" unitRef="usd">19589802</us-gaap-ebp:EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForInterestIncomeOnNoteReceivableFromParticipant>
    <us-gaap-ebp:EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncrease contextRef="c-1" decimals="0" id="f-31" unitRef="usd">2774131247</us-gaap-ebp:EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncrease>
    <us-gaap-ebp:EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecreaseForPaymentToParticipant contextRef="c-1" decimals="0" id="f-32" unitRef="usd">1565382437</us-gaap-ebp:EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecreaseForPaymentToParticipant>
    <us-gaap-ebp:EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecreaseForAdministrativeExpense contextRef="c-1" decimals="0" id="f-33" unitRef="usd">6421506</us-gaap-ebp:EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecreaseForAdministrativeExpense>
    <us-gaap-ebp:EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecrease contextRef="c-1" decimals="0" id="f-34" unitRef="usd">1571803943</us-gaap-ebp:EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecrease>
    <us-gaap-ebp:EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecrease contextRef="c-1" decimals="0" id="f-35" unitRef="usd">1202327304</us-gaap-ebp:EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecrease>
    <us-gaap-ebp:EmployeeBenefitPlanNetAssetAvailableForBenefit contextRef="c-4" decimals="0" id="f-36" unitRef="usd">12110585543</us-gaap-ebp:EmployeeBenefitPlanNetAssetAvailableForBenefit>
    <us-gaap-ebp:EmployeeBenefitPlanNetAssetAvailableForBenefit contextRef="c-3" decimals="0" id="f-37" unitRef="usd">13312912847</us-gaap-ebp:EmployeeBenefitPlanNetAssetAvailableForBenefit>
    <us-gaap-ebp:EmployeeBenefitPlanDescriptionOfPlanTextBlock contextRef="c-1" id="f-38">&lt;div style="margin-bottom:9pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;1. Description of the Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following description of the Elevance Health 401(k) Plan (the &#x201c;Plan&#x201d;) provides only general information. More detailed information concerning the Plan may be found by consulting the summary plan description.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;General &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Plan is a qualified defined contribution plan which provides savings opportunities for eligible employees of Elevance Health, Inc. (&#x201c;Elevance Health&#x201d;) and certain of its subsidiaries (the &#x201c;Participating Employers&#x201d;) and is subject to the provisions of the Employee Retirement Income Security Act of 1974, as amended  ("ERISA"). Employees of the Participating Employers are generally eligible to participate in the Plan 30 days after their date of hire. The net assets of the Plan, excluding notes receivable from participants, are held in the Elevance Health Defined Contribution Master Trust (the "EH Master Trust"). Fidelity Management Trust Company serves as the trustee for the EH Master Trust and Fidelity Workplace Services LLC serves as the recordkeeper (collectively, "Fidelity"). The Plan Sponsor is ATH Holding Company, LLC, a wholly owned subsidiary of Elevance Health. The Retirement Committee of ATH Holding Company, LLC is the Plan Administrator.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Participant Accounts&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;An individual account is maintained by the Plan for each eligible employee who participates in the Plan.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Each participant&#x2019;s account is credited with the participant&#x2019;s contributions, rollover contributions, allocations of the Plan Sponsor&#x2019;s contributions, and an allocation of investment earnings or losses, reduced by participant withdrawals and certain administrative expenses. The benefit to which a participant is entitled is the benefit that can be provided from the participant&#x2019;s account.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Contributions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Participants may make voluntary contributions of 1% to 80% of eligible compensation, as defined in the Plan document, subject to limitations imposed by applicable Internal Revenue Service (&#x201c;IRS&#x201d;) regulations. Participants may make pretax contributions to a traditional 401(k) account, after-tax contributions to a Roth 401(k) account or a combination of the two through automatic payroll deduction. Participants are automatically enrolled in the Plan at an initial pretax deferral rate of 6%, with an annual automatic increase of the rate of 1%, up to 15% of the participant's eligible compensation, unless the participant directs otherwise.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Plan Sponsor provides a matching contribution of 100% on the first 4% of the participant's eligible compensation, plus 50% of the next 2% of the participant's eligible compensation contributed, for a total potential Plan Sponsor matching contribution of 5%. Additionally, the Plan provides for a true-up matching contribution to ensure that eligible participants who elected to contribute the maximum contribution allowed by the Plan receive the maximum matching contribution of eligible compensation determined as of the end of the plan year. The Plan permits additional Plan Sponsor discretionary contributions to be made, but no such discretionary contributions were made during the 2025 plan year. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Participants who attain age 50 by the end of the plan year may contribute additional "catch up" contributions to their account beyond the regular annual IRS limit, in accordance with applicable law and the Plan's terms. Catch-up contributions are eligible for matching contributions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Rollover Contributions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Plan may accept rollover contributions. Rollover contributions represent distributions received from other qualified retirement plans, as defined in Section 401(a)(31)(E) of the Internal Revenue Code (the "Code"), including &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;any such distributions contributed via a "conduit" individual retirement account. Distributions from other plans are subject to certain conditions to be eligible for rollover into the Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Vesting&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Participants have a 100% vested interest in the Plan Sponsor match after completing a two-year period of service. Nonvested account balances of terminated employees are forfeited (subject to reinstatement upon reemployment as required by applicable law and the Plan's terms).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Investments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Participants direct their elective contributions and employer matching contributions into various investment options offered by the Plan, including target date funds, several mutual and collective investment trust funds, all of which are subject to change from time to time by the Plan Administrator, and the Elevance Health Stock Fund, which is provided for in the Plan document and overseen by an independent fiduciary. The Plan also provides access to a self-directed brokerage option. If a participant has not elected an investment option, their contributions will automatically be invested in the Plan&#x2019;s qualified default investment alternative, which is the target date fund aligned with the year the participant turns 65.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Elevance Health Stock Fund is a unitized fund, which means participants do not actually own shares of Elevance Health common stock but rather own an interest in the unitized fund. A portion of the fund may be invested in short-term reserves to accommodate daily transactions. Investment in the Elevance Health Stock Fund is limited to no more than 20% of a participant's total account balance. Each participant is entitled to exercise voting rights attributable to the shares allocated to his or her account. Any cash dividends paid to the participant&#x2019;s account will be reinvested in the Elevance Health Stock Fund unless the participant elects to receive the dividend in cash paid directly to the participant. Participants may change their election to receive dividends in cash or to reinvest dividends at least quarterly. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Benefit Payments and Withdrawals&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A participant may make a withdrawal of voluntary after-tax contributions made to a traditional 401(k) account prior to January 1, 2012, or take a qualified distribution of Roth 401(k) contributions, as defined by the IRS, at any time. Additionally, after attaining age 59&#xbd;, a participant may withdraw participant and Plan Sponsor matching contributions for any reason. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Subject to the provisions and conditions specified in the Plan document, an active participant in the Plan may make certain hardship withdrawals of amounts held in the participant&#x2019;s account attributable to the participant&#x2019;s contributions, vested Plan Sponsor matching contributions, rollovers, pre-2006 employer match, and income allocated to the contributions account.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Upon termination of employment, the participant is entitled to receive the fully vested current value of his or her account. If the current value of the vested account is $1,000 or less, the account is paid in a lump-sum payment. If the vested account value is $1,000 or more, but less than $5,000, the account will be rolled over into an individual retirement account unless the participant elects otherwise. If the vested account value is $5,000 or more, the account will remain in the Plan unless the participant elects otherwise. The participant may elect to have the entire portion, if any, of the account held in the Elevance Health Stock Fund paid in whole shares of Elevance Health common stock, with fractional shares and any uninvested funds paid in cash. Distribution of participant accounts must commence by the later of retirement or the latest date permitted under Section 401(a)(9) of the Code, as amended by federal legislation known as the SECURE Act and SECURE 2.0 (including regulatory guidance issued thereunder). Upon death, payments are made to the participant&#x2019;s beneficiary in the form of a lump-sum payment or in installments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Notes Receivable from Participants&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Participants may request a loan not in excess of the lesser of: (1) 50% of the vested account balance, or (2) $50,000, less the highest outstanding loan balance during the preceding year. A participant may not have more than two loans outstanding at any one time and must wait 30 days from when a loan is paid off before requesting a new loan. Repayment of loans shall not exceed five years except for loans used to acquire the participant&#x2019;s principal residence. Each loan bears interest in accordance with the Plan's loan policy and applicable regulations. Repayments are made by payroll deduction or remitted directly to Fidelity. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Forfeitures and Certain Plan Expenses&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Forfeited nonvested account balances totaled $3,875,557 and $506,167 as of December 31, 2025 and 2024, respectively. Forfeitures may be used to offset employer contributions or to pay certain administrative expenses, as determined by the Plan Sponsor. During the year ended December&#160;31, 2025, forfeitures of $6,093,646 were used to offset employer contributions and forfeitures of $73,579 were used to pay Plan administrative expenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, Fidelity maintains, on behalf of the Plan, a&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;plan revenue credit account in connection with net float earnings received from certain investment managers and amounts (if any) owed by Fidelity with respect to performance guarantees under the recordkeeping agreement.&lt;/span&gt;&lt;span style="color:#ff0000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the plan year ended December&#160;31, 2025,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the plan&lt;/span&gt;&lt;span style="color:#e97132;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;revenue credit account was used to pay Plan administrative expenses totaling $360,106.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Plan Termination&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Although it has not expressed any intent to do so, the Plan Sponsor has the right to terminate the Plan subject to the terms of the Plan and the provisions of ERISA. In the event the Plan is terminated, each participant&#x2019;s account shall be non-forfeitable with respect to both the participant&#x2019;s and the Plan Sponsor&#x2019;s contributions. The Plan Sponsor has the right to amend the Plan or to suspend matching contributions to the Plan at any time, either permanently or temporarily, for any length of time.&lt;/span&gt;&lt;/div&gt;</us-gaap-ebp:EmployeeBenefitPlanDescriptionOfPlanTextBlock>
    <elv:EBPEligibilityServicePeriod contextRef="c-1" id="f-39">P30D</elv:EBPEligibilityServicePeriod>
    <elv:EBPParticipantContributionEligibleCompensationPercentage contextRef="c-5" decimals="2" id="f-40" unitRef="number">0.01</elv:EBPParticipantContributionEligibleCompensationPercentage>
    <elv:EBPParticipantContributionEligibleCompensationPercentage contextRef="c-6" decimals="2" id="f-41" unitRef="number">0.80</elv:EBPParticipantContributionEligibleCompensationPercentage>
    <us-gaap-ebp:EmployeeBenefitPlanParticipantContributionAutomaticDeferralRate contextRef="c-1" decimals="2" id="f-42" unitRef="number">0.06</us-gaap-ebp:EmployeeBenefitPlanParticipantContributionAutomaticDeferralRate>
    <elv:EBPParticipantContributionIncrementalIncreaseOfAutomaticAnnualEscalation contextRef="c-1" decimals="2" id="f-43" unitRef="number">0.01</elv:EBPParticipantContributionIncrementalIncreaseOfAutomaticAnnualEscalation>
    <elv:EBPParticipantContributionCapOfAutomaticAnnualEscalation contextRef="c-1" decimals="2" id="f-44" unitRef="number">0.15</elv:EBPParticipantContributionCapOfAutomaticAnnualEscalation>
    <us-gaap-ebp:EmployeeBenefitPlanEmployerContributionMatchingPercentage contextRef="c-7" decimals="2" id="f-45" unitRef="number">1</us-gaap-ebp:EmployeeBenefitPlanEmployerContributionMatchingPercentage>
    <us-gaap-ebp:EmployeeBenefitPlanEmployerContributionParticipantCompensationMatchedPercentage contextRef="c-7" decimals="2" id="f-46" unitRef="number">0.04</us-gaap-ebp:EmployeeBenefitPlanEmployerContributionParticipantCompensationMatchedPercentage>
    <us-gaap-ebp:EmployeeBenefitPlanEmployerContributionMatchingPercentage contextRef="c-8" decimals="2" id="f-47" unitRef="number">0.50</us-gaap-ebp:EmployeeBenefitPlanEmployerContributionMatchingPercentage>
    <us-gaap-ebp:EmployeeBenefitPlanEmployerContributionParticipantCompensationMatchedPercentage contextRef="c-8" decimals="2" id="f-48" unitRef="number">0.02</us-gaap-ebp:EmployeeBenefitPlanEmployerContributionParticipantCompensationMatchedPercentage>
    <us-gaap-ebp:EmployeeBenefitPlanEmployerContributionParticipantCompensationMatchedPercentage contextRef="c-1" decimals="2" id="f-49" unitRef="number">0.05</us-gaap-ebp:EmployeeBenefitPlanEmployerContributionParticipantCompensationMatchedPercentage>
    <elv:EBPParticipantCatchUpContributionMinimumAge contextRef="c-1" decimals="0" id="f-50" unitRef="number">50</elv:EBPParticipantCatchUpContributionMinimumAge>
    <elv:EBPEmployerContributionVestingPercentage contextRef="c-1" decimals="2" id="f-51" unitRef="number">1</elv:EBPEmployerContributionVestingPercentage>
    <elv:EBPEmployerContributionVestingPeriod contextRef="c-1" id="f-52">P2Y</elv:EBPEmployerContributionVestingPeriod>
    <elv:EBPParticipantContributionMaximumContributionToEmployeeStockPlan contextRef="c-1" decimals="2" id="f-53" unitRef="number">0.20</elv:EBPParticipantContributionMaximumContributionToEmployeeStockPlan>
    <elv:EBPAutomaticDistributionToParticipantThreshold contextRef="c-3" decimals="0" id="f-54" unitRef="usd">1000</elv:EBPAutomaticDistributionToParticipantThreshold>
    <elv:EBPDistributionOfAccountBalanceRolledIntoIRAThreshold contextRef="c-9" decimals="0" id="f-55" unitRef="usd">1000</elv:EBPDistributionOfAccountBalanceRolledIntoIRAThreshold>
    <elv:EBPDistributionOfAccountBalanceRolledIntoIRAThreshold contextRef="c-10" decimals="0" id="f-56" unitRef="usd">5000</elv:EBPDistributionOfAccountBalanceRolledIntoIRAThreshold>
    <elv:EBPDistributionOfAccountBalanceStaysInPlanThreshold contextRef="c-3" decimals="0" id="f-57" unitRef="usd">5000</elv:EBPDistributionOfAccountBalanceStaysInPlanThreshold>
    <us-gaap-ebp:EmployeeBenefitPlanNoteReceivableFromParticipantAccountMaximumBorrowingToTotalAccountPercentage contextRef="c-3" decimals="2" id="f-58" unitRef="number">0.50</us-gaap-ebp:EmployeeBenefitPlanNoteReceivableFromParticipantAccountMaximumBorrowingToTotalAccountPercentage>
    <us-gaap-ebp:EmployeeBenefitPlanNoteReceivableFromParticipantAccountMaximumBorrowingAmount contextRef="c-3" decimals="0" id="f-59" unitRef="usd">50000</us-gaap-ebp:EmployeeBenefitPlanNoteReceivableFromParticipantAccountMaximumBorrowingAmount>
    <elv:EBPNoteReceivableFromParticipantGeneralLoanTerm contextRef="c-1" id="f-60">P5Y</elv:EBPNoteReceivableFromParticipantGeneralLoanTerm>
    <us-gaap-ebp:EmployeeBenefitPlanForfeitedNonvestedAccount contextRef="c-3" decimals="0" id="f-61" unitRef="usd">3875557</us-gaap-ebp:EmployeeBenefitPlanForfeitedNonvestedAccount>
    <us-gaap-ebp:EmployeeBenefitPlanForfeitedNonvestedAccount contextRef="c-4" decimals="0" id="f-62" unitRef="usd">506167</us-gaap-ebp:EmployeeBenefitPlanForfeitedNonvestedAccount>
    <us-gaap-ebp:EmployeeBenefitPlanForfeitedNonvestedAccountDecreaseForEmployerContribution contextRef="c-1" decimals="0" id="f-63" unitRef="usd">6093646</us-gaap-ebp:EmployeeBenefitPlanForfeitedNonvestedAccountDecreaseForEmployerContribution>
    <us-gaap-ebp:EmployeeBenefitPlanForfeitedNonvestedAccountDecreaseForAdministrativeExpense contextRef="c-1" decimals="0" id="f-64" unitRef="usd">73579</us-gaap-ebp:EmployeeBenefitPlanForfeitedNonvestedAccountDecreaseForAdministrativeExpense>
    <elv:EBPPlanRevenueCreditAccountDecreaseFromAdministrativeExpense contextRef="c-1" decimals="0" id="f-65" unitRef="usd">360106</elv:EBPPlanRevenueCreditAccountDecreaseFromAdministrativeExpense>
    <us-gaap-ebp:EmployeeBenefitPlanSummaryOfAccountingPolicyTextBlock contextRef="c-1" id="f-66">&lt;div style="margin-bottom:9pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2. Significant Accounting Policies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying financial statements of the Plan have been prepared on the accrual basis of accounting and are in conformity with U.S. generally accepted accounting principles (&#x201c;GAAP&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in accordance with GAAP requires the use of estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results may differ from those estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Investment Valuation and Income Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The EH Master Trust's investments are stated at fair value. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. See Note&#160;4, "Fair Value Measurements", for further discussion.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Plan's interest in the net investment income of the EH Master Trust consists of the Plan's allocation of realized gains and losses on investments that were sold during the period, unrealized appreciation and depreciation of the underlying investments held at year end, and net investment income/loss based upon the total of each Plan participant's share of the EH Master Trust.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Purchases and sales of securities are recorded on a trade-date basis and interest income is recorded on the accrual basis. Dividends are recorded on the ex-dividend date. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Investment securities are exposed to various risks, such as interest rate, market, and credit risks. Due to the level of risk associated with certain investment securities, it is reasonably possible that changes in the values of investment securities will occur in the near term and that such changes could materially affect the amounts reported in the statements of net assets available for benefits, participant accounts and the statement of changes in net assets available for benefits.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Notes Receivable from Participants&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Notes receivable from participants represent participant loans that are recorded at their unpaid principal balance plus any accrued but unpaid interest. Interest income on notes receivable from participants is recorded when it is earned. Related fees are recorded as administrative expenses and are expensed when they are incurred. Delinquent participant loans are recorded as distributions based on the terms of the Plan document. No allowance for credit losses has been recorded as of December&#160;31, 2025 or 2024. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Benefits Paid to Participants&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Benefit payments to participants are recorded upon distribution.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Administrative Expenses&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain administrative expenses of maintaining the Plan are paid from Plan assets. The Plan Sponsor may bear certain costs associated with administering the Plan; these costs are not included in the accompanying financial statements and constitute exempt party-in-interest transactions. Certain transaction fees, such as those related to loan processing, are paid from individual participant accounts and are included in administrative expenses. Investment related expenses are included in the Plan's interest in EH Master Trust net investment income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There have been no recently adopted or issued accounting standards that had, or will have, a material impact on the financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap-ebp:EmployeeBenefitPlanSummaryOfAccountingPolicyTextBlock>
    <us-gaap-ebp:EmployeeBenefitPlanBasisOfAccountingPolicyTextBlock contextRef="c-1" id="f-67">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying financial statements of the Plan have been prepared on the accrual basis of accounting and are in conformity with U.S. generally accepted accounting principles (&#x201c;GAAP&#x201d;).&lt;/span&gt;&lt;/div&gt;</us-gaap-ebp:EmployeeBenefitPlanBasisOfAccountingPolicyTextBlock>
    <us-gaap-ebp:EmployeeBenefitPlanUseOfEstimatePolicyTextBlock contextRef="c-1" id="f-68">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in accordance with GAAP requires the use of estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results may differ from those estimates.&lt;/span&gt;&lt;/div&gt;</us-gaap-ebp:EmployeeBenefitPlanUseOfEstimatePolicyTextBlock>
    <us-gaap-ebp:EmployeeBenefitPlanInvestmentPolicyTextBlock contextRef="c-1" id="f-69">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Investment Valuation and Income Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The EH Master Trust's investments are stated at fair value. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. See Note&#160;4, "Fair Value Measurements", for further discussion.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Plan's interest in the net investment income of the EH Master Trust consists of the Plan's allocation of realized gains and losses on investments that were sold during the period, unrealized appreciation and depreciation of the underlying investments held at year end, and net investment income/loss based upon the total of each Plan participant's share of the EH Master Trust.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Purchases and sales of securities are recorded on a trade-date basis and interest income is recorded on the accrual basis. Dividends are recorded on the ex-dividend date. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Investment securities are exposed to various risks, such as interest rate, market, and credit risks. Due to the level of risk associated with certain investment securities, it is reasonably possible that changes in the values of investment securities will occur in the near term and that such changes could materially affect the amounts reported in the statements of net assets available for benefits, participant accounts and the statement of changes in net assets available for benefits.&lt;/span&gt;&lt;/div&gt;</us-gaap-ebp:EmployeeBenefitPlanInvestmentPolicyTextBlock>
    <us-gaap-ebp:EmployeeBenefitPlanNoteReceivableFromParticipantPolicyTextBlock contextRef="c-1" id="f-70">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Notes Receivable from Participants&lt;/span&gt;&lt;/div&gt;Notes receivable from participants represent participant loans that are recorded at their unpaid principal balance plus any accrued but unpaid interest. Interest income on notes receivable from participants is recorded when it is earned. Related fees are recorded as administrative expenses and are expensed when they are incurred. Delinquent participant loans are recorded as distributions based on the terms of the Plan document. No allowance for credit losses has been recorded as of December&#160;31, 2025 or 2024.</us-gaap-ebp:EmployeeBenefitPlanNoteReceivableFromParticipantPolicyTextBlock>
    <us-gaap-ebp:EmployeeBenefitPlanPaymentToParticipantPolicyTextBlock contextRef="c-1" id="f-71">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Benefits Paid to Participants&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Benefit payments to participants are recorded upon distribution.&lt;/span&gt;&lt;/div&gt;</us-gaap-ebp:EmployeeBenefitPlanPaymentToParticipantPolicyTextBlock>
    <us-gaap-ebp:EmployeeBenefitPlanExpensePolicyTextBlock contextRef="c-1" id="f-72">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Administrative Expenses&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain administrative expenses of maintaining the Plan are paid from Plan assets. The Plan Sponsor may bear certain costs associated with administering the Plan; these costs are not included in the accompanying financial statements and constitute exempt party-in-interest transactions. Certain transaction fees, such as those related to loan processing, are paid from individual participant accounts and are included in administrative expenses. Investment related expenses are included in the Plan's interest in EH Master Trust net investment income.&lt;/span&gt;&lt;/div&gt;</us-gaap-ebp:EmployeeBenefitPlanExpensePolicyTextBlock>
    <elv:EBPAccountingPolicyAdoptionPolicyTextBlock contextRef="c-1" id="f-73">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There have been no recently adopted or issued accounting standards that had, or will have, a material impact on the financial statements.&lt;/span&gt;&lt;/div&gt;</elv:EBPAccountingPolicyAdoptionPolicyTextBlock>
    <us-gaap-ebp:EmployeeBenefitPlanMasterTrustTextBlock contextRef="c-1" id="f-74">&lt;div style="margin-bottom:9pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;3. Plan's Interest in EH Master Trust&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Elevance Health Defined Contribution Master Trust was established on January 1, 2024 pursuant to a trust agreement between the Plan Administrator and Fidelity in order to facilitate the administration of transactions in certain investment options offered in both this Plan and the Elevance Health Puerto Rico Retirement Savings Plan (together, the "Participating Plans"). Each Participating Plan has a divided interest in specific investment assets held in the EH Master Trust. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the net assets of the EH Master Trust and the Plan's interest in the net assets of the EH Master Trust as of December&#160;31, 2025 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:2.188%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:30.747%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.596%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.664%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.436%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.664%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.436%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.664%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.436%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.669%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;EH Master Trust Balances&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Plan's Interest in EH Master Trust Balances&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;EH Master Trust Balances&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Plan's Interest in EH Master Trust Balances&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments at fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Collective investment trusts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$12,095,039,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$12,093,468,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$10,874,772,817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$10,873,336,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Elevance Health common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;352,309,761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;352,194,754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;408,045,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;408,004,931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mutual funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;302,657,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;302,656,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;329,248,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;329,247,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Self-directed brokerage accounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;316,803,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;316,803,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250,803,504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250,803,504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total investments at fair value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,066,810,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,065,123,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,862,869,563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,861,392,588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets (liabilities)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(64,169)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(64,148)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37,723)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37,719)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total net assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$13,066,746,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$13,065,058,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$11,862,831,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$11,861,354,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December&#160;31, 2025, the EH Master Trust net investment income was comprised of the following:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:82.874%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.926%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;EH Master Trust Balances&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net appreciation in fair value of investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1,774,360,282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest and dividends&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,516,628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total EH Master Trust net investment income&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1,817,876,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap-ebp:EmployeeBenefitPlanMasterTrustTextBlock>
    <us-gaap-ebp:EmployeeBenefitPlanMasterTrustTableTextBlock contextRef="c-1" id="f-75">&lt;div style="margin-bottom:9pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the net assets of the EH Master Trust and the Plan's interest in the net assets of the EH Master Trust as of December&#160;31, 2025 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:2.188%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:30.747%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.596%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.664%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.436%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.664%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.436%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.664%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.436%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.669%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;EH Master Trust Balances&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Plan's Interest in EH Master Trust Balances&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;EH Master Trust Balances&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Plan's Interest in EH Master Trust Balances&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments at fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Collective investment trusts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$12,095,039,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$12,093,468,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$10,874,772,817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$10,873,336,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Elevance Health common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;352,309,761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;352,194,754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;408,045,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;408,004,931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mutual funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;302,657,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;302,656,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;329,248,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;329,247,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Self-directed brokerage accounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;316,803,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;316,803,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250,803,504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250,803,504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total investments at fair value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,066,810,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,065,123,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,862,869,563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,861,392,588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets (liabilities)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(64,169)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(64,148)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37,723)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37,719)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total net assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$13,066,746,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$13,065,058,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$11,862,831,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$11,861,354,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December&#160;31, 2025, the EH Master Trust net investment income was comprised of the following:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:82.874%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.926%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;EH Master Trust Balances&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net appreciation in fair value of investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1,774,360,282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest and dividends&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,516,628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total EH Master Trust net investment income&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1,817,876,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap-ebp:EmployeeBenefitPlanMasterTrustTableTextBlock>
    <us-gaap-ebp:EmployeeBenefitPlanInvestmentFairValue contextRef="c-11" decimals="0" id="f-76" unitRef="usd">12095039709</us-gaap-ebp:EmployeeBenefitPlanInvestmentFairValue>
    <us-gaap-ebp:EmployeeBenefitPlanInvestmentFairValue contextRef="c-12" decimals="0" id="f-77" unitRef="usd">12093468072</us-gaap-ebp:EmployeeBenefitPlanInvestmentFairValue>
    <us-gaap-ebp:EmployeeBenefitPlanInvestmentFairValue contextRef="c-13" decimals="0" id="f-78" unitRef="usd">10874772817</us-gaap-ebp:EmployeeBenefitPlanInvestmentFairValue>
    <us-gaap-ebp:EmployeeBenefitPlanInvestmentFairValue contextRef="c-14" decimals="0" id="f-79" unitRef="usd">10873336349</us-gaap-ebp:EmployeeBenefitPlanInvestmentFairValue>
    <us-gaap-ebp:EmployeeBenefitPlanInvestmentFairValue contextRef="c-15" decimals="0" id="f-80" unitRef="usd">352309761</us-gaap-ebp:EmployeeBenefitPlanInvestmentFairValue>
    <us-gaap-ebp:EmployeeBenefitPlanInvestmentFairValue contextRef="c-16" decimals="0" id="f-81" unitRef="usd">352194754</us-gaap-ebp:EmployeeBenefitPlanInvestmentFairValue>
    <us-gaap-ebp:EmployeeBenefitPlanInvestmentFairValue contextRef="c-17" decimals="0" id="f-82" unitRef="usd">408045086</us-gaap-ebp:EmployeeBenefitPlanInvestmentFairValue>
    <us-gaap-ebp:EmployeeBenefitPlanInvestmentFairValue contextRef="c-18" decimals="0" id="f-83" unitRef="usd">408004931</us-gaap-ebp:EmployeeBenefitPlanInvestmentFairValue>
    <us-gaap-ebp:EmployeeBenefitPlanInvestmentFairValue contextRef="c-19" decimals="0" id="f-84" unitRef="usd">302657683</us-gaap-ebp:EmployeeBenefitPlanInvestmentFairValue>
    <us-gaap-ebp:EmployeeBenefitPlanInvestmentFairValue contextRef="c-20" decimals="0" id="f-85" unitRef="usd">302656679</us-gaap-ebp:EmployeeBenefitPlanInvestmentFairValue>
    <us-gaap-ebp:EmployeeBenefitPlanInvestmentFairValue contextRef="c-21" decimals="0" id="f-86" unitRef="usd">329248156</us-gaap-ebp:EmployeeBenefitPlanInvestmentFairValue>
    <us-gaap-ebp:EmployeeBenefitPlanInvestmentFairValue contextRef="c-22" decimals="0" id="f-87" unitRef="usd">329247804</us-gaap-ebp:EmployeeBenefitPlanInvestmentFairValue>
    <us-gaap-ebp:EmployeeBenefitPlanInvestmentFairValue contextRef="c-23" decimals="0" id="f-88" unitRef="usd">316803497</us-gaap-ebp:EmployeeBenefitPlanInvestmentFairValue>
    <us-gaap-ebp:EmployeeBenefitPlanInvestmentFairValue contextRef="c-24" decimals="0" id="f-89" unitRef="usd">316803497</us-gaap-ebp:EmployeeBenefitPlanInvestmentFairValue>
    <us-gaap-ebp:EmployeeBenefitPlanInvestmentFairValue contextRef="c-25" decimals="0" id="f-90" unitRef="usd">250803504</us-gaap-ebp:EmployeeBenefitPlanInvestmentFairValue>
    <us-gaap-ebp:EmployeeBenefitPlanInvestmentFairValue contextRef="c-26" decimals="0" id="f-91" unitRef="usd">250803504</us-gaap-ebp:EmployeeBenefitPlanInvestmentFairValue>
    <us-gaap-ebp:EmployeeBenefitPlanInvestmentFairValue contextRef="c-27" decimals="0" id="f-92" unitRef="usd">13066810650</us-gaap-ebp:EmployeeBenefitPlanInvestmentFairValue>
    <us-gaap-ebp:EmployeeBenefitPlanInvestmentFairValue contextRef="c-28" decimals="0" id="f-93" unitRef="usd">13065123002</us-gaap-ebp:EmployeeBenefitPlanInvestmentFairValue>
    <us-gaap-ebp:EmployeeBenefitPlanInvestmentFairValue contextRef="c-29" decimals="0" id="f-94" unitRef="usd">11862869563</us-gaap-ebp:EmployeeBenefitPlanInvestmentFairValue>
    <us-gaap-ebp:EmployeeBenefitPlanInvestmentFairValue contextRef="c-30" decimals="0" id="f-95" unitRef="usd">11861392588</us-gaap-ebp:EmployeeBenefitPlanInvestmentFairValue>
    <us-gaap-ebp:EmployeeBenefitPlanOtherAsset contextRef="c-27" decimals="0" id="f-96" unitRef="usd">-64169</us-gaap-ebp:EmployeeBenefitPlanOtherAsset>
    <us-gaap-ebp:EmployeeBenefitPlanOtherAsset contextRef="c-28" decimals="0" id="f-97" unitRef="usd">-64148</us-gaap-ebp:EmployeeBenefitPlanOtherAsset>
    <us-gaap-ebp:EmployeeBenefitPlanOtherAsset contextRef="c-29" decimals="0" id="f-98" unitRef="usd">-37723</us-gaap-ebp:EmployeeBenefitPlanOtherAsset>
    <us-gaap-ebp:EmployeeBenefitPlanOtherAsset contextRef="c-30" decimals="0" id="f-99" unitRef="usd">-37719</us-gaap-ebp:EmployeeBenefitPlanOtherAsset>
    <us-gaap-ebp:EmployeeBenefitPlanNetAssetAvailableForBenefit contextRef="c-27" decimals="0" id="f-100" unitRef="usd">13066746481</us-gaap-ebp:EmployeeBenefitPlanNetAssetAvailableForBenefit>
    <us-gaap-ebp:EmployeeBenefitPlanNetAssetAvailableForBenefit contextRef="c-28" decimals="0" id="f-101" unitRef="usd">13065058854</us-gaap-ebp:EmployeeBenefitPlanNetAssetAvailableForBenefit>
    <us-gaap-ebp:EmployeeBenefitPlanNetAssetAvailableForBenefit contextRef="c-29" decimals="0" id="f-102" unitRef="usd">11862831840</us-gaap-ebp:EmployeeBenefitPlanNetAssetAvailableForBenefit>
    <us-gaap-ebp:EmployeeBenefitPlanNetAssetAvailableForBenefit contextRef="c-30" decimals="0" id="f-103" unitRef="usd">11861354869</us-gaap-ebp:EmployeeBenefitPlanNetAssetAvailableForBenefit>
    <us-gaap-ebp:EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForGainLossOnInvestment contextRef="c-1" decimals="0" id="f-104" unitRef="usd">1774360282</us-gaap-ebp:EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForGainLossOnInvestment>
    <us-gaap-ebp:EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForInterestAndDividendIncomeOnInvestment contextRef="c-1" decimals="0" id="f-105" unitRef="usd">43516628</us-gaap-ebp:EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForInterestAndDividendIncomeOnInvestment>
    <us-gaap-ebp:EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForIncomeLossOnInvestment contextRef="c-1" decimals="0" id="f-106" unitRef="usd">1817876910</us-gaap-ebp:EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecreaseForIncomeLossOnInvestment>
    <us-gaap-ebp:EmployeeBenefitPlanInvestmentFairValueAndNavTextBlock contextRef="c-1" id="f-107">&lt;div style="margin-bottom:9pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;4. Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The framework for measuring fair value provides a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. Level inputs, as defined by the Financial Accounting Standards Board guidance for fair value measurements and disclosures, are as follows: Level 1, inputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date; Level 2, inputs other than quoted prices included in Level 1 that are observable for the asset or liability through corroboration with market data; and Level 3, unobservable inputs that reflect management's best estimate of what market participants would use in pricing the asset or liability. Assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following methods and assumptions were used to determine the fair value of investments recorded at fair value in the statements of net assets available for benefits.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Elevance Health common stock: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Valued at the closing price on the New York Stock Exchange on the last business day of the plan year.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Mutual funds:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Valued at quoted market prices, which represent net asset value ("NAV") of shares held by the Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Self-directed brokerage accounts: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The self-directed brokerage account allows participants the opportunity to invest in a wide array of individual securities including stocks, mutual funds, exchange-traded funds, unit investment trusts, corporate bonds, U.S. Treasury securities, and certificates of deposits, which are primarily valued using quoted prices in active markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Collective investment trusts (CITs):&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Valued based on the NAV of the units of a collective trust. The NAV, as provided by the trustee, is used as a practical expedient to estimate fair value. The NAV is based on the fair value of the underlying investments held by the trust less its liabilities. There are no restrictions on redemptions from the CITs and no unfunded commitments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth by level within the fair value hierarchy a summary of the EH Master Trust investments by general types measured at fair value on a recurring basis as of December&#160;31, 2025:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:33.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.723%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.765%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:2.203%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.723%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.723%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.845%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Elevance Health common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;352,309,761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;352,309,761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mutual funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;302,657,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;302,657,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Self-directed brokerage accounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;316,803,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;312,048,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,544,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments measured at fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;971,770,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;967,015,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,544,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments measured at NAV&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,095,039,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total investments at fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,066,810,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth by level within the fair value hierarchy a summary of the EH Master Trust investments by general types measured at fair value on a recurring basis as of December&#160;31, 2024:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.198%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:32.987%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.738%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.893%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.577%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.954%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.738%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.954%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.959%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Elevance Health common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;408,045,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;408,045,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mutual funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;329,248,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;329,248,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Self-directed brokerage accounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250,803,504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246,848,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,920,987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,041&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments measured at fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;988,096,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;984,141,718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,920,987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,041&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments measured at NAV&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,874,772,817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total investments at fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,862,869,563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our Level 3 securities as of December&#160;31, 2025 and December&#160;31, 2024 primarily consisted of certain corporate fixed maturity securities for which observable inputs were not always available. The fair values of these securities were estimated using inputs including, but not limited to, credit spreads, default rates and benchmark yields. There were no material transfers in or out of Level 3 during either the year ended December&#160;31, 2025 or the year ended  December&#160;31, 2024.&lt;/span&gt;&lt;/div&gt;</us-gaap-ebp:EmployeeBenefitPlanInvestmentFairValueAndNavTextBlock>
    <us-gaap-ebp:EmployeeBenefitPlanInvestmentFairValueAndNavTableTextBlock contextRef="c-1" id="f-108">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth by level within the fair value hierarchy a summary of the EH Master Trust investments by general types measured at fair value on a recurring basis as of December&#160;31, 2025:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:33.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.723%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.765%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:2.203%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.723%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.723%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.845%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Elevance Health common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;352,309,761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;352,309,761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mutual funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;302,657,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;302,657,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Self-directed brokerage accounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;316,803,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;312,048,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,544,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments measured at fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;971,770,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;967,015,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,544,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments measured at NAV&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,095,039,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total investments at fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,066,810,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth by level within the fair value hierarchy a summary of the EH Master Trust investments by general types measured at fair value on a recurring basis as of December&#160;31, 2024:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.198%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:32.987%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.738%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.893%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.577%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.954%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.738%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.954%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.959%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Elevance Health common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;408,045,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;408,045,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mutual funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;329,248,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;329,248,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Self-directed brokerage accounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250,803,504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246,848,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,920,987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,041&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments measured at fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;988,096,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;984,141,718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,920,987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,041&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments measured at NAV&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,874,772,817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total investments at fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,862,869,563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap-ebp:EmployeeBenefitPlanInvestmentFairValueAndNavTableTextBlock>
    <us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue contextRef="c-31" decimals="0" id="f-109" unitRef="usd">352309761</us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue>
    <us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue contextRef="c-32" decimals="0" id="f-110" unitRef="usd">352309761</us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue>
    <us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue contextRef="c-33" decimals="0" id="f-111" unitRef="usd">0</us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue>
    <us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue contextRef="c-34" decimals="0" id="f-112" unitRef="usd">0</us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue>
    <us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue contextRef="c-35" decimals="0" id="f-113" unitRef="usd">302657683</us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue>
    <us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue contextRef="c-36" decimals="0" id="f-114" unitRef="usd">302657683</us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue>
    <us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue contextRef="c-37" decimals="0" id="f-115" unitRef="usd">0</us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue>
    <us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue contextRef="c-38" decimals="0" id="f-116" unitRef="usd">0</us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue>
    <us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue contextRef="c-39" decimals="0" id="f-117" unitRef="usd">316803497</us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue>
    <us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue contextRef="c-40" decimals="0" id="f-118" unitRef="usd">312048032</us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue>
    <us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue contextRef="c-41" decimals="0" id="f-119" unitRef="usd">4544392</us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue>
    <us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue contextRef="c-42" decimals="0" id="f-120" unitRef="usd">211073</us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue>
    <us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue contextRef="c-43" decimals="0" id="f-121" unitRef="usd">971770941</us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue>
    <us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue contextRef="c-44" decimals="0" id="f-122" unitRef="usd">967015476</us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue>
    <us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue contextRef="c-45" decimals="0" id="f-123" unitRef="usd">4544392</us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue>
    <us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue contextRef="c-46" decimals="0" id="f-124" unitRef="usd">211073</us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue>
    <us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue contextRef="c-47" decimals="0" id="f-125" unitRef="usd">12095039709</us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue>
    <us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue contextRef="c-3" decimals="0" id="f-126" unitRef="usd">13066810650</us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue>
    <us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue contextRef="c-48" decimals="0" id="f-127" unitRef="usd">408045086</us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue>
    <us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue contextRef="c-49" decimals="0" id="f-128" unitRef="usd">408045086</us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue>
    <us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue contextRef="c-50" decimals="0" id="f-129" unitRef="usd">0</us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue>
    <us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue contextRef="c-51" decimals="0" id="f-130" unitRef="usd">0</us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue>
    <us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue contextRef="c-52" decimals="0" id="f-131" unitRef="usd">329248156</us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue>
    <us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue contextRef="c-53" decimals="0" id="f-132" unitRef="usd">329248156</us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue>
    <us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue contextRef="c-54" decimals="0" id="f-133" unitRef="usd">0</us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue>
    <us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue contextRef="c-55" decimals="0" id="f-134" unitRef="usd">0</us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue>
    <us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue contextRef="c-56" decimals="0" id="f-135" unitRef="usd">250803504</us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue>
    <us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue contextRef="c-57" decimals="0" id="f-136" unitRef="usd">246848476</us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue>
    <us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue contextRef="c-58" decimals="0" id="f-137" unitRef="usd">3920987</us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue>
    <us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue contextRef="c-59" decimals="0" id="f-138" unitRef="usd">34041</us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue>
    <us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue contextRef="c-60" decimals="0" id="f-139" unitRef="usd">988096746</us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue>
    <us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue contextRef="c-61" decimals="0" id="f-140" unitRef="usd">984141718</us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue>
    <us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue contextRef="c-62" decimals="0" id="f-141" unitRef="usd">3920987</us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue>
    <us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue contextRef="c-63" decimals="0" id="f-142" unitRef="usd">34041</us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue>
    <us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue contextRef="c-64" decimals="0" id="f-143" unitRef="usd">10874772817</us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue>
    <us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue contextRef="c-4" decimals="0" id="f-144" unitRef="usd">11862869563</us-gaap-ebp:EmployeeBenefitPlanInvestmentExcludingPlanInterestInMasterTrustFairValue>
    <us-gaap-ebp:EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsTextBlock contextRef="c-1" id="f-145">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;5. Exempt Related Party and Party-In-Interest Transactions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Parties-in-interest are defined under Department of Labor regulations as any fiduciary of the Plan, any party rendering services to the Plan, the employer, and certain others. Certain administrative functions are performed by officers and employees of the Plan Sponsor or affiliates of the Plan Sponsor. No such officer or employee is compensated from the Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December&#160;31, 2025, the Plan reimbursed the Plan Sponsor $59,943 for administrative expenses. This reimbursement is included in administrative expenses in the statement of changes in net assets available for benefits.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Transactions in shares of Elevance Health common stock qualify as exempt party-in-interest transactions under the provisions of ERISA. The Plan owned approximately 1,004,692 and 1,105,902 shares of Elevance Health common stock as of December&#160;31, 2025 and 2024, respectively. During the year ended December&#160;31, 2025, the Plan had net sales of Elevance Health common stock totaling $38,322,881 and the total dividends on Elevance Health common stock in the Elevance Health Stock Fund were $7,148,373.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain Plan investments include funds that are managed by affiliates of Fidelity, which constitute party-in-interest transactions. In addition, certain investments in the self-directed brokerage accounts are issued by Fidelity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Notes receivable from participants also reflect exempt party-in-interest transactions.&lt;/span&gt;&lt;/div&gt;</us-gaap-ebp:EmployeeBenefitPlanRelatedPartyAndPartyInInterestTransactionsTextBlock>
    <us-gaap-ebp:EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecreaseForAdministrativeExpense contextRef="c-65" decimals="0" id="f-146" unitRef="usd">59943</us-gaap-ebp:EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitDecreaseForAdministrativeExpense>
    <us-gaap-ebp:EmployeeBenefitPlanInvestmentNumberOfShares contextRef="c-66" decimals="0" id="f-147" unitRef="shares">1004692</us-gaap-ebp:EmployeeBenefitPlanInvestmentNumberOfShares>
    <us-gaap-ebp:EmployeeBenefitPlanInvestmentNumberOfShares contextRef="c-67" decimals="0" id="f-148" unitRef="shares">1105902</us-gaap-ebp:EmployeeBenefitPlanInvestmentNumberOfShares>
    <us-gaap-ebp:EmployeeBenefitPlanInvestmentNumberOfSharesSold contextRef="c-65" decimals="0" id="f-149" unitRef="shares">38322881</us-gaap-ebp:EmployeeBenefitPlanInvestmentNumberOfSharesSold>
    <us-gaap-ebp:EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForDividendIncomeOnInvestment contextRef="c-65" decimals="0" id="f-150" unitRef="usd">7148373</us-gaap-ebp:EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseForDividendIncomeOnInvestment>
    <us-gaap-ebp:EmployeeBenefitPlanTaxStatusTextBlock contextRef="c-1" id="f-151">&lt;div style="margin-bottom:9pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;6. Income Tax Status&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Plan has received a determination letter from the IRS dated October 24, 2017, stating the Plan is qualified under Section 401(a) of the Code and, therefore, exempt from taxation. Although the Plan has been restated and amended since receiving the determination letter, the Plan Sponsor believes the Plan is designed and being operated in compliance with the applicable requirements of the Code. The Plan's EH Master Trust is intended to be considered as an organization as described in Section 401(a) of the Code and exempt under Section 501(a) of the Code. &lt;/span&gt;&lt;/div&gt;GAAP requires Plan management to evaluate tax positions taken by the Plan and recognize a tax liability if the Plan has taken an uncertain tax position that more likely than not would not be sustained upon examination by the IRS. Plan management has analyzed the tax positions taken by the Plan and has concluded there are no uncertain positions taken or expected to be taken. The Plan is subject to routine audits by taxing jurisdictions; however, there are currently no audits for any tax periods in progress.</us-gaap-ebp:EmployeeBenefitPlanTaxStatusTextBlock>
    <us-gaap-ebp:EmployeeBenefitPlanReconciliationToForm5500TextBlock contextRef="c-1" id="f-152">&lt;div style="margin-bottom:9pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;7. Reconciliation to Form 5500&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Reconciliation of net assets available for benefits per the financial statements to the Form 5500 as of December&#160;31, 2025 and 2024, is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:66.047%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.925%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.927%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net assets available for benefits per the financial statements&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,312,912,847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,110,585,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: deemed distributions of participant loans&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;776,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;721,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net assets available for benefits per the Form 5500&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,312,136,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,109,864,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Reconciliation of the increase in net assets available for benefits per the financial statements to the net income (loss) per the Form 5500 for the year ended December&#160;31, 2025 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:82.874%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.926%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase in net assets available for benefits per the financial statements&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,202,327,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deemed distributions of participant loans activity&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55,249)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss) per the Form 5500&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,202,272,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap-ebp:EmployeeBenefitPlanReconciliationToForm5500TextBlock>
    <us-gaap-ebp:EmployeeBenefitPlanReconciliationToForm5500TableTextBlock contextRef="c-1" id="f-153">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Reconciliation of net assets available for benefits per the financial statements to the Form 5500 as of December&#160;31, 2025 and 2024, is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:66.047%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.925%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.927%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net assets available for benefits per the financial statements&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,312,912,847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,110,585,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: deemed distributions of participant loans&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;776,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;721,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net assets available for benefits per the Form 5500&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,312,136,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,109,864,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Reconciliation of the increase in net assets available for benefits per the financial statements to the net income (loss) per the Form 5500 for the year ended December&#160;31, 2025 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:82.874%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.926%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase in net assets available for benefits per the financial statements&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,202,327,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deemed distributions of participant loans activity&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55,249)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss) per the Form 5500&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,202,272,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap-ebp:EmployeeBenefitPlanReconciliationToForm5500TableTextBlock>
    <us-gaap-ebp:EmployeeBenefitPlanNetAssetAvailableForBenefit contextRef="c-3" decimals="0" id="f-154" unitRef="usd">13312912847</us-gaap-ebp:EmployeeBenefitPlanNetAssetAvailableForBenefit>
    <us-gaap-ebp:EmployeeBenefitPlanNetAssetAvailableForBenefit contextRef="c-4" decimals="0" id="f-155" unitRef="usd">12110585543</us-gaap-ebp:EmployeeBenefitPlanNetAssetAvailableForBenefit>
    <us-gaap-ebp:EmployeeBenefitPlanReconciliationToForm5500NetAssetAvailableForBenefitDeemedDistribution contextRef="c-3" decimals="0" id="f-156" unitRef="usd">776730</us-gaap-ebp:EmployeeBenefitPlanReconciliationToForm5500NetAssetAvailableForBenefitDeemedDistribution>
    <us-gaap-ebp:EmployeeBenefitPlanReconciliationToForm5500NetAssetAvailableForBenefitDeemedDistribution contextRef="c-4" decimals="0" id="f-157" unitRef="usd">721481</us-gaap-ebp:EmployeeBenefitPlanReconciliationToForm5500NetAssetAvailableForBenefitDeemedDistribution>
    <us-gaap-ebp:EmployeeBenefitPlanForm5500CaptionNetAssetAvailableForBenefit contextRef="c-3" decimals="0" id="f-158" unitRef="usd">13312136117</us-gaap-ebp:EmployeeBenefitPlanForm5500CaptionNetAssetAvailableForBenefit>
    <us-gaap-ebp:EmployeeBenefitPlanForm5500CaptionNetAssetAvailableForBenefit contextRef="c-4" decimals="0" id="f-159" unitRef="usd">12109864062</us-gaap-ebp:EmployeeBenefitPlanForm5500CaptionNetAssetAvailableForBenefit>
    <us-gaap-ebp:EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecrease contextRef="c-1" decimals="0" id="f-160" unitRef="usd">1202327304</us-gaap-ebp:EmployeeBenefitPlanChangeInNetAssetAvailableForBenefitIncreaseDecrease>
    <us-gaap-ebp:EmployeeBenefitPlanReconciliationToForm5500PaymentToParticipantIncreaseDecreaseForDeemedDistribution contextRef="c-1" decimals="0" id="f-161" unitRef="usd">55249</us-gaap-ebp:EmployeeBenefitPlanReconciliationToForm5500PaymentToParticipantIncreaseDecreaseForDeemedDistribution>
    <us-gaap-ebp:EmployeeBenefitPlanForm5500CaptionNetIncomeLoss contextRef="c-1" decimals="0" id="f-162" unitRef="usd">1202272055</us-gaap-ebp:EmployeeBenefitPlanForm5500CaptionNetIncomeLoss>
    <us-gaap-ebp:EmployeeBenefitPlanSubsequentEventTextBlock contextRef="c-1" id="f-163">&lt;div style="margin-bottom:9pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;8. Subsequent Events&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Plan Sponsor has evaluated the impact of subsequent events through June&#160;17, 2026, the date the financial statements were issued. No subsequent events have been recognized or required additional disclosure in the financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap-ebp:EmployeeBenefitPlanSubsequentEventTextBlock>
    <us-gaap-ebp:EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentTableTextBlock contextRef="c-1" id="f-164">&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Elevance Health 401(k) Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Schedule H, Line 4i&#x2014;Schedule of Assets (Held at End of Year)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Plan Sponsor: ATH Holding Company, LLC.     EIN #11-3713086     Plan #003&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:81.805%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:2.125%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.648%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:23.857%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.648%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:22.499%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.200%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:2.125%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.596%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.988%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:5.521%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.479%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.714%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(c)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(d)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(e)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Identity of issuer, borrower,&lt;br/&gt;lessor, or similar party&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Description of&#160;investment including maturity date, &lt;br/&gt;interest rate, collateral and par or maturity value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost**&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Current&lt;br/&gt;value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-168"&gt;JP Morgan&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-169"&gt;Plan's interest in EH Master Trust&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-170"&gt;&#x2014;&lt;/span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,065,058,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Notes receivable from participants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rates range from&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.25%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;to&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237,618,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;maturing at various dates through&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5/26/2045&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap-ebp:EmployeeBenefitPlanScheduleOfAssetHeldForInvestmentTableTextBlock>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-165">11-3713086</dei:EntityTaxIdentificationNumber>
    <us-gaap-ebp:EmployeeBenefitPlanPlanNumber contextRef="c-1" id="f-166">003</us-gaap-ebp:EmployeeBenefitPlanPlanNumber>
    <us-gaap-ebp:EmployeeBenefitPlanAssetHeldForInvestmentPartyInInterest contextRef="c-68" id="f-167">true</us-gaap-ebp:EmployeeBenefitPlanAssetHeldForInvestmentPartyInInterest>
    <us-gaap-ebp:EmployeeBenefitPlanInvestmentPlanInterestInMasterTrustFairValue contextRef="c-3" decimals="0" id="f-171" unitRef="usd">13065058854</us-gaap-ebp:EmployeeBenefitPlanInvestmentPlanInterestInMasterTrustFairValue>
    <us-gaap-ebp:EmployeeBenefitPlanParticipantLoanInterestRate contextRef="c-5" decimals="4" id="f-172" unitRef="number">0.0325</us-gaap-ebp:EmployeeBenefitPlanParticipantLoanInterestRate>
    <us-gaap-ebp:EmployeeBenefitPlanParticipantLoanInterestRate contextRef="c-6" decimals="4" id="f-173" unitRef="number">0.1050</us-gaap-ebp:EmployeeBenefitPlanParticipantLoanInterestRate>
    <us-gaap-ebp:EmployeeBenefitPlanAssetHeldForInvestmentParticipantLoanAfterDeemedDistribution contextRef="c-3" decimals="0" id="f-174" unitRef="usd">237618710</us-gaap-ebp:EmployeeBenefitPlanAssetHeldForInvestmentParticipantLoanAfterDeemedDistribution>
    <us-gaap-ebp:EmployeeBenefitPlanParticipantLoanMaturityDate contextRef="c-6" id="f-175">2045-05-26</us-gaap-ebp:EmployeeBenefitPlanParticipantLoanMaturityDate>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
